case_id	case_submitter_id	external_case_id	diagnosis_id	diagnosis_uuid	status	disease_type	primary_site	consent_type	days_to_consent	ethnicity	gender	race	vital_status	days_to_birth	days_to_death	year_of_birth	year_of_death	age_at_index	premature_at_birth	weeks_gestation_at_birth	age_is_obfuscated	cause_of_death_source	occupation_duration_years	country_of_residence_at_enrollment	age_at_diagnosis	classification_of_tumor	days_to_last_follow_up	days_to_last_known_disease_status	days_to_recurrence	last_known_disease_status	morphology	primary_diagnosis	progression_or_recurrence	site_of_resection_or_biopsy	tissue_or_organ_of_origin	tumor_grade	tumor_stage	tumor_cell_content	tumor_largest_dimension_diameter	prior_malignancy	ajcc_clinical_m	ajcc_clinical_n	ajcc_clinical_stage	ajcc_clinical_t	ajcc_pathologic_m	ajcc_pathologic_n	ajcc_pathologic_stage	ajcc_pathologic_t	ajcc_staging_system_edition	ann_arbor_b_symptoms	ann_arbor_clinical_stage	ann_arbor_extranodal_involvement	ann_arbor_pathologic_stage	best_overall_response	burkitt_lymphoma_clinical_variant	cause_of_death	circumferential_resection_margin	colon_polyps_history	days_to_best_overall_response	days_to_diagnosis	days_to_hiv_diagnosis	days_to_new_event	figo_stage	hiv_positive	hpv_positive_type	hpv_status	iss_stage	laterality	ldh_level_at_diagnosis	ldh_normal_range_upper	lymph_nodes_positive	lymphatic_invasion_present	method_of_diagnosis	new_event_anatomic_site	new_event_type	overall_survival	perineural_invasion_present	prior_treatment	progression_free_survival	progression_free_survival_event	residual_disease	vascular_invasion_present	year_of_diagnosis	icd_10_code	synchronous_malignancy	anaplasia_present	anaplasia_present_type	child_pugh_classification	cog_liver_stage	cog_neuroblastoma_risk_group	cog_renal_stage	cog_rhabdomyosarcoma_risk_group	enneking_msts_grade	enneking_msts_metastasis	enneking_msts_stage	enneking_msts_tumor_site	esophageal_columnar_dysplasia_degree	esophageal_columnar_metaplasia_present	first_symptom_prior_to_diagnosis	gastric_esophageal_junction_involvement	goblet_cells_columnar_mucosa_present	gross_tumor_weight	inpc_grade	inpc_histologic_group	inrg_stage	inss_stage	irs_group	irs_stage	ishak_fibrosis_score	lymph_nodes_tested	medulloblastoma_molecular_classification	metastasis_at_diagnosis	metastasis_at_diagnosis_site	mitosis_karyorrhexis_index	peripancreatic_lymph_nodes_positive	peripancreatic_lymph_nodes_tested	supratentorial_localization	tumor_confined_to_organ_of_origin	tumor_focality	tumor_regression_grade	vascular_invasion_type	wilms_tumor_histologic_subtype	breslow_thickness	gleason_grade_group	igcccg_stage	international_prognostic_index	largest_extrapelvic_peritoneal_focus	masaoka_stage	non_nodal_regional_disease	non_nodal_tumor_deposits	ovarian_specimen_status	ovarian_surface_involvement	percent_tumor_invasion	peritoneal_fluid_cytological_status	primary_gleason_grade	secondary_gleason_grade	weiss_assessment_score	adrenal_hormone	ann_arbor_b_symptoms_described	diagnosis_is_primary_disease	eln_risk_classification	figo_staging_edition_year	gleason_grade_tertiary	gleason_patterns_percent	margin_distance	margins_involved_site	pregnant_at_diagnosis	satellite_nodule_present	sites_of_involvement	tumor_depth	who_cns_grade	who_nte_grade	auxiliary_data	project_name	program_name
0067a0e0-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1911		ff2cb83d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-20144	 	1950	 	 	 	 	 	 	 	 	20144	Not Reported	1293.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIA	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
00cb6713-234c-465c-9c2e-397168bb3bca	93		f65a7b48-0688-437a-af3e-d4fe6efaf18e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	45	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
00dc49de-1fba-11e9-b7f8-0a80fada099c	NCI7-2		7342064a-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
01072f05-118a-11e9-afb9-0a9c39d33490	C3L-00413		0491c8f8-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-21961	 	1956	 	 	 	 	 	 	 	 	21961	Not Reported	1767.00	1767.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
010df72d-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A10A		ff312994-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-15085	 	1966	 	 	 	 	 	 	 	 	15085	Not Reported	1229.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
015815e9-3bfe-4a73-a9a5-6f804dd8ed89	NTN022		d7e08cf1-1d66-40a7-a65a-9d1a5096cfde	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
018f030a-4925-4514-910a-543e226721d8	3219		40cc5f22-0466-4ab7-a00e-80757370a037	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	64	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
01b2691b-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1914		ff2c5b05-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-23850	 	1938	 	 	 	 	 	 	 	 	23850	Not Reported	1722.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
01ba6a03-ac4e-40f8-be7d-179452b1ad88	C3N-01526		3869c05e-54a7-4b30-92b5-aebb444a3815	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	Other	Alive	-24258	 	1950	 	 	 	 	 	 	 	 	24258	 	663.00	663.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0214a752-a1a8-4751-a0f3-7ed1aeb7c82f	AP-HMFR		3f0da56d-30a1-4cb0-8209-95727a3ade74	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24836	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Middle lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
0232701d-6d00-440c-af6c-5899fbbf4142	OSCC_13		90972454-6af2-4704-bb16-c0010829f703	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
024cad7d-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A150		ff30166d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-17580	 	1961	 	 	 	 	 	 	 	 	17580	Not Reported	1935.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
024d00a1-9124-452c-a525-e4a087aab6d5	FP-bridge		9bbd8e66-0d09-4bf4-9c2a-51752403bc7a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Not Reported			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
028bc843-491a-4708-be65-e1ad695e8ee2	MB170		3b109094-c1d3-474e-bd11-c6f82e0bccf7	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	5840	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
02b84fb5-1fba-11e9-b7f8-0a80fada099c	NCI7-3		7577447e-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
02dc17a7-0261-45be-a70e-15189dc6c2dd	16-00479		b0dd93e7-6820-43e2-8532-16d7ea97011a	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Unknown	Dead	-14566	232	 	 	39	 	 	false	Medical Record	 	United States	14566	 	232.00	232.00	 	Tumor free	Not Reported	Therapy-related acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
02dcc58d-656d-49af-a5bc-154bf2e86dee	PDAC233		fef73f86-c343-4b3d-a8ab-57751a5fcf9a	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	 	260.00	260.00	235.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
02f4db2f-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1915		ff2eae98-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-18424	 	1953	 	 	 	 	 	 	 	 	18424	Not Reported	2061.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
02f4f83c-b5e4-4416-9c34-3502900725c9	CU-44		65b427d4-5d2c-4bc7-8429-582cf174fc4f	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	78	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
031977b7-2409-4b98-87cd-63efc023dafc	WHIM IR		00d96c4f-af75-4287-abd5-6f9051897226	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
032d27ba-118a-11e9-afb9-0a9c39d33490	C3L-00449		04991995-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-21705	 	1957	 	 	 	 	 	 	 	 	21705	Not Reported	1749.00	1749.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
033d8be8-274d-4e76-a060-c72386f91096	C3N-03417		bbe8c372-925b-456e-8072-9ca4bccd438c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	3	Not Reported	Female	White	Alive	-24766	 	1950	 	 	 	 	 	 	 	 	24766	 	1432.00	1432.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
038a0679-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A154		ff30aed2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-24999	 	1941	 	 	 	 	 	 	 	 	24999	Not Reported	591.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
03b220ed-d7f9-4873-aa29-f038107198e7	C3N-01657		6b13af53-652d-447c-9e30-bc4c2b0863c1	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	White	Alive	-27232	 	1942	 	 	 	 	 	 	 	 	27232	 	1880.00	1880.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
03d0deb3-78fe-4c6b-b34f-984e2cfb5e33	C3N-02429		44b2789c-18db-4c68-880c-9b584c00c778	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Male	Asian	Alive	-15227	 	1975	 	 	 	 	 	 	 	 	15227	 	1063.00	1063.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
040cb595-4bd9-48da-a20d-b3a329294aa4	C3L-02800		f776ce30-df04-4dc1-9a42-9ce462aa0e1b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	Not Reported	Alive	-22902	 	1955	 	 	 	 	 	 	 	 	22902	 	1099.00	1099.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC1	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
043a5f9d-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1918		ff2e988f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-16689	479	1957	2003	 	 	 	 	 	 	 	16689	Not Reported	479.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
04556aba-1fba-11e9-b7f8-0a80fada099c	NCI7-4		77a10c77-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
045e5a19-36fe-4cff-91e4-04af0e418614	NTN074		8c814152-5879-4b49-9a19-a74f6bc70630	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
04606c9c-ff6f-4acb-a9bd-e0122bf19ee1	C3L-01687		5b39376a-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-28838	376	1938	2018	 	 	 	 	 	 	 	28838	Not Reported	376.00	376.00	259.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	23	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
047d297b-d99f-4f49-9744-11364d047dcf	C3N-01897		3f71b824-9501-4a88-b520-d77a0793be5a	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	3	Not Reported	Male	White	Dead	-20477	494	1961	2018	 	 	 	 	 	 	 	20477	Not Reported	494.00	494.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Pancreas, NOS	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
04aa3d05-75b5-498f-92c8-63c37746f0d2	PDAC082		cff5b01f-6e4c-47c7-97f2-7d275a4d5632	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	 	238.00	238.00	102.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
04c68980-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A158		ff31404e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-15903	 	1966	 	 	 	 	 	 	 	 	15903	Not Reported	450.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1mi	Stage IIA	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
05030046-763c-48d8-b727-100f34c9d6a5	WHIM4		cbc4b41c-32b1-45a3-802e-baa3a9a949a6	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
0515d2dd-3c2d-424d-93b3-14860e228378	C3L-02389		dc66444b-2e76-4f62-bb48-94f5f4d27397	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-61	Not Reported	Female	White	Alive	-24371	 	1950	 	 	 	 	 	 	 	 	24371	 	1188.00	1188.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
05207fb4-ba30-4fc2-ad21-e5610ead7b89	C3L-00982		0eb5abc1-e6e6-4360-b0e0-765e20ac1530	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	10	Not Reported	Male	Other	Alive	-23210	 	1953	 	 	 	 	 	 	 	 	23210	 	294.00	294.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
052c671d-118a-11e9-afb9-0a9c39d33490	C3L-00563		049fba31-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	Asian	Alive	-22777	 	1954	 	 	 	 	 	 	 	 	22777	Not Reported	1785.00	1785.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0578f49d-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1919		ff31860d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-21199	1161	1943	2004	 	 	 	 	 	 	 	21199	Not Reported	1161.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
05c52807-7cd0-415f-844c-8a6b1d0c897b	NX036		3818815a-062f-4eba-809b-1d731bbc5fea	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
05e50d4c-1271-453c-a6c4-39a3565073ef	C3L-01328		5addaee6-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-26268	 	1945	 	 	 	 	 	 	 	 	26268	Not Reported	271.00	271.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0608bb08-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A159		ff30e191-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-18621	 	1959	 	 	 	 	 	 	 	 	18621	Not Reported	762.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
062fdb7f-1fba-11e9-b7f8-0a80fada099c	NCI7-5		79d34d6a-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0640d7cc-de5c-45ca-9335-7a085fcfb0f8	NTN069		53495c53-ec33-4f5d-8687-92fbf4c9a3ad	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
065e375b-3719-4e27-9246-2e80a50f0902	C3N-02337		6b95cb86-7d3e-47e8-9a67-8ff9e9f1c737	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-52	Not Reported	Female	Other	Not Reported	-25527	 	1947	 	 	 	 	 	 	 	 	25527	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0670e9b8-07ff-4b46-b4ac-98b622cc6e87	C3N-02972		035585b9-a52f-490c-891d-d63a710df5a7	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-42	Not Hispanic or Latino	Female	White	Dead	-27311	905	1942	2020	 	 	 	 	 	 	 	27311	 	905.00	905.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
06b79e23-63d8-11e8-bcf1-0a2705229b82	TCGA-61-1995		ff2bdd49-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-16016	 	1966	 	 	 	 	 	 	 	 	16016	Not Reported	61.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
06d18ddd-b386-40af-acd2-6673929d656e	22		4d99a825-45c2-4279-b27e-3b1e9b7e5ecb	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	63	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
06d18ddd-b386-40af-acd2-6673929d656e	22		73a75f74-1818-4603-8a9d-7ea997189327	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	63	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
07209754-7cb3-4ead-bcf8-7fd5e1f3fe9d	C3N-00872		8c61d7ed-25eb-43ed-8348-004161a724d5	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Alive	-27503	 	1941	 	 	 	 	 	 	 	 	27503	 	1736.00	1736.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
07468279-63d9-11e8-bcf1-0a2705229b82	TCGA-E2-A15A		ff305bc0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	alive	-16750	 	1964	 	 	 	 	 	 	 	 	16750	Not Reported	710.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	--	--	 	 	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	--	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0761408b-d4b6-419a-a474-2ce5351a2e4a	C3N-01989		2c178bd7-e495-4998-b050-2e1197ddb17f	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Hispanic or Latino	Female	White	Alive	-25700	 	1947	 	 	 	 	 	 	 	 	25700	 	346.00	346.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0774e352-a193-4c70-8351-11f40108fd03	C3N-02585		5ed2f675-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	-23804	 	1952	 	 	 	 	 	 	 	 	23804	Not Reported	1051.00	1051.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Pancreas, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
07c98976-ad56-4a3a-a255-eda12db5eca7	PDAC135		6b954972-828d-4b91-96b6-c1b5053c47b9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20805	 	930.00	930.00	194.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
07e96995-726b-4b35-8fde-49fa5d6a1758	C3N-00517		5dc94b90-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-25407	1142	1947	2020	 	 	 	 	 	 	 	25407	Not Reported	1142.00	1142.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
07f9368e-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2008		ff2bc65e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Alive	-14791	 	1967	 	 	 	 	 	 	 	 	14791	Not Reported	932.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0809987b-1fba-11e9-b7f8-0a80fada099c	QC1		7bf87559-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
08347a9e-778d-4a6d-9b3f-5a280ac40f9e	PDAC159		afa732cf-aa9b-4d62-a8d2-e11201aa4d5c	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	 	605.00	605.00	605.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
0843167c-f874-4e23-a334-6e5ad7a6c04b	C3L-02953		8f7cd9f5-d17d-499f-b361-a4d2db85b85c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Hispanic or Latino	Female	White	Alive	-20752	 	1960	 	 	 	 	 	 	 	 	20752	 	1725.00	1725.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0848657d-76f9-4dbf-a7c7-f19685365270	MB281		4ca383e2-b970-4646-9b2d-117a3ac6d972	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	4380	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
085aa512-e5af-41f1-bb5f-852fd0c33258	NX020		84923872-9317-43f3-a863-a099684fbf6f	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
086e75d7-3bdc-4dfb-9a0e-ff0da1a29403	MB287		8db5cdd4-ee2c-49e1-8d26-bf8c88639883	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	730	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
087198d9-0eb8-4891-9615-b7363a690dc9	70		5b445088-02b6-46a0-b7e0-b0e75bb912ef	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
087198d9-0eb8-4891-9615-b7363a690dc9	70		989b81c6-8773-4526-a995-bd9495ef4dc5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
088e15dd-a61d-4b2e-959c-9120060a4666	C3L-07035		5d12322e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Male	Unknown	Not Reported	 	 	1951	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0896517a-e471-41dc-b829-582817f6f470	PDAC012		dd0fe7cf-a6c0-4fc7-a086-1637219ffd32	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18615	 	707.00	707.00	328.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
08a154c5-ea51-4f89-810d-3e125a052c1e	QC6		60f20464-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
08e33c2e-86d0-471e-8d4a-4e9b43145a9d	CU-05		c3c25af8-9d49-40fb-b6a7-5757b1098f9b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	36	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0939ac6b-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2087		ff2c6af7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-18182	 	1960	 	 	 	 	 	 	 	 	18182	Not Reported	146.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
094251a9-3970-4f02-bb00-43bce5a6e5d9	MDA-13		643491e9-8683-4937-bacc-aff68fd93eb3	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	32	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
09433645-87bd-4063-9586-2686aba4ed00	JX0052		7aa6a559-ccad-49f3-a6fc-f343921b94d4	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
094e5402-eac9-42f0-9fda-84c538381332	40		b1da9868-3dc5-4fb1-bb9f-26696c3cd859	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	48	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0955e456-8de6-4c99-b6bb-f720525e5a28	AP-2E8Q		0b8cb9cd-5ab4-41fe-9a31-26728a185059	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	17166	 	1205.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
097a21bf-5143-4c26-95fb-7fa946712967	C3N-02298		3e4acafc-9a39-4c12-95ea-e21de8ac47c8	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	White	Alive	-30352	 	1934	 	 	 	 	 	 	 	 	30352	 	1723.00	1723.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
098b33b8-0c30-4604-9469-ffc02e7c7dfa	7053		052e7465-5352-4431-a512-06d79c8b8ab9	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	64	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
099a979a-7127-4e88-a39f-a6a5e5ce84ec	C3N-02947		8a434f29-79af-4e42-a6c0-63c4c3733674	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-18827	 	1966	 	 	 	 	 	 	 	 	18827	 	856.00	856.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
099d098c-4e7b-4e4a-b5ee-c805daa56c5b	PDAC113		b2f2a838-dd74-438e-85de-9ff5c77df6b9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	25185	 	1960.00	1960.00	313.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
09a53ad8-1fba-11e9-b7f8-0a80fada099c	QC2		7e34f686-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
09b738d0-562a-4e08-aee6-593ec9aa99ca	C3L-02202		f43c05c1-68d4-40c5-897b-b14ce29b7438	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	32	Not Reported	Male	White	Alive	-22609	 	1955	 	 	 	 	 	 	 	 	22609	 	962.00	962.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
09cd7eb4-42a9-4619-8809-ef5cf6e66f67	87		23ccad5a-cf99-4a97-823d-f830ba15d3f5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	44	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0a088f7a-118a-11e9-afb9-0a9c39d33490	C3L-00586		04a62204-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-18580	 	1965	 	 	 	 	 	 	 	 	18580	Not Reported	1801.00	1801.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0a72ab09-1fb9-11e9-b7f8-0a80fada099c	C3L-01281		4f9ff333-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-24243	 	1950	 	 	 	 	 	 	 	 	24243	Not Reported	1779.00	1779.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24243\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0a774083-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2088		ff2c04d8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-18770	 	1958	 	 	 	 	 	 	 	 	18770	Not Reported	145.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0ab4beb9-3dda-4847-aaa8-61cbe4c9976f	7203		76022c7d-d78a-45fc-acdb-5fa20519e474	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0b2864ca-d12c-42bf-a74e-280213ca525f	QC5		60e35ad4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0b43d28c-1fba-11e9-b7f8-0a80fada099c	QC3		805cdd20-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0ba60abe-2490-4fd5-8998-503981650647	19		205c0815-427e-418b-abad-a830cde4cb12	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	56	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0bbad2ef-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2094		ff2d5cc1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-23273	 	1940	 	 	 	 	 	 	 	 	23273	Not Reported	2182.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0bc46cbd-63d6-11e8-bcf1-0a2705229b82	05CO002		ff2ee94b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0c06c8bd-1fb9-11e9-b7f8-0a80fada099c	C3L-01283		4fa8b95d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Hispanic or Latino	Male	White	Alive	-13526	 	1980	 	 	 	 	 	 	 	 	13526	Not Reported	735.00	735.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-13526\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0c0e9203-ab48-4005-afbf-8c0db774a9b2	C3N-01766		cbc58a8d-87a1-4842-9d01-588fafa29e4f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-23195	 	1953	 	 	 	 	 	 	 	 	23195	 	520.00	520.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0c47fcef-118a-11e9-afb9-0a9c39d33490	C3L-00601		04b2faf7-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-20899	 	1959	 	 	 	 	 	 	 	 	20899	Not Reported	1722.00	1722.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0ca6b2e4-3d99-439b-a4bb-5bd980ca252a	PDAC245		d592e6f3-98ad-4601-a922-c919a2edb9f1	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	 	1070.00	1070.00	1070.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
0ccb7a89-85b2-46f2-a140-97f77da85a1f	8985		2597fa78-d947-469b-b3c6-7570396353fa	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0cdd85f4-1fba-11e9-b7f8-0a80fada099c	QC4		828554d9-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0cfb6014-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2095		ff2c1638-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-19797	1875	1949	2008	 	 	 	 	 	 	 	19797	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0d000f9c-f76f-42a0-b88b-9a9054919adb	C3N-02589		5eeb367e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-26008	398	1946	2018	 	 	 	 	 	 	 	26008	Not Reported	398.00	398.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0d04dd23-63d6-11e8-bcf1-0a2705229b82	05CO003		ff2eef1f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0d33d944-089d-4afc-b567-d2ce79e5cecc	PDAC020		60b99c09-aa06-4bba-98c0-02495d3deb53	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24090	 	411.00	411.00	411.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	Unknown	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
0d507744-28f4-48c7-8185-aef3dae3761b	60		dc24292d-8c7c-443f-bfb0-1ae5050dbc52	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0d555838-fb25-43e0-9809-82e055fa9a42	AP-NMZS		55350709-074c-4655-8bff-c6efede42203	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	18627	 	 	 	 	Not Reported	8250/3	Lepidic adenocarcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
0d5fdb95-4a5a-4a03-a571-08a6e4e94aeb	52		bca650eb-6260-4179-a7da-b2eaa97c7c3c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	52	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0d62fbcd-9b05-4732-9f41-9b1cab8cef4e	PDAC273		2f614282-551e-4466-a3d5-2132ff69e402	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	707.00	707.00	611.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
0d6bdae8-4082-419b-a78c-8963d395d4ad	JX0062		1c335806-1985-4328-a9ce-6a15443b63ab	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0d98b6e2-f618-4449-b76a-1c197ff5b45b	25		685e2cc4-2699-43f1-be4b-dc10691c4faa	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	85	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0d98b6e2-f618-4449-b76a-1c197ff5b45b	25		7ce3033a-d859-46dc-abee-e02fa35a833a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	85	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0d99be24-1fb9-11e9-b7f8-0a80fada099c	C3L-01286		4faf78dc-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-21429	1028	1958	2019	 	 	 	 	 	 	 	21429	 	1028.00	1028.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21429\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0dbb0ac7-5c68-461d-b02d-34af63506dff	MB234		e8228b80-63eb-4fc3-9851-df2449bfc45a	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	9855	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
0dd9546d-9962-4bf5-bc5f-0d0d7c79207d	PDAC213		02539a49-d606-421f-ac7f-8aab7a19b07c	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	21535	 	1284.00	1284.00	1284.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
0e06b68f-118a-11e9-afb9-0a9c39d33490	C3L-00605		04b9d0f2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-26936	 	1943	 	 	 	 	 	 	 	 	26936	Not Reported	1795.00	1795.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0e2161e1-bd0b-46f4-bc2a-c52288f522c1	7270		a057d921-647c-47c6-ac80-a6464cad84ae	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	65	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Sigmoid colon	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0e419aab-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2096		ff2c79fe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-20663	 	1947	 	 	 	 	 	 	 	 	20663	Not Reported	1776.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0e47d03c-63d6-11e8-bcf1-0a2705229b82	05CO004		ff2ef1b7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		0.00	 	 	Not Reported	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0e55cd78-015f-4747-8163-1f20cf20a434	C3N-01090		e8795659-2019-4287-9ca1-8391409cf7a8	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	White	Not Reported	 	 	1954	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0e79bef5-1fba-11e9-b7f8-0a80fada099c	QC5		84b05022-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0e943de7-c277-48f2-8fa9-b2e836b03c2c	OSCC_25		ae7a3f6c-173c-44d3-8a3e-381347861151	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
0e9c47ed-1bb0-495f-bb4a-b73ff49ca2d9	C3L-02802		05172692-204e-4cdf-bc98-ccbbfa22cfdd	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20647	 	1961	 	 	 	 	 	 	 	 	20647	 	844.00	844.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0ec91b79-a1fd-4a53-8d40-09f3b2a004d6	JX0122		0dbc1dd0-3696-4577-925d-74f24482dbd1	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0f06151e-53a2-4573-84c3-76e1b5c0ce34	C3N-00518		5dd89184-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-25462	427	1947	2017	 	 	 	 	 	 	 	25462	Not Reported	422.00	427.00	340.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0f0e4bc0-4bc6-4d5a-8e41-f730f4cab85c	C3N-01902		358433cb-a9f4-45d9-8d5a-c02c1f066909	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	21	Not Reported	Male	White	Dead	-23391	1170	1953	2020	 	 	 	 	 	 	 	23391	 	1170.00	1170.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0f345723-1fb9-11e9-b7f8-0a80fada099c	C3L-01287		4fc74932-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-22045	633	1956	2018	 	 	 	 	 	 	 	22045	 	630.00	633.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22045\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0f36f356-056a-4474-b555-c63b76553cad	27		325b645b-57f0-4e33-8ca6-6c39999b37d0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	63	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
0f80f1fe-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2612		ff2bbbaa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-23074	193	1939	2002	 	 	 	 	 	 	 	23074	Not Reported	193.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
0f9261c8-63d6-11e8-bcf1-0a2705229b82	05CO006		ff2f0537-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
0fc99975-d413-4582-b800-ea22bc755c7b	WHIM24		7a1c1cdc-5800-4517-8e0f-d3df6ff1beb9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
0fdc2d7a-e945-4c3b-9df5-5745197e1513	C3L-02899		5c085eff-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-26705	91	1944	2018	 	 	 	 	 	 	 	26705	Not Reported	44.00	91.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10135c5c-1fba-11e9-b7f8-0a80fada099c	QC6		86da12d2-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0406-2139-11ea-aee1-0e1aae319e49	C3L-00104		3b2f12dd-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-21197	129	1958	2016	 	 	 	 	 	 	 	21197	Not Reported	128.00	129.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"129\",\"days_to_birth\":\"-21197\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0852-2139-11ea-aee1-0e1aae319e49	C3L-00365		3b360ec0-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-21654	322	1957	2017	 	 	 	 	 	 	 	21654	Not Reported	280.00	322.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Parietal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"322\",\"days_to_birth\":\"-21654\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0976-2139-11ea-aee1-0e1aae319e49	C3L-00674		3b3e9cd7-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-16667	478	1971	2018	 	 	 	 	 	 	 	16667	Not Reported	385.00	478.00	 	Unknown tumor status	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"478\",\"days_to_birth\":\"-16667\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0a5a-2139-11ea-aee1-0e1aae319e49	C3L-00677		3b454bc4-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-25562	155	1946	2017	 	 	 	 	 	 	 	25562	Not Reported	155.00	155.00	 	Unknown tumor status	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"154\",\"days_to_birth\":\"-25562\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0c43-2139-11ea-aee1-0e1aae319e49	C3L-01040		3b4c4a9f-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Alive	-28387	 	1939	 	 	 	 	 	 	 	 	28387	Not Reported	608.00	608.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28387\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0d21-2139-11ea-aee1-0e1aae319e49	C3L-01043		3b532aa3-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-21551	79	1958	2017	 	 	 	 	 	 	 	21551	Not Reported	1.00	79.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Parietal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"79\",\"days_to_birth\":\"-21551\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c0df1-2139-11ea-aee1-0e1aae319e49	C3L-01045		3b61fed1-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Dead	-26843	66	1943	2017	 	 	 	 	 	 	 	26843	Not Reported	0.00	66.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Infection\",\"vital_status\":\"Dead\",\"days_to_death\":\"66\",\"days_to_birth\":\"-26843\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c101f-2139-11ea-aee1-0e1aae319e49	C3L-01046		3b71d0cc-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-18595	349	1966	2018	 	 	 	 	 	 	 	18595	Not Reported	195.00	349.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"349\",\"days_to_birth\":\"-18595\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1105-2139-11ea-aee1-0e1aae319e49	C3L-01048		3b808392-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Alive	-22109	 	1957	 	 	 	 	 	 	 	 	22109	Not Reported	806.00	806.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22109\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c11d9-2139-11ea-aee1-0e1aae319e49	C3L-01049		3b8fc610-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-17038	191	1971	2018	 	 	 	 	 	 	 	17038	Not Reported	69.00	191.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"191\",\"days_to_birth\":\"-17038\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c13d8-2139-11ea-aee1-0e1aae319e49	C3L-01061		3b9f07af-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Alive	-24196	 	1951	 	 	 	 	 	 	 	 	24196	Not Reported	840.00	840.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Occipital lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24196\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c14b2-2139-11ea-aee1-0e1aae319e49	C3L-01142		3bae4729-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Alive	-15483	 	1975	 	 	 	 	 	 	 	 	15483	Not Reported	0.00	0.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-15483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1581-2139-11ea-aee1-0e1aae319e49	C3L-01146		3bbf92db-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-21566	509	1958	2019	 	 	 	 	 	 	 	21566	Not Reported	508.00	509.00	 	With tumor	9440/3	Glioblastoma	No	Parietal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21566\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c178c-2139-11ea-aee1-0e1aae319e49	C3L-01149		3bccceea-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Alive	-17725	 	1969	 	 	 	 	 	 	 	 	17725	Not Reported	666.00	666.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17725\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1862-2139-11ea-aee1-0e1aae319e49	C3L-01154		3beb8bc7-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Dead	-18992	496	1965	2019	 	 	 	 	 	 	 	18992	Not Reported	496.00	496.00	 	With tumor	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18992\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1938-2139-11ea-aee1-0e1aae319e49	C3L-01155		3bfa9478-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Alive	-24461	 	1950	 	 	 	 	 	 	 	 	24461	Not Reported	362.00	362.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24461\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1b5c-2139-11ea-aee1-0e1aae319e49	C3L-01156		3c09d841-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-20999	291	1960	2018	 	 	 	 	 	 	 	20999	Not Reported	182.00	291.00	 	With tumor	9440/3	Glioblastoma	No	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"291\",\"days_to_birth\":\"-20999\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1c36-2139-11ea-aee1-0e1aae319e49	C3L-01157		3c1917a0-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Dead	-24372	984	1951	2020	 	 	 	 	 	 	 	24372	Not Reported	984.00	984.00	 	Tumor free	9440/3	Glioblastoma	No	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24372\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1d05-2139-11ea-aee1-0e1aae319e49	C3L-01327		3c285c19-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-27160	646	1942	2018	 	 	 	 	 	 	 	27160	Not Reported	2.00	646.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"645\",\"days_to_birth\":\"-27160\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c1f4b-2139-11ea-aee1-0e1aae319e49	C3L-01834		3c37aaff-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-24846	497	1949	2018	 	 	 	 	 	 	 	24846	Not Reported	482.00	497.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"497\",\"days_to_birth\":\"-24846\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2075-2139-11ea-aee1-0e1aae319e49	C3L-01887		3c46dfa7-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-17887	1703	1968	2022	 	 	 	 	 	 	 	17887	Not Reported	1622.00	1703.00	1468.00	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17887\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2149-2139-11ea-aee1-0e1aae319e49	C3L-02041		3c5621b1-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Alive	-18904	 	1965	 	 	 	 	 	 	 	 	18904	Not Reported	1030.00	1030.00	235.00	Unknown tumor status	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18904\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c22ff-2139-11ea-aee1-0e1aae319e49	C3L-02465		3c6562ca-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Hispanic or Latino	Male	Unknown	Dead	-18464	591	1966	2019	 	 	 	 	 	 	 	18464	Not Reported	550.00	591.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"591\",\"days_to_birth\":\"-18464\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2495-2139-11ea-aee1-0e1aae319e49	C3L-02504		3c74a5a8-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-26277	873	1945	2020	 	 	 	 	 	 	 	26277	Not Reported	866.00	873.00	454.00	With tumor	9440/3	Glioblastoma	Yes	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26277\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c257c-2139-11ea-aee1-0e1aae319e49	C3L-02542		3c83ec09-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Hispanic or Latino	Female	White	Dead	-21544	180	1958	2018	 	 	 	 	 	 	 	21544	Not Reported	154.00	180.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"180\",\"days_to_birth\":\"-21544\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c273b-2139-11ea-aee1-0e1aae319e49	C3L-02642		3c932aee-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-28231	828	1940	2020	 	 	 	 	 	 	 	28231	Not Reported	828.00	828.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28231\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2847-2139-11ea-aee1-0e1aae319e49	C3L-02704		3c999848-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Alive	-19879	 	1963	 	 	 	 	 	 	 	 	19879	Not Reported	186.00	186.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19879\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c291d-2139-11ea-aee1-0e1aae319e49	C3L-02705		3ca82933-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-22025	111	1957	2017	 	 	 	 	 	 	 	22025	Not Reported	104.00	111.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"111\",\"days_to_birth\":\"-22025\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2aed-2139-11ea-aee1-0e1aae319e49	C3L-02707		3caeb87e-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Alive	-21250	 	1959	 	 	 	 	 	 	 	 	21250	Not Reported	91.00	91.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21250\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2bce-2139-11ea-aee1-0e1aae319e49	C3L-02708		3cb5b697-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-16016	738	1973	2019	 	 	 	 	 	 	 	16016	Not Reported	738.00	738.00	525.00	With tumor	9440/3	Glioblastoma	Yes	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16016\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2c9e-2139-11ea-aee1-0e1aae319e49	C3L-02900		3cc0f1b8-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-19332	1053	1965	2021	 	 	 	 	 	 	 	19332	Not Reported	1053.00	1053.00	 	With tumor	9440/3	Glioblastoma	No	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19332\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2e6e-2139-11ea-aee1-0e1aae319e49	C3L-02955		3cd04108-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-27855	378	1941	2018	 	 	 	 	 	 	 	27855	Not Reported	350.00	378.00	154.00	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"378\",\"days_to_birth\":\"-27855\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c2f4b-2139-11ea-aee1-0e1aae319e49	C3L-02970		3cd6d760-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-21524	381	1959	2019	 	 	 	 	 	 	 	21524	Not Reported	381.00	381.00	 	With tumor	9440/3	Glioblastoma	No	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21524\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3018-2139-11ea-aee1-0e1aae319e49	C3L-02984		3cdf6e74-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	Asian	Alive	-12449	 	1983	 	 	 	 	 	 	 	 	12449	Not Reported	1469.00	1469.00	 	Tumor free	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-12449\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3202-2139-11ea-aee1-0e1aae319e49	C3L-03260		3ceebef5-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-27394	43	1942	2018	 	 	 	 	 	 	 	27394	Not Reported	42.00	43.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"43\",\"days_to_birth\":\"-27394\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c32dc-2139-11ea-aee1-0e1aae319e49	C3L-03266		3cfe02a3-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Hispanic or Latino	Female	White	Dead	-22583	281	1956	2018	 	 	 	 	 	 	 	22583	Not Reported	223.00	281.00	 	Unknown tumor status	9440/3	Glioblastoma	No	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"280\",\"days_to_birth\":\"-22583\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c33ac-2139-11ea-aee1-0e1aae319e49	C3L-03387		3d0d40d3-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-25839	403	1947	2019	 	 	 	 	 	 	 	25839	Not Reported	403.00	403.00	 	With tumor	9440/3	Glioblastoma	No	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25839\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c35a5-2139-11ea-aee1-0e1aae319e49	C3L-03390		3d1ca84d-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Alive	-16133	 	1974	 	 	 	 	 	 	 	 	16133	Not Reported	815.00	815.00	 	With tumor	9440/3	Glioblastoma	Yes	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16133\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3685-2139-11ea-aee1-0e1aae319e49	C3L-03392		3d2bdce9-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Dead	-18509	147	1967	2018	 	 	 	 	 	 	 	18509	Not Reported	-9.00	147.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Parietal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"146\",\"days_to_birth\":\"-18509\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3751-2139-11ea-aee1-0e1aae319e49	C3L-03400		3d3bcb54-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Alive	-14028	 	1979	 	 	 	 	 	 	 	 	14028	Not Reported	786.00	786.00	 	With tumor	9440/3	Glioblastoma	No	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-14028\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c39a6-2139-11ea-aee1-0e1aae319e49	C3L-03405		3d4a4c14-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-21614	87	1959	2018	 	 	 	 	 	 	 	21614	Not Reported	87.00	87.00	 	Tumor free	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"87\",\"days_to_birth\":\"-21614\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3a87-2139-11ea-aee1-0e1aae319e49	C3L-03407		3d59c205-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Hispanic or Latino	Female	Not Reported	Dead	-20944	238	1960	2018	 	 	 	 	 	 	 	20944	Not Reported	176.00	238.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"237\",\"days_to_birth\":\"-20944\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3b55-2139-11ea-aee1-0e1aae319e49	C3L-03681		3d697d7b-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-22946	7	1955	2018	 	 	 	 	 	 	 	22946	Not Reported	7.00	7.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"7\",\"days_to_birth\":\"-22946\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3d6f-2139-11ea-aee1-0e1aae319e49	C3L-03727		3d780e07-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-26097	721	1946	2020	 	 	 	 	 	 	 	26097	Not Reported	613.00	721.00	457.00	With tumor	9440/3	Glioblastoma	Yes	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26097\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c3e4d-2139-11ea-aee1-0e1aae319e49	C3L-03728		3d87d09e-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-29326	127	1937	2018	 	 	 	 	 	 	 	29326	Not Reported	127.00	127.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"126\",\"days_to_birth\":\"-29326\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c407d-2139-11ea-aee1-0e1aae319e49	C3L-03744		3d9694ad-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Alive	-27552	 	1942	 	 	 	 	 	 	 	 	27552	Not Reported	1040.00	1040.00	 	Tumor free	9440/3	Glioblastoma	No	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27552\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c415d-2139-11ea-aee1-0e1aae319e49	C3L-03747		3da5cd84-2848-11ec-b712-0a4e2186f121	 	Disqualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-22930	705	1955	2020	 	 	 	 	 	 	 	22930	Not Reported	705.00	705.00	231.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22930\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c43cc-2139-11ea-aee1-0e1aae319e49	C3L-03748		3db50fda-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-23735	401	1953	2019	 	 	 	 	 	 	 	23735	Not Reported	397.00	401.00	162.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23735\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c44b0-2139-11ea-aee1-0e1aae319e49	C3L-03968		3dc4540b-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Alive	-22241	 	1957	 	 	 	 	 	 	 	 	22241	Not Reported	1394.00	1394.00	 	Tumor free	9440/3	Glioblastoma	Not Reported	Brain, NOS	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22241\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c46fd-2139-11ea-aee1-0e1aae319e49	C3L-04084		3dd39c49-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-23267	274	1954	2019	 	 	 	 	 	 	 	23267	Not Reported	206.00	274.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"274\",\"days_to_birth\":\"-23267\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c47ef-2139-11ea-aee1-0e1aae319e49	C3N-00661		3dd9d358-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Alive	-18038	 	1967	 	 	 	 	 	 	 	 	18038	Not Reported	1107.00	1107.00	 	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18038\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4900-2139-11ea-aee1-0e1aae319e49	C3N-00662		3de318a0-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Dead	-28406	116	1939	2017	 	 	 	 	 	 	 	28406	Not Reported	116.00	116.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Infection\",\"vital_status\":\"Dead\",\"days_to_death\":\"116\",\"days_to_birth\":\"-28406\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c49d4-2139-11ea-aee1-0e1aae319e49	C3N-00663		3de9c661-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-14468	1	1977	2016	 	 	 	 	 	 	 	14468	Not Reported	1.00	1.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"1\",\"days_to_birth\":\"-14468\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4b82-2139-11ea-aee1-0e1aae319e49	C3N-00665		3df2507a-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Alive	-24055	 	1951	 	 	 	 	 	 	 	 	24055	Not Reported	1585.00	1585.00	1291.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24055\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4c5f-2139-11ea-aee1-0e1aae319e49	C3N-01192		3df91cd9-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Dead	-21957	1209	1956	2020	 	 	 	 	 	 	 	21957	Not Reported	1209.00	1209.00	 	Unknown tumor status	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21957\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4d31-2139-11ea-aee1-0e1aae319e49	C3N-01196		3e007171-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-24546	653	1949	2018	 	 	 	 	 	 	 	24546	Not Reported	230.00	653.00	194.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"684\",\"days_to_birth\":\"-24546\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4ee1-2139-11ea-aee1-0e1aae319e49	C3N-01334		3e06d461-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Dead	-23573	7	1952	2017	 	 	 	 	 	 	 	23573	Not Reported	7.00	7.00	 	With tumor	9440/3	Glioblastoma	No	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"7\",\"days_to_birth\":\"-23573\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c4fbb-2139-11ea-aee1-0e1aae319e49	C3N-01364		3e0d2060-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Alive	-12483	 	1982	 	 	 	 	 	 	 	 	12483	Not Reported	1972.00	1972.00	480.00	Unknown tumor status	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-12483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5089-2139-11ea-aee1-0e1aae319e49	C3N-01366		3e13bf5a-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-23121	6	1953	2017	 	 	 	 	 	 	 	23121	Not Reported	6.00	6.00	 	Tumor free	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Surgical Complications\",\"vital_status\":\"Dead\",\"days_to_death\":\"6\",\"days_to_birth\":\"-23121\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c524a-2139-11ea-aee1-0e1aae319e49	C3N-01367		3e19f55c-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-27364	349	1942	2018	 	 	 	 	 	 	 	27364	Not Reported	349.00	349.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-27364\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5325-2139-11ea-aee1-0e1aae319e49	C3N-01368		3e2054ca-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-24115	245	1951	2017	 	 	 	 	 	 	 	24115	Not Reported	245.00	245.00	63.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"245\",\"days_to_birth\":\"-24115\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c53f6-2139-11ea-aee1-0e1aae319e49	C3N-01369		3e26d862-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Dead	-21015	606	1959	2018	 	 	 	 	 	 	 	21015	Not Reported	606.00	606.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-21015\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5609-2139-11ea-aee1-0e1aae319e49	C3N-01505		3e2d6761-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Male	White	Dead	-27131	192	1942	2017	 	 	 	 	 	 	 	27131	Not Reported	192.00	192.00	189.00	With tumor	9440/3	Glioblastoma	Yes	Parietal lobe	Parietal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"191\",\"days_to_birth\":\"-27131\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c56ef-2139-11ea-aee1-0e1aae319e49	C3N-01515		3e338c77-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Hispanic or Latino	Female	White	Dead	-26969	19	1943	2017	 	 	 	 	 	 	 	26969	Not Reported	19.00	19.00	 	With tumor	9440/3	Glioblastoma	No	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"19\",\"days_to_birth\":\"-26969\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5875-2139-11ea-aee1-0e1aae319e49	C3N-01517		3e3a1344-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Alive	-18211	 	1967	 	 	 	 	 	 	 	 	18211	Not Reported	1023.00	1023.00	894.00	Tumor free	9440/3	Glioblastoma	Yes	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18211\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5a8f-2139-11ea-aee1-0e1aae319e49	C3N-01518		3e407c17-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-26312	805	1945	2019	 	 	 	 	 	 	 	26312	Not Reported	805.00	805.00	538.00	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"804\",\"days_to_birth\":\"-26312\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5b6d-2139-11ea-aee1-0e1aae319e49	C3N-01798		3e472906-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-16195	590	1972	2018	 	 	 	 	 	 	 	16195	Not Reported	590.00	590.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"590\",\"days_to_birth\":\"-16195\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5c3e-2139-11ea-aee1-0e1aae319e49	C3N-01814		3e4df1d5-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-17813	 	1968	 	 	 	 	 	 	 	 	17813	Not Reported	383.00	383.00	 	Tumor free	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17813\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5e6c-2139-11ea-aee1-0e1aae319e49	C3N-01815		3e54ef30-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-25973	121	1946	2017	 	 	 	 	 	 	 	25973	Not Reported	96.00	121.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"121\",\"days_to_birth\":\"-25973\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c5f4b-2139-11ea-aee1-0e1aae319e49	C3N-01816		3e5b1d25-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-19634	841	1963	2019	 	 	 	 	 	 	 	19634	Not Reported	841.00	841.00	 	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"841\",\"days_to_birth\":\"-19634\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c6019-2139-11ea-aee1-0e1aae319e49	C3N-01818		3e61c9ca-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-22156	270	1956	2018	 	 	 	 	 	 	 	22156	Not Reported	221.00	270.00	 	Unknown tumor status	9440/3	Glioblastoma	Not Reported	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"270\",\"days_to_birth\":\"-22156\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c6224-2139-11ea-aee1-0e1aae319e49	C3N-01851		3e684664-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-17508	363	1969	2018	 	 	 	 	 	 	 	17508	Not Reported	363.00	363.00	 	With tumor	9440/3	Glioblastoma	Yes	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"363\",\"days_to_birth\":\"-17508\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c62fe-2139-11ea-aee1-0e1aae319e49	C3N-01852		3e6e7f2c-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Alive	-21869	 	1957	 	 	 	 	 	 	 	 	21869	Not Reported	3.00	3.00	 	Tumor free	9440/3	Glioblastoma	Not Reported	Frontal lobe	Frontal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21869\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c63cb-2139-11ea-aee1-0e1aae319e49	C3N-01856		3e75763c-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-24242	382	1950	2018	 	 	 	 	 	 	 	24242	Not Reported	382.00	382.00	281.00	Unknown tumor status	9440/3	Glioblastoma	Yes	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"382\",\"days_to_birth\":\"-24242\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c65ee-2139-11ea-aee1-0e1aae319e49	C3N-01857		3e7c140f-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	White	Dead	-25423	651	1947	2019	 	 	 	 	 	 	 	25423	Not Reported	651.00	651.00	 	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"651\",\"days_to_birth\":\"-25423\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c66c7-2139-11ea-aee1-0e1aae319e49	C3N-02181		3e8313d9-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-19396	 	1964	 	 	 	 	 	 	 	 	19396	Not Reported	388.00	388.00	 	With tumor	9440/3	Glioblastoma	No	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19396\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c679a-2139-11ea-aee1-0e1aae319e49	C3N-02183		3e8ab1e8-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-23246	340	1953	2018	 	 	 	 	 	 	 	23246	Not Reported	340.00	340.00	 	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"340\",\"days_to_birth\":\"-23246\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c69cf-2139-11ea-aee1-0e1aae319e49	C3N-02185		3e99f428-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Other	Alive	-22613	 	1955	 	 	 	 	 	 	 	 	22613	Not Reported	386.00	386.00	279.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22613\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c6aa6-2139-11ea-aee1-0e1aae319e49	C3N-02186		3ea95225-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Alive	-19526	 	1964	 	 	 	 	 	 	 	 	19526	Not Reported	264.00	264.00	99.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19526\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c6ce5-2139-11ea-aee1-0e1aae319e49	C3N-02188		3eb05587-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-21709	411	1958	2018	 	 	 	 	 	 	 	21709	Not Reported	411.00	411.00	260.00	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"411\",\"days_to_birth\":\"-21709\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c6dbe-2139-11ea-aee1-0e1aae319e49	C3N-02190		3ebe7c3d-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-19534	311	1964	2018	 	 	 	 	 	 	 	19534	Not Reported	311.00	311.00	261.00	With tumor	9440/3	Glioblastoma	Yes	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"311\",\"days_to_birth\":\"-19534\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c701e-2139-11ea-aee1-0e1aae319e49	C3N-02255		3ec49923-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-32483	265	1928	2018	 	 	 	 	 	 	 	32483	Not Reported	265.00	265.00	 	With tumor	9440/3	Glioblastoma	No	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"265\",\"days_to_birth\":\"-32483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7150-2139-11ea-aee1-0e1aae319e49	C3N-02256		3ecacdcd-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	White	Dead	-23761	263	1952	2018	 	 	 	 	 	 	 	23761	Not Reported	188.00	263.00	160.00	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"294\",\"days_to_birth\":\"-23761\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7225-2139-11ea-aee1-0e1aae319e49	C3N-02769		3ed15fda-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-19701	1115	1963	2020	 	 	 	 	 	 	 	19701	Not Reported	1115.00	1115.00	673.00	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19701\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c73ca-2139-11ea-aee1-0e1aae319e49	C3N-02770		3ed793c4-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-25753	779	1947	2019	 	 	 	 	 	 	 	25753	Not Reported	779.00	779.00	 	With tumor	9440/3	Glioblastoma	Yes	Frontal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"779\",\"days_to_birth\":\"-25753\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c74a2-2139-11ea-aee1-0e1aae319e49	C3N-02782		3ee64181-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-17506	 	1969	 	 	 	 	 	 	 	 	17506	Not Reported	985.00	985.00	 	With tumor	9440/3	Glioblastoma	Yes	Parietal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17506\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c757a-2139-11ea-aee1-0e1aae319e49	C3N-02783		3ef78b6d-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-8889	 	1993	 	 	 	 	 	 	 	 	8889	Not Reported	977.00	977.00	 	Tumor free	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-8889\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c772f-2139-11ea-aee1-0e1aae319e49	C3N-02784		3f04c82c-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-13569	391	1980	2018	 	 	 	 	 	 	 	13569	Not Reported	391.00	391.00	555.00	With tumor	9440/3	Glioblastoma	Yes	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"391\",\"days_to_birth\":\"-13569\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c780c-2139-11ea-aee1-0e1aae319e49	C3N-02785		3f1405c8-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-25301	546	1948	2019	 	 	 	 	 	 	 	25301	Not Reported	546.00	546.00	466.00	With tumor	9440/3	Glioblastoma	Yes	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"546\",\"days_to_birth\":\"-25301\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c78dc-2139-11ea-aee1-0e1aae319e49	C3N-02786		3f23488e-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-14593	 	1977	 	 	 	 	 	 	 	 	14593	Not Reported	1047.00	1047.00	 	With tumor	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-14593\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7a9a-2139-11ea-aee1-0e1aae319e49	C3N-02788		3f29e468-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-23634	845	1953	2020	 	 	 	 	 	 	 	23634	Not Reported	845.00	845.00	 	With tumor	9440/3	Glioblastoma	Yes	Temporal lobe	Temporal lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-23634\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7b7e-2139-11ea-aee1-0e1aae319e49	C3N-03070		3f328e7e-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Alive	-24111	 	1952	 	 	 	 	 	 	 	 	24111	Not Reported	332.00	332.00	 	Tumor free	9440/3	Glioblastoma	No	Temporal lobe	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24111\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7c51-2139-11ea-aee1-0e1aae319e49	C3N-03088		3f38d20b-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-11589	142	1986	2018	 	 	 	 	 	 	 	11589	Not Reported	27.00	142.00	 	Tumor free	9440/3	Glioblastoma	No	Occipital lobe	Occipital lobe	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"141\",\"days_to_birth\":\"-11589\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7e20-2139-11ea-aee1-0e1aae319e49	C3N-03180		3f41c8ff-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-19399	511	1964	2019	 	 	 	 	 	 	 	19399	Not Reported	511.00	511.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-19399\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7ef9-2139-11ea-aee1-0e1aae319e49	C3N-03182		3f5115a0-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-17461	763	1970	2019	 	 	 	 	 	 	 	17461	Not Reported	763.00	763.00	 	With tumor	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17461\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c7fc8-2139-11ea-aee1-0e1aae319e49	C3N-03183		3f6054e6-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Other	Dead	-19616	315	1964	2018	 	 	 	 	 	 	 	19616	Not Reported	315.00	315.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"314\",\"days_to_birth\":\"-19616\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c81a1-2139-11ea-aee1-0e1aae319e49	C3N-03184		3f6fa8c7-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Alive	-12827	 	1982	 	 	 	 	 	 	 	 	12827	Not Reported	390.00	390.00	 	Tumor free	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-12827\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8277-2139-11ea-aee1-0e1aae319e49	C3N-03186		3f7f2041-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-20009	646	1963	2019	 	 	 	 	 	 	 	20009	Not Reported	646.00	646.00	459.00	With tumor	9440/3	Glioblastoma	Yes	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20009\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8344-2139-11ea-aee1-0e1aae319e49	C3N-03188		3f8e5f0a-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Male	Asian	Dead	-19856	1022	1963	2020	 	 	 	 	 	 	 	19856	Not Reported	1022.00	1022.00	 	With tumor	9440/3	Glioblastoma	No	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19856\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c852f-2139-11ea-aee1-0e1aae319e49	C3N-03473		3f9d9d38-2848-11ec-b712-0a4e2186f121	 	Qualified	Glioblastoma	Brain			Not Reported	Female	Asian	Dead	-11053	297	1987	2018	 	 	 	 	 	 	 	11053	Not Reported	297.00	297.00	 	With tumor	9440/3	Glioblastoma	Not Reported	Brain, NOS	Brain, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-11053\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8607-2139-11ea-aee1-0e1aae319e49	GTEX-NPJ7-0011-R10A-SM-HAKXW		3fae07cf-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	24820	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c86dc-2139-11ea-aee1-0e1aae319e49	GTEX-P44H-0011-R10A-SM-HAKXX		3fbc3101-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	15695	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c88e0-2139-11ea-aee1-0e1aae319e49	GTEX-Q2AG-0011-R10A-SM-HAKXT		3fcb7006-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	15330	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c89b9-2139-11ea-aee1-0e1aae319e49	GTEX-QVJO-0011-R10A-SM-HAKXV		3fda5f43-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Infection\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8c6e-2139-11ea-aee1-0e1aae319e49	GTEX-R55F-0011-R10A-SM-HAKXY		3fe0f0c7-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8d61-2139-11ea-aee1-0e1aae319e49	GTEX-RN5K-0011-R10A-SM-HAKXU		3fe9bab5-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	20440	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c8f7f-2139-11ea-aee1-0e1aae319e49	GTEX-RU72-0011-R10A-SM-HAKXS		3ff09a52-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c9078-2139-11ea-aee1-0e1aae319e49	GTEX-UTHO-0011-R10A-SM-HAKY2		3ffe9eda-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	24820	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c92ad-2139-11ea-aee1-0e1aae319e49	GTEX-WVLH-0011-R10A-SM-HAKXZ		40082a85-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Reported	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	21170	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c9383-2139-11ea-aee1-0e1aae319e49	GTEX-Y8DK-0011-R10A-SM-HAKY1		400e5488-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	22630	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
104c97f7-2139-11ea-aee1-0e1aae319e49	ref		4017657b-2848-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10784784-5101-4f5e-aefa-1311e0000fdf	C3N-01900		5e86cdb2-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Male	White	Dead	-19495	831	1964	2019	 	 	 	 	 	 	 	19495	Not Reported	831.00	831.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1086ba40-2dfc-4828-8b5b-ded36a4b2176	C3N-00647		43504b73-9c4d-4aa6-9391-ac50641499c1	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1960	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
109080ea-8c45-4b76-9311-51115576b110	C3N-02439		a76a4b38-c857-49bc-bfe1-fcebcf5f3453	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20891	 	1960	 	 	 	 	 	 	 	 	20891	 	1174.00	1174.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
109369bc-354e-46c4-aa26-69d13194b085	C3L-00881		5a69f4cc-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-29330	 	1936	 	 	 	 	 	 	 	 	29330	Not Reported	3.00	3.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10bca000-c4a8-4501-b4b8-7ad5f17c5961	MB136		9f0153ec-f1ec-479a-bf37-b01dec5b0e56	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	9490	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
10c6a31e-63d8-11e8-bcf1-0a2705229b82	TCGA-61-2613		ff2e1dfe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-26779	945	1925	2000	 	 	 	 	 	 	 	26779	Not Reported	945.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
10c75345-63d6-11e8-bcf1-0a2705229b82	05CO007		ff2f0a2f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10c9e898-1fb9-11e9-b7f8-0a80fada099c	C3L-01288		4fd68b30-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-25898	 	1946	 	 	 	 	 	 	 	 	25898	Not Reported	1800.00	1800.00	1416.00	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25898\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10e97ad4-5464-4ed2-9b16-554f8714f41b	C3N-02945		16d5f4df-04d2-437f-9ed0-34aa93e90600	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-24182	 	1951	 	 	 	 	 	 	 	 	24182	 	95.00	95.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
10fae524-2581-4ae5-97fa-7a677fe942dd	C3N-01536		818cc6c9-70df-41a7-a3e4-c0b78f5162aa	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Male	Other	Alive	-23816	 	1952	 	 	 	 	 	 	 	 	23816	 	686.00	686.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1104505a-9890-49ce-8d7d-7a8070261324	OSCC_23		4c1cade2-18a6-4a2e-8264-949a3611fd88	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Retromolar area	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
11362304-fd12-4f36-8e9d-608972ae1a26	AP-MAZ4		182be20e-6bd1-415b-a5e5-4d35a3e1cdb8	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	25566	 	800.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
1186193d-462a-498d-8827-d2120814d9a7	CU-33		fa891047-a33f-41b8-b0bb-66c48627ac29	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
119d6747-1d4a-489c-8dde-a346020b0ea7	MB265		ad043b62-eb08-4c90-854b-4f8524c4c309	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	3285	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
11b585a4-1fba-11e9-b7f8-0a80fada099c	QC7		890067c6-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
11b63998-52c4-471e-92c5-6ccd6ab7469e	Universal reference		8ff210ca-3d5a-426d-8ea8-b8addb9914b8	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Not Reported	Not Reported	Not reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
11da2414-f1d8-4b91-9e8a-8e7ead0897ae	H36960-002		05afb95e-bec5-4a4b-8459-d93e626013fe	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
12047797-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0CM		ff307fa4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Dead	-14969	754	1963	2005	 	 	 	 	 	 	 	14969	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1214f792-74c8-447f-882f-ce3bfc09a9af	CU-08		bc681852-3848-4702-a37f-ae982eb08bbc	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	64	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
121b989b-ecfa-11ea-b1fd-0aad30af8a83	LSCC KGG CR		a8357fb3-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
121b9a4d-ecfa-11ea-b1fd-0aad30af8a83	LUAD KGG CR		a8728bde-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
12293bed-45a2-4c7e-91f2-fa954cf5ea55	AP-JDN4		bf9044e5-9a63-4d65-a9dc-395fd02fc348	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	20453	 	780.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
123ebacf-63d6-11e8-bcf1-0a2705229b82	05CO011		ff2f0c93-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
12689277-1fb9-11e9-b7f8-0a80fada099c	C3L-01302		4fe5cebd-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Dead	-26084	55	1945	2017	 	 	 	 	 	 	 	26084	Not Reported	53.00	55.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Unknown	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"55\",\"days_to_birth\":\"-26084\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
12997b94-118a-11e9-afb9-0a9c39d33490	C3L-00767		04c25331-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-20657	 	1959	 	 	 	 	 	 	 	 	20657	Not Reported	419.00	419.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
12a04b0b-19ac-41ee-be85-8a8682edfbd7	56		c83738c5-177a-4810-9f38-113d63d31360	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
13012ed3-ed29-41ab-8733-973140233700	C3L-02352		59af439f-4200-4038-ab15-ad9a704f3cb2	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Hispanic or Latino	Female	White	Alive	-24735	 	1949	 	 	 	 	 	 	 	 	24735	 	1766.00	1766.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
131b3172-8e24-4bb8-be95-38566b0f84c9	AP-DMUM		87404290-5946-4b89-bcac-485bd844f272	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28854	 	1505.00	 	 	Not Reported	8253/3	Invasive mucinous adenocarcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
1324f7bb-34f6-4ebb-81f7-30952f4a5b62	CR2		6b60f087-aa78-4b59-8ce4-069d95070992	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
1341b7df-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0D0		ff312192-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Alive	-22115	 	1948	 	 	 	 	 	 	 	 	22115	Not Reported	2048.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
139225aa-1fba-11e9-b7f8-0a80fada099c	QC8		8cbe9034-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
139a0253-63d6-11e8-bcf1-0a2705229b82	05CO015		ff2f1276-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
13ac1593-912d-47ff-889e-3a55d952773a	99		2e2af23a-3b23-43c7-ba1e-cdf089920b51	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	65	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
13ac1593-912d-47ff-889e-3a55d952773a	99		d6ab650b-b166-400b-9646-b8d3fee59b6a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	65	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
13b998b5-93a9-400b-a694-3ee3cc682912	PDAC272		233b4acc-2544-470a-a924-b1b78181b216	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	89.00	89.00	144.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
14074e8f-1fb9-11e9-b7f8-0a80fada099c	C3L-01313		4ff50c4d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Dead	-23275	1229	1953	2020	 	 	 	 	 	 	 	23275	Not Reported	1229.00	1229.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-23275\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1411a35b-1847-4d87-b57f-993dfb9659f8	15-00051		8b7de95c-f4fd-49b7-89fc-65fffc9a11aa	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-24456	1715	 	 	66	 	 	false	Medical Record	 	United States	24456	 	1715.00	1715.00	 	Tumor free	Not Reported	Therapy-related acute myeloid leukemia, NOS	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1477014f-e3d8-485a-81e0-e7fd623178fe	C3L-00815		3e078c9a-7b0f-4906-a34f-8a0246360091	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	34	Not Reported	Female	White	Alive	-28832	 	1938	 	 	 	 	 	 	 	 	28832	 	1318.00	1318.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
149f9c82-09d1-433f-82ba-82e7db9aec2e	PDAC234		9f15ceb4-d2a6-43d1-8e3b-3d8afc62321f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24090	 	376.00	376.00	121.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
14b73c43-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0D1		ff302e5f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-28084	 	1932	 	 	 	 	 	 	 	 	28084	Not Reported	1051.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
14cee5b1-828e-442a-9d93-d08532062508	WHIM20		4b543020-ab00-41ed-9b0d-927ba05601b0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
15004c8d-69c0-4772-8f3b-d88691fe8d52	C3L-07032		5ce6437a-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Male	White	Not Reported	 	 	1943	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
15279ad5-f36f-4197-aea1-1ea7e83d40be	MDA-09		d430d904-6ea1-420e-9b4f-e43f06aa4ac6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	77	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
153161ec-1fba-11e9-b7f8-0a80fada099c	Pooled Sample		8ee8c262-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
15853521-e538-48f3-bc9c-c0a6e3ffc864	CU-36		4f107c67-4b5a-4454-a6af-ca7ada9abdbe	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
15a3cb22-1fb9-11e9-b7f8-0a80fada099c	C3L-01352		5004504d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Hispanic or Latino	Female	White	Alive	-27874	 	1940	 	 	 	 	 	 	 	 	27874	Not Reported	233.00	233.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27874\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
15d0c3f2-b9ed-45d0-add6-a9d7065072d0	57		4b19f23f-6f5c-42cb-a14c-c9ef43eb2d40	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
15d4ab5c-f183-4a1c-b5b8-9f766b774d2b	NTN072		ce92c95d-0ae0-4876-9c78-a9e6f8cdd6c2	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
15d7eb12-63d6-11e8-bcf1-0a2705229b82	05CO020		ff2f14df-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
15fadb80-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0D2		ff316256-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-16623	 	1963	 	 	 	 	 	 	 	 	16623	Not Reported	1027.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
160d8256-b9ee-4823-ad80-707a10818c58	C3N-02338		0138d4dc-5a09-487b-a2b9-e867de850959	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Other	Alive	-21451	 	1958	 	 	 	 	 	 	 	 	21451	 	10.00	10.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1641e669-51eb-420d-92e3-cec18d23ea0d	C3N-03666		600d2380-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-23228	701	1954	2019	 	 	 	 	 	 	 	23228	Not Reported	701.00	701.00	348.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIB	T2	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
168e87be-118a-11e9-afb9-0a9c39d33490	C3L-00769		04c8e2a0-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-20660	 	1960	 	 	 	 	 	 	 	 	20660	Not Reported	1507.00	1507.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1725f439-598a-420f-8f5c-e355e14cedd9	16-01225		f30a735f-9764-4ece-a14c-21b2f30be814	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-22463	316	 	 	61	 	 	false	Medical Record	 	United States	22463	 	316.00	316.00	 	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
172fa521-c7b8-4b12-b306-7b147f1a283d	C3N-01765		d043f917-f061-40de-a52c-6be491d8e5eb	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	34	Not Reported	Female	White	Alive	-21285	 	1958	 	 	 	 	 	 	 	 	21285	 	1812.00	1812.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
17380b66-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0EQ		ff3184d8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Alive	-23543	 	1940	 	 	 	 	 	 	 	 	23543	Not Reported	2426.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
175ccf46-63d6-11e8-bcf1-0a2705229b82	05CO026		ff2f188f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1833a52c-63d7-11e8-bcf1-0a2705229b82	20CO001		ff31873c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1835a3be-cbd4-4ad4-91b0-184192e46443	PDX  CR		bdb00b44-789d-4a56-8884-c72529bb222f	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
184bea79-034a-4b29-a66f-7d28a67365b0	8005		29c2977d-154e-4cfe-984d-7f62043f3543	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
18768947-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0EV		ff2b80b0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-29285	 	1928	 	 	 	 	 	 	 	 	29285	Not Reported	968.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IA	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
18b64ae1-2fe2-40d2-9126-bd1ed2ce4e95	C3L-02890		5bfa651d-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-24050	1007	1951	2020	 	 	 	 	 	 	 	24050	Not Reported	1007.00	1007.00	868.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
18cbb873-a702-4a7e-b646-7d67671646eb	C3N-02253		597847a4-d175-4d5c-bd05-96e2bb743509	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Not Hispanic or Latino	Female	White	Not Reported	 	 	1963	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
18cffd55-6993-48ca-81ed-9096a5ec7f9a	C3N-01529		9ee02928-dc22-4a44-ac54-83a772935add	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-27	Not Reported	Female	Other	Alive	-25559	 	1947	 	 	 	 	 	 	 	 	25559	 	27.00	27.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1907a949-118a-11e9-afb9-0a9c39d33490	C3L-00770		04cf9b1b-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-26769	 	1943	 	 	 	 	 	 	 	 	26769	Not Reported	1547.00	1547.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1917299c-e324-4a06-92ce-79372a1d4efb	AP-4LRG		7e7318f0-e61e-4071-81ec-bbf79d339966	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21184	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
193b277a-63d6-11e8-bcf1-0a2705229b82	05CO028		ff2f1c16-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
19518ff8-4c98-4ecd-8160-d240f9f65519	13-00034		9d7bf625-a582-4ec3-a9a0-026aece8371c	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-22304	16	 	 	61	 	 	false	Medical Record	 	United States	22304	 	16.00	16.00	 	With tumor	Not Reported	Therapy-related acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
195cd133-0d53-402d-b31c-3d4fe0481858	OSCC_37		e993cc6a-3774-4ef6-9f6a-77e9fe59c2a3	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
196e410d-63d7-11e8-bcf1-0a2705229b82	20CO003		ff318ad5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1978e6d5-749a-45ae-b842-ec8aac61709a	14-00045		e3bd6b42-699e-4c27-aa40-8c4a59408170	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Unknown	Dead	-17178	582	 	 	47	 	 	false	Medical Record	 	United States	17178	 	582.00	582.00	510.00	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
19bc0395-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0EX		ff2b87f9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-16858	 	1963	 	 	 	 	 	 	 	 	16858	Not Reported	752.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage IIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1a1f506d-b1ca-4117-aaad-ff410f915dd3	C3L-01106		754a7399-37ae-4488-953d-07317ca53510	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Female	Asian	Dead	-18693	32	1966	2017	 	 	 	 	 	 	 	18693	 	0.00	32.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1a918d3f-8bd9-493d-8cff-304981a8a932	CU-40		8eda0f4d-4efa-4c22-8da0-6112dc86c41b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1aa5bc23-63d6-11e8-bcf1-0a2705229b82	05CO029		ff2f1fa2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1aa8ef3a-63d7-11e8-bcf1-0a2705229b82	20CO004		ff318e5c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1afb10ed-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0EY		ff31471b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-22872	 	1947	 	 	 	 	 	 	 	 	22872	Not Reported	1925.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1b069720-0562-4840-b45e-1c7aa11e5dc3	C3L-01464		b1a27d0d-896f-4098-bd2b-52dd9b59b029	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	14	Not Reported	Male	White	Alive	-28740	 	1938	 	 	 	 	 	 	 	 	28740	 	1520.00	1520.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1b2350ca-cd83-4fa7-8b67-08723698df89	C3L-02211		0ea910af-d037-4e2e-bd43-b6728432ea1e	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	23	Not Reported	Female	Black or African American	Dead	-20669	330	1960	2018	 	 	 	 	 	 	 	20669	 	330.00	330.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1b42f935-3efa-4508-9d54-07247c6973e1	C3N-01342		d278cbc5-42a4-45db-a94d-0cece1ebbc48	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	15	Not Reported	Female	White	Alive	-24941	 	1948	 	 	 	 	 	 	 	 	24941	 	1749.00	1749.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1b4c05eb-63d9-11e8-bcf1-0a2705229b82	263d3f-I		ee5e10b6-824c-11e9-9a07-0a80fada099c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1bb1400e-04fd-448c-930f-2454805f39a4	NTN057		6dfe401a-1141-4498-9011-f4a8aadb5ff3	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1bc93e93-d026-4010-b808-26c5d6b76ba7	NTN052		ee47689b-3846-4f4b-a304-de2a2862d9eb	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1be99027-63d7-11e8-bcf1-0a2705229b82	20CO006		ff3191e8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		0.00	 	 	Not Reported	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c11288a-63d6-11e8-bcf1-0a2705229b82	05CO032		ff2f247e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c2a7daa-7cfa-4273-9e03-7bd7ef923ebb	PDAC186		ff493852-1f0e-43b2-a884-01f3271d2e2b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	345.00	345.00	127.00	Distant met recurrence/progression	8560/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
1c3815d3-e6f3-4841-a07f-d50d16c18ce2	AP-8MWD		ecdb5326-2d8e-4c55-b17a-aae68a528451	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	23740	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
1c39d311-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0SW		ff2ffac4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-30085	1365	1924	2009	 	 	 	 	 	 	 	30085	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1c63ce99-d028-11ea-b1fd-0aad30af8a83	C3L-00081		cfc7adc1-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Dead	-22629	473	1954	2017	 	 	 	 	 	 	 	22629	Not Reported	472.00	473.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"473\",\"days_to_birth\":\"-22629\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63cfc0-d028-11ea-b1fd-0aad30af8a83	C3L-00415		cfce8aa9-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-23586	 	1952	 	 	 	 	 	 	 	 	23586	Not Reported	1786.00	1786.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23586\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d0a2-d028-11ea-b1fd-0aad30af8a83	C3L-00445		cfd4c4ff-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-27320	3	1942	2017	 	 	 	 	 	 	 	27320	Not Reported	3.00	3.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"3\",\"days_to_birth\":\"-27320\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d251-d028-11ea-b1fd-0aad30af8a83	C3L-00568		cfdbd2e1-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Hispanic or Latino	Female	White	Alive	-27278	 	1942	 	 	 	 	 	 	 	 	27278	Not Reported	93.00	93.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27278\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d345-d028-11ea-b1fd-0aad30af8a83	C3L-00603		cfe2948b-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-26424	 	1944	 	 	 	 	 	 	 	 	26424	Not Reported	1794.00	1794.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26424\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d424-d028-11ea-b1fd-0aad30af8a83	C3L-00904		cfe91155-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-26190	795	1945	2019	 	 	 	 	 	 	 	26190	Not Reported	761.00	795.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"795\",\"days_to_birth\":\"-26190\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d504-d028-11ea-b1fd-0aad30af8a83	C3L-00923		cfef796e-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-25994	 	1945	 	 	 	 	 	 	 	 	25994	Not Reported	1792.00	1792.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25994\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d5d9-d028-11ea-b1fd-0aad30af8a83	C3L-00927		cff65e8d-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-27187	 	1942	 	 	 	 	 	 	 	 	27187	Not Reported	1777.00	1777.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27187\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d6b0-d028-11ea-b1fd-0aad30af8a83	C3L-00965		cffcdcf0-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-23305	 	1953	 	 	 	 	 	 	 	 	23305	Not Reported	1857.00	1857.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23305\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d788-d028-11ea-b1fd-0aad30af8a83	C3L-00993		d003fc32-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Dead	-27610	-1	1941	2017	 	 	 	 	 	 	 	27610	Not Reported	-1.00	-1.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"-1\",\"days_to_birth\":\"-27610\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63d909-d028-11ea-b1fd-0aad30af8a83	C3L-01000		d00a8558-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-21800	 	1957	 	 	 	 	 	 	 	 	21800	Not Reported	1376.00	1376.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21800\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63da0d-d028-11ea-b1fd-0aad30af8a83	C3L-01285		d0117dc4-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-19737	 	1963	 	 	 	 	 	 	 	 	19737	Not Reported	1697.00	1697.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19737\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63dae9-d028-11ea-b1fd-0aad30af8a83	C3L-01455		d017d337-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-32312	33	1928	2017	 	 	 	 	 	 	 	32312	Not Reported	16.00	33.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"33\",\"days_to_birth\":\"-32312\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63dcc3-d028-11ea-b1fd-0aad30af8a83	C3L-01606		d01e6296-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-24376	 	1950	 	 	 	 	 	 	 	 	24376	Not Reported	1782.00	1782.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24376\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63ddae-d028-11ea-b1fd-0aad30af8a83	C3L-01663		d0257a25-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Dead	-26868	1729	1943	2021	 	 	 	 	 	 	 	26868	Not Reported	1723.00	1729.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T1a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26868\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63de88-d028-11ea-b1fd-0aad30af8a83	C3L-01838		d02c2831-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25663	 	1947	 	 	 	 	 	 	 	 	25663	Not Reported	1707.00	1707.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25663\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63df63-d028-11ea-b1fd-0aad30af8a83	C3L-01884		d032c5e9-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-27320	1653	1942	2021	 	 	 	 	 	 	 	27320	Not Reported	1483.00	1653.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27320\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e03e-d028-11ea-b1fd-0aad30af8a83	C3L-02127		d0397906-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-24389	 	1950	 	 	 	 	 	 	 	 	24389	Not Reported	1826.00	1826.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24389\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e11c-d028-11ea-b1fd-0aad30af8a83	C3L-02130		d0401153-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-25907	1407	1946	2021	 	 	 	 	 	 	 	25907	Not Reported	1386.00	1407.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25907\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e1f8-d028-11ea-b1fd-0aad30af8a83	C3L-02163		d0473d64-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-21020	 	1960	 	 	 	 	 	 	 	 	21020	Not Reported	727.00	727.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21020\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e2ef-d028-11ea-b1fd-0aad30af8a83	C3L-02164		d04dbd53-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-21252	 	1959	 	 	 	 	 	 	 	 	21252	Not Reported	370.00	370.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21252\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e414-d028-11ea-b1fd-0aad30af8a83	C3L-02168		d054bd2a-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-24298	 	1951	 	 	 	 	 	 	 	 	24298	Not Reported	1421.00	1421.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Lung, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	N0	Stage II	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24298\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e5c7-d028-11ea-b1fd-0aad30af8a83	C3L-02170		d05be093-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-26717	 	1944	 	 	 	 	 	 	 	 	26717	Not Reported	27.00	27.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26717\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e6ac-d028-11ea-b1fd-0aad30af8a83	C3L-02349		d062cacb-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-29600	 	1936	 	 	 	 	 	 	 	 	29600	Not Reported	1800.00	1800.00	1016.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29600\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e857-d028-11ea-b1fd-0aad30af8a83	C3L-02358		d0693aff-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-27672	 	1941	 	 	 	 	 	 	 	 	27672	Not Reported	1792.00	1792.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27672\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63e93a-d028-11ea-b1fd-0aad30af8a83	C3L-02546		d06ff1b5-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-27236	 	1942	 	 	 	 	 	 	 	 	27236	Not Reported	1749.00	1749.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M1	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27236\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63eaf1-d028-11ea-b1fd-0aad30af8a83	C3L-02552		d0772e97-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-25114	1387	1948	2021	 	 	 	 	 	 	 	25114	Not Reported	1387.00	1387.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25114\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63ebdb-d028-11ea-b1fd-0aad30af8a83	C3L-02619		d07d7c8e-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-25633	 	1947	 	 	 	 	 	 	 	 	25633	Not Reported	505.00	505.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIIA	T4	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25633\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63ed9b-d028-11ea-b1fd-0aad30af8a83	C3L-02624		d084bee3-2dc9-11ec-b712-0a4e2186f121	 	Disqualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-23126	832	1955	2020	 	 	 	 	 	 	 	23126	Not Reported	776.00	832.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23126\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63ee84-d028-11ea-b1fd-0aad30af8a83	C3L-02625		d08bcabb-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-24167	489	1951	2019	 	 	 	 	 	 	 	24167	Not Reported	503.00	489.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"489\",\"days_to_birth\":\"-24167\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f055-d028-11ea-b1fd-0aad30af8a83	C3L-02627		d0925def-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-23667	 	1953	 	 	 	 	 	 	 	 	23667	Not Reported	1411.00	1411.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23667\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f13d-d028-11ea-b1fd-0aad30af8a83	C3L-02629		d0991a8e-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-21143	 	1960	 	 	 	 	 	 	 	 	21143	Not Reported	40.00	40.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21143\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f317-d028-11ea-b1fd-0aad30af8a83	C3L-02646		d09f8d4f-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-27321	1027	1943	2021	 	 	 	 	 	 	 	27321	Not Reported	1027.00	1027.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	NX	Stage IIIA	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27321\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f40c-d028-11ea-b1fd-0aad30af8a83	C3L-02648		d0a6e8b4-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-26627	261	1945	2018	 	 	 	 	 	 	 	26627	Not Reported	1.00	261.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIA	T2	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"261\",\"days_to_birth\":\"-26627\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f5f6-d028-11ea-b1fd-0aad30af8a83	C3L-02649		d0ad3569-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-22773	1072	1955	2021	 	 	 	 	 	 	 	22773	Not Reported	1019.00	1072.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	MX	 	 	 	 	N2	Stage IIIA	T3a	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22773\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f6e1-d028-11ea-b1fd-0aad30af8a83	C3L-02650		d0b3a771-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-19414	 	1965	 	 	 	 	 	 	 	 	19414	Not Reported	1422.00	1422.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19414\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f908-d028-11ea-b1fd-0aad30af8a83	C3L-02660		d0baa002-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-26351	355	1946	2019	 	 	 	 	 	 	 	26351	Not Reported	1.00	355.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"355\",\"days_to_birth\":\"-26351\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63f9f7-d028-11ea-b1fd-0aad30af8a83	C3L-02665		d0c13e02-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-18659	 	1966	 	 	 	 	 	 	 	 	18659	Not Reported	3.00	3.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	NX	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18659\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63fbee-d028-11ea-b1fd-0aad30af8a83	C3L-02669		d0c80635-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-26778	796	1944	2020	 	 	 	 	 	 	 	26778	Not Reported	637.00	796.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage II	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26778\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63fcd6-d028-11ea-b1fd-0aad30af8a83	C3L-02891		d0cf13fe-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-24282	 	1951	 	 	 	 	 	 	 	 	24282	Not Reported	1412.00	1412.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIA	T1c	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24282\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63fed7-d028-11ea-b1fd-0aad30af8a83	C3L-02951		d0d5ae58-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-22502	 	1956	 	 	 	 	 	 	 	 	22502	Not Reported	1420.00	1420.00	853.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	 	N0	Stage IIA	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22502\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c63ffbf-d028-11ea-b1fd-0aad30af8a83	C3L-02963		d0dc5159-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25991	 	1947	 	 	 	 	 	 	 	 	25991	Not Reported	1435.00	1435.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	 	N0	Stage I	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25991\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6401d8-d028-11ea-b1fd-0aad30af8a83	C3L-02964		d0e2e106-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-21194	766	1960	2020	 	 	 	 	 	 	 	21194	Not Reported	766.00	766.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	Unknown	 	 	 	 	N0	Stage IIA	T2b	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21194\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6402c3-d028-11ea-b1fd-0aad30af8a83	C3L-02968		d0ea01ec-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-23682	 	1953	 	 	 	 	 	 	 	 	23682	Not Reported	1795.00	1795.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	 	N0	Stage IIA	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23682\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6404e3-d028-11ea-b1fd-0aad30af8a83	C3L-02969		d0f0a74c-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-28108	 	1941	 	 	 	 	 	 	 	 	28108	Not Reported	1427.00	1427.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage I	T1c	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28108\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6405c7-d028-11ea-b1fd-0aad30af8a83	C3L-03272		d0f7366d-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-24779	 	1950	 	 	 	 	 	 	 	 	24779	Not Reported	155.00	155.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Upper lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IV	T4	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24779\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6407fd-d028-11ea-b1fd-0aad30af8a83	C3L-03678		d0fe1370-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-18220	485	1968	2019	 	 	 	 	 	 	 	18220	Not Reported	485.00	485.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"485\",\"days_to_birth\":\"-18220\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6408e5-d028-11ea-b1fd-0aad30af8a83	C3L-03961		d1045830-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-17760	 	1969	 	 	 	 	 	 	 	 	17760	Not Reported	5.00	5.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17760\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c640b35-d028-11ea-b1fd-0aad30af8a83	C3L-03962		d10b7730-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-23986	 	1952	 	 	 	 	 	 	 	 	23986	Not Reported	5.00	5.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Main bronchus	Lung, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23986\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c640c5a-d028-11ea-b1fd-0aad30af8a83	C3L-03963		d11224fb-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-26748	 	1945	 	 	 	 	 	 	 	 	26748	Not Reported	1398.00	1398.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26748\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c640e00-d028-11ea-b1fd-0aad30af8a83	C3L-03965		d11904cf-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-19760	 	1964	 	 	 	 	 	 	 	 	19760	Not Reported	1422.00	1422.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	N2	Stage IIIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19760\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c640ee1-d028-11ea-b1fd-0aad30af8a83	C3L-04013		d11f6d31-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-22508	 	1956	 	 	 	 	 	 	 	 	22508	Not Reported	5.00	5.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22508\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64108f-d028-11ea-b1fd-0aad30af8a83	C3L-04014		d125e193-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-21035	 	1960	 	 	 	 	 	 	 	 	21035	Not Reported	444.00	444.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IA	T1	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21035\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641170-d028-11ea-b1fd-0aad30af8a83	C3L-04071		d137cc9f-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25328	 	1948	 	 	 	 	 	 	 	 	25328	Not Reported	1532.00	1532.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-25328\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641335-d028-11ea-b1fd-0aad30af8a83	C3L-04391		d13ec05f-2dc9-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25641	 	1948	 	 	 	 	 	 	 	 	25641	Not Reported	1414.00	1414.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	 	N0	Stage I	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25641\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641421-d028-11ea-b1fd-0aad30af8a83	C3N-00211		302a7141-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Dead	-14952	92	1976	2017	 	 	 	 	 	 	 	14952	Not Reported	0.00	92.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"92\",\"days_to_birth\":\"-14952\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6415e2-d028-11ea-b1fd-0aad30af8a83	C3N-00221		3031766b-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	Not Reported	Alive	-28711	 	1938	 	 	 	 	 	 	 	 	28711	Not Reported	548.00	548.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28711\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6416ca-d028-11ea-b1fd-0aad30af8a83	C3N-00247		3037ff06-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-28330	 	1939	 	 	 	 	 	 	 	 	28330	Not Reported	1580.00	1580.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	N1	Stage IIA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28330\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641892-d028-11ea-b1fd-0aad30af8a83	C3N-00497		303edce6-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-23739	 	1951	 	 	 	 	 	 	 	 	23739	Not Reported	1812.00	1812.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIB	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23739\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64197c-d028-11ea-b1fd-0aad30af8a83	C3N-00555		30452774-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21771	 	1957	 	 	 	 	 	 	 	 	21771	Not Reported	787.00	787.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21771\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641b53-d028-11ea-b1fd-0aad30af8a83	C3N-01017		304b5f57-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20756	 	1960	 	 	 	 	 	 	 	 	20756	Not Reported	459.00	459.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20756\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641c39-d028-11ea-b1fd-0aad30af8a83	C3N-01018		3052507f-2dc6-11ec-b712-0a4e2186f121	 	Disqualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23718	 	1952	 	 	 	 	 	 	 	 	23718	Not Reported	419.00	419.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23718\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641e23-d028-11ea-b1fd-0aad30af8a83	C3N-01020		3058cc8b-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23841	 	1952	 	 	 	 	 	 	 	 	23841	Not Reported	403.00	403.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23841\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c641f10-d028-11ea-b1fd-0aad30af8a83	C3N-01025		30602a06-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-19325	 	1964	 	 	 	 	 	 	 	 	19325	Not Reported	7.00	7.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19325\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6420fb-d028-11ea-b1fd-0aad30af8a83	C3N-01028		30666387-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-26623	345	1944	2017	 	 	 	 	 	 	 	26623	Not Reported	345.00	345.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"345\",\"days_to_birth\":\"-26623\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6421e2-d028-11ea-b1fd-0aad30af8a83	C3N-01194		306dc9d1-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-25483	 	1947	 	 	 	 	 	 	 	 	25483	Not Reported	1741.00	1741.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6423d5-d028-11ea-b1fd-0aad30af8a83	C3N-01411		30742769-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23433	 	1953	 	 	 	 	 	 	 	 	23433	Not Reported	445.00	445.00	424.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23433\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6424b9-d028-11ea-b1fd-0aad30af8a83	C3N-01846		307a4dce-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Dead	-25518	533	1947	2018	 	 	 	 	 	 	 	25518	Not Reported	533.00	533.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	NX	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"533\",\"days_to_birth\":\"-25518\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6426b6-d028-11ea-b1fd-0aad30af8a83	C3N-01892		3080f798-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-28359	903	1939	2019	 	 	 	 	 	 	 	28359	Not Reported	903.00	903.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28359\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64279e-d028-11ea-b1fd-0aad30af8a83	C3N-01893		30877563-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-25889	663	1946	2019	 	 	 	 	 	 	 	25889	Not Reported	663.00	663.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIIA	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25889\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6429b6-d028-11ea-b1fd-0aad30af8a83	C3N-02252		308e0f81-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Not Reported	 	 	1949	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"0\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c642a9a-d028-11ea-b1fd-0aad30af8a83	C3N-02283		3095036d-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-24583	 	1950	 	 	 	 	 	 	 	 	24583	Not Reported	1522.00	1522.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	GX	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24583\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c642cb7-d028-11ea-b1fd-0aad30af8a83	C3N-02284		309b2f1d-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-25536	 	1947	 	 	 	 	 	 	 	 	25536	Not Reported	1818.00	1818.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Main bronchus	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25536\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c642d99-d028-11ea-b1fd-0aad30af8a83	C3N-02285		30a21536-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-26573	 	1944	 	 	 	 	 	 	 	 	26573	Not Reported	1833.00	1833.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26573\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c642ffd-d028-11ea-b1fd-0aad30af8a83	C3N-02288		30a86c6f-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-21432	 	1959	 	 	 	 	 	 	 	 	21432	Not Reported	1462.00	1462.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21432\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6430e2-d028-11ea-b1fd-0aad30af8a83	C3N-02289		30aec1c2-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-26931	 	1944	 	 	 	 	 	 	 	 	26931	Not Reported	1407.00	1407.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26931\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643357-d028-11ea-b1fd-0aad30af8a83	C3N-02300		30b5eda7-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-25366	 	1948	 	 	 	 	 	 	 	 	25366	Not Reported	1785.00	1785.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25366\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643493-d028-11ea-b1fd-0aad30af8a83	C3N-02339		30bcfb77-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-28848	 	1938	 	 	 	 	 	 	 	 	28848	Not Reported	170.00	170.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28848\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64363e-d028-11ea-b1fd-0aad30af8a83	C3N-02374		30c37a47-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-24670	 	1949	 	 	 	 	 	 	 	 	24670	Not Reported	1061.00	1061.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lung, NOS	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24670\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643723-d028-11ea-b1fd-0aad30af8a83	C3N-02375		30ca64f1-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21871	 	1957	 	 	 	 	 	 	 	 	21871	Not Reported	1179.00	1179.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21871\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6438c7-d028-11ea-b1fd-0aad30af8a83	C3N-02425		30d0b130-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22361	 	1956	 	 	 	 	 	 	 	 	22361	Not Reported	1064.00	1064.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22361\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6439ab-d028-11ea-b1fd-0aad30af8a83	C3N-02426		30d7c974-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	Asian	Dead	-25528	442	1947	2018	 	 	 	 	 	 	 	25528	Not Reported	338.00	442.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"442\",\"days_to_birth\":\"-25528\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643b5a-d028-11ea-b1fd-0aad30af8a83	C3N-02434		30de0143-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-27102	1849	1943	2022	 	 	 	 	 	 	 	27102	Not Reported	1802.00	1849.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27102\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643c43-d028-11ea-b1fd-0aad30af8a83	C3N-02435		30e535e6-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-23531	 	1954	 	 	 	 	 	 	 	 	23531	Not Reported	1462.00	1462.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIB	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23531\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643e02-d028-11ea-b1fd-0aad30af8a83	C3N-02494		30ec5ad4-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Female	Black or African American	Not Reported	-24467	 	1950	 	 	 	 	 	 	 	 	24467	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Middle lobe, lung	Middle lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-24467\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c643ee9-d028-11ea-b1fd-0aad30af8a83	C3N-02523		30f2cd1f-2dc6-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Not Reported	-22428	 	1956	 	 	 	 	 	 	 	 	22428	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-22428\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6440b1-d028-11ea-b1fd-0aad30af8a83	C3N-02575		a74160fa-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-25569	540	1947	2019	 	 	 	 	 	 	 	25569	Not Reported	491.00	540.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"540\",\"days_to_birth\":\"-25569\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644197-d028-11ea-b1fd-0aad30af8a83	C3N-02675		a750f315-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Dead	-25361	1338	1948	2021	 	 	 	 	 	 	 	25361	Not Reported	1338.00	1338.00	750.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N2	Stage IIIA	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25757\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644364-d028-11ea-b1fd-0aad30af8a83	C3N-03051		a75fda62-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-24037	 	1952	 	 	 	 	 	 	 	 	24037	Not Reported	735.00	735.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24037\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644444-d028-11ea-b1fd-0aad30af8a83	C3N-03072		a76f21b3-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22994	 	1955	 	 	 	 	 	 	 	 	22994	Not Reported	323.00	323.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22994\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64461c-d028-11ea-b1fd-0aad30af8a83	C3N-03076		a77e6d00-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-24846	 	1950	 	 	 	 	 	 	 	 	24846	Not Reported	332.00	332.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIA	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24846\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6446ff-d028-11ea-b1fd-0aad30af8a83	C3N-03092		a7869fd0-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Not Reported	 	 	1956	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"0\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6448e6-d028-11ea-b1fd-0aad30af8a83	C3N-03093		a7945b00-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	Other	Not Reported	 	 	1947	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lung, NOS	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"0\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6449cd-d028-11ea-b1fd-0aad30af8a83	C3N-03204		a79cddb1-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22652	 	1955	 	 	 	 	 	 	 	 	22652	Not Reported	835.00	835.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IA3	T1c	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22652\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644bbd-d028-11ea-b1fd-0aad30af8a83	C3N-03424		a7a34d94-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-27161	 	1943	 	 	 	 	 	 	 	 	27161	Not Reported	1330.00	1330.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27161\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644ca4-d028-11ea-b1fd-0aad30af8a83	C3N-03425		a7a98771-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-23574	 	1953	 	 	 	 	 	 	 	 	23574	Not Reported	1332.00	1332.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23574\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644ea0-d028-11ea-b1fd-0aad30af8a83	C3N-03441		a7b2ea94-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-24774	 	1950	 	 	 	 	 	 	 	 	24774	Not Reported	1332.00	1332.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	 	N2	Stage IIIA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24774\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c644f86-d028-11ea-b1fd-0aad30af8a83	C3N-03486		a7bb653f-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-23849	 	1952	 	 	 	 	 	 	 	 	23849	Not Reported	315.00	315.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	GX	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23849\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645197-d028-11ea-b1fd-0aad30af8a83	C3N-03662		a7c29723-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-23732	 	1953	 	 	 	 	 	 	 	 	23732	Not Reported	6.00	6.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	 	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23732\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64527c-d028-11ea-b1fd-0aad30af8a83	C3N-03848		a7ca12d0-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-20674	 	1961	 	 	 	 	 	 	 	 	20674	Not Reported	635.00	635.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20674\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c64549b-d028-11ea-b1fd-0aad30af8a83	C3N-03851		a7d05b19-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-16108	 	1974	 	 	 	 	 	 	 	 	16108	Not Reported	642.00	642.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16108\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645582-d028-11ea-b1fd-0aad30af8a83	C3N-03875		a7d7c18d-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-24881	 	1950	 	 	 	 	 	 	 	 	24881	Not Reported	1017.00	1017.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24881\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6457de-d028-11ea-b1fd-0aad30af8a83	C3N-03877		a7ded9bf-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-19674	 	1964	 	 	 	 	 	 	 	 	19674	Not Reported	682.00	682.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIIB	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19674\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6458c9-d028-11ea-b1fd-0aad30af8a83	C3N-03880		a7e52628-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-27786	 	1942	 	 	 	 	 	 	 	 	27786	Not Reported	736.00	736.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T1c	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27786\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645b1c-d028-11ea-b1fd-0aad30af8a83	C3N-03882		a7eb6143-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-25174	 	1949	 	 	 	 	 	 	 	 	25174	Not Reported	715.00	715.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25174\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645c44-d028-11ea-b1fd-0aad30af8a83	C3N-03886		a7f21454-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-22042	 	1957	 	 	 	 	 	 	 	 	22042	Not Reported	360.00	360.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	GX	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22042\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645d23-d028-11ea-b1fd-0aad30af8a83	C3N-04124		a7f8b66e-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22895	 	1955	 	 	 	 	 	 	 	 	22895	Not Reported	974.00	974.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22895\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645ebc-d028-11ea-b1fd-0aad30af8a83	C3N-04127		a7ff83e6-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23148	 	1954	 	 	 	 	 	 	 	 	23148	Not Reported	765.00	765.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T2b	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23148\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c645f9f-d028-11ea-b1fd-0aad30af8a83	C3N-04155		a805cce1-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-28060	 	1941	 	 	 	 	 	 	 	 	28060	Not Reported	46.00	46.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28060\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c646074-d028-11ea-b1fd-0aad30af8a83	C3N-04162		a80c78f6-2b73-11ec-b712-0a4e2186f121	 	Qualified	Lung Squamous Cell Carcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-17099	 	1971	 	 	 	 	 	 	 	 	17099	Not Reported	349.00	349.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	 	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17099\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c646210-d028-11ea-b1fd-0aad30af8a83	JHU HNSCC CR		a816efe7-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6462fd-d028-11ea-b1fd-0aad30af8a83	LSCC Global CR		a8263872-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6463d7-d028-11ea-b1fd-0aad30af8a83	LSCC Tumor ONLY CR		a844bd00-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6465b6-d028-11ea-b1fd-0aad30af8a83	LUAD Global CR (pool 1)		a853ff6d-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c6466a3-d028-11ea-b1fd-0aad30af8a83	LUAD Global CR (pool 2)		a8633e99-2b73-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1c91a7a9-63d9-11e8-bcf1-0a2705229b82	blcdb9-I		f5ce6bca-824c-11e9-9a07-0a80fada099c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1cb787b1-0023-4435-b4ae-a26a8a5c53f3	MB282		a69fb8c3-3b95-4dd3-858a-5b0b632b48dd	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	3285	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
1cc0625d-118a-11e9-afb9-0a9c39d33490	C3L-00771		04e0c174-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-31649	134	1929	2016	 	 	 	 	 	 	 	31649	Not Reported	134.00	134.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1ce589d3-f145-422b-8f7a-85f1e608fc39	C3L-01598		5b0b76dc-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-26697	913	1944	2019	 	 	 	 	 	 	 	26697	Not Reported	913.00	913.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1d23f919-63d7-11e8-bcf1-0a2705229b82	20CO007		ff319592-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1d469d14-63d6-11e8-bcf1-0a2705229b82	05CO033		ff2f2713-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1d5d727b-0bc7-4695-90a3-7a4907f4101a	AP-F595		c24e07cd-ef24-42fd-a12d-04fe62527a08	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	27027	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
1d759414-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0SX		ff311444-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-17774	 	1959	 	 	 	 	 	 	 	 	17774	Not Reported	1534.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IA	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1da67c04-9de1-441e-9626-c9a5470a7f02	MDA-20		e6910134-22d0-418c-bc23-5236e5f782c7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	67	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1dbc2b35-d3f2-47d1-89c1-87dfefeeeee6	C3N-01847		8f2ec684-f45b-4852-b138-0916d8479f78	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-21	Not Reported	Female	Other	Alive	-21027	 	1959	 	 	 	 	 	 	 	 	21027	 	32.00	32.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1df726a4-8520-4474-8c00-d238a7384be1	OSCC_06		60422ff9-30a2-41da-ac80-7839e85c05c5	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
1df7f83f-63d9-11e8-bcf1-0a2705229b82	c4155b-C		fc500f64-824c-11e9-9a07-0a80fada099c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1e05fbc3-c2f1-412b-8c4f-8fed99480130	41		c58fe7e9-c34d-41a2-80ad-2d8085e46c56	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	87	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1e7a2c18-f528-44b6-b4d8-3d3198e55d0f	C3L-02412		1b9d5c7a-35c8-4843-b61d-d4751d7d0c7a	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-7	Not Hispanic or Latino	Female	White	Alive	-27039	 	1943	 	 	 	 	 	 	 	 	27039	 	1110.00	1110.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1e8db80f-63d6-11e8-bcf1-0a2705229b82	05CO034		ff2f2bf2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1ebafb1f-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0T1		ff2bdc18-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	American Indian or Alaska Native	Alive	-20227	 	1954	 	 	 	 	 	 	 	 	20227	Not Reported	521.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3	Stage IIIC	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
1ef863b4-118a-11e9-afb9-0a9c39d33490	C3L-00780		04f0070f-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Hispanic or Latino	Female	White	Alive	-25267	 	1947	 	 	 	 	 	 	 	 	25267	Not Reported	1053.00	1053.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IA	Not Reported	8th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1f121037-782c-46b5-a26c-2e2063e0e204	20		44428a93-1db6-44c0-8a39-3a3e0c5b31ae	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1f4311cb-1fb9-11e9-b7f8-0a80fada099c	C3L-01553		50139190-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-21899	 	1957	 	 	 	 	 	 	 	 	21899	Not Reported	384.00	384.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21899\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1f44bbcb-2083-482a-9f75-25828c013e96	MOLM14 Pooled Reference		210e2493-e438-4156-a527-f7fc585c9264	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
1f59a7fc-e0a5-4135-8c40-2dfbe9a7a551	MB102		251140d7-de24-42eb-8d99-05a83443d3a4	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	8395	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
1f79bdee-1e11-4750-9f08-a0ba6523133e	C3L-01676		b86b3b48-b269-41ce-b41c-ca886b2c636e	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Hispanic or Latino	Male	White	Alive	-19568	 	1963	 	 	 	 	 	 	 	 	19568	 	489.00	489.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1fc52010-b6e7-4f19-9cad-afb7bb55d487	C3N-03211		5fa25706-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-16048	286	1973	2018	 	 	 	 	 	 	 	16048	Not Reported	278.00	286.00	210.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1fd9f337-63d6-11e8-bcf1-0a2705229b82	05CO035		ff2f2e5a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
1fdbbc88-2258-4ec9-b7d8-f5fe633e990a	WHIM12		24ba07cd-df9e-4d1e-8d85-e0cbfcd79e20	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
202280ea-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0T2		ff2ff3ce-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-24235	255	1943	2009	 	 	 	 	 	 	 	24235	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N3	Stage IV	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2024d5c3-8ddd-44a2-9114-3f454dfcf03f	55		01c6bd63-fc08-454a-b53e-afc8507042c3	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	48	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
202a6ed9-9417-4436-bebd-30d8d560276b	C3N-03767		1506dad8-a07d-4aec-bfa6-4beddbe9d117	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-24142	1002	1951	2020	 	 	 	 	 	 	 	24142	 	897.00	1002.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
20873fc1-f8b7-41de-a237-d2c8d44a6069	PDAC281		744959f9-1e3e-4f43-a676-e57cdfe5ebb9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	478.00	478.00	69.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
208a78e1-1d87-474d-a995-80abe7c32eb6	PDAC080		96367026-9a44-4884-94f2-ac57372d7237	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25550	 	271.00	271.00	154.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
208bfb7e-141e-4754-af0f-0dcef3d4fd5a	AP-KGMR		8a5fc532-33a5-4cdd-8bd9-8df125834b0a	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	24471	 	1221.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N0	Stage IIA	T2b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
20e173fc-1fb9-11e9-b7f8-0a80fada099c	C3L-01557		5023406c-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Black or African American	Alive	-18652	 	1966	 	 	 	 	 	 	 	 	18652	Not Reported	329.00	329.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18652\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2114ec5d-63d6-11e8-bcf1-0a2705229b82	05CO037		ff2f31cf-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	American Indian or Alaska Native	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
215978de-53f4-4f53-a441-f062103fdee4	2685		f3c1ab65-b60f-41bb-9799-72d0a9618198	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	77	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Pelvic bones, sacrum, coccyx and associated joints	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
217889b2-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0T3		ff313835-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-13680	 	1972	 	 	 	 	 	 	 	 	13680	Not Reported	1516.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1mi	Stage IB	T1c	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
21ac97b6-c265-410a-b98e-31735d669ab4	WHIM68		6d4c880f-5814-4636-9d4e-a2b19b080ef0	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
220ba648-122a-403d-8b81-9a32a4611c4c	AP-FEPR		db6ca33b-186e-48e6-947c-8ffd08be6ab6	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
221c00a5-5af5-4793-988d-223263ecfb38	WHIM30		364cd5ec-54cd-4c01-af96-bea6c4dda74c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
2254625e-63d6-11e8-bcf1-0a2705229b82	05CO039		ff2f357b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
227bf2e8-1fb9-11e9-b7f8-0a80fada099c	C3L-01560		50321506-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-19752	 	1963	 	 	 	 	 	 	 	 	19752	Not Reported	250.00	250.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-19752\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
22923fe7-21ea-4b3e-9159-ae3da2c7434e	X1M6		e5ceb5b0-b2d7-4d44-ba28-c6eb14316d13	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2920	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
22a90157-5e79-433c-8859-76893b79fbb0	C3N-02635		275aa0b1-beb0-4125-a44f-49043432b85f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-20705	 	1960	 	 	 	 	 	 	 	 	20705	 	1557.00	1557.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
22ac5d1d-118a-11e9-afb9-0a9c39d33490	C3L-00781		04ff4be3-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Hispanic or Latino	Female	White	Alive	-17739	 	1968	 	 	 	 	 	 	 	 	17739	Not Reported	1519.00	1519.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
22b3e9f3-10db-4733-964a-6f607da5c63a	C3L-02551		0af99211-789e-4f2b-9c8b-a4f28c7a1217	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-18567	 	1966	 	 	 	 	 	 	 	 	18567	 	1742.00	1742.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
22c2b43e-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0T6		ff2bb6f3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-18334	 	1959	 	 	 	 	 	 	 	 	18334	Not Reported	575.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIB	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
22e32210-cd82-4cad-a7c9-b6ae39e05ad1	C3N-02271		a4097646-2895-46ab-9668-3b17e8d6233b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	15	Not Reported	Female	White	Alive	-21506	 	1958	 	 	 	 	 	 	 	 	21506	 	1853.00	1853.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
233611b9-9c0f-4137-983e-867a541a2646	C3L-00966		4cc267c6-1b4f-4ffb-9b89-00eb0b107808	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Female	Other	Alive	-21878	 	1957	 	 	 	 	 	 	 	 	21878	 	1647.00	1647.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
23434bf3-f0eb-4070-964e-0c9a3ba61140	C3N-03000		5f285006-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-20844	487	1960	2019	 	 	 	 	 	 	 	20844	Not Reported	487.00	487.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
234b3e4e-525d-438f-a71a-4c007ba6ccbb	C3L-01662		5b29ec90-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-21979	344	1957	2018	 	 	 	 	 	 	 	21979	Not Reported	322.00	344.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	10	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
23856a8c-9b2b-455a-ab55-fb2791b79d05	NX033		e77e8ad3-c1a9-4991-b3c3-6da379e304d7	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
238fa734-63d6-11e8-bcf1-0a2705229b82	05CO041		ff2f37d6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
239c3712-63d7-11e8-bcf1-0a2705229b82	21CO006		ff319912-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
240188c9-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0T7		ff2bbe15-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-18756	 	1958	 	 	 	 	 	 	 	 	18756	Not Reported	631.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
241693ab-1fb9-11e9-b7f8-0a80fada099c	C3L-01603		5039001b-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Hispanic or Latino	Male	White	Alive	-23226	 	1953	 	 	 	 	 	 	 	 	23226	 	1765.00	1765.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-23226\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
24b35310-8beb-11ea-b1fd-0aad30af8a83	P001		24b68805-8beb-11ea-b1fd-0aad30af8a83	 	Disqualified	Other	Lung			Not Reported	Unspecified	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35854-8beb-11ea-b1fd-0aad30af8a83	P002		24b68a35-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1943	 	 	 	 	 	 	 	 	26929	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35997-8beb-11ea-b1fd-0aad30af8a83	P003		24b68bf9-8beb-11ea-b1fd-0aad30af8a83	 	Disqualified	Other	Lung			Not Reported	Unspecified	Not Reported	 	 	 	1964	 	 	 	 	 	 	 	 	19337	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35be2-8beb-11ea-b1fd-0aad30af8a83	P004		24b68dee-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	19345	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35cd4-8beb-11ea-b1fd-0aad30af8a83	P005		24b68fb1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1944	 	 	 	 	 	 	 	 	26554	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35dac-8beb-11ea-b1fd-0aad30af8a83	P006		24b69171-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1970	 	 	 	 	 	 	 	 	17104	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b35f98-8beb-11ea-b1fd-0aad30af8a83	P007		24b69341-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1949	 	 	 	 	 	 	 	 	24603	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3607a-8beb-11ea-b1fd-0aad30af8a83	P008		24b6950f-8beb-11ea-b1fd-0aad30af8a83	 	Disqualified	Lung Adenocarcinoma	Lung			Not Reported	Unspecified	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36177-8beb-11ea-b1fd-0aad30af8a83	P009		24b69730-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Unspecified	Not Reported	 	 	 	1963	 	 	 	 	 	 	 	 	19639	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36376-8beb-11ea-b1fd-0aad30af8a83	P010		24b69942-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1960	 	 	 	 	 	 	 	 	20615	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3645a-8beb-11ea-b1fd-0aad30af8a83	P011		24b69af7-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21543	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36531-8beb-11ea-b1fd-0aad30af8a83	P012		24b69cad-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1955	 	 	 	 	 	 	 	 	22579	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3672b-8beb-11ea-b1fd-0aad30af8a83	P013		24b69e94-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1972	 	 	 	 	 	 	 	 	16394	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36807-8beb-11ea-b1fd-0aad30af8a83	P014		24b6a05d-8beb-11ea-b1fd-0aad30af8a83	 	Disqualified	Other	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b368d8-8beb-11ea-b1fd-0aad30af8a83	P015		24b6a227-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1962	 	 	 	 	 	 	 	 	19781	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36b1d-8beb-11ea-b1fd-0aad30af8a83	P016		24b6a435-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21837	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36c03-8beb-11ea-b1fd-0aad30af8a83	P017		24b6a645-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1945	 	 	 	 	 	 	 	 	26026	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36cd2-8beb-11ea-b1fd-0aad30af8a83	P018		24b6a84d-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23958	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36ef3-8beb-11ea-b1fd-0aad30af8a83	P019		24b6aa02-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1938	 	 	 	 	 	 	 	 	28736	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b36fce-8beb-11ea-b1fd-0aad30af8a83	P020		24b6abc1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1950	 	 	 	 	 	 	 	 	24255	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b371f8-8beb-11ea-b1fd-0aad30af8a83	P021		24b6adc0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1931	 	 	 	 	 	 	 	 	31341	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b372d1-8beb-11ea-b1fd-0aad30af8a83	P022		24b6afc7-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1953	 	 	 	 	 	 	 	 	23320	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3753f-8beb-11ea-b1fd-0aad30af8a83	P023		24b6b191-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1960	 	 	 	 	 	 	 	 	20653	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37628-8beb-11ea-b1fd-0aad30af8a83	P024		24b6b363-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	21941	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3789b-8beb-11ea-b1fd-0aad30af8a83	P025		24b6b548-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1941	 	 	 	 	 	 	 	 	27568	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b379c5-8beb-11ea-b1fd-0aad30af8a83	P026		24b6b756-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1952	 	 	 	 	 	 	 	 	23678	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37a9a-8beb-11ea-b1fd-0aad30af8a83	P027		24b6b917-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1946	 	 	 	 	 	 	 	 	25626	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37c54-8beb-11ea-b1fd-0aad30af8a83	P028		24b6bb41-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1966	 	 	 	 	 	 	 	 	18461	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37d32-8beb-11ea-b1fd-0aad30af8a83	P029		24b6bd38-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1950	 	 	 	 	 	 	 	 	24446	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37e04-8beb-11ea-b1fd-0aad30af8a83	P030		24b6bf4c-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1967	 	 	 	 	 	 	 	 	18035	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b37fe2-8beb-11ea-b1fd-0aad30af8a83	P031		24b6c127-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1953	 	 	 	 	 	 	 	 	23147	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b380c7-8beb-11ea-b1fd-0aad30af8a83	P032		24b6c2f1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1938	 	 	 	 	 	 	 	 	28626	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38193-8beb-11ea-b1fd-0aad30af8a83	P033		24b6c4cd-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1965	 	 	 	 	 	 	 	 	18664	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38358-8beb-11ea-b1fd-0aad30af8a83	P034		24b6c6c1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1953	 	 	 	 	 	 	 	 	23172	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3845b-8beb-11ea-b1fd-0aad30af8a83	P035		24b6c874-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1934	 	 	 	 	 	 	 	 	30090	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3853f-8beb-11ea-b1fd-0aad30af8a83	P036		24b6ca31-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1955	 	 	 	 	 	 	 	 	22501	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3871b-8beb-11ea-b1fd-0aad30af8a83	P037		24b6cca3-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1955	 	 	 	 	 	 	 	 	22472	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b387fe-8beb-11ea-b1fd-0aad30af8a83	P038		24b6ce89-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21756	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b388cc-8beb-11ea-b1fd-0aad30af8a83	P039		24b6d050-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1942	 	 	 	 	 	 	 	 	27114	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38ab2-8beb-11ea-b1fd-0aad30af8a83	P040		24b6d21b-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1969	 	 	 	 	 	 	 	 	17363	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38b8f-8beb-11ea-b1fd-0aad30af8a83	P041		24b6d44a-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1976	 	 	 	 	 	 	 	 	14683	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38d81-8beb-11ea-b1fd-0aad30af8a83	P042		24b6d647-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	22242	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b38e5d-8beb-11ea-b1fd-0aad30af8a83	P043		24b6d7f4-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1938	 	 	 	 	 	 	 	 	28633	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39063-8beb-11ea-b1fd-0aad30af8a83	P044		24b6d9a7-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1944	 	 	 	 	 	 	 	 	26640	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39145-8beb-11ea-b1fd-0aad30af8a83	P045		24b6db5e-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1940	 	 	 	 	 	 	 	 	27905	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39353-8beb-11ea-b1fd-0aad30af8a83	P046		24b6dd21-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1958	 	 	 	 	 	 	 	 	21530	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39432-8beb-11ea-b1fd-0aad30af8a83	P047		24b6df86-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	22166	Primary	 	 	 	Not Reported	Not Reported	Acantholytic squamous cell carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39652-8beb-11ea-b1fd-0aad30af8a83	P048		24b6e15d-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1962	 	 	 	 	 	 	 	 	19978	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39731-8beb-11ea-b1fd-0aad30af8a83	P049		24b6e361-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1964	 	 	 	 	 	 	 	 	19332	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3995c-8beb-11ea-b1fd-0aad30af8a83	P050		24b6e5cd-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1947	 	 	 	 	 	 	 	 	25490	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39a34-8beb-11ea-b1fd-0aad30af8a83	P051		24b6e78f-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23826	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39c6d-8beb-11ea-b1fd-0aad30af8a83	P052		24b6e94e-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23961	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39d4b-8beb-11ea-b1fd-0aad30af8a83	P053		24b6eb73-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1953	 	 	 	 	 	 	 	 	23248	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b39f91-8beb-11ea-b1fd-0aad30af8a83	P054		24b6ed3c-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1958	 	 	 	 	 	 	 	 	21348	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a073-8beb-11ea-b1fd-0aad30af8a83	P055		24b6ef0b-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1950	 	 	 	 	 	 	 	 	24326	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a2d4-8beb-11ea-b1fd-0aad30af8a83	P056		24b6f0da-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1937	 	 	 	 	 	 	 	 	29059	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a3f4-8beb-11ea-b1fd-0aad30af8a83	P057		24b6f304-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1959	 	 	 	 	 	 	 	 	21091	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a4cf-8beb-11ea-b1fd-0aad30af8a83	P058		24b6f50e-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1931	 	 	 	 	 	 	 	 	31265	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a683-8beb-11ea-b1fd-0aad30af8a83	P059		24b6f6fa-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1959	 	 	 	 	 	 	 	 	20967	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a764-8beb-11ea-b1fd-0aad30af8a83	P060		24b6f8b8-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	22118	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a835-8beb-11ea-b1fd-0aad30af8a83	P061		24b6fa79-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1932	 	 	 	 	 	 	 	 	30906	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3a9f0-8beb-11ea-b1fd-0aad30af8a83	P062		24b6fc34-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21873	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3aace-8beb-11ea-b1fd-0aad30af8a83	P063		24b6fe41-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1948	 	 	 	 	 	 	 	 	25026	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3ab9d-8beb-11ea-b1fd-0aad30af8a83	P064		24b70040-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1945	 	 	 	 	 	 	 	 	26183	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3ad62-8beb-11ea-b1fd-0aad30af8a83	P065		24b7022a-8beb-11ea-b1fd-0aad30af8a83	 	Disqualified	Other	Lung			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3ae40-8beb-11ea-b1fd-0aad30af8a83	P066		24b70467-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1941	 	 	 	 	 	 	 	 	27461	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3af11-8beb-11ea-b1fd-0aad30af8a83	P067		24b7062b-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1975	 	 	 	 	 	 	 	 	15288	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b0e7-8beb-11ea-b1fd-0aad30af8a83	P068		24b707e5-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1948	 	 	 	 	 	 	 	 	24844	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b1c6-8beb-11ea-b1fd-0aad30af8a83	P069		24b709f0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21883	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b292-8beb-11ea-b1fd-0aad30af8a83	P070		24b70c80-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1932	 	 	 	 	 	 	 	 	30700	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b47b-8beb-11ea-b1fd-0aad30af8a83	P071		24b70e56-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1948	 	 	 	 	 	 	 	 	25042	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b55c-8beb-11ea-b1fd-0aad30af8a83	P072		24b7101f-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23891	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b62b-8beb-11ea-b1fd-0aad30af8a83	P073		24b711fc-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1946	 	 	 	 	 	 	 	 	25673	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b837-8beb-11ea-b1fd-0aad30af8a83	P074		24b71433-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1936	 	 	 	 	 	 	 	 	29257	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3b916-8beb-11ea-b1fd-0aad30af8a83	P075		24b715fa-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1969	 	 	 	 	 	 	 	 	17407	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3bb45-8beb-11ea-b1fd-0aad30af8a83	P076		24b717ff-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	22227	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3bc2a-8beb-11ea-b1fd-0aad30af8a83	P077		24b719c9-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1972	 	 	 	 	 	 	 	 	16173	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3bef1-8beb-11ea-b1fd-0aad30af8a83	P078		24b71bbf-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1946	 	 	 	 	 	 	 	 	25619	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3bff6-8beb-11ea-b1fd-0aad30af8a83	P079		24b71dc5-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1958	 	 	 	 	 	 	 	 	21316	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c21f-8beb-11ea-b1fd-0aad30af8a83	P080		24b71f97-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1941	 	 	 	 	 	 	 	 	27728	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c33a-8beb-11ea-b1fd-0aad30af8a83	P081		24b7217a-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	22182	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c56f-8beb-11ea-b1fd-0aad30af8a83	P082		24b723b1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1947	 	 	 	 	 	 	 	 	25241	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c64b-8beb-11ea-b1fd-0aad30af8a83	P083		24b72571-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1964	 	 	 	 	 	 	 	 	19141	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c882-8beb-11ea-b1fd-0aad30af8a83	P084		24b72729-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1958	 	 	 	 	 	 	 	 	21341	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3c95d-8beb-11ea-b1fd-0aad30af8a83	P085		24b728e1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1953	 	 	 	 	 	 	 	 	23206	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3cbab-8beb-11ea-b1fd-0aad30af8a83	P086		24b72acb-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1946	 	 	 	 	 	 	 	 	25658	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3cc9f-8beb-11ea-b1fd-0aad30af8a83	P087		24b72cef-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Lung			Not Reported	Male	Not Reported	 	 	 	1943	 	 	 	 	 	 	 	 	26740	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3cdba-8beb-11ea-b1fd-0aad30af8a83	P088		24b72ed3-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1954	 	 	 	 	 	 	 	 	22863	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3ce90-8beb-11ea-b1fd-0aad30af8a83	P089		24b730b9-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1942	 	 	 	 	 	 	 	 	27298	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3cf5e-8beb-11ea-b1fd-0aad30af8a83	P090		24b732b0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23827	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d10e-8beb-11ea-b1fd-0aad30af8a83	P091		24b734bf-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1952	 	 	 	 	 	 	 	 	23422	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d1ea-8beb-11ea-b1fd-0aad30af8a83	P092		24b736b0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21655	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d2b5-8beb-11ea-b1fd-0aad30af8a83	P093		24b73872-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1943	 	 	 	 	 	 	 	 	26671	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IV	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d37f-8beb-11ea-b1fd-0aad30af8a83	P094		24b73a3a-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1966	 	 	 	 	 	 	 	 	18359	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d53f-8beb-11ea-b1fd-0aad30af8a83	P095		24b73c02-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1950	 	 	 	 	 	 	 	 	24329	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIA	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d61f-8beb-11ea-b1fd-0aad30af8a83	P096		24b73dce-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Squamous Cell Carcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1947	 	 	 	 	 	 	 	 	25215	Primary	 	 	 	Not Reported	Not Reported	Squamous Cell Carcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IV	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d6ed-8beb-11ea-b1fd-0aad30af8a83	P097		24b73fb1-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1950	 	 	 	 	 	 	 	 	24302	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d7bc-8beb-11ea-b1fd-0aad30af8a83	P098		24b741a5-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1970	 	 	 	 	 	 	 	 	16971	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIA	 	 	 	 	N1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3d98c-8beb-11ea-b1fd-0aad30af8a83	P099		24b74353-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	21907	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3da66-8beb-11ea-b1fd-0aad30af8a83	P100		24b74502-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1940	 	 	 	 	 	 	 	 	27857	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3db33-8beb-11ea-b1fd-0aad30af8a83	P101		24b746ba-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1961	 	 	 	 	 	 	 	 	20075	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IV	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3dbf9-8beb-11ea-b1fd-0aad30af8a83	P102		24b74904-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1966	 	 	 	 	 	 	 	 	18556	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IIIB	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3dde2-8beb-11ea-b1fd-0aad30af8a83	P103		24b74acf-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	1956	 	 	 	 	 	 	 	 	21977	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IV	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3dec3-8beb-11ea-b1fd-0aad30af8a83	P104		24b74ca2-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1964	 	 	 	 	 	 	 	 	19280	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IV	 	 	 	 	N2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3df92-8beb-11ea-b1fd-0aad30af8a83	P109		24b74e83-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1973	 	 	 	 	 	 	 	 	15827	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3e25f-8beb-11ea-b1fd-0aad30af8a83	P110		24b750ec-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1968	 	 	 	 	 	 	 	 	17593	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IA	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3e355-8beb-11ea-b1fd-0aad30af8a83	P111		24b752fc-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1951	 	 	 	 	 	 	 	 	23974	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3e42e-8beb-11ea-b1fd-0aad30af8a83	P112		24b754f0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	1957	 	 	 	 	 	 	 	 	21539	Primary	 	 	 	Not Reported	Not Reported	Adenocarcinoma	Not Reported	Lung, NOS	Lung, NOS	Not Reported	IB	 	 	 	 	N0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"aajcc_pathologic_m\":null}	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3e63b-8beb-11ea-b1fd-0aad30af8a83	QC1_(Tumor+Adjacent Normal)pool		24b756ca-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Lung			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24b3e719-8beb-11ea-b1fd-0aad30af8a83	QC2_LateStageTumor_pool		24b758d0-8beb-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Primary	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Lung, NOS	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Academia Sinica LUAD-100	International Cancer Proteogenome Consortium
24cb0fcb-63d6-11e8-bcf1-0a2705229b82	05CO044		ff2fad6e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIB	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
24f12372-b37a-4967-a9c0-ab237940a959	C3L-02220		10163b22-2f50-451f-a3d1-cf7dc694d31d	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	Black or African American	Alive	-26508	 	1944	 	 	 	 	 	 	 	 	26508	 	709.00	709.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
251e36a8-63d7-11e8-bcf1-0a2705229b82	21CO007		ff319b6f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
253cee23-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YC		ff2be43f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-21685	 	1949	 	 	 	 	 	 	 	 	21685	Not Reported	990.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1mi	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
25bac97e-ae38-44eb-b61a-1d8d383f0085	C3L-01637		5b1aab75-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-28706	715	1938	2019	 	 	 	 	 	 	 	28706	Not Reported	715.00	715.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
25bf2158-3ab8-4f85-b801-c0d646b3893e	C3N-01761		53bbdd37-3a02-470f-8526-c3adf736a0c4	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	20	Not Reported	Female	White	Alive	-25238	 	1948	 	 	 	 	 	 	 	 	25238	 	1917.00	1917.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
25e420f4-1fb9-11e9-b7f8-0a80fada099c	C3L-01607		503fc286-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-30462	 	1933	 	 	 	 	 	 	 	 	30462	 	1794.00	1794.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-30462\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
260fb98a-63d6-11e8-bcf1-0a2705229b82	05CO045		ff2fb3c2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2657813b-ca46-4047-889c-f98ed05f2796	C3N-00512		5d8c43bc-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-15559	1006	1974	2019	 	 	 	 	 	 	 	15559	Not Reported	1006.00	1006.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
267ec01a-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YD		ff30d1df-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-23021	 	1946	 	 	 	 	 	 	 	 	23021	Not Reported	769.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage IIB	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2693abc5-4d4f-49c8-a689-0532d9d71fa8	AP-9PXS		cb03e92d-8d4b-4a0f-8f9f-eba3818f9d3e	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24836	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
26cb8025-b6c8-4943-8532-47bc895166b3	C3L-01967		8dd83f61-eb0e-4dd1-93f4-a5ff3075c65e	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	Not Reported	Alive	-23966	 	1951	 	 	 	 	 	 	 	 	23966	 	0.00	0.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
26e577e8-0794-4234-b401-9de63fc51a6a	C3L-02357		5fd5504a-895f-4ce5-9293-0ee126122aaf	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-19771	 	1963	 	 	 	 	 	 	 	 	19771	 	349.00	349.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
26f4d1fa-ee01-4bf5-b0d2-766619d20a5c	C3L-01732		24b7daa7-21cd-4cde-ad7d-361a24e5d91d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-21	Not Reported	Female	White	Alive	-30733	 	1933	 	 	 	 	 	 	 	 	30733	 	1085.00	1085.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
274d1bfb-63d6-11e8-bcf1-0a2705229b82	05CO047		ff2fb75d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2794dfbd-93bf-4369-bbe0-01e692938eed	12		313cf520-35ff-4963-89c8-21b1b57aca06	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	69	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
27bf90ad-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YF		ff3135cf-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Alive	-24660	 	1942	 	 	 	 	 	 	 	 	24660	Not Reported	1535.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage I	T1b	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
27c73fcd-8c45-475c-bcfc-4c51a01f2e67	MB099		37b7c80b-92ba-41bf-b738-782a24cfb426	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2920	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
27d10bf9-bab9-4875-ac2f-8e44ab646fd7	CU-11		bba1bc80-d221-4625-9e4c-fc31093e96c5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	92	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
27e42cfa-a743-43ee-bd6a-a8020a982a8c	C3L-03589		ffba8201-f998-42e7-a746-3707e0eaac6e	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-7	Not Hispanic or Latino	Female	White	Alive	-21871	 	1958	 	 	 	 	 	 	 	 	21871	 	883.00	883.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
28294208-46e9-4581-ae2f-27f239f8ae78	C3N-01167		5e29e876-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-28149	754	1939	2019	 	 	 	 	 	 	 	28149	Not Reported	754.00	754.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
287695c7-59dd-47b2-bf0f-0895b23258c0	WHIM14		b7a8cdf9-3b76-41d5-a826-073533d8b9b7	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
287855cd-a513-4142-88c7-a6734fd69e59	PDAC270		f2b9bc8c-5224-498f-a521-ba536d550bb9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	29930	 	29.00	29.00	302.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
28873930-63d6-11e8-bcf1-0a2705229b82	05CO048		ff2fbaf8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
28c67334-e064-4692-8868-add8d830e983	C3L-04853		5cd85546-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-31222	279	1933	2019	 	 	 	 	 	 	 	31222	Not Reported	251.00	279.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
28d18f3d-63d7-11e8-bcf1-0a2705229b82	22CO004		ff2b78d1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
28fe59bd-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YG		ff2fb258-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-23058	 	1946	 	 	 	 	 	 	 	 	23058	Not Reported	666.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3a	Stage IIIC	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
290611f4-da9c-4614-8c76-56ff8049b0fa	AP-D9X4		fe0bcf83-f8ca-42f4-86ea-10bfb33c6083	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	26297	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
29182985-6507-4015-9312-8492afc060ad	WHIM25		8fe9bea8-c5d3-4a40-8bbb-6a47821870cf	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
2918bdf7-3046-416a-bca8-e6bea1d3859e	PDAC280		fe9c737a-64f8-44c3-81a2-4b9987f9cd40	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18250	 	720.00	720.00	526.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
2945b77e-33ec-470b-93ab-a7052251b9f5	NX029		b0ff9b8e-6928-4108-a03f-f34c2d2441b6	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2956fdfc-5bc2-4446-84a0-20092b07a792	C3N-02332		ac1153a8-2ec3-447d-9293-e44d3daa1941	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Female	Other	Alive	-24138	 	1951	 	 	 	 	 	 	 	 	24138	 	741.00	741.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
29787fcd-8aec-4ef2-aae8-de02ffc07314	NTN025		b1b9d870-d98e-4180-8a01-2e6723a74d9f	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
297ac34a-cdfe-487d-8210-346932eedbbe	C3L-01277		4a8b2e56-d1ae-40e3-be00-4655374e1816	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-29	Not Reported	Female	White	Alive	-22367	 	1955	 	 	 	 	 	 	 	 	22367	 	1732.00	1732.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2993c8b1-bf22-4f09-92ab-0a6d991c93de	AP-QD4Q		b17f2548-ba3f-40a4-8e67-3206d8d33289	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	18992	 	1022.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
2995a447-118a-11e9-afb9-0a9c39d33490	C3L-00905		050e881a-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23742	 	1951	 	 	 	 	 	 	 	 	23742	Not Reported	1749.00	1749.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
29bd5349-63d6-11e8-bcf1-0a2705229b82	05CO049		ff2fbfe4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
29fc111e-69fe-40ae-8cd4-f8f92a7fac7b	AP-M3W6		91bdcdd5-7584-4622-8210-f502d6a2e6e0	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
2a0e6d9d-63d7-11e8-bcf1-0a2705229b82	22CO006		ff2b7bb0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2a306e1b-2a79-4e0e-98c8-0c809025e63a	AP-JK59		a866fd4c-4030-47f1-b8c8-fb05b3817c4c	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	18627	 	1070.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
2a407548-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YI		ff2f36af-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-22961	 	1947	 	 	 	 	 	 	 	 	22961	Not Reported	1505.00	 	 	Not Reported	8522/3	Infiltrating duct and lobular carcinoma	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage I	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2a4d5c2c-db95-43d9-98ca-4af132ffbbc3	C3N-00859		61c4d6df-5c65-4be9-a81c-025e2079e6b5	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	16	Not Reported	Female	White	Alive	-22165	 	1956	 	 	 	 	 	 	 	 	22165	 	1722.00	1722.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2aa8dafc-2f41-424c-90f4-a1be93e1cb68	MB174		38769f97-89c2-473a-8a43-fa1e8e5f8448	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	5840	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
2ae9b699-e485-4880-a3a2-f84970d70a5a	1		37023fc4-2a3b-48b3-b8e5-24ced11abee8	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	82	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2ae9b699-e485-4880-a3a2-f84970d70a5a	1		e9c85c5c-d927-4daf-9392-df93bca8353d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	82	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2af8ac24-63d6-11e8-bcf1-0a2705229b82	05CO050		ff2fc4a4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2b4204ab-87af-4a79-913f-fabdcb2d02b4	OSCC_41		82901169-4165-40db-b88f-d9b2781a23d4	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Floor of mouth, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
2b604152-3251-4abd-a782-fb4ae42e346c	AP-5L2V		b704bd79-fe2a-479a-ab29-69fd90840f97	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	22279	 	398.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N0	Stage IIA	T2b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
2b6db9ed-9fbf-488e-927c-fc3cd273ec5f	C3N-02994		062bfe85-616c-40de-a363-38395c05d722	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-25102	 	1949	 	 	 	 	 	 	 	 	25102	 	1385.00	1385.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2b811776-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YL		ff2faecc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-17702	 	1962	 	 	 	 	 	 	 	 	17702	Not Reported	1474.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2bcedd65-d776-411a-a459-b7f062cc9134	PDAC042		43c2e9fc-5c69-4df6-a86e-00b2424c62e7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	15695	 	1086.00	1086.00	420.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
2bd188fe-2c61-4481-af47-7805ca1d9ea8	C3L-01633		91c2b431-0c8d-40e4-8aa8-5d00f733658d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-22150	 	1956	 	 	 	 	 	 	 	 	22150	 	664.00	664.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2bf62061-246d-46e4-adcf-9f122748d0bc	NX031		91afa0a9-f7cd-4f3a-aa35-d23ca8552184	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2c346c06-63d6-11e8-bcf1-0a2705229b82	05CO053		ff2fc850-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2c58dc70-261f-4a1f-b1af-4b7324bed392	17-00444		c5438f1b-c6b6-4656-90b5-b452a35d5a7f	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-27508	93	 	 	75	 	 	false	Medical Record	 	United States	27508	 	93.00	 	 	Unknown tumor status	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2c9d2692-1fb9-11e9-b7f8-0a80fada099c	C3L-01836		5047ffa3-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Hispanic or Latino	Male	White	Alive	-17215	 	1970	 	 	 	 	 	 	 	 	17215	 	1575.00	1575.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17215\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2cb645f4-0733-48c8-9021-c880ebf23c4b	C3L-04475		5cbd4955-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-28419	893	1940	2021	 	 	 	 	 	 	 	28419	Not Reported	881.00	893.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2cbe7b53-63d8-11e8-bcf1-0a2705229b82	TCGA-A2-A0YM		ff305503-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-24831	 	1941	 	 	 	 	 	 	 	 	24831	Not Reported	965.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2d564f02-68ff-40f7-8925-9387d98582f3	C3N-02632		45ae8e19-9592-4186-bcb9-46bffe0a4d77	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	White	Alive	-21150	 	1959	 	 	 	 	 	 	 	 	21150	 	1405.00	1405.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2d701098-63d6-11e8-bcf1-0a2705229b82	05CO054		ff2fcad4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2d91591d-e2d2-4a13-af75-7cc0eca9c4ec	CU-13		2b89df56-3cce-4f88-8b5f-3e7f240a3243	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	67	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2d93f181-de35-4553-978a-ac868cf40322	C3N-02262		e868d2c8-3012-4e79-a060-78031b86ca15	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	White	Alive	-24568	 	1950	 	 	 	 	 	 	 	 	24568	 	1852.00	1852.00	1401.00	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2dadf04d-43cd-4335-94ae-47a465247d0f	PDAC038		149c4c4c-863e-47c7-b1c9-61e15cf87594	 	Disqualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28470	 	1051.00	1051.00	767.00	Loco-regional recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
2db24546-75ad-4105-af29-e309dac3a889	JX0102		81c86605-bd8e-4841-9fe7-cd8b084be869	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2dd556f8-37ae-4d29-8ab4-5ef7095dc39f	16-00474		0390a25f-f71c-446f-8bf7-cda18f23f299	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Black or African American	Alive	-18512	 	 	 	50	 	 	false	 	 	United States	18512	 	424.00	424.00	 	Tumor free	Not Reported	Acute myeloid leukemia, t(8;21)(q22;q22)	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2defc710-1e1d-4254-bab5-bda0839e5bd6	29		975db992-009b-4cd6-8f4b-659c76d275c7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2dfc05ef-63d8-11e8-bcf1-0a2705229b82	TCGA-A6-3807		ff2bf844-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Alive	-19624	 	1956	 	 	 	 	 	 	 	 	19624	Not Reported	1054.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2e36da05-deef-49b5-af92-09b5c17dd5bc	MB118		8d56faff-e436-4462-bb4e-5ce990665fc5	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	4015	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
2e5b4a35-6949-447f-bb2e-8160045c40d2	PDAC010		da790884-e0a6-4f79-9400-a8263e1ccc11	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	 	1280.00	1280.00	1099.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
2e6540fd-1fb9-11e9-b7f8-0a80fada099c	C3L-01861		50509fba-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20974	 	1959	 	 	 	 	 	 	 	 	20974	 	1761.00	1761.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20974\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2e864bd1-d1fe-4942-b6a4-f80624f72802	MB271		20284e27-d8b3-4198-b7a8-e44e8c843ce8	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
2e8728ef-9103-44de-bcda-b6b429ea62e2	2303		61f0f1f2-062b-43f3-8f9b-4985c99d82aa	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	80	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2e9286ac-bd5b-4565-bf9c-4f55fd48bb65	5462		e4d4e46a-913f-462b-945c-87585bdef6fe	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2ec22c96-ee70-48a6-bc34-4923a31adc9d	C3N-01525		5bdd63f2-305d-4c47-aa23-4bc0ca4bed90	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-15	Not Reported	Female	Other	Alive	-28217	 	1939	 	 	 	 	 	 	 	 	28217	 	678.00	678.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2eca2103-118a-11e9-afb9-0a9c39d33490	C3L-00918		051dc9a8-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-25195	1192	1947	2020	 	 	 	 	 	 	 	25195	Not Reported	1176.00	1192.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2ee1964f-9d11-48a2-8297-60f7921d8e9d	89		c60dfe06-c875-4ff7-8dd9-8426ed810bc5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
2f35a510-63d8-11e8-bcf1-0a2705229b82	TCGA-A6-3808		ff2c30ea-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Alive	-26666	 	1936	 	 	 	 	 	 	 	 	26666	Not Reported	1014.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
2f35aea1-2028-429d-8e54-ed360f3cf078	C3L-03264		26eae324-9c00-414e-be14-0553417c1dd0	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-26833	 	1944	 	 	 	 	 	 	 	 	26833	 	847.00	847.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2f6b797a-5a51-482b-bc6e-fa7e5468180c	WHIM 02		08e3341b-9f78-4a38-908a-14726fc3d95b	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
2f7cf95f-e94e-4898-8ef0-60739e313422	C3L-02990		42f10781-19ea-4fcd-8f1f-c42714a9e903	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-14	Not Hispanic or Latino	Female	White	Alive	-24520	 	1951	 	 	 	 	 	 	 	 	24520	 	274.00	274.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
2fc6f553-0f59-443f-a937-e5086611e9a9	NTN063		a5c02969-401f-4bc7-bbac-88bea8a5cba1	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
301c2377-cb9d-43d4-bf4b-3cf478fc2197	C3N-04283		606f6018-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-24187	1	1952	2018	 	 	 	 	 	 	 	24187	Not Reported	1.00	1.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Pancreas, NOS	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R2	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3073d082-63d8-11e8-bcf1-0a2705229b82	TCGA-A6-3810		ff2c4265-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Alive	-22999	 	1947	 	 	 	 	 	 	 	 	22999	Not Reported	1111.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
307fd220-d518-40ae-8eea-8cdc3476f145	C3N-01375		5e3769c8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-25895	143	1946	2017	 	 	 	 	 	 	 	25895	Not Reported	396.00	143.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
309801a3-3169-4987-9aef-47f25005eca6	C3L-00976		12a64ad7-dc58-43cc-9766-d5361fe6b154	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Reported	Male	Other	Dead	-24864	896	1949	2020	 	 	 	 	 	 	 	24864	 	896.00	896.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cardiovascular Disorder, NOS	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3150e7be-07b2-4deb-ad73-b99fce3db045	73		d947e173-8961-4439-a05f-e774fa621059	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
31659499-6500-4dbb-8fcd-8abaeebd2211	C3N-02070		f5e8fdbb-06a7-48dd-bbe8-19628ccc3a04	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Male	Asian	Alive	-20054	 	1962	 	 	 	 	 	 	 	 	20054	 	352.00	352.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
316c9b11-048b-4d88-a90e-03c478b5211f	C3N-01341		5022df72-63f3-4b56-8684-1e7619d27a8d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Alive	-23404	 	1953	 	 	 	 	 	 	 	 	23404	 	343.00	343.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3195cf36-998a-4f48-a7f1-a84f2b9fdcc5	OSCC_39		0833dc7e-0fbc-4ee5-8385-5329898e31a5	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
319d0e7a-a654-4146-8fc6-1f9654d1de59	MB226		aa44898b-0da3-44fe-aa2d-a87cca673567	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1825	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
31acb306-1fb9-11e9-b7f8-0a80fada099c	C3L-01882		5065c7a8-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-17820	 	1968	 	 	 	 	 	 	 	 	17820	Not Reported	350.00	350.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17820\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
31d14399-b60b-4d00-ad37-72a55ec733df	C3L-07036		5d2173f4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Male	White	Not Reported	 	 	1940	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
31d4b8ba-63d8-11e8-bcf1-0a2705229b82	TCGA-A7-A0CD		ff2ffe73-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-24242	 	1943	 	 	 	 	 	 	 	 	24242	Not Reported	1165.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
320a183a-5a99-4084-8a76-82b53360c809	AP-K24D		1a3c1f4d-558f-4197-87af-00123d153101	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	25932	 	141.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N1	Stage IIIA	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
320df578-47ba-41a8-9991-a4972ce48810	C3L-01054		5abf1b85-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-14036	860	1978	2019	 	 	 	 	 	 	 	14036	Not Reported	860.00	860.00	457.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f4a65-0a5d-11eb-bc0e-0aad30af8a83	604		3281d19d-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14964	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f4fe6-0a5d-11eb-bc0e-0aad30af8a83	01BR001		3281d3c2-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	20074	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5116-0a5d-11eb-bc0e-0aad30af8a83	01BR008		3281d5d4-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5207-0a5d-11eb-bc0e-0aad30af8a83	01BR009		3281d7e4-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f52eb-0a5d-11eb-bc0e-0aad30af8a83	01BR010		3281daef-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f53c8-0a5d-11eb-bc0e-0aad30af8a83	01BR015		3281dd09-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	12774	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f57e4-0a5d-11eb-bc0e-0aad30af8a83	01BR017		3281debc-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	16424	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5945-0a5d-11eb-bc0e-0aad30af8a83	01BR018		3281e075-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24089	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5a36-0a5d-11eb-bc0e-0aad30af8a83	01BR020		3281e23b-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5b14-0a5d-11eb-bc0e-0aad30af8a83	01BR023		3281e3ff-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5bee-0a5d-11eb-bc0e-0aad30af8a83	01BR025		3281e5e0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22629	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5cc6-0a5d-11eb-bc0e-0aad30af8a83	01BR026		3281e76b-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5d9e-0a5d-11eb-bc0e-0aad30af8a83	01BR027		3281e89c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	29199	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5e74-0a5d-11eb-bc0e-0aad30af8a83	01BR030		3281ea3f-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	30659	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f5f4b-0a5d-11eb-bc0e-0aad30af8a83	01BR031		3281eb83-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22264	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f604b-0a5d-11eb-bc0e-0aad30af8a83	01BR032		3281edf2-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	15329	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6256-0a5d-11eb-bc0e-0aad30af8a83	01BR033		3281ef62-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14599	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6408-0a5d-11eb-bc0e-0aad30af8a83	01BR040		3281f0e4-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14599	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f65b9-0a5d-11eb-bc0e-0aad30af8a83	01BR042		3281f271-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21139	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6771-0a5d-11eb-bc0e-0aad30af8a83	01BR043		3281f38e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21747	Not Reported	0.00	0.00	0.00	Not Reported	8140/33	Adenocarcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6928-0a5d-11eb-bc0e-0aad30af8a83	01BR044		3281f534-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	30994	Not Reported	 	 	 	Not Reported	8070/33	Squamous cell carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6add-0a5d-11eb-bc0e-0aad30af8a83	03BR002		3281f672-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22112	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6c98-0a5d-11eb-bc0e-0aad30af8a83	03BR004		3281f99a-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	32363	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f6e5a-0a5d-11eb-bc0e-0aad30af8a83	03BR005		3281fb25-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22417	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f701b-0a5d-11eb-bc0e-0aad30af8a83	03BR006		3281fca0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	15512	Not Reported	0.00	0.00	0.00	Not Reported	8500/2	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f71ea-0a5d-11eb-bc0e-0aad30af8a83	03BR010		3281fe18-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28652	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f73c0-0a5d-11eb-bc0e-0aad30af8a83	03BR011		3281ff44-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	25945	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Invasive lobular carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7599-0a5d-11eb-bc0e-0aad30af8a83	03BR013		328200f2-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19010	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7770-0a5d-11eb-bc0e-0aad30af8a83	05BR001		3282026c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	25549	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7984-0a5d-11eb-bc0e-0aad30af8a83	05BR003		328204a9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	13717	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7b7d-0a5d-11eb-bc0e-0aad30af8a83	05BR004		32820612-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7d6e-0a5d-11eb-bc0e-0aad30af8a83	05BR005		32820790-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18249	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f7f64-0a5d-11eb-bc0e-0aad30af8a83	05BR009		3282098b-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23299	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f8188-0a5d-11eb-bc0e-0aad30af8a83	05BR016		32820b3c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28530	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f8397-0a5d-11eb-bc0e-0aad30af8a83	05BR026		32820cf3-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26097	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f85a8-0a5d-11eb-bc0e-0aad30af8a83	05BR029		32820f72-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22599	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f87bb-0a5d-11eb-bc0e-0aad30af8a83	05BR038		3282114e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19040	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f89d1-0a5d-11eb-bc0e-0aad30af8a83	05BR042		3282132a-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14599	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f8beb-0a5d-11eb-bc0e-0aad30af8a83	05BR043		3282152e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18249	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f8e0f-0a5d-11eb-bc0e-0aad30af8a83	05BR044		328216ec-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22903	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f903a-0a5d-11eb-bc0e-0aad30af8a83	05BR045		3282189e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22264	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9271-0a5d-11eb-bc0e-0aad30af8a83	06BR003		32821a53-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	27374	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f94c9-0a5d-11eb-bc0e-0aad30af8a83	06BR005		32821c0b-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21169	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9693-0a5d-11eb-bc0e-0aad30af8a83	06BR006		32821ea3-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18614	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Performed	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f988c-0a5d-11eb-bc0e-0aad30af8a83	06BR014		328220c6-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18614	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9a31-0a5d-11eb-bc0e-0aad30af8a83	09BR001		32822287-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9bd2-0a5d-11eb-bc0e-0aad30af8a83	09BR004		32822444-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	27496	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9d7a-0a5d-11eb-bc0e-0aad30af8a83	09BR005		32822602-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14143	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327f9f23-0a5d-11eb-bc0e-0aad30af8a83	09BR007		328227c9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28287	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa0db-0a5d-11eb-bc0e-0aad30af8a83	11BR003		328229a9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19527	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa292-0a5d-11eb-bc0e-0aad30af8a83	11BR004		32822bb4-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19892	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa44c-0a5d-11eb-bc0e-0aad30af8a83	11BR006		32822d5c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19892	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa60f-0a5d-11eb-bc0e-0aad30af8a83	11BR009		32822f19-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	15877	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa7d6-0a5d-11eb-bc0e-0aad30af8a83	11BR010		328230db-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	12957	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fa99f-0a5d-11eb-bc0e-0aad30af8a83	11BR011		32823296-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26097	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fac01-0a5d-11eb-bc0e-0aad30af8a83	11BR012		32823473-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28226	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fae36-0a5d-11eb-bc0e-0aad30af8a83	11BR013		3282366e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	25549	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb028-0a5d-11eb-bc0e-0aad30af8a83	11BR014		32823844-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14356	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb213-0a5d-11eb-bc0e-0aad30af8a83	11BR015		32823a03-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21869	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb3fd-0a5d-11eb-bc0e-0aad30af8a83	11BR016		32823bcd-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	11284	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb5ed-0a5d-11eb-bc0e-0aad30af8a83	11BR017		32823d9d-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	27283	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb7df-0a5d-11eb-bc0e-0aad30af8a83	11BR018		32823f7d-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19862	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fb9da-0a5d-11eb-bc0e-0aad30af8a83	11BR019		32824181-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22173	Not Reported	0.00	0.00	0.00	Not Reported	8522/3	Infiltrating duct and lobular carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fbbe8-0a5d-11eb-bc0e-0aad30af8a83	11BR020		32824333-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	13687	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fbdf0-0a5d-11eb-bc0e-0aad30af8a83	11BR022		328244e7-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	17763	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fc001-0a5d-11eb-bc0e-0aad30af8a83	11BR023		328246b0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21322	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fc219-0a5d-11eb-bc0e-0aad30af8a83	11BR024		3282487c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	29473	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fc435-0a5d-11eb-bc0e-0aad30af8a83	11BR025		32824a55-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28257	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fc656-0a5d-11eb-bc0e-0aad30af8a83	11BR027		32824c51-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	27770	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fc87e-0a5d-11eb-bc0e-0aad30af8a83	11BR028		32824e05-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	20196	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fcac6-0a5d-11eb-bc0e-0aad30af8a83	11BR030		32824fbd-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18462	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fcc44-0a5d-11eb-bc0e-0aad30af8a83	11BR031		3282517b-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18432	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd0be-0a5d-11eb-bc0e-0aad30af8a83	11BR032		32826863-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18067	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd1dc-0a5d-11eb-bc0e-0aad30af8a83	11BR036		32826b92-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18736	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd2c0-0a5d-11eb-bc0e-0aad30af8a83	11BR038		32826de0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	17215	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd3a1-0a5d-11eb-bc0e-0aad30af8a83	11BR040		32826fab-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24667	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd483-0a5d-11eb-bc0e-0aad30af8a83	11BR042		32827170-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26067	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd561-0a5d-11eb-bc0e-0aad30af8a83	11BR043		32827334-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	13352	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd641-0a5d-11eb-bc0e-0aad30af8a83	11BR044		3282750a-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	17519	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd721-0a5d-11eb-bc0e-0aad30af8a83	11BR047		328276eb-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21595	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd7f9-0a5d-11eb-bc0e-0aad30af8a83	11BR049		3282787d-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	16729	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fd9af-0a5d-11eb-bc0e-0aad30af8a83	11BR050		328279ba-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19709	Not Reported	0.00	0.00	0.00	Not Reported	8480/3	Mucinous carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fda9e-0a5d-11eb-bc0e-0aad30af8a83	11BR051		32827b6c-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23877	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fdb81-0a5d-11eb-bc0e-0aad30af8a83	11BR053		32827cb1-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22477	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fdc5e-0a5d-11eb-bc0e-0aad30af8a83	11BR054		32827f15-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	30781	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fde8b-0a5d-11eb-bc0e-0aad30af8a83	11BR055		3282808f-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	20531	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fdfb5-0a5d-11eb-bc0e-0aad30af8a83	11BR056		32828209-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19284	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe08e-0a5d-11eb-bc0e-0aad30af8a83	11BR057		32828416-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18919	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe16b-0a5d-11eb-bc0e-0aad30af8a83	11BR058		328285c9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23937	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe245-0a5d-11eb-bc0e-0aad30af8a83	11BR059		32828779-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	16759	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe319-0a5d-11eb-bc0e-0aad30af8a83	11BR060		32828930-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19284	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe4df-0a5d-11eb-bc0e-0aad30af8a83	11BR072		32828ae5-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	25793	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe5c7-0a5d-11eb-bc0e-0aad30af8a83	11BR073		32828cc3-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23572	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe698-0a5d-11eb-bc0e-0aad30af8a83	11BR074		32828ec9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24150	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe768-0a5d-11eb-bc0e-0aad30af8a83	11BR075		32829076-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28956	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe83a-0a5d-11eb-bc0e-0aad30af8a83	11BR076		3282922f-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	18979	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe90a-0a5d-11eb-bc0e-0aad30af8a83	11BR078		328293ef-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fe9e1-0a5d-11eb-bc0e-0aad30af8a83	11BR080		328295ae-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24941	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327feabe-0a5d-11eb-bc0e-0aad30af8a83	13BR009		328297a1-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	27374	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327feb91-0a5d-11eb-bc0e-0aad30af8a83	14BR005		328299af-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28530	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fec71-0a5d-11eb-bc0e-0aad30af8a83	14BR008		32829b68-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24089	Not Reported	0.00	0.00	0.00	Not Reported	8520/3	Infiltrating lobular carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fee92-0a5d-11eb-bc0e-0aad30af8a83	14BR014		32829d27-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	21565	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fefbb-0a5d-11eb-bc0e-0aad30af8a83	15BR003		32829ee8-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff0d3-0a5d-11eb-bc0e-0aad30af8a83	16BR012		3282a0b0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14599	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff1a7-0a5d-11eb-bc0e-0aad30af8a83	18BR002		3282a291-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23390	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff275-0a5d-11eb-bc0e-0aad30af8a83	18BR003		3282a4b0-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24029	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff343-0a5d-11eb-bc0e-0aad30af8a83	18BR004		3282a670-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	28013	Not Reported	0.00	0.00	0.00	Not Reported	8523/3	Infiltrating duct and mucinous carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff40f-0a5d-11eb-bc0e-0aad30af8a83	18BR006		3282a828-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	22721	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff4e2-0a5d-11eb-bc0e-0aad30af8a83	18BR007		3282a9e4-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23359	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff5b2-0a5d-11eb-bc0e-0aad30af8a83	18BR009		3282abad-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23177	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff67e-0a5d-11eb-bc0e-0aad30af8a83	18BR010		3282ad98-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	14934	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff752-0a5d-11eb-bc0e-0aad30af8a83	18BR016		3282afa3-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26918	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff81e-0a5d-11eb-bc0e-0aad30af8a83	18BR017		3282b155-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26492	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff8f1-0a5d-11eb-bc0e-0aad30af8a83	18BR019		3282b310-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	24819	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ff9d7-0a5d-11eb-bc0e-0aad30af8a83	20BR001		3282b4cd-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	29929	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ffaef-0a5d-11eb-bc0e-0aad30af8a83	20BR002		3282b680-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	32872	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ffbc5-0a5d-11eb-bc0e-0aad30af8a83	20BR005		3282b85a-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	17276	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ffc97-0a5d-11eb-bc0e-0aad30af8a83	20BR006		3282baab-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	23877	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ffd6b-0a5d-11eb-bc0e-0aad30af8a83	20BR007		3282bbea-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19679	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327ffe40-0a5d-11eb-bc0e-0aad30af8a83	20BR008		3282bd9e-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	26249	Not Reported	0.00	0.00	0.00	Not Reported	8503/3	Intraductal papillary carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fff0c-0a5d-11eb-bc0e-0aad30af8a83	21BR001		3282bee9-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
327fffdd-0a5d-11eb-bc0e-0aad30af8a83	21BR002		3282c0d3-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3280018b-0a5d-11eb-bc0e-0aad30af8a83	21BR010		3282c2dc-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	25914	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3280026a-0a5d-11eb-bc0e-0aad30af8a83	22BR005		3282c461-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	16759	Not Reported	0.00	0.00	0.00	Not Reported	8522/1	Infiltrating duct and lobular carcinoma	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
32800338-0a5d-11eb-bc0e-0aad30af8a83	22BR006		3282c698-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	19922	Not Reported	0.00	0.00	0.00	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Not Reported	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
32800407-0a5d-11eb-bc0e-0aad30af8a83	Internal Reference - Pooled Sample		3282c854-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
328004d8-0a5d-11eb-bc0e-0aad30af8a83	RetroIR		3282c982-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
328005a9-0a5d-11eb-bc0e-0aad30af8a83	P5		3282cb40-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
32800688-0a5d-11eb-bc0e-0aad30af8a83	P6		3282cc88-0a5d-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
32b6f61f-63d7-11e8-bcf1-0a2705229b82	26OV011		ff315534-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
330e4133-63d8-11e8-bcf1-0a2705229b82	TCGA-A7-A0CE		ff30cc7d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-20863	 	1952	 	 	 	 	 	 	 	 	20863	Not Reported	1074.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3346ca6e-1fb9-11e9-b7f8-0a80fada099c	C3L-01885		506f24ea-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-24752	 	1949	 	 	 	 	 	 	 	 	24752	Not Reported	342.00	342.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24752\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
338845cd-4ec7-404e-89b5-eecd05c9f3e5	BCN 1303		b6bcd9c8-e02c-412b-b129-119f5e20ba87	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
33ae5c0b-cede-4d0e-a609-60a4d1d0717f	JX0193		7dc63a9c-8199-40b1-8024-2182c47a2cb5	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
33c37478-63d6-11e8-bcf1-0a2705229b82	06CO001		ff2fd690-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Male	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
33dbd57e-9e0f-4d11-8abb-f24a8664d626	PDAC262		a93bc9ea-f10c-42bd-8d5d-033edda1af60	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26645	 	196.00	196.00	125.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
33f2e3fb-63d7-11e8-bcf1-0a2705229b82	26OV013		ff3158c8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
33f484e3-9bf2-4985-8999-567e3022ac15	C3N-04282		6068be64-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-27699	303	1942	2019	 	 	 	 	 	 	 	27699	Not Reported	303.00	303.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3406ba91-a386-4e61-931e-a6eceea00123	C3N-01715		5e72d475-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-22534	109	1955	2017	 	 	 	 	 	 	 	22534	Not Reported	283.00	109.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
34182d96-19ca-4892-a607-75682969b240	4541		27b959ff-aef9-4772-bd43-16f2946462d5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	65	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
341a08dc-bb2b-4e5d-8c46-8e7a8a181eec	PDAC205		908bd1af-ba50-4a1f-8a9e-da73abb0b0dc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25550	 	548.00	548.00	261.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
34318a9c-8e98-448d-835b-5fb7d2789217	C3L-02382		9dca36c8-7eab-4775-8ff9-b8a00c5b42d1	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-69	Not Hispanic or Latino	Female	White	Dead	-23312	1726	1953	2022	 	 	 	 	 	 	 	23312	 	1693.00	1726.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
344adec2-63d8-11e8-bcf1-0a2705229b82	TCGA-A7-A0CJ		ff3083c2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-21014	 	1953	 	 	 	 	 	 	 	 	21014	Not Reported	931.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
344f4536-d2cf-4162-99d8-dcc40972c80b	C3L-01703		5b57b0f4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-22902	287	1954	2018	 	 	 	 	 	 	 	22902	Not Reported	287.00	287.00	175.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIA	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3460584e-6f02-4ef1-aefb-3d4c8fbcf2ef	PDAC078		09908e4c-eae8-4c4a-aca1-08b1a90c4bd5	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	 	264.00	264.00	48.00	Distant met recurrence/progression	8035/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
34eda8e1-69d9-4e62-8350-95337f1cb0c7	C3L-02544		7dd98a99-5e95-4088-b215-8bc8a3715542	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-21058	912	1959	2020	 	 	 	 	 	 	 	21058	 	889.00	912.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
350512c9-27a5-43f2-83d5-3a7748b98fde	13129		aaab393c-c401-469f-b5f0-b44a6797c467	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
350842fa-63d6-11e8-bcf1-0a2705229b82	06CO002		ff2fe6e7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
35087999-242b-43fd-9188-84424d7bdbc9	NTN056		26310c39-bd29-44a5-b146-5dcc93b3e5bf	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
351f0feb-de40-472d-815d-822aa1611a09	MB104		44afff42-b728-4b42-b739-3cbd122cfe35	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	12775	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
3535c42f-63d7-11e8-bcf1-0a2705229b82	27CO004		ff2b8335-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
354aa1db-a43e-4972-a704-6536c164b6f5	C3L-01689		5b487636-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-22672	594	1955	2018	 	 	 	 	 	 	 	22672	Not Reported	594.00	594.00	289.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
35627660-781e-4e75-8d88-55a347969544	4421		269d4372-fc22-4d5f-b00c-adb09041c756	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	61	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3588ee7d-63d8-11e8-bcf1-0a2705229b82	TCGA-A7-A13F		ff2ff720-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-16363	 	1966	 	 	 	 	 	 	 	 	16363	Not Reported	765.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
35adc129-34de-4a9e-8243-caece2a6c6d2	WHIM11		b6a05087-83c4-4c4b-bd8b-5a32d83a20a0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
35b3d3ec-1f17-443b-830f-07f741dfbffd	C3N-02979		3e31adcb-a825-46f3-a8c9-51ee554281f9	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	43	Not Reported	Female	White	Alive	-22542	 	1956	 	 	 	 	 	 	 	 	22542	 	1431.00	1431.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
35e0e07f-ddeb-4b90-9d13-3069d0fe4d8f	NTN020		7a623ef7-0142-4690-bcbf-fb65e6c82fc4	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
35f2b9d8-4422-4c8e-91ad-a71959dc3726	C3N-02015		5320ca33-8b04-4202-856b-b120db4394a0	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-19939	 	1962	 	 	 	 	 	 	 	 	19939	 	1383.00	1383.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3639f4a9-758d-4393-86d5-8c3222d0e869	C3N-01502		5e65715f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-27522	 	1941	 	 	 	 	 	 	 	 	27522	Not Reported	1695.00	1695.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Pancreas, NOS	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage III	T4	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3645cf95-3be4-4b1f-828a-0e65e8c098e6	C3N-02811		22ebb1f3-3bff-492f-aa64-f499d360e4a4	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-27281	 	1942	 	 	 	 	 	 	 	 	27281	 	812.00	812.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
36506ff4-d802-4a8b-9f4d-0380f5e0383e	15-00464		357e2719-6ea4-4c43-82af-b31726b8b125	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Dead	-26063	288	 	 	71	 	 	false	Medical Record	 	United States	26063	 	288.00	288.00	 	With tumor	Not Reported	Acute myeloid leukemia, NOS	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
367f624e-63d7-11e8-bcf1-0a2705229b82	TCGA-09-1664		ff2e11e2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-13739	2279	1965	2008	 	 	 	 	 	 	 	13739	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
36af1bb9-4655-43f8-860a-b686ef6ed570	CU-35		a2b61f2e-0383-45fd-b45f-d2d85c4d8b15	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
36c681be-118a-11e9-afb9-0a9c39d33490	C3L-00921		052d0cd5-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-24157	 	1950	 	 	 	 	 	 	 	 	24157	Not Reported	1776.00	1776.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	Unknown	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
36cfed45-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A06N		ff2bc18d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-24288	 	1943	 	 	 	 	 	 	 	 	24288	Not Reported	0.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIIB	T4b	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3778ba1a-64f8-4b7e-a926-94d95fbc1655	PDAC126		3e3f6ba0-8586-4d9a-8595-e92130506dbf	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Unknown	 	 	 	 	 	 	 	 	 	 	 	19710	 	287.00	287.00	287.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Unknown\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
37944a65-4fe5-4a3a-8c19-010cba3ecfa8	C3L-02449		a3a379db-9104-4857-9442-bb2964bc55c9	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	Black or African American	Alive	-21243	 	1959	 	 	 	 	 	 	 	 	21243	 	1452.00	1452.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
37c09d33-1e4f-4e11-929e-96345a433fff	C3N-01078		47b2a05b-bc1f-4af8-ad47-58cdb39ba1e4	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1947	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
37c198b5-63d7-11e8-bcf1-0a2705229b82	TCGA-09-2056		ff2f024d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	White	Alive	-22864	 	1946	 	 	 	 	 	 	 	 	22864	Not Reported	379.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
37ea85c2-5e02-4d7c-846a-7cd40ef1912d	OSCC_21		d82aa8ec-dd2b-4090-8b79-3e0956e42c42	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
37ffb1e8-b6fd-4c6c-8405-3538034d21fd	PDAC025		1792a774-6e29-4e22-9a6e-ee61f1e45445	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	173.00	173.00	159.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
381030bf-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A06Z		ff30d989-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-30984	 	1923	 	 	 	 	 	 	 	 	30984	Not Reported	31.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
387c8fdf-39d2-467f-8324-6022658fc8d8	PDAC013		8a36fa1b-7a35-463e-afef-a356f158e147	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27740	 	514.00	514.00	514.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
38cda9f1-23b8-47f1-9c1e-4d3cf20d35f4	AP-UNC9		8e5e6284-4a4f-4be9-8193-10434b93db21	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
38dc2806-482f-4f76-b453-b3db91e4b6be	C3N-02224		a4b49c56-e226-4dc8-872c-4ac53c055221	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1975	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
38e2c451-b052-44d1-b1f7-54e6b3fc15d7	2807		9aca119d-67a9-48b6-9276-8b11459039c7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	49	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
38fc229e-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1404		ff2ed6dd-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-17784	 	1960	 	 	 	 	 	 	 	 	17784	Not Reported	2469.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
395ce860-c2a6-46d2-972e-83620e058dbf	WHIM74		7e4af98e-9db7-40a6-a2e7-eb44dc3768f0	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3964c3f9-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A076		ff3159f5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-24230	 	1940	 	 	 	 	 	 	 	 	24230	Not Reported	1642.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
39cdf46f-8489-433b-8a38-e5d24bfd52c1	MB264		20669a6d-1076-4d44-b228-b0acef858254	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1825	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
3a099f1d-63d6-11e8-bcf1-0a2705229b82	09CO005		ff2fea90-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3a09be31-4db5-4cf5-bd0e-2b40de692990	PDAC268		a88d07b5-67a5-4133-975b-fb1e3b99f1fa	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18250	 	9.00	9.00	52.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3a1fcd67-79a9-4f48-b687-8657b4a0ca03	AP-B2SL		1d03df88-904b-4d6e-88c0-445955bfbce4	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	19723	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3a36a497-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1409		ff2f0efb-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26836	1742	1935	 	 	 	 	 	 	 	 	26836	Not Reported	208.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3aa0a974-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A079		ff2fd1d0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-25294	 	1938	 	 	 	 	 	 	 	 	25294	Not Reported	274.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3	Stage IIIB	T4b	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3aec5261-2d0c-410a-b117-7513b5e54def	PDAC239		e5e18896-abe9-47cb-bea4-496ba2bac418	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	 	1033.00	1033.00	36.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3b1a2314-101b-40e6-b9fa-bca6acf47b0a	C3N-02244		797d60dd-effe-4b46-afd3-98aa4f83e2b6	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Hispanic or Latino	Female	Not Reported	Not Reported	 	 	1955	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3b26efed-c1e5-4e83-846a-9be38ede3168	3845		28735055-9f10-40e9-b682-61b32e149fd3	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	75	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3b406ce7-2293-4804-8547-c0831d71d1cc	CU-45		717fba62-f16f-4d62-9624-56a367f5056d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Other	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3b526aa4-63d6-11e8-bcf1-0a2705229b82	09CO006		ff2fee27-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3b54253f-accc-48ad-a3f3-c79ab97521bd	PDAC189		e551508a-0945-4f10-bc15-b4c6cb19fa08	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	 	195.00	195.00	107.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3b72a8e5-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1410		ff2ca176-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-20950	 	1951	 	 	 	 	 	 	 	 	20950	Not Reported	2464.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3bb399bd-3ff4-4429-8aac-a792c05cfbf8	AP-D35H		83d6d7f6-1bc1-4396-b743-f83494dc8ad7	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21184	 	811.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3bbc3803-a692-4da4-9da9-5ae279b9d43a	AP-B9CH		3cfa6fd9-2ede-4022-95ae-07b85aecbb66	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	20088	 	1825.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3bdfde9b-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A08G		ff2fc249-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-14976	 	1968	 	 	 	 	 	 	 	 	14976	Not Reported	607.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3beac08e-60f1-4ea2-85c9-f7bef1efb04b	QC4		60d37f72-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3c0f892a-fd54-464d-891e-0bb89b4e7aab	PDAC257		6b649aeb-0ba2-40f3-8576-53f10a323b68	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27740	 	117.00	117.00	178.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3c166691-515f-4ec5-8185-e740a7a7c5f6	JX0201		f3debac2-1e4e-4486-abe0-994aa58fead1	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3c430dc1-7b8b-4ba2-ac4e-554aee3a068e	AP-HFEA		55888649-c17f-46e3-aa73-2ee3c45a703a	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	17531	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3c5685fb-b96f-4cf2-adb6-9e31e86c1b6e	C3L-00395		59f8bef8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-27653	1099	1940	2019	 	 	 	 	 	 	 	27653	Not Reported	1099.00	1099.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3c96e1aa-43e1-47e2-84bb-0ea3a8624a71	C3N-02590		4af43925-80c1-47ca-a2b7-fe60c3909813	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	5	Not Reported	Female	White	Dead	-25019	145	1949	2018	 	 	 	 	 	 	 	25019	Not Reported	145.00	145.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3c9e4169-63d6-11e8-bcf1-0a2705229b82	09CO008		ff2ff272-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3ca2cf34-fa0c-40e8-81ea-ca353e74e4fe	AP-DT88		bf7617d1-2e94-4423-889b-13308ba29edf	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	30680	 	310.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3cafc3bc-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1482		ff2cafc7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-19178	1877	1948	2005	 	 	 	 	 	 	 	19178	Not Reported	1877.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3cc8f7a4-0d29-4974-b4cc-f1ed5dfd2884	PDAC168		522d3a11-5119-4d04-b672-3b5a67a86cf0	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	31755	 	324.00	324.00	118.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3cf0a0ac-6fa7-4c71-851a-5e9b771d7afc	C3L-01749		17996dfc-a71b-4b3b-b0d0-5ca21737fedd	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-23	Not Reported	Female	White	Alive	-19978	 	1962	 	 	 	 	 	 	 	 	19978	 	1177.00	1177.00	987.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3d20a9a7-3477-423c-96be-1dde3eeb9d67	CU-15		6d4fcec5-033c-4098-9415-cadf69a65f53	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3d30e438-118a-11e9-afb9-0a9c39d33490	C3L-00930		053c5385-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Not Reported	-26559	 	1944	 	 	 	 	 	 	 	 	26559	Not Reported	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3d3122af-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A08Z		ff319a42-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-28003	 	1928	 	 	 	 	 	 	 	 	28003	Not Reported	1217.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3a	Not Reported	T4b	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3d65abbe-5af5-4b1f-b887-43ac4f9fac6b	C3N-00302		5d4f3d3f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-21532	323	1957	2017	 	 	 	 	 	 	 	21532	Not Reported	323.00	323.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M1	 	 	 	M1	N1	Stage IV	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	9	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3dd29f9b-382e-44c5-9f89-51799a668359	BCN 1369		054f2e9b-09b9-4d29-8d17-8c125c2e610c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
3de574db-63d6-11e8-bcf1-0a2705229b82	09CO011		ff2ff85b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3dee2ec8-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1483		ff3197e1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22342	895	1939	2002	 	 	 	 	 	 	 	22342	Not Reported	895.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3e019b1e-be2a-4139-a0bc-20cd4ddb7142	AP-TBFQ		8f14e68c-98f2-4d15-b2c8-25f57cdaf4fb	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	29219	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
3e2290e6-57ec-4975-a014-9daca3c2f91e	PDAC045		cc382164-1ac0-4d73-82fc-38a14a7fdc49	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26645	 	386.00	386.00	97.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3e79db01-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A09G		ff2bd156-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-29006	 	1929	 	 	 	 	 	 	 	 	29006	Not Reported	0.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3a	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3e9936db-6201-4c92-9c54-1f8d90ced85d	PDAC102		6ad29fe4-1479-495e-ad5e-794eff139ba8	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	 	805.00	805.00	6.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3e99aeea-1913-42a0-81b6-f76a12470cb7	PDAC064		5c1cfd22-0eec-46fe-9245-e6765799b349	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23725	 	316.00	316.00	313.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
3eaf30d6-8609-4091-9c15-9cb162d8de2a	JX0186		0761d368-e6ac-4691-b53d-b5aa266b4fbc	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3f0cf051-2ab3-4ad4-82c7-dfe4ff096342	7598		0be946eb-d7e1-4660-a44d-9fbb4ed550f5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	74	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3f240d38-63d6-11e8-bcf1-0a2705229b82	09CO013		ff2ffbf1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
3f2e40bf-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1484		ff2c19ca-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22698	3785	1938	 	 	 	 	 	 	 	 	22698	Not Reported	2982.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
3f53f968-eda1-488d-a2bc-0f0b6a3b2e39	NTN005		5b733040-ddd4-45b0-925e-d0f7b0ba4166	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
3f603218-b2e1-4e76-8cf9-b7a432257a35	BCN 1365		dcdc7508-9d77-44e7-b212-c67550caa9e2	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
3f8aba34-9229-4701-bd5d-869b3705d4a6	OSCC_59		345d0762-8415-4ed0-82cc-9c53822f8207	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
3fb775e7-63d8-11e8-bcf1-0a2705229b82	TCGA-A8-A09I		ff30f457-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-30711	 	1924	 	 	 	 	 	 	 	 	30711	Not Reported	1371.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
40453a62-6664-42fc-ba26-f624589b36e5	C3N-02263		0b1a15d7-5366-4888-8b6c-757453a6494a	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Reported	Female	White	Alive	-25262	 	1948	 	 	 	 	 	 	 	 	25262	 	1858.00	1858.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
406b207b-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1485		ff2bcea3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-17642	629	1953	2002	 	 	 	 	 	 	 	17642	Not Reported	629.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
406db86e-63d6-11e8-bcf1-0a2705229b82	09CO014		ff2fffa8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
40a7b022-671f-4fcc-a0be-9214ae433f5f	5		2f0ee7fd-7133-4725-877d-102b10eb5c1c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	62	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
40a7b022-671f-4fcc-a0be-9214ae433f5f	5		94b604d1-5355-43b3-bb40-37014a574282	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
40f43066-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3518		ff2d4bca-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-29769	 	1926	 	 	 	 	 	 	 	 	29769	Not Reported	31.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
40fb622c-0e06-473c-87f8-e00c8fdfd070	4322		830126a6-bccd-4cc7-8d88-2bef615ffc39	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	54	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Sigmoid colon	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
41032920-118a-11e9-afb9-0a9c39d33490	C3L-00932		054b94c5-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-24510	 	1949	 	 	 	 	 	 	 	 	24510	Not Reported	1502.00	1502.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4105096b-ce19-4783-b383-a80632b77254	WHIM75		32f3835e-dd86-42b6-8206-38ba99a6b206	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4141d9a6-f720-44f6-aa21-987e239c28fd	AP-UG7J		b74a6840-0b19-49f9-a511-a707e8db3b33	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	25566	 	1753.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
41422b5d-7ed1-4f9a-abad-498f1b8892d6	80		0d744cb8-9e50-4581-b78d-e4d0217f5b5d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	59	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
41422b5d-7ed1-4f9a-abad-498f1b8892d6	80		6993345e-7f1f-406e-a596-dae8a4f34511	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	59	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
41438573-538a-42cd-86a1-b1d66a6c5478	4		7a74ce1d-be57-4786-bb40-3d1320f777e7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	60	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
414d1928-3385-49b1-a4a8-3f3ad07acdb7	WHIM47		cd21f179-b444-4a78-aa9f-ee8e80890d51	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
41556113-b239-46b4-a176-a2dfd04cb666	C3N-02061		c1ef8f7f-e4d3-44b6-8100-d7fe6c6ff781	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-37	Not Reported	Female	Other	Alive	-24760	 	1949	 	 	 	 	 	 	 	 	24760	 	54.00	54.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
41a2e118-258f-4ba1-894d-042e403d5e04	16-00981		8a2ff4f9-2e12-4e9c-ae6d-2f9fc202ca34	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Unknown	Alive	-25475	 	 	 	69	 	 	false	 	 	United States	25475	 	255.00	255.00	 	Tumor free	Not Reported	Acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
41a983c2-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1487		ff2e8c96-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-27176	681	1928	2003	 	 	 	 	 	 	 	27176	Not Reported	681.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
41b23df2-63d6-11e8-bcf1-0a2705229b82	09CO015		ff300230-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
423218ed-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3525		ff2d37b3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-32871	 	1917	 	 	 	 	 	 	 	 	32871	Not Reported	245.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIIB	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
42a86377-86c9-43f6-b05c-5c0c2b1423eb	15		829a5e7d-0419-4d0d-9da9-913fa28e7d0f	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	59	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
42e5fc6a-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1488		ff2dea77-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-21726	2154	1943	2007	 	 	 	 	 	 	 	21726	Not Reported	2154.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
42f4ed44-63d6-11e8-bcf1-0a2705229b82	09CO018		ff300794-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
43015b48-4788-400e-a307-a9c7c9bc2555	core pool		6d3de411-127e-4cd3-8ff6-b6a0dbaed35f	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
430aa4bc-cbce-4035-b426-1b343ba7ada5	76		149c081a-92b7-46ca-b662-b7aadc6d2b17	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
43174e44-bdcc-43a4-99e8-206cf06e345b	WHIM9		5154df8a-d321-4f1c-9663-2a0872a35c89	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
4377f550-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3526		ff2c6d4c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-21123	 	1950	 	 	 	 	 	 	 	 	21123	Not Reported	580.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
43906e3f-fbbf-4cc4-8364-c1c08a5ad94b	JX0079		2307300e-b918-419a-9530-465fc70837eb	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
439d3376-3ac9-4698-893a-63bee91c9f94	C3L-01963		b216d6bd-892f-4803-b1f7-1b590e5e3a10	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	22	Not Reported	Female	Not Reported	Alive	-23301	 	1953	 	 	 	 	 	 	 	 	23301	 	13.00	13.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
43a16a7c-0193-4318-97ad-0d7b22ffdb4d	3714		475987ed-176a-4865-a75d-f2a898af3acf	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	62	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
43cb11a0-b404-4a33-88be-0fa826110ab6	C3N-02295		5eb4d562-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-20557	371	1961	2018	 	 	 	 	 	 	 	20557	Not Reported	383.00	371.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
43f378ff-51c2-45c4-bafb-db37b72dff03	PDAC047		13f64155-964a-4971-882d-2607d73b318e	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25185	 	412.00	412.00	231.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
44159120-a5f5-4748-8d4b-0a092edb9416	Standard ref		96904adc-b2c5-4994-a76f-304198da3781	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
44232167-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1489		ff2c620e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-25768	2553	1932	 	 	 	 	 	 	 	 	25768	Not Reported	2521.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4437ea63-21c8-42d8-9b4f-b922867e2e32	CU-17		a8f9d32a-4f15-46fd-b871-8faafde19e05	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
443f2901-63d6-11e8-bcf1-0a2705229b82	09CO019		ff301121-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4445d74e-8e23-4466-88d3-e6fdcdd48d18	H36960-008		a356e0a1-a594-472c-9f56-6a29859bbc58	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
44635ad8-58ca-4adc-8ab0-92ca00ba8dde	C3N-01656		fe8f2cc8-f81d-48f7-90d3-b88fca7b5c93	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	17	Not Reported	Male	White	Alive	-25181	 	1948	 	 	 	 	 	 	 	 	25181	 	1880.00	1880.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
448f6d70-bd0e-46ac-95bb-fbe25683cffc	CU-20		26a4d419-212c-49df-ae4b-cb4ff3c23f7b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	80	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
44b504f0-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3529		ff2c48cd-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-28609	 	1929	2007	 	 	 	 	 	 	 	28609	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4532760f-499e-4da3-99ef-0015bf0ce2b3	JX0230		83db2f2e-bd6d-4db0-b7c0-bfab2e4227f7	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
45439896-b780-4b9e-a517-95dfb6994adb	C3L-01929		e216b033-7502-496c-a484-dacf33916546	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	11	Not Reported	Male	White	Alive	-19698	 	1963	 	 	 	 	 	 	 	 	19698	 	10.00	10.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
455df4a4-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1492		ff2f19b5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-24332	3819	1936	 	 	 	 	 	 	 	 	24332	Not Reported	2237.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
456587bd-118a-11e9-afb9-0a9c39d33490	C3L-00938		055af58d-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-19395	 	1963	 	 	 	 	 	 	 	 	19395	Not Reported	1561.00	1561.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
458f0219-c07b-45a2-95d2-85a23c955ecb	77		11399fa6-0809-47ab-9249-97d8020bff3c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
459e3b69-63d6-11e8-bcf1-0a2705229b82	09CO022		ff301535-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
45b33376-aa99-48b7-aae7-5824d1ece67b	PDAC117		89557e02-bfb9-420f-83a4-d2a3ab9cbe06	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	21170	 	1817.00	1817.00	1817.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
45c372ce-1d77-47eb-8098-de5943996fa4	PDAC050		d60552a7-6abe-4e9c-9ef6-dfc9fded5b8b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	379.00	379.00	258.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
45dcaca6-c4bb-4f11-a014-c55c78ee175d	BCN 1367		a2bba9c5-f712-4e00-98fd-99369506898c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
45e072c0-3603-46f9-a86b-3d8492532eef	C3L-03371		5c29aad3-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Male	Other	Dead	-19582	560	1965	2020	 	 	 	 	 	 	 	19582	Not Reported	560.00	560.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
45f0cbee-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3531		ff2d3bbd-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-27514	 	1932	 	 	 	 	 	 	 	 	27514	Not Reported	1035.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4633e71f-5fbe-49b0-9721-9769182a08eb	OSCC_14		519b1b07-fa20-4f9e-b576-a5013d464ce7	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
46823369-5e7c-44a6-ab05-649e0c59dfd0	NX035		a86b8ccb-09d4-4365-9538-e4fd6d4671d0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
469cc236-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1494		ff2c6fa2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-15993	2856	1961	 	 	 	 	 	 	 	 	15993	Not Reported	1162.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
46e88769-bf3d-4aa4-a5fc-5ab149bc74ed	NTN049		2d66daf4-3a49-4ba7-b7db-7f713d00f483	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
47080ec6-a3c1-42ad-bbc3-442cc5302947	CAKI-2		44a952f3-7c0f-42e9-9e04-db1942fa9bc2	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
471583d8-f3c3-4de8-ab99-697f68bf478c	13-00166		8a6b510d-6a2a-42e8-a0b0-23bd45228cdb	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Dead	-23894	1020	 	 	65	 	 	false	Medical Record	 	United States	23894	 	1020.00	1020.00	581.00	With tumor	Not Reported	Acute myeloid leukemia with maturation	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
471bfec8-6509-48cd-b650-94424b39fb0a	PDAC061		c92d781c-30a0-4948-91d3-255339f4d3bc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21900	 	2608.00	2608.00	1186.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
472f0ffd-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3534		ff2cb5ec-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-28489	 	1929	 	 	 	 	 	 	 	 	28489	Not Reported	882.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
477424c6-349d-4620-a354-24c6652da2e3	C3L-03624		64ff463b-dda9-4b5e-88ee-0c3c64beb1f5	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	10	Not Reported	Female	Other	Alive	-25430	 	1948	 	 	 	 	 	 	 	 	25430	Not Reported	1501.00	1501.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4791e768-de1f-4f46-bf3b-96e9bf402c07	C3L-00968		6a365aa9-0d0d-430b-8086-e357f1f59385	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Reported	Male	Other	Dead	-22612	529	1955	2018	 	 	 	 	 	 	 	22612	 	529.00	529.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
47ab50d9-2905-41ac-825e-dc3370dd5eb1	C3L-01639		2d6820f3-8630-4b43-9ba1-a7eb476017b7	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-26166	 	1945	 	 	 	 	 	 	 	 	26166	 	1761.00	1761.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
47e19302-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1495		ff2e4e0f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22046	2749	1944	 	 	 	 	 	 	 	 	22046	Not Reported	1498.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
47f2962e-1c0c-49da-bcd4-93d9c1874ec2	C3L-03628		5c589f27-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-25282	596	1948	2019	 	 	 	 	 	 	 	25282	Not Reported	596.00	596.00	352.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
482dd5ba-9c50-4ee3-a3f2-3bb0ad6487dc	OSCC_35		2561b26f-3469-4687-9c16-a2fba97856da	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
48696542-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3552		ff2d40c5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-31290	396	1923	 	 	 	 	 	 	 	 	31290	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
48772971-6230-4918-b9a7-dd1b5af9aade	C3L-02613		5be53090-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-19066	211	1965	2018	 	 	 	 	 	 	 	19066	Not Reported	211.00	211.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
488c2146-5542-43ec-a814-6e609e8baeae	C3L-01952		3c36880f-be1c-4121-8c15-96bac78bf384	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	White	Alive	-18518	 	1966	 	 	 	 	 	 	 	 	18518	 	6.00	6.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
48a1f1f7-1624-45d1-aca8-e28b02937129	81		d8e7548f-9086-4fd4-a326-5fb6fb57ef24	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	47	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
48a71da7-7c31-41b4-8dc4-09eacf767d87	AP-V6UJ		eb1512ec-1e9c-4de8-994c-a22263139180	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	26662	 	1821.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Middle lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
48c0a8d3-75be-4055-9e38-da84f1c340bd	C3L-02602		fcb335fa-39f6-4c03-9189-48adf12946c2	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20872	 	1960	 	 	 	 	 	 	 	 	20872	 	1793.00	1793.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
48c2f98b-4194-435b-938d-7a2f24b6a9b3	C3N-02084		d4b0b6ae-eff3-4dc1-b065-de952de01d70	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Male	Asian	Alive	-19205	 	1964	 	 	 	 	 	 	 	 	19205	 	352.00	352.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
48c5ef63-81a1-497e-89fe-21f96813de49	C3L-01453		5aeceb4f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Hispanic or Latino	Male	White	Alive	-25473	 	1947	 	 	 	 	 	 	 	 	25473	Not Reported	5.00	5.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	NX	Stage IIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
491eedde-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1497		ff2c3ecc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-17528	 	1957	 	 	 	 	 	 	 	 	17528	Not Reported	3871.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
49441ac0-645e-41b4-bf61-e7a78ec534b0	C3L-01668		df8914cf-c5ba-46fd-943e-875c7c7db4f8	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-13619	 	1980	 	 	 	 	 	 	 	 	13619	 	377.00	377.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
49b093b2-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3554		ff2c743e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-22799	 	1946	 	 	 	 	 	 	 	 	22799	Not Reported	546.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	Yes	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
49d79df1-4e2e-476e-a91a-5c4c1f51deb7	TaxolIR		ad96260f-070e-4971-ba08-b081128fd989	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
4a0b2e2d-bdeb-4c03-9388-57bba5735505	C3N-02085		40c90b4a-cfcd-460d-ab7d-327bdc7f3950	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Male	Asian	Alive	-16810	 	1971	 	 	 	 	 	 	 	 	16810	 	352.00	352.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4a109eb2-118a-11e9-afb9-0a9c39d33490	C3L-00942		056a5672-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23631	 	1952	 	 	 	 	 	 	 	 	23631	Not Reported	1382.00	1382.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4a4b2172-550c-4dbd-adad-8b3425f3ddea	MOLM14		68608158-3b87-4b3c-b77b-c5e7b2cb9b1e	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4a4e4119-73e6-468a-8e6b-05acf4c1b7f5	C3N-01168		5e30472b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-22172	415	1956	2018	 	 	 	 	 	 	 	22172	Not Reported	415.00	415.00	320.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4a5b0f8b-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1499		ff2e506f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-20668	 	1949	 	 	 	 	 	 	 	 	20668	Not Reported	3500.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4a6a400f-651d-4ec8-ad7c-b3e8d6dd1944	AP-3FY5		286de3bf-c9a9-4fdf-8123-9caed464ae40	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	22279	 	279.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
4a9ddc6a-11ad-4165-82c4-af3ba4fda9c6	MV411		cb8c5128-98dc-4b69-bf89-2eb4162e5405	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4aa84758-d881-4d0e-9c9d-cd085ae05eac	C3N-02160		fe0129f8-e9c3-4080-89c6-63ab4135c251	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	Asian	Not Reported	 	 	1966	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4aaeb5f7-55bd-44ac-aa60-bdadca895243	C3L-02125		b775f0be-9ab2-42b9-90ab-09880ad583ed	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-24837	 	1949	 	 	 	 	 	 	 	 	24837	 	410.00	410.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4ab8aa9d-c16c-442e-8f9c-daf1003de902	C3N-02012		e0c1a011-bd0f-45d6-b8a0-776bc295ee1b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-20	Not Hispanic or Latino	Female	White	Alive	-25277	 	1948	 	 	 	 	 	 	 	 	25277	 	1663.00	1663.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4ae1b34f-dd4a-4266-8f0a-85b8b164eb51	4086		0229db12-2493-410b-85d5-f424134d95d2	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	63	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4afcfca3-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3558		ff2ca3c8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-25752	 	1938	 	 	 	 	 	 	 	 	25752	Not Reported	638.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4b289d27-ea64-415b-8f8a-c2e09310908d	PDAC022		f2d9bb56-25c6-4ec2-9daa-d36641dde56b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21900	 	485.00	485.00	305.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
4b51d6c0-4ac8-43db-8e4f-f7152318874d	C3N-03039		5f560789-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Not Reported	 	 	1944	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Pancreas, NOS	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4b6b7f5a-0f83-4102-98c1-51b5c5158c94	HCI027		0e835493-8a32-4c38-b323-55add8975f21	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4b774462-0bf7-4d13-92fe-ca2c016a55b3	17-00177		fbfad3c9-3aa9-4ade-a75a-555b188a9d96	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	White	Alive	-9548	 	 	 	26	 	 	false	 	 	United States	9548	 	289.00	289.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4b8b5694-3e57-47b8-aec4-2dc2ee192d23	AP-XVLY		886d9164-0f0d-4a6b-a92d-dc9bc2866664	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21184	 	1544.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
4b99e241-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1500		ff2c81e8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26172	425	1935	2007	 	 	 	 	 	 	 	26172	Not Reported	425.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4bc3f300-118a-11e9-afb9-0a9c39d33490	C3L-00946		057955cd-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23444	 	1952	 	 	 	 	 	 	 	 	23444	Not Reported	995.00	995.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4c112051-2b65-43e4-a972-fe4aa5de7044	NTN076		887afcad-0b25-4b70-acd3-9f3312dd7c6e	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4c2b0b7e-648e-487d-8052-65dcbe84cb8d	98		6b6666b1-5d05-46c0-9fe0-582128f4b44c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4c2fc223-0f54-4143-a379-290552598b6d	C3N-00957		5e065129-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-27089	 	1942	 	 	 	 	 	 	 	 	27089	Not Reported	1189.00	1189.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4c39731c-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3561		ff2c7d6f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-26420	 	1937	 	 	 	 	 	 	 	 	26420	Not Reported	424.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4c5e9b7e-79f5-4569-8873-217f0c73d887	Luminal (WHIM 16)		7ecb4ce9-567c-44e2-8cda-b306dfdc846c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
4c848c55-2c7e-4d32-9a17-b2531a18a19a	OSCC_43		a971fb29-58a3-459e-a948-4b76a4727234	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
4cddd56b-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1501		ff2ecf07-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-18393	1314	1956	 	 	 	 	 	 	 	 	18393	Not Reported	999.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4d755a0c-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3664		ff2d3f8c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-27363	 	1931	 	 	 	 	 	 	 	 	27363	Not Reported	1643.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Ascending colon	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4e18b240-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1504		ff2bd9c8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-25008	1059	1939	 	 	 	 	 	 	 	 	25008	Not Reported	504.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4e5ae10d-eff7-4a93-8882-ad1594f52eab	JX0141		57ea4f7a-cc8c-41e8-b260-e336592e9cd2	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4e6f4885-bc09-451c-b1b4-c57bd9cf2c6c	PDAC076		d3686401-b494-4fb6-b39c-e846dd36b0af	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	251.00	251.00	120.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
4e845b20-de08-42ae-8226-13adacfe432a	C3L-02409		84a5d4b7-aae2-4e4d-99f5-536284f9e9fd	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-23	Not Hispanic or Latino	Female	White	Alive	-22254	 	1956	 	 	 	 	 	 	 	 	22254	 	427.00	427.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4eb1190e-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3666		ff2c2329-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-25020	61	1937	2005	 	 	 	 	 	 	 	25020	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4f0d67e3-992d-40f5-b60e-0066b6c80b29	AP-QAHT		295887f4-e13d-4f2c-b2fa-78559f7da6f8	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	16801	 	1526.00	 	 	Not Reported	8253/3	Invasive mucinous adenocarcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Unknown	 	 	 	 	 	 	 	M0	NX	Unknown	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
4f655fb1-aaba-457b-a0c7-93ae2ea0d9a8	CU-38		b680993d-8abd-42e0-9e2e-2c745f1e7d36	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4f81b22b-9439-4f9d-8172-6b3be932ae26	CU-34		95b3d6a3-01d5-4b15-94b6-b32f5633c879	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4f9060a4-5dc6-42ef-8914-1fd12952bf5b	BCN 1371		1c8f12c8-a4b4-4bec-98db-4e9af8af2efc	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
4f90a2a7-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1507		ff2e0a39-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-28445	1993	1931	 	 	 	 	 	 	 	 	28445	Not Reported	145.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
4fbbdb30-8292-4050-ac65-1dd70e762fac	AP-52RG		8ad845f3-0eb8-45bf-8ef4-59b0de67125f	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	23740	 	1047.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
4fc8d10b-c3c4-4137-881a-59148033b259	C3N-03086		5f749176-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	-25502	 	1948	 	 	 	 	 	 	 	 	25502	Not Reported	733.00	733.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
4fe131b7-427c-4e0f-99f4-f0ccc4a884cb	FFPE-bridge		d5b11025-0d59-4606-8c1c-6ed3a7e1feda	 	Qualified	Ovarian Serous Cystadenocarcinoma	Not Reported			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
4fef1084-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3672		ff2c833e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-32872	 	1916	 	 	 	 	 	 	 	 	32872	Not Reported	28.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Transverse colon	Transverse colon	Not Reported	Stage III	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
50cd5e0c-63d7-11e8-bcf1-0a2705229b82	TCGA-13-1511		ff2f07af-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Dead	-19258	1650	1956	 	 	 	 	 	 	 	 	19258	Not Reported	119.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
512f2ad5-a686-48ca-9296-4cd80585ecfd	3604		01e6012d-026c-4c8a-91c8-be182e16b78d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	80	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Uterus, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5168c0f2-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3684		ff2c8d8c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-23741	 	1942	 	 	 	 	 	 	 	 	23741	Not Reported	0.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Cecum	Cecum	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T4	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
516ca172-b609-4b5d-87e1-044ff22bc59d	C3N-02577		637e4b33-ce19-4257-8b43-490f5d899bee	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	Asian	Alive	-17439	 	1969	 	 	 	 	 	 	 	 	17439	 	1129.00	1129.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5189f07f-0070-4f24-b256-73b7396057db	PDAC229		01333572-3f3b-40fc-87a3-73eff83618e5	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	836.00	836.00	545.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
51a3f71a-57e7-437d-b0be-3f143b2b44a0	NTN021		d492d7be-fe68-44c5-8915-92a74733c9c3	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
51b3ee8c-69b9-45d9-a24a-0402b5f55601	QC2		60b4fb7b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
51c65bc0-2ae1-4566-9509-3a06140e4c2d	C3L-01355		d9e044c8-5bae-47d1-b2a8-fc6fc5056d26	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20413	 	1961	 	 	 	 	 	 	 	 	20413	 	75.00	75.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
52005a80-e7c0-47a1-9607-18538ff0b267	C3N-02726		d0854fe9-e4af-4c41-8adf-fe860678e557	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Male	Other	Alive	-19566	 	1964	 	 	 	 	 	 	 	 	19566	 	306.00	306.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
52009f09-b933-4b83-a4fe-cfc9c8fe9681	WHIM2		22012b28-fa95-4d2f-a365-678b6f508e63	 	Qualified	Breast Invasive Carcinoma	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
5209aea6-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2059		ff2c88f0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-18449	 	1959	 	 	 	 	 	 	 	 	18449	Not Reported	2387.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
526a3222-0881-11eb-bc0e-0aad30af8a83	01OV007		526bf33c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3812-0881-11eb-bc0e-0aad30af8a83	01OV008		526bf4bb-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3949-0881-11eb-bc0e-0aad30af8a83	01OV010		526bf676-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3b90-0881-11eb-bc0e-0aad30af8a83	01OV013		526bf792-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3c86-0881-11eb-bc0e-0aad30af8a83	01OV017		526bf934-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3d60-0881-11eb-bc0e-0aad30af8a83	01OV018		526bfa50-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a3f3c-0881-11eb-bc0e-0aad30af8a83	01OV019		526bfc0d-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a4022-0881-11eb-bc0e-0aad30af8a83	01OV023		526bfd80-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a41f5-0881-11eb-bc0e-0aad30af8a83	01OV024		526bff26-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a42f3-0881-11eb-bc0e-0aad30af8a83	01OV026		526c0044-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a44db-0881-11eb-bc0e-0aad30af8a83	01OV029		526c01e5-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a45be-0881-11eb-bc0e-0aad30af8a83	01OV030		526c0307-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a47af-0881-11eb-bc0e-0aad30af8a83	01OV039		526c04ca-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a488e-0881-11eb-bc0e-0aad30af8a83	01OV041		526c064c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a4a82-0881-11eb-bc0e-0aad30af8a83	01OV045		526c07f8-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a4b64-0881-11eb-bc0e-0aad30af8a83	01OV046		526c0911-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a4d66-0881-11eb-bc0e-0aad30af8a83	01OV049		526c0ab2-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a4e47-0881-11eb-bc0e-0aad30af8a83	02OV001		526c0bc8-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Received	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5065-0881-11eb-bc0e-0aad30af8a83	02OV005		526c0d7c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a514c-0881-11eb-bc0e-0aad30af8a83	02OV008		526c0eda-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a53ac-0881-11eb-bc0e-0aad30af8a83	02OV015		526c107e-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a548e-0881-11eb-bc0e-0aad30af8a83	02OV022		526c1191-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5774-0881-11eb-bc0e-0aad30af8a83	02OV023		526c1357-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a587e-0881-11eb-bc0e-0aad30af8a83	02OV032		526c1479-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5ae9-0881-11eb-bc0e-0aad30af8a83	02OV035		526c1630-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5c31-0881-11eb-bc0e-0aad30af8a83	02OV040		526c178c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5d16-0881-11eb-bc0e-0aad30af8a83	02OV042		526c192b-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a5f28-0881-11eb-bc0e-0aad30af8a83	02OV045		526c1a44-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6002-0881-11eb-bc0e-0aad30af8a83	04OV001		526c1bea-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a60d3-0881-11eb-bc0e-0aad30af8a83	04OV004		526c1cf8-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a62a5-0881-11eb-bc0e-0aad30af8a83	04OV005		526c1eb9-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6387-0881-11eb-bc0e-0aad30af8a83	04OV008		526c2022-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6457-0881-11eb-bc0e-0aad30af8a83	04OV011		526c21c6-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a662f-0881-11eb-bc0e-0aad30af8a83	04OV012		526c22e2-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6716-0881-11eb-bc0e-0aad30af8a83	04OV013		526c248c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a67e6-0881-11eb-bc0e-0aad30af8a83	04OV017		526c259b-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a69a7-0881-11eb-bc0e-0aad30af8a83	04OV018		526c2751-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6a80-0881-11eb-bc0e-0aad30af8a83	04OV021		526c28c1-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6b52-0881-11eb-bc0e-0aad30af8a83	04OV023		526c2a64-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6d21-0881-11eb-bc0e-0aad30af8a83	04OV024		526c2c11-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6df9-0881-11eb-bc0e-0aad30af8a83	04OV027		526c2dda-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a6ec8-0881-11eb-bc0e-0aad30af8a83	04OV028		526c2eff-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a70a6-0881-11eb-bc0e-0aad30af8a83	04OV031		526c30bc-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a717c-0881-11eb-bc0e-0aad30af8a83	04OV033		526c3215-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a724a-0881-11eb-bc0e-0aad30af8a83	04OV036		526c33be-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a743e-0881-11eb-bc0e-0aad30af8a83	04OV037		526c34d2-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a751a-0881-11eb-bc0e-0aad30af8a83	04OV039		526c3675-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a75e7-0881-11eb-bc0e-0aad30af8a83	04OV040		526c378d-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a77f1-0881-11eb-bc0e-0aad30af8a83	04OV041		526c3951-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a78cd-0881-11eb-bc0e-0aad30af8a83	04OV044		526c3ab5-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a79a5-0881-11eb-bc0e-0aad30af8a83	04OV045		526c3c64-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a7bd7-0881-11eb-bc0e-0aad30af8a83	04OV048		526c3d7a-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a7cfe-0881-11eb-bc0e-0aad30af8a83	04OV049		526c3f16-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a7dd0-0881-11eb-bc0e-0aad30af8a83	04OV050		526c404b-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIB	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a7f76-0881-11eb-bc0e-0aad30af8a83	04OV051		526c4211-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8051-0881-11eb-bc0e-0aad30af8a83	04OV053		526c4375-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8125-0881-11eb-bc0e-0aad30af8a83	04OV054		526c4515-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a82cb-0881-11eb-bc0e-0aad30af8a83	04OV055		526c462b-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a83a7-0881-11eb-bc0e-0aad30af8a83	04OV057		526c47c6-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a847d-0881-11eb-bc0e-0aad30af8a83	04OV058		526c4908-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8634-0881-11eb-bc0e-0aad30af8a83	04OV063		526c4acf-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Fallopian tube	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8712-0881-11eb-bc0e-0aad30af8a83	11OV002		526c4c35-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a88d1-0881-11eb-bc0e-0aad30af8a83	11OV009		526c4dd4-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a89a7-0881-11eb-bc0e-0aad30af8a83	11OV010		526c4ee9-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Ovary	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8b79-0881-11eb-bc0e-0aad30af8a83	13OV004		526c507f-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8c5a-0881-11eb-bc0e-0aad30af8a83	14OV011		526c5198-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8e33-0881-11eb-bc0e-0aad30af8a83	14OV029		526c5355-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a8f0c-0881-11eb-bc0e-0aad30af8a83	15OV001		526c54ca-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a90f2-0881-11eb-bc0e-0aad30af8a83	17OV001		526c566c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage III	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a91cb-0881-11eb-bc0e-0aad30af8a83	17OV002		526c5784-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a93bc-0881-11eb-bc0e-0aad30af8a83	17OV003		526c591f-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Ovary	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9497-0881-11eb-bc0e-0aad30af8a83	17OV004		526c5a3d-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Ovary	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9697-0881-11eb-bc0e-0aad30af8a83	17OV005		526c5bf6-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Ovary	Not Reported	Not Reported	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9779-0881-11eb-bc0e-0aad30af8a83	17OV011		526c5d5b-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Not Reported/ Unknown	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a99c0-0881-11eb-bc0e-0aad30af8a83	17OV012		526c5fc1-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Ovary	Not Reported	Not Reported	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9aa9-0881-11eb-bc0e-0aad30af8a83	17OV013		526c60f9-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIA	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9cc6-0881-11eb-bc0e-0aad30af8a83	17OV014		526c62a3-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9d9d-0881-11eb-bc0e-0aad30af8a83	17OV015		526c63bd-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526a9fbc-0881-11eb-bc0e-0aad30af8a83	17OV017		526c6581-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa0b0-0881-11eb-bc0e-0aad30af8a83	17OV018		526c66f7-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa1ce-0881-11eb-bc0e-0aad30af8a83	17OV019		526c68a4-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIB	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa2aa-0881-11eb-bc0e-0aad30af8a83	17OV025		526c69d0-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa37f-0881-11eb-bc0e-0aad30af8a83	17OV028		526c6b78-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa526-0881-11eb-bc0e-0aad30af8a83	17OV029		526c6d7f-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Not Reported/ Unknown	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa60a-0881-11eb-bc0e-0aad30af8a83	17OV030		526c6f54-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIB	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa6dd-0881-11eb-bc0e-0aad30af8a83	17OV034		526c70bd-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa7b2-0881-11eb-bc0e-0aad30af8a83	17OV036		526c7262-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Not Reported/ Unknown	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aa956-0881-11eb-bc0e-0aad30af8a83	17OV039		526c737e-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aaa31-0881-11eb-bc0e-0aad30af8a83	18OV001		526c751d-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aab00-0881-11eb-bc0e-0aad30af8a83	20OV005		526c7634-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aabd0-0881-11eb-bc0e-0aad30af8a83	22OV001		526c77f1-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aad86-0881-11eb-bc0e-0aad30af8a83	26OV002		526c7952-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aae61-0881-11eb-bc0e-0aad30af8a83	26OV008		526c7afc-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IV	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aaf30-0881-11eb-bc0e-0aad30af8a83	26OV009		526c7c1c-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIC	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526aafff-0881-11eb-bc0e-0aad30af8a83	26OV010		526c7dc3-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Stage IIIB	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526ab1ce-0881-11eb-bc0e-0aad30af8a83	Ovarian Tumor Sample 5776		526c7f18-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
526ab2b2-0881-11eb-bc0e-0aad30af8a83	pooled sample		526c80ea-0881-11eb-bc0e-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"breslow_thickness\":null,\"ajcc_staging_system_edition\":null}	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
52c1dfe9-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3695		ff2c2ae8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-23164	 	1946	 	 	 	 	 	 	 	 	23164	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
52ec0528-aa7e-42ea-a407-f934ecaf673c	NTN085		bc5b537d-f974-4451-9ef7-9c325edf40e6	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
53097cb9-d461-4ad6-b7a2-a8d57520222a	C3L-03514		5c4b1363-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5344fc26-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2060		ff2e377c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-18635	 	1958	 	 	 	 	 	 	 	 	18635	Not Reported	2369.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
535262d2-313c-4d8b-84e4-761cd95003bf	PDAC134		1e5acf12-08b5-4540-943f-97bb3bbc8aa2	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	586.00	586.00	211.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
53e22614-3ea9-43b6-a8fc-3c45a4f5ee0e	C3L-01064		62615b05-eb4c-4cf8-902e-fd401fc1a735	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-28	Not Hispanic or Latino	Female	White	Alive	-20028	 	1962	 	 	 	 	 	 	 	 	20028	 	1842.00	1842.00	871.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
53ffab37-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3710		ff2c36a9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-29465	 	1928	 	 	 	 	 	 	 	 	29465	Not Reported	821.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Hepatic flexure of colon	Ascending colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
54035534-1ed4-498e-9eac-62b0880b7d87	C3N-02789		b6fd7b03-6261-4c59-9470-eca75cdbd745	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-30	Not Hispanic or Latino	Female	White	Alive	-22610	 	1955	 	 	 	 	 	 	 	 	22610	 	1683.00	1683.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
54559a36-d9bc-4373-86f5-98d50a203d76	NCI-7		b05a7783-41f8-4024-9495-45339f1cd4a9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
5481781f-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2061		ff2f2333-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-21543	 	1951	 	 	 	 	 	 	 	 	21543	Not Reported	2339.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5498017e-118a-11e9-afb9-0a9c39d33490	C3L-00947		058895ca-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-26010	 	1945	 	 	 	 	 	 	 	 	26010	Not Reported	1426.00	1426.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
54bd49cd-0642-47b7-b56c-70c1dc358435	QC1		60a5bdf4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
54d3eb3e-7cef-48de-891b-0be632167c5a	AP-YTZ8		27d75ec5-1bb9-4f95-a796-3e5f3ff6d7e8	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21914	 	1825.00	 	 	Not Reported	8250/3	Lepidic adenocarcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
54d8b0b8-123e-4ecc-8943-a9bedbbc9f57	JX0008		5e9e641f-5f50-4959-9ec0-9bcdf8a57a0a	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5522c20e-841e-49eb-ae4b-de17b19a66db	C3L-01869		d81c7dce-45dc-4323-a783-953afba40080	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20066	 	1962	 	 	 	 	 	 	 	 	20066	 	1766.00	1766.00	576.00	Tumor free	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
55548339-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3715		ff2d4824-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-28428	579	1929	 	 	 	 	 	 	 	 	28428	Not Reported	30.00	 	 	Not Reported	8560/3	Adenosquamous carcinoma	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage II	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
55c53353-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2065		ff317a83-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Alive	-25973	 	1938	 	 	 	 	 	 	 	 	25973	Not Reported	1993.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
561e83fa-6042-4c7f-adbd-a513ad273f3d	MDA-05		ca4e570d-71ed-4b43-9fde-6d7be9c4a114	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5629fe7e-ee5e-4e2e-bc4b-2c4a99183d61	AP-RA2G		bda3fd3c-9b41-4daf-9ff3-65850cd5c133	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	30315	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
562f6eea-546c-4bd6-a9f6-5424499da28c	CU-18		790f6f95-9f1c-44ee-a7ed-08f33b04573a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	71	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
56954cc3-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3818		ff2c03b7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-28763	30	1929	2007	 	 	 	 	 	 	 	28763	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
56aeb967-2b35-43ed-b517-a577490f14d3	44		78f9971f-3180-43e8-8c53-bf7654e464ab	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	45	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Lymph nodes of inguinal region or leg	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
57017226-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2066		ff2c58ba-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	White	Dead	-18170	2133	1960	 	 	 	 	 	 	 	 	18170	Not Reported	295.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
57056fca-096c-4850-ac88-be4c74fe8b2d	C3N-01655		5d18846a-9126-44d6-a4c7-6993c826532e	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	White	Alive	-23430	 	1953	 	 	 	 	 	 	 	 	23430	 	1894.00	1894.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
575574a0-118a-11e9-afb9-0a9c39d33490	C3L-00949		0597da60-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23564	 	1952	 	 	 	 	 	 	 	 	23564	Not Reported	1522.00	1522.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5757fd61-ceb5-4daf-a663-2a6fb3d72e75	AP-MUQL		3126a42f-acb7-41ac-8b11-c92de7142a27	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
57da6e5e-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3848		ff2c502b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-30194	306	1927	 	 	 	 	 	 	 	 	30194	Not Reported	30.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
57efbe85-edb9-4a0a-b18f-85d178623807	33		afcc3f46-27d6-44b1-8911-75e19e4d8cf6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	58	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
57efbe85-edb9-4a0a-b18f-85d178623807	33		fe875eae-d6fa-498d-84e9-d54f669287f5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5835414d-63d7-11e8-bcf1-0a2705229b82	TCGA-13-2071		ff2eea77-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-23367	773	1946	 	 	 	 	 	 	 	 	23367	Not Reported	191.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
58355fa4-e2ad-434b-a915-acbd09abbb77	OSCC_62		e32cee85-6d08-4a1b-8b87-30c6f1146273	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
58369844-d03e-492a-8964-241e31aea807	WHIM21		fa6bbd71-972a-445e-b27c-136886076a6f	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
588c0d27-fc63-4f2b-904a-09cd2507fc00	C3L-04473		5cb6a51b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-24550	290	1951	2019	 	 	 	 	 	 	 	24550	Not Reported	290.00	290.00	164.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
58b20ae0-7890-46eb-9004-72a38093df8d	MB260		a1bf61f7-2031-45eb-98aa-e8a60dd7375b	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1825	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	N/A	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
58b42d9e-bba2-4a1f-9066-77586c0d6eb9	C3N-02768		5efa7898-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-17037	430	1971	2018	 	 	 	 	 	 	 	17037	Not Reported	366.00	430.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Pancreas, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
591895b2-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3864		ff2c77ba-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-26237	 	1934	 	 	 	 	 	 	 	 	26237	Not Reported	1612.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
59448f1d-6be8-466f-bb1a-1a3aef693d4f	OSCC_01		b2311c0c-bbc1-4ff6-ae43-15162e0a5e36	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
596e1d74-118a-11e9-afb9-0a9c39d33490	C3L-00961		05a71c3d-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Dead	-21764	1290	1957	2020	 	 	 	 	 	 	 	21764	Not Reported	1289.00	1290.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
596fbde2-63d7-11e8-bcf1-0a2705229b82	TCGA-23-1121		ff2c2c2a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	Alive	-18983	 	1957	 	 	 	 	 	 	 	 	18983	Not Reported	194.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
59a5722f-cb98-41a0-b7df-a6ab104f0943	AP-YF3B		ad4ddcac-4ec2-4051-8014-96f6565cb7e5	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	21549	 	1701.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
59a60dc7-c1eb-4b8f-a100-4927c2199561	C3N-02598		10bff78e-b93d-45d0-9fa4-e17dd8f5e9a2	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	White	Alive	-21956	 	1957	 	 	 	 	 	 	 	 	21956	 	1482.00	1482.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
59cf06b0-b257-4e36-9302-ec3615d23dfc	AP-KNF9		729ccc30-8b42-47dd-9bbf-6c6e85e854ec	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
59fa191b-648f-486e-b3a6-815e12b7fb57	AP-XSR5		6ea52cd3-e090-4e3a-8c43-91fa86c769cb	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	29584	 	1066.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Middle lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N2	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
5a3fd9f7-cd11-4ed9-b122-3096ba0e93a5	C3L-01124		5ace5d7c-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Alive	-25921	 	1947	 	 	 	 	 	 	 	 	25921	Not Reported	399.00	399.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5a578797-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3986		ff2c9b6e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-26967	 	1934	 	 	 	 	 	 	 	 	26967	Not Reported	580.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage I	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5a724af8-ec98-473c-8f7a-f938eea86569	PDAC179		fb2f48fd-1a5a-41f7-8cc6-86d19d4cc3dd	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	25185	 	1512.00	1512.00	1512.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5a807e7e-3916-4bba-b219-b6ec7d3db4e7	AP-E7CU		362422f8-6c87-4924-8285-fd48836d7ac9	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	25566	 	8.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
5a8d1b2b-cfbe-4939-baf1-9bcddf1b28cd	PDAC016		b893af41-0f03-408d-b94c-fa7eb7f9e5cd	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	 	374.00	374.00	194.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5aa447a4-84ce-4215-81b3-107210b3f38d	C3N-02027		8499abfb-62b4-427c-8945-49ad70a2743f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-58	Not Reported	Female	Other	Alive	-20045	 	1962	 	 	 	 	 	 	 	 	20045	 	874.00	874.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5ab4a191-63d7-11e8-bcf1-0a2705229b82	TCGA-23-1122		ff2bede7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19537	1189	1945	2001	 	 	 	 	 	 	 	19537	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5ad5ab78-553a-4817-9d94-e48b973ccc94	PDAC152		2bd6ab66-28ee-402f-92e8-b45ee5215d59	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	710.00	710.00	229.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5ae65a59-056f-46a1-a210-21c52df62aca	CU-39		234b9bd9-ef30-4197-a404-452f220d7912	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	64	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5aff3251-f272-4dcc-8bbd-b4ee767469f4	C3L-00625		5a544e06-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-12736	1198	1982	2020	 	 	 	 	 	 	 	12736	Not Reported	1198.00	1198.00	417.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5b1cce78-d0fd-456f-b124-df8efcc0fae3	PDAC054		184c4c69-834d-44ad-acb7-2c830305c9a1	 	Disqualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24090	 	629.00	629.00	195.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5b309f1b-9aec-45fb-82e4-ed0da0e12ed8	WHIM13		6c18c13e-186b-47d3-8730-7bf7113c57a7	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
5b9e462f-18ba-442e-9004-4f52bb448d40	2121		519b27f5-01a2-4b1b-b06a-7e52a9193d38	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	56	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Appendix	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5bc65c89-e0fd-4de5-865f-591de7e93379	NTN040		522c2094-5991-4652-985a-0399f360f536	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5bd59267-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-3989		ff2c6599-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-30712	242	1925	 	 	 	 	 	 	 	 	30712	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5be58e2e-118a-11e9-afb9-0a9c39d33490	C3L-00963		05b65f36-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-21815	 	1957	 	 	 	 	 	 	 	 	21815	Not Reported	810.00	810.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5be94d2a-2e05-4d82-b843-3b6b55f84582	PDAC029		a130feb7-52c5-4a96-b2aa-e2de5cc1dde6	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24820	 	972.00	972.00	462.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5bf3a933-63d7-11e8-bcf1-0a2705229b82	TCGA-23-1123		ff2ea154-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-21552	1018	1939	2000	 	 	 	 	 	 	 	21552	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5c1beb3a-88ba-474f-94b4-0efe617d451b	C3N-01080		0c35429a-934d-4da4-b92c-f005be433258	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	White	Not Reported	 	 	1951	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5c441a41-89ca-4727-b00b-3fff3ecbcfd8	C3N-02639		25847a75-2147-4c28-a443-070d4d349f26	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	3	Not Reported	Female	White	Dead	-21610	526	1958	2019	 	 	 	 	 	 	 	21610	 	703.00	526.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Fundus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5c6510ff-7c6f-4a37-9aa4-a3854a00fdf4	C3L-01459		0e26a7dd-4402-482c-aeb4-6e837da1e707	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Reported	Female	White	Alive	-25061	 	1948	 	 	 	 	 	 	 	 	25061	 	432.00	432.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5c73bda5-c5a8-489e-9a89-8329d420db55	WHIM20		84a41ae3-8851-4a36-96ea-1957a103dd2a	 	Qualified	Breast Invasive Carcinoma	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
5ca01586-1a9e-4389-b6a8-d7b2af088b48	PDAC236		1a57be62-d8f0-45f5-8fc9-48c999d4b90d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	16060	 	570.00	570.00	466.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5ca4d8a5-198f-4564-8c03-faaeb605620a	JX0114		34329891-3abd-45b9-977b-962c739d06c0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5cb83094-1c86-476f-bd52-efdcd2d3a01f	CU-28		808b6ca4-8da9-48f6-8b99-007742076534	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	51	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5cbebdb4-06f9-4230-aca4-f114e406bf12	96		bce42ff3-517f-4bdf-8aee-2d8af3e06b16	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	64	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5cce075d-02fb-4fd0-8c93-7dc2a0c3cdb1	C3L-02121		2e6c9404-2aea-461c-b4c7-789bcfb04ab7	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-247	Not Hispanic or Latino	Female	White	Alive	-14259	 	1977	 	 	 	 	 	 	 	 	14259	 	417.00	417.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5d13fcec-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A004		ff2c3daa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-27943	 	1933	 	 	 	 	 	 	 	 	27943	Not Reported	424.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5d248f11-caf0-4269-9ff4-a559bb9de3f0	PDAC005		3f762761-01e5-4539-86d7-482c24cb6191	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	 	232.00	232.00	115.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5d2fb710-63d7-11e8-bcf1-0a2705229b82	TCGA-23-1124		ff2ee7fe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-23005	1768	1937	2003	 	 	 	 	 	 	 	23005	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5d3eca31-7a37-4db9-b5ed-67b49099a6cb	C3L-00980		9f7b815e-e6b7-4e55-80c9-8a030676fbe3	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	Other	Alive	-23135	 	1954	 	 	 	 	 	 	 	 	23135	 	271.00	271.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5d645d2c-6a59-4f82-a19b-28f052ac6771	MDA-04		d729bc40-79ad-4825-8a67-99f09bbdb20f	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	40	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5d66255e-9161-42b2-a59f-4764a4e7b570	WHIM27		0dbfa6eb-7865-4bc1-bcad-bda770d71212	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
5db30623-1c54-4607-b6bb-16cdad8869ac	C3N-01082		534fa79c-65d5-48a7-9b9a-5ddb52cd7f58	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1965	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5dbe6168-33b6-48f8-a6bb-364e5b0f52d1	PDAC018		291aa343-216a-440b-a1e0-8039f28a7cba	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	13505	 	1118.00	1118.00	1041.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5dc4d9fa-aae4-4f08-bbf8-d6c65a9fa444	PDAC183		4bb3c424-8cba-46a8-9030-6d000c72486e	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	 	770.00	770.00	187.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5ddf94da-57d9-4751-add8-0f5e65f3e509	AP-AJWE		ba2ff8e4-b4fc-4954-b38d-e4359d58e783	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21549	 	1184.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N1	Stage IIIA	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
5de688b5-fd15-474f-8f3f-d82b708b18ba	5161		2d123bfd-1e7b-4800-b372-53d523038c9e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	57	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5e29a8d7-118a-11e9-afb9-0a9c39d33490	C3L-01246		05c5a36b-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-22948	 	1954	 	 	 	 	 	 	 	 	22948	Not Reported	1538.00	1538.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5e3a7a9b-219e-46aa-916f-4b1b9c2a2cf5	NTN012		bb0f2f6e-ebc8-41e8-a46f-25ffa09f2daa	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5e4f679d-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00A		ff2c59e2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-29463	 	1929	 	 	 	 	 	 	 	 	29463	Not Reported	1157.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5e60818a-bed9-4d00-ade5-98ee3c7887fe	C3N-02761		6670dfe4-7945-455d-8231-7e332819a113	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	Asian	Alive	-11513	 	1986	 	 	 	 	 	 	 	 	11513	 	1066.00	1066.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5e6fa63a-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1103		ff2c8c6e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-18583	1646	1951	2005	 	 	 	 	 	 	 	18583	Not Reported	1646.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5e79b89c-af0e-4623-8082-0080c2daeeaf	Pool		225c884f-5296-4e63-bb2b-00037425ca1a	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
5e99d311-24f2-4ee5-abfe-c9d40771e8e3	OSCC_61		449aa236-f610-48ab-8120-ae30cfe3f019	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
5ebff13b-dc1c-40b3-bea3-d6e12c5335fc	JX0093		2f663d80-7bca-46ef-addb-10bdaae5bdc1	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5f0b87e2-c427-4465-9721-2c1e8923888f	C3N-02573		5ebd74a9-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	-15316	 	1975	 	 	 	 	 	 	 	 	15316	Not Reported	479.00	479.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5f38c09b-b5e6-4142-b3b0-dee4cf878e06	C3N-01012		5e15933f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-25953	 	1947	 	 	 	 	 	 	 	 	25953	Not Reported	1352.00	1352.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage IB	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5f692f17-d1b1-42ae-b7c9-a76d46fa6966	PDAC167		f6bb9dfc-d0f4-444e-a099-fa9de98e3cf5	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	28835	 	1375.00	1375.00	1375.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
5f81b377-3e44-4442-bf10-cabfab4aec04	14-00083		fd9dbe26-87d0-4f98-9971-afce458ddf94	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Unknown	-17109	 	 	 	46	 	 	false	 	 	United States	17109	 	874.00	874.00	278.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5f930e6f-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00E		ff2bfbe1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-23741	 	1942	 	 	 	 	 	 	 	 	23741	Not Reported	913.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5f980495-81f1-4e46-b665-ec4c5a392401	13136		121de675-e70f-41f4-841b-14d737eeb9f6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	78	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
5f9e7f05-b8d1-4dbc-88f0-8b057ef87eea	C3N-01998		5e9b4229-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-25293	186	1948	2017	 	 	 	 	 	 	 	25293	Not Reported	4.00	186.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
5fb453f2-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1104		ff2c9364-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20527	1933	1945	2006	 	 	 	 	 	 	 	20527	Not Reported	1933.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
5feac127-118a-11e9-afb9-0a9c39d33490	C3L-01247		05d4e3b4-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23181	 	1953	 	 	 	 	 	 	 	 	23181	Not Reported	1464.00	1464.00	1310.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6039aa8e-1fb9-11e9-b7f8-0a80fada099c	C3N-00148		5076079e-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	10	Not Reported	Male	White	Alive	-19314	 	1964	 	 	 	 	 	 	 	 	19314	 	-9.00	-9.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-19314\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
604e0a19-d354-45d2-a6c2-fda6872c199e	34		ee66521b-06cd-40d5-ae68-e582e48ae667	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	77	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
604e0a19-d354-45d2-a6c2-fda6872c199e	34		ff39ded4-c8ac-4927-b028-c39f1ce11622	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	77	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
60a125d8-c9d9-4092-b9d5-c22182b5c0e4	MB018		15a092df-9604-447b-a285-0218fdcb7963	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	4745	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
60cc215d-be76-4e06-a94f-7c90d53a569a	PDAC193		3c42968f-6327-4a78-a897-582e78f64c76	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	 	104.00	104.00	79.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
60d3e64a-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00F		ff2c9484-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-24379	 	1941	 	 	 	 	 	 	 	 	24379	Not Reported	1035.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
60f2f721-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1105		ff2e254f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-13187	1442	1965	2004	 	 	 	 	 	 	 	13187	Not Reported	1442.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6113ff67-7e0a-45af-82ec-0f280c72e7d6	NTN062		bab616b9-9dbf-49c4-8bfc-418b0018d6a8	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
615cb54c-3246-430b-8ea7-259314ba5aa2	C3N-02978		27af0633-e4c5-4831-828a-203cdaeb4ff0	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-24162	 	1951	 	 	 	 	 	 	 	 	24162	 	1311.00	1311.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6162346f-af60-4809-ae37-61d25bda9510	4564		e3036261-c36a-4466-9c51-5e6f0feb9fb6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	45	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Abdomen, NOS	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
61681af3-ac1b-469c-bf25-1c9de84e95d4	83		2ff6fd63-a9a1-4cfc-b53e-3c08d5d1cddf	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	48	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
619df278-118a-11e9-afb9-0a9c39d33490	C3L-01248		05e424aa-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-15531	 	1974	 	 	 	 	 	 	 	 	15531	Not Reported	798.00	798.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
61ea104e-1fb9-11e9-b7f8-0a80fada099c	C3N-00149		507c51c8-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Female	White	Alive	-24990	 	1948	 	 	 	 	 	 	 	 	24990	 	-8.00	-8.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24990\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
61fe740d-ae0d-4541-8fae-ab0c33b0f708	C3L-00277		59e99750-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-25515	610	1946	2018	 	 	 	 	 	 	 	25515	Not Reported	730.00	610.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R2	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
620b0449-9eca-4cdf-bdf0-461925cac669	16-01102		6f6c1a21-4da7-456e-9795-64524e3f6788	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	White	Alive	-26602	 	 	 	72	 	 	false	 	 	United States	26602	 	373.00	373.00	358.00	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
621a752f-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00J		ff2c7b20-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-29371	 	1929	 	 	 	 	 	 	 	 	29371	Not Reported	549.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T4	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
622bfcbb-af4c-4893-8e1d-c6f65cbb8da8	C3L-01052		5aa09da0-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-23696	743	1952	2018	 	 	 	 	 	 	 	23696	Not Reported	725.00	743.00	565.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6235da72-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1416		ff2d671f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-12772	 	1974	 	 	 	 	 	 	 	 	12772	Not Reported	194.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
62d4788b-a03f-46f3-8438-b64aa60b1b72	AP-E9CK		d7bd214f-eb75-4f42-b41b-9f7a8c97e6a1	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
62d6a247-8c3a-4efc-a135-728af7a7c3a6	C3N-02247		a002d991-5b03-4f4b-9610-7f04d409b167	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Hispanic or Latino	Female	Unknown	Not Reported	 	 	1949	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
62e371a8-4754-4c85-8c2b-bcf2f93ddd79	AP-9D3B		ed7ed9fd-7cbe-4da9-ae7f-55e407a8f051	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	21549	 	1153.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
62fed149-d8b8-4462-93fd-ec190649b379	C3L-02744		84767f6f-5d5e-4ac1-85e5-251a817ea357	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-19	Not Hispanic or Latino	Female	White	Alive	-26966	 	1944	 	 	 	 	 	 	 	 	26966	 	455.00	455.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
63252ba3-3e1d-490d-aecc-b1c424d28606	C3L-02216		01e51238-427d-4ba9-852f-60318fabe3ae	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-25087	 	1948	 	 	 	 	 	 	 	 	25087	 	1801.00	1801.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC1	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
63649645-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00K		ff2d433e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-29189	 	1930	 	 	 	 	 	 	 	 	29189	Not Reported	549.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
636ec295-118a-11e9-afb9-0a9c39d33490	C3L-01249		05ead848-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23797	 	1951	 	 	 	 	 	 	 	 	23797	Not Reported	1517.00	1517.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
63722b39-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1422		ff2f161f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-30234	23	1926	2008	 	 	 	 	 	 	 	30234	Not Reported	23.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6386852c-1fb9-11e9-b7f8-0a80fada099c	C3N-00150		5082c4a0-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Female	White	Alive	-20286	 	1961	 	 	 	 	 	 	 	 	20286	 	-7.00	-7.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20286\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
638d5afc-317b-47c3-b7d7-6850f620a462	WHIM14		0f571097-0889-4342-bf8b-5f642dbbc692	 	Qualified	Breast Invasive Carcinoma	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
64a2daab-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00N		ff2c0aba-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-27667	122	1933	2008	 	 	 	 	 	 	 	27667	Not Reported	 	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Cecum	Cecum	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIB	T4	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
64b49f60-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1428		ff2d8aee-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-18306	 	1958	 	 	 	 	 	 	 	 	18306	Not Reported	529.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
651057dc-c9ab-488a-9795-2cb73704ea33	WHIM 30		7195cc47-b94e-4bcb-ae6c-94faaec4075b	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
651c6f2e-413f-4c02-aeb5-4f9199e1e0b9	C3N-02678		2f320478-61d2-4432-9f21-0ad690768491	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-25556	598	1947	2019	 	 	 	 	 	 	 	25556	 	580.00	598.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
654a927d-2695-49c0-91e6-33adb9e26d08	C3L-01913		15fac439-3545-4ba9-9e2f-33494cc0ffbf	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20093	 	1962	 	 	 	 	 	 	 	 	20093	 	1765.00	1765.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	High Grade	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC1	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
65556ece-1fb9-11e9-b7f8-0a80fada099c	C3N-00154		50898581-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-25116	 	1948	 	 	 	 	 	 	 	 	25116	Not Reported	-7.00	-7.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25116\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
656b9d5a-ac9b-419d-8300-52b31eb56be6	C3N-00198		5d30b847-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-20306	 	1960	 	 	 	 	 	 	 	 	20306	Not Reported	1592.00	1592.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
65786c81-1ca9-4836-89a4-d80d7dbf773c	C3N-00514		5daaef20-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-22057	1874	1956	2021	 	 	 	 	 	 	 	22057	Not Reported	1874.00	1874.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
65961f24-e423-4dc7-b416-ec8f858ca39c	C3L-02604		5bca008e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-31007	118	1932	2017	 	 	 	 	 	 	 	31007	Not Reported	110.00	118.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Tail of pancreas	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
65e185dd-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00O		ff2caea5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-30316	 	1925	 	 	 	 	 	 	 	 	30316	Not Reported	822.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
65f1931c-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1430		ff2d45a0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24939	863	1932	2002	 	 	 	 	 	 	 	24939	Not Reported	863.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
66180ee3-f012-4749-97a4-fb622843bd1a	C3N-03190		5f9314fb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-11659	398	1985	2018	 	 	 	 	 	 	 	11659	Not Reported	286.00	398.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Body of pancreas	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
661e8210-219d-4708-8d6d-a1b14d7a7a22	PDAC240		760ca140-f238-4327-9e61-2cd7d136c5e1	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Unknown	 	 	 	 	 	 	 	 	 	 	 	31025	 	233.00	233.00	233.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Unknown\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
662e2c6f-8ed1-4494-b241-7e674e977bec	CU-01		6402ddbf-0dc3-4ba9-b333-45d23429027e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	81	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
664c0023-23cd-4e55-82e6-4359d6696891	C3N-00715		37ddfb9a-3224-4b65-ad5e-2ee2d21a2ba6	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Hispanic or Latino	Male	White	Not Reported	 	 	1964	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6669352a-bd73-438b-91ac-4a0c6939e73b	AP-Y6T7		e2acf6b8-2fec-4206-8002-8b8f4b6f59af	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
669af5fb-0ace-47d8-ad5b-40ab44ada190	C3L-00928		5a72f962-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-21418	761	1958	2019	 	 	 	 	 	 	 	21418	Not Reported	755.00	761.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G1	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
66ee6e22-118a-11e9-afb9-0a9c39d33490	C3L-01252		05f1d1fe-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-28034	 	1940	 	 	 	 	 	 	 	 	28034	Not Reported	1581.00	1581.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6724e778-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00R		ff2c70c3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-23528	 	1944	 	 	 	 	 	 	 	 	23528	Not Reported	30.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
67344504-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1431		ff2c0d02-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24758	583	1932	2000	 	 	 	 	 	 	 	24758	Not Reported	583.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
675d0c38-1fb9-11e9-b7f8-0a80fada099c	C3N-00168		50900ba5-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Male	Asian	Alive	-17349	 	1969	 	 	 	 	 	 	 	 	17349	 	826.00	826.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17349\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
676dfb4e-e4e1-4bbb-87ef-f71109212e18	CU-19		a30a6883-54e5-410d-a261-c4ba817a1e7a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6777c1c7-362e-4603-bd94-a1be78ec5306	MB274		423bd7aa-8c3b-4803-a961-007d3a40a9ec	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	730	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
6807c77c-80b2-4de6-bea8-4d08b06f04b4	90		734f9276-3caa-4f2b-97a4-794cceca6480	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	64	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
68141a72-2915-4223-a078-df4c0b3d3711	C3N-01382		5e51a25f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-27136	764	1942	2019	 	 	 	 	 	 	 	27136	Not Reported	764.00	764.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
682fe9cf-9425-4fc3-9764-777e54efe5eb	2398		16a0b099-60fe-4ba2-b7fd-913770965779	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6851595a-aa93-4c94-9977-5384ebedff4a	CU-42		3f637a25-24f4-4cc5-b373-862d1d2e2faf	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	74	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6860e8b8-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A00U		ff2c13a3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-18263	 	1959	 	 	 	 	 	 	 	 	18263	Not Reported	518.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
686f8e1f-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1435		ff2bc2b2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-21107	1324	1942	2002	 	 	 	 	 	 	 	21107	Not Reported	1324.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
687af547-97c0-4d56-8469-ff4d9079f563	PDAC106		3e404cb3-a5d0-48b1-88b1-faec200f8faf	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	25550	 	2212.00	2212.00	2212.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
689fbfab-258b-4895-8130-231e0277d545	PDAC056		fe04ec94-7e0a-49b1-83b7-dca77362965b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25550	 	410.00	410.00	97.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
6915ff3b-1fb1-47a3-a36c-b43e8756718f	NX025		8666bf07-f6a2-46aa-bf47-f14334ea655e	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
694ab8e6-118a-11e9-afb9-0a9c39d33490	C3L-01253		05f84d69-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-28187	 	1939	 	 	 	 	 	 	 	 	28187	Not Reported	1532.00	1532.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
694efa39-8a4f-4e34-9b7b-d5643fc73f18	PDAC019		47f92615-c518-410c-a4f5-e03932cc031f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18980	 	575.00	575.00	155.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
695400f2-1fb9-11e9-b7f8-0a80fada099c	C3N-00177		50970bae-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Male	Asian	Alive	-19161	 	1964	 	 	 	 	 	 	 	 	19161	 	841.00	841.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-19161\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
69987aea-3042-4eb0-a30f-361caddde015	C3N-03853		60486b1f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-17976	393	1969	2019	 	 	 	 	 	 	 	17976	Not Reported	259.00	393.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
699e7081-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A010		ff2c2e73-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-16922	 	1962	 	 	 	 	 	 	 	 	16922	Not Reported	1064.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Transverse colon	Transverse colon	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIB	T4	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
69ad9617-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1436		ff2c96c9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20881	260	1942	1999	 	 	 	 	 	 	 	20881	Not Reported	260.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
69cee145-e701-4f59-b30c-2cf293463bfd	MB227		1e5ebb2d-2787-483b-ba8f-98d7cbaf5aa4	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1460	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
69fcab73-ca86-4d83-850b-eaec4dfeb280	MB239		44e8ed35-91f5-4369-be80-eddf5d2069ab	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	10220	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
6a1d4639-edc2-4563-a0f1-6b17e73c31de	8318		bd47a2cf-4e9e-4d40-9cdf-7c749699503d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6a320878-e4fd-4cf2-8639-b01352acd5cf	14-00488		8b239a80-15e3-4a3d-a1ed-4a0d21aabfa7	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Unknown	Dead	-16246	342	 	 	44	 	 	false	Medical Record	 	United States	16246	 	342.00	342.00	204.00	With tumor	Not Reported	Acute myeloid leukemia, NOS	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6a4781d0-ec51-11e9-81b4-2a2ae2dbcce4	Internal Reference		872323c4-f649-11e9-9a07-0a80fada099c	 		Other	Not Reported			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6a47870c-ec51-11e9-81b4-2a2ae2dbcce4	OVARIAN-CONTROL		87232c66-f649-11e9-9a07-0a80fada099c	 		Other	Not Reported			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6a4788b0-ec51-11e9-81b4-2a2ae2dbcce4	PNNL-JHU Ref		87232dcc-f649-11e9-9a07-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6a478d6a-ec51-11e9-81b4-2a2ae2dbcce4	ColonRef		872331e3-f649-11e9-9a07-0a80fada099c	 		Other	Not Reported			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6a478efa-ec51-11e9-81b4-2a2ae2dbcce4	JHU QC		8723333a-f649-11e9-9a07-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6a5a6ef0-9622-40e2-9e62-8abb31ec4739	PDAC051		1bd1dc1e-09b5-487c-80b0-101eb193dc8d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18980	 	1703.00	1703.00	833.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
6a865304-6c02-49b3-a9f9-3c49f12c7b76	66		dd5b0d73-2b2d-4062-a362-25eae587856f	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6a9ab0d8-41c4-4a3f-b4e4-feb265255493	3		ce87f644-8461-4572-9e4e-54a8ed09cfb4	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	41	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6ab4ef83-840f-45d5-b7df-1108e51b1f1d	AP-67ZV		a3085043-e7e7-4600-ac5e-93fa41ade01e	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28123	 	1460.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
6abc5a95-7e95-4706-93f4-8ab0eac7d60e	C3L-00640		5a5aaa28-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Alive	-21667	 	1957	 	 	 	 	 	 	 	 	21667	Not Reported	594.00	594.00	585.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6abdfa5b-ab89-4ac9-974f-427a4007a133	C3L-04848		5cd21ce3-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-26284	196	1946	2019	 	 	 	 	 	 	 	26284	Not Reported	196.00	196.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6adc680a-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A017		ff2c0048-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-21032	 	1952	 	 	 	 	 	 	 	 	21032	Not Reported	457.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6aecf005-aecb-4438-b591-b82d30baa842	C3N-02030		3b88faf5-18fb-404e-b62c-25fcbf8919aa	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	Other	Alive	-22893	 	1954	 	 	 	 	 	 	 	 	22893	 	808.00	808.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6aeed922-1fb9-11e9-b7f8-0a80fada099c	C3N-00194		509e2440-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Hispanic or Latino	Female	White	Alive	-18885	 	1964	 	 	 	 	 	 	 	 	18885	 	208.00	208.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18885\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6aefca09-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1464		ff2de247-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-25874	379	1928	1999	 	 	 	 	 	 	 	25874	Not Reported	379.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6afe4b38-f943-481e-90ec-a11c0df1da7c	CU-29		cd11ebeb-0187-48c7-957e-2c3a4e20b4e0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	75	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6b043589-118a-11e9-afb9-0a9c39d33490	C3L-01256		0602aa4c-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-27474	 	1941	 	 	 	 	 	 	 	 	27474	Not Reported	1435.00	1435.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6b882756-f4dd-4ced-8d22-61a123dfc3f1	JX0150		e928c647-e667-4334-ae3f-d40a6b0e7cbd	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6bd6c016-7321-49e8-be04-5c9c6583177d	PDAC221		e8faf6ee-a665-488a-9d4b-ece0b45714cc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	637.00	637.00	548.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
6c011edb-1341-4284-9bc7-a309bac3b4a1	C3L-00898		652705f5-8ff8-4ea0-b51a-0e37cdc05c66	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Hispanic or Latino	Female	White	Alive	-20081	 	1962	 	 	 	 	 	 	 	 	20081	 	1600.00	1600.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6c2116cf-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01C		ff2c69d3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-27729	 	1934	 	 	 	 	 	 	 	 	27729	Not Reported	457.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6c315d5f-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1466		ff2d51ff-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27307	1373	1924	2001	 	 	 	 	 	 	 	27307	Not Reported	1373.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6c3a122e-9f69-4252-bbaa-3ee501db83c1	69		36a8733e-7826-4cb1-b7dd-91182bba76c2	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6c3a122e-9f69-4252-bbaa-3ee501db83c1	69		a8aa879c-9d7f-4959-ad59-6e7ddd151b33	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6c3a122e-9f69-4252-bbaa-3ee501db83c1	69		dcd195db-d79b-48cf-8b9f-fc5cfbe64190	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6c798241-06f0-4893-a465-7fd32d40f95c	NX028		62d11a29-d590-460b-b4ef-0f8d12392a0d	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6ca0d37c-1fb9-11e9-b7f8-0a80fada099c	C3N-00242		50ac2c7b-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-25345	 	1947	 	 	 	 	 	 	 	 	25345	Not Reported	1793.00	1793.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25345\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6ca3c5dc-9ddd-40f3-9ca7-90329df28422	MB166		4bd6a76a-40cd-4293-876b-bf8c3f6ea1a4	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2555	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
6cb0df35-8edc-4833-ac1b-1de94495208d	7		619b90c4-06fb-45a2-8774-8fca605db1a5	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6cb0df35-8edc-4833-ac1b-1de94495208d	7		c80ef2bf-11ee-4c3e-bd82-8f05c8d5a11f	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6cea33b1-3543-4a57-942d-e94f76c0c705	HCI030		907c0bc3-451f-4e90-968e-2fc80f6b9b2e	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6cff65ae-5de8-4779-a4d6-b029d6253dba	CU-06		09d29d31-b1c8-4889-9938-d45848650d3e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6d3aa7dd-ee5b-48aa-bf99-736a67a85eeb	54		fdb8d07d-8685-44d1-b5eb-d6dd74a46dcb	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	50	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6d5fca8a-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01D		ff2c4ca1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-17318	334	1962	 	 	 	 	 	 	 	 	17318	Not Reported	30.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6d6e91a5-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1467		ff2baec9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18652	3224	1947	2006	 	 	 	 	 	 	 	18652	Not Reported	3224.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6d89f470-f821-4ea0-bb6e-143b103fc5bb	C3N-01876		2c3e4d39-20e8-40db-90fa-11c7c5148541	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	17	Not Reported	Female	White	Alive	-23808	 	1952	 	 	 	 	 	 	 	 	23808	 	1509.00	1509.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6db7609d-dba9-443b-9a71-62a631118ccd	BCN 1357		472b6dbe-7a16-4263-a97d-24f49cb98af8	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
6dc777d4-4a5b-4387-9ed2-0d2fa9f4ff72	Frozen-bridge		75b046f0-90a0-4cc0-aa72-c6685bc89be7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Not Reported			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6dee66bf-1c08-45c5-a2f1-b19adc5faef3	PDAC132		dfa6903e-d47f-423e-a3f5-6cfc7e25bbb7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	 	1854.00	1854.00	1854.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
6e0a57bc-442e-4b07-abf0-bab5b435b98a	C3N-01088		4c9c92f7-67ae-408b-acff-c7aecab5cf3a	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1941	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6e4c8397-715c-4dc5-8782-2437ff207241	OSCC_36		fc81484a-469f-40b7-9a03-8ddcd1e4792f	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
6e67aadb-1fb9-11e9-b7f8-0a80fada099c	C3N-00244		50b31084-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-16873	 	1970	 	 	 	 	 	 	 	 	16873	Not Reported	728.00	728.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-16873\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6e7501ca-118a-11e9-afb9-0a9c39d33490	C3L-01257		06092448-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-26274	 	1945	 	 	 	 	 	 	 	 	26274	Not Reported	603.00	603.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6e7561ef-f5b3-4bf0-8148-f0d155fb0d9d	CR3		876ae2e1-dda0-4c08-9878-f0ae34002f46	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
6ea93395-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01F		ff2c0f4a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-26298	 	1937	 	 	 	 	 	 	 	 	26298	Not Reported	974.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6eaae670-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1474		ff2ea344-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-20902	676	1943	2001	 	 	 	 	 	 	 	20902	Not Reported	676.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6eda4334-661a-4946-9b2d-33e564470017	PDAC283		82666f00-880f-468c-a019-ef4eb11f9542	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	24455	 	746.00	746.00	746.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
6f19e788-95f1-45d1-8dcc-191799f146d2	C3N-01007		c84a0511-8f21-461e-9c31-ad76200d4166	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Alive	-21777	 	1957	 	 	 	 	 	 	 	 	21777	 	364.00	364.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6f2c070e-a11a-4a0b-bbf8-1c109f400c5a	67		123edd95-13a7-4992-9b70-bae17dbe8c48	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	51	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6f77ed26-36ec-40b1-854b-fb55699526e6	NTN044		7288ec7d-a77b-43c6-abee-765e71c4fda4	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6f970451-69cb-4710-b77d-7b9f8706e71f	16-01138		efdc24fd-b838-4cd0-9cac-e8eac3e21ccb	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Dead	-22871	424	 	 	62	 	 	false	Medical Record	 	United States	22871	 	424.00	424.00	410.00	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
6fa52ee6-5dc2-4bed-8f6b-c6d4471fb81a	C3N-03007		5f471041-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-21772	58	1958	2017	 	 	 	 	 	 	 	21772	Not Reported	58.00	58.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
6fe98d15-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1544		ff2e72ca-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-26141	820	1929	2002	 	 	 	 	 	 	 	26141	Not Reported	820.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6ffd96e5-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01I		ff2c5d56-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-27759	 	1933	 	 	 	 	 	 	 	 	27759	Not Reported	943.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
6fff5e5f-4966-480b-83df-8e475230d122	NTN009		f25ba5b3-c1a5-4c8a-9e3b-a4465f240e70	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7001a54f-1fb9-11e9-b7f8-0a80fada099c	C3N-00246		50caad65-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-16268	 	1972	 	 	 	 	 	 	 	 	16268	Not Reported	2006.00	2006.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-16268\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
70207e73-118a-11e9-afb9-0a9c39d33490	C3L-01275		0611f0b0-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Not Reported	Alive	-23768	 	1951	 	 	 	 	 	 	 	 	23768	Not Reported	1485.00	1485.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
70a5567e-0fb8-4094-9004-5067e4760e59	AP-5JDU		6121e3b1-5b28-462a-b0c1-0ab8be120cd1	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24471	 	1454.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
70eaedcb-0537-4122-b8f5-2d91d3fce5b2	C3N-03005		b75601cd-6e19-4662-be99-e8ab9f11e66c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-32872	898	1926	2020	 	 	 	 	 	 	 	32872	 	857.00	898.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7111616d-0956-455e-b803-813d2f713dc7	PDAC023		09463ed8-a49b-4dad-8f37-055f4d0890fd	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	 	1119.00	1119.00	558.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
712748c9-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1545		ff2e5695-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-25460	1746	1928	2001	 	 	 	 	 	 	 	25460	Not Reported	1746.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
71565a38-0036-4748-b4e4-e4b921ad1f72	C3N-02579		5ec42279-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-18922	358	1965	2018	 	 	 	 	 	 	 	18922	Not Reported	245.00	358.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
715e0715-ccb0-4f6b-be65-133a28daa0ed	13-00602		7304b726-db9c-4251-90ea-128b66fe7462	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Alive	-23351	 	 	 	63	 	 	false	 	 	United States	23351	 	1346.00	1346.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated CEBPA	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7166b8a0-f458-434a-b675-dc42b0bc3ee9	JX0076		582bb47f-fdb4-42ce-8a2c-a27b8c24b5d8	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
716f932c-5ca2-476e-beb2-2599733115c2	NX026		50fc65a7-70a2-4f88-8760-97add55a89f9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
719aeb75-fc2f-490a-a89b-556b18788d61	C3L-00165		a66565a3-fb28-450d-ab6e-c807c687c40e	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	37	Hispanic or Latino	Male	White	Alive	-17397	 	1969	 	 	 	 	 	 	 	 	17397	 	678.00	678.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
719c4076-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01K		ff2ca7e2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-27029	 	1935	 	 	 	 	 	 	 	 	27029	Not Reported	943.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIC	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
71a049ed-1fb9-11e9-b7f8-0a80fada099c	C3N-00305		50d9f02c-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-21957	 	1956	 	 	 	 	 	 	 	 	21957	Not Reported	1913.00	1913.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21957\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
71bdfdcb-358b-446b-86fa-7a3879bb460e	C3N-02944		5f0834ca-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	-22648	 	1955	 	 	 	 	 	 	 	 	22648	Not Reported	609.00	609.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Tail of pancreas	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
71dfac9d-118a-11e9-afb9-0a9c39d33490	C3L-01282		0618f11a-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23414	 	1952	 	 	 	 	 	 	 	 	23414	Not Reported	1784.00	1784.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
71ebb445-ec2c-4ee1-aeaa-9cf30bb3bfff	OSCC_49		3d23eadc-f1b3-4fb7-92ea-84aca053acc7	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
71f6efc4-5999-49d0-8d8b-88feddda3642	17-00676		06f02d6b-f3d4-4534-a417-a798a297de74	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Dead	-20289	1	 	 	55	 	 	false	Medical Record	 	United States	20289	 	1.00	1.00	 	With tumor	Not Reported	Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7283dd67-1777-4f7b-89cb-6167b69bf1a1	PDAC250		0f454975-2abe-455e-8395-a691a10a4427	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	29565	 	1084.00	1084.00	1084.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
72a73c91-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1548		ff2c44a1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20945	493	1940	1998	 	 	 	 	 	 	 	20945	Not Reported	493.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
72a823aa-562b-445e-96bb-a954af508d21	PDAC192		6bc559f0-7020-4d67-a7ba-a1c241caff1f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28470	 	568.00	568.00	310.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
72acdfce-342d-44e5-b7c0-c588f4690a83	C3L-02364		efe219e4-d650-42dd-89d0-72998f39290b	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20720	 	1960	 	 	 	 	 	 	 	 	20720	 	1785.00	1785.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
72b5746e-c370-4bc0-a134-b86846c1ac37	CU-12		8f7f978e-073e-4e45-b092-7a08fade0b14	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
72dabc4e-ff33-4ecb-8676-234e6ae27a8b	C3L-00401		5a0801b5-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-22991	1262	1953	2020	 	 	 	 	 	 	 	22991	Not Reported	1262.00	1262.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
72e26998-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01P		ff2c1c33-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-29554	1158	1923	 	 	 	 	 	 	 	 	29554	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
731c9266-b4c1-4fe2-8492-444b0c10a51c	CU-31		cbf61ed2-1010-40aa-b6f2-e24a58245856	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7327f919-d75e-4992-842f-4e0ab63fce69	C3L-00969		41df1c48-be37-4c13-ab6f-d53c9c94e0dd	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	2	Not Reported	Male	Other	Alive	-14933	 	1976	 	 	 	 	 	 	 	 	14933	 	1604.00	1604.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
73a51a51-118a-11e9-afb9-0a9c39d33490	C3L-01284		061fe0a4-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	Asian	Alive	-18243	 	1967	 	 	 	 	 	 	 	 	18243	 	357.00	357.00	0.00	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Stage I	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
73b649eb-1fb9-11e9-b7f8-0a80fada099c	C3N-00310		50e93505-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	White	Dead	-31016	1623	1931	2020	 	 	 	 	 	 	 	31016	 	1623.00	1623.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-31016\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
73e3518e-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1550		ff2d3cfe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18049	1249	1948	2000	 	 	 	 	 	 	 	18049	Not Reported	1249.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
73e5b1c7-a06b-4255-b674-7b1700fcd111	4378		090a653c-6d03-4db8-89ce-4cef934d3269	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	68	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
742176df-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01R		ff2c60ed-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-17289	 	1957	 	 	 	 	 	 	 	 	17289	Not Reported	1065.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7424dc9d-eb03-488d-906f-8abf12384771	94		4e32cc39-2ec0-4190-b821-9dc0132e3a7a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	81	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
74480206-a77e-4c1d-b33a-a8648990eba0	PDAC158		fb5f36d2-4702-4287-b78b-934ab833b930	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	27740	 	1318.00	1318.00	953.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
75298f3c-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1551		ff2c5ea5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19661	1579	1944	2001	 	 	 	 	 	 	 	19661	Not Reported	1579.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
75330a2d-d702-4683-b428-87a32aed5a5e	NX021		9fe67c65-42f9-4fb9-9e45-7999728711e3	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
754db279-1fb9-11e9-b7f8-0a80fada099c	C3N-00312		50f8b7ad-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	10	Not Reported	Male	White	Alive	-25123	 	1947	 	 	 	 	 	 	 	 	25123	 	1888.00	1888.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25123\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
75533b4a-b4a6-46b0-8030-4ac968e512d5	C3N-00155		aa2f506b-6bfa-4ed4-9777-84a794c80975	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-18	Not Reported	Female	White	Alive	-20946	 	1959	 	 	 	 	 	 	 	 	20946	 	18.00	18.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
75615f99-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01S		ff2c53ec-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-17257	 	1957	 	 	 	 	 	 	 	 	17257	Not Reported	31.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
75729ffc-ec0d-40cf-83c6-adb6f1d78d57	NTN014		ee4058a1-f5a7-4661-9176-ca759f02343f	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
759378e9-118a-11e9-afb9-0a9c39d33490	C3L-01304		06262ab4-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-25175	 	1948	 	 	 	 	 	 	 	 	25175	Not Reported	1862.00	1862.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7599a933-49b1-4c8c-8bff-f74a39341418	WHIM37		e7cbd2da-abf9-49ed-838e-2a8f458373c9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
75a184cf-d780-4d30-aa25-2d65efcac9e7	PDAC055		b4424958-9ebe-4ca9-9b1f-1150ce8ff43c	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	 	1875.00	1875.00	1875.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
761dc1a7-720d-458f-b8b3-639674546cb0	C3N-02437		8aa19eaa-9d47-4c5b-be67-eee8f03dbea2	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-18	Not Hispanic or Latino	Female	White	Alive	-22411	 	1956	 	 	 	 	 	 	 	 	22411	 	1811.00	1811.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
762c9f38-6669-4c81-94e9-70f3e4b693aa	53		ba858b88-100e-49ec-95f7-c464f61e1f0b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	51	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
766f86d2-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1552		ff2c8fd0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-28129	1259	1920	2000	 	 	 	 	 	 	 	28129	Not Reported	1259.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
769eda03-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01T		ff2c18ad-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-23192	 	1941	 	 	 	 	 	 	 	 	23192	Not Reported	1005.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
76af815d-920b-4fe8-859a-bbaec597cab8	JX0025		bc212a7b-4915-4758-b9a3-ea2ef907d665	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
76cd4edc-6c8f-4bb4-91a8-f264281ece13	PDAC277		3982fd0f-34f8-4d7f-9377-920e556d5469	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	27740	 	797.00	797.00	797.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
77001dc1-1fb9-11e9-b7f8-0a80fada099c	C3N-00313		5107b0dc-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-11619	 	1984	 	 	 	 	 	 	 	 	11619	Not Reported	1869.00	1869.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-11619\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7702b2fa-2aca-47dc-9757-a517585ab11d	84		56620ee5-2369-4641-8f22-27c9657c3ce3	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7702b2fa-2aca-47dc-9757-a517585ab11d	84		847a39b0-209f-4496-9c6f-97581de71a72	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
77399a00-c63a-11ea-b1fd-0aad30af8a83	NX10		085189fb-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
77399c25-c63a-11ea-b1fd-0aad30af8a83	NX11		08582f57-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
77399cfd-c63a-11ea-b1fd-0aad30af8a83	NX12		086504f3-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
77399f35-c63a-11ea-b1fd-0aad30af8a83	NX13		087448fb-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7739a015-c63a-11ea-b1fd-0aad30af8a83	NX14		087a8e56-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7739a270-c63a-11ea-b1fd-0aad30af8a83	NX15		08838952-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7739a390-c63a-11ea-b1fd-0aad30af8a83	NX16		088a4e61-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7739a462-c63a-11ea-b1fd-0aad30af8a83	NX17		0892cbf8-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7739a536-c63a-11ea-b1fd-0aad30af8a83	NX18		089998bd-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
774332e2-118a-11e9-afb9-0a9c39d33490	C3L-01307		062c7664-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-27242	205	1942	2017	 	 	 	 	 	 	 	27242	Not Reported	181.00	205.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
779c33cb-e62c-45df-9d7a-39c105e61632	PDAC254		1c0f5477-7b25-4ac8-87c5-a9c4939ed054	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	17885	 	756.00	756.00	328.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
77b97df4-53e0-4406-ae92-298e44bb2201	NTN016		20407460-67fe-4cac-a711-18957c88cb8b	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
77c6c6ac-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1553		ff2e4b72-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19393	1767	1944	2001	 	 	 	 	 	 	 	19393	Not Reported	1767.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
77d3d027-7ded-4b8b-8164-cb5a92272d33	PDAC226		6f296198-34be-4e1a-b65f-8e7af41c1274	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25550	 	283.00	283.00	101.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
77dfb88f-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01V		ff2bf4db-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-21792	 	1945	 	 	 	 	 	 	 	 	21792	Not Reported	31.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
77e6c9de-2a62-4c1f-9fb0-f07e86c9b6de	C3L-01051		5a915afb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Alive	-22192	 	1956	 	 	 	 	 	 	 	 	22192	Not Reported	0.00	0.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
77f95cb0-454e-456b-a4af-d56773467bff	PDAC073		57e124a4-43bb-45b6-859f-94fe09d98784	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27740	 	251.00	251.00	65.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
78081bea-6b0b-404b-b9a1-f64ced91f728	C3L-02610		5bdeb3d5-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-29536	190	1936	2018	 	 	 	 	 	 	 	29536	Not Reported	190.00	190.00	151.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	8th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
78783b04-18e8-4eb4-8f60-28c91ff26cf4	PDAC264		7db76743-c1a2-4b3e-b5ce-e7ba2bbadd9d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21900	 	727.00	727.00	578.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7897abd2-6559-422a-9765-6235164f0f38	JX0041		b7b84a36-3a53-408f-9025-fbdbca217b07	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
78a0147b-4098-49fa-8a8a-70718f320490	WHIM43		97751491-7b36-4c34-b008-14a8111a62e0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
78a71616-1fb9-11e9-b7f8-0a80fada099c	C3N-00314		5116f037-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	14	Not Reported	Male	White	Dead	-28865	126	1937	2016	 	 	 	 	 	 	 	28865	 	62.00	126.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"126\",\"days_to_birth\":\"-28865\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
78ff5de8-118a-11e9-afb9-0a9c39d33490	C3L-01311		0632b549-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-20175	 	1961	 	 	 	 	 	 	 	 	20175	Not Reported	1785.00	1785.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7904baf7-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1555		ff2eaab2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18404	2692	1947	2004	 	 	 	 	 	 	 	18404	Not Reported	2692.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7921f294-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01X		ff2c3a37-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-29281	 	1924	 	 	 	 	 	 	 	 	29281	Not Reported	791.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
792a4397-366c-480c-8ec8-7abcc8f399ce	A-498		7a4c0e23-83ff-47fe-9b29-ec5a6f5c7e72	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
79544443-38fe-441e-8730-17fe46d0f8d0	AP-7KJ6		f094d096-24e8-4a85-b572-a4749a38495d	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	23375	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
79659a0c-08bf-4127-afcc-23656e48207e	BCN 1335		2e50b24e-ea1a-4814-841d-8dd9fdb86056	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
79a55d15-7f96-4ce7-ac9d-a06416b132db	5980		51de52c8-9eda-4493-9a38-b016e64f7e98	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	50	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of thorax	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7a0682d0-c23f-4ba2-b1db-263f7442bf99	AP-WDKZ		0ba292ff-1532-4861-92bd-03e8f1a39a0f	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	23375	 	467.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
7a1f7596-6e6b-418c-a9e5-21a3b3ffb14c	WHIM 2		9af1e587-fc2a-4887-a18f-7bd394b69071	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7a42cc9a-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1556		ff2c9cb5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18517	2148	1950	2005	 	 	 	 	 	 	 	18517	Not Reported	2148.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7a590d23-1168-11ea-9bfa-0a42f3c845fe	1		7a5e1bcb-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	25185	Hepatocellular carcinoma	 	1437.00	401.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59102c-1168-11ea-9bfa-0a42f3c845fe	2		7a5e1f4f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	1488.00	342.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5912dc-1168-11ea-9bfa-0a42f3c845fe	3		7a5e2473-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	28835	Hepatocellular carcinoma	 	470.00	317.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5913d7-1168-11ea-9bfa-0a42f3c845fe	4		7a5e2775-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	279.00	279.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591639-1168-11ea-9bfa-0a42f3c845fe	5		7a5e2b90-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23725	Hepatocellular carcinoma	 	1449.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59176c-1168-11ea-9bfa-0a42f3c845fe	6		7a5e2e58-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18250	Hepatocellular carcinoma	 	1449.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59183e-1168-11ea-9bfa-0a42f3c845fe	7		7a5e30ef-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	760.00	760.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5919df-1168-11ea-9bfa-0a42f3c845fe	8		7a5e323d-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17885	Hepatocellular carcinoma	 	1443.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591ab7-1168-11ea-9bfa-0a42f3c845fe	9		7a5e3396-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	29565	Hepatocellular carcinoma	 	1493.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591b7e-1168-11ea-9bfa-0a42f3c845fe	10		7a5e353c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	1495.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591d76-1168-11ea-9bfa-0a42f3c845fe	11		7a5e3655-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	12045	Hepatocellular carcinoma	 	900.00	900.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Abdominal cavity	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591e5c-1168-11ea-9bfa-0a42f3c845fe	12		7a5e38e7-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	1434.00	186.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a591f23-1168-11ea-9bfa-0a42f3c845fe	13		7a5e3a23-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	Hepatocellular carcinoma	 	436.00	436.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5920da-1168-11ea-9bfa-0a42f3c845fe	14		7a5e3be0-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	25550	Hepatocellular carcinoma	 	1419.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5921c0-1168-11ea-9bfa-0a42f3c845fe	15		7a5e3e26-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	1413.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59228f-1168-11ea-9bfa-0a42f3c845fe	16		7a5e3f97-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	1413.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592456-1168-11ea-9bfa-0a42f3c845fe	17		7a5e413c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14235	Hepatocellular carcinoma	 	1410.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592530-1168-11ea-9bfa-0a42f3c845fe	18		7a5e424a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16060	Hepatocellular carcinoma	 	300.00	300.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5925f7-1168-11ea-9bfa-0a42f3c845fe	19		7a5e43e7-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	1404.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5927cb-1168-11ea-9bfa-0a42f3c845fe	20		7a5e44f2-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	1404.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5928a3-1168-11ea-9bfa-0a42f3c845fe	21		7a5e4695-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	26280	Hepatocellular carcinoma	 	1407.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59296b-1168-11ea-9bfa-0a42f3c845fe	22		7a5e47b6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	1401.00	620.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592b54-1168-11ea-9bfa-0a42f3c845fe	23		7a5e4909-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592c31-1168-11ea-9bfa-0a42f3c845fe	24		7a5e4aac-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21535	Hepatocellular carcinoma	 	1387.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592e26-1168-11ea-9bfa-0a42f3c845fe	25		7a5e4bb5-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23725	Hepatocellular carcinoma	 	1387.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a592f01-1168-11ea-9bfa-0a42f3c845fe	26		7a5e4d51-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	1363.00	211.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593100-1168-11ea-9bfa-0a42f3c845fe	27		7a5e4e61-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14235	Hepatocellular carcinoma	 	1383.00	88.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5931dd-1168-11ea-9bfa-0a42f3c845fe	28		7a5e500a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	1272.00	1272.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5933f1-1168-11ea-9bfa-0a42f3c845fe	29		7a5e512c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	24090	Hepatocellular carcinoma	 	143.00	143.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5934ca-1168-11ea-9bfa-0a42f3c845fe	30		7a5e5352-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	21170	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5936eb-1168-11ea-9bfa-0a42f3c845fe	31		7a5e5517-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	1414.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5937dc-1168-11ea-9bfa-0a42f3c845fe	32		7a5e562c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	269.00	269.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5938eb-1168-11ea-9bfa-0a42f3c845fe	33		7a5e57c9-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	593.00	421.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Lung	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5939b4-1168-11ea-9bfa-0a42f3c845fe	34		7a5e58d3-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	1345.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593b4e-1168-11ea-9bfa-0a42f3c845fe	35		7a5e5a7c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16060	Hepatocellular carcinoma	 	140.00	140.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593c21-1168-11ea-9bfa-0a42f3c845fe	36		7a5e5b9f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	1342.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593cee-1168-11ea-9bfa-0a42f3c845fe	37		7a5e5cee-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	1318.00	1318.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Metastasis	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593e94-1168-11ea-9bfa-0a42f3c845fe	38		7a5e5f39-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	1377.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a593f6a-1168-11ea-9bfa-0a42f3c845fe	39		7a5e6068-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	13140	Hepatocellular carcinoma	 	1331.00	34.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59402d-1168-11ea-9bfa-0a42f3c845fe	40		7a5e6215-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	1331.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5941d9-1168-11ea-9bfa-0a42f3c845fe	41		7a5e6328-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	18250	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5942ae-1168-11ea-9bfa-0a42f3c845fe	42		7a5e6823-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	1329.00	0.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594378-1168-11ea-9bfa-0a42f3c845fe	43		7a5e6d0e-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	24090	Hepatocellular carcinoma	 	1320.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594537-1168-11ea-9bfa-0a42f3c845fe	44		7a5e7200-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	1329.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59460e-1168-11ea-9bfa-0a42f3c845fe	45		7a5e773f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5946d0-1168-11ea-9bfa-0a42f3c845fe	46		7a5e7a08-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	311.00	311.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594899-1168-11ea-9bfa-0a42f3c845fe	47		7a5e7f48-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	1320.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59496d-1168-11ea-9bfa-0a42f3c845fe	48		7a5e82e2-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	1319.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594a32-1168-11ea-9bfa-0a42f3c845fe	49		7a5e870d-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	27010	Hepatocellular carcinoma	 	1318.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594c16-1168-11ea-9bfa-0a42f3c845fe	50		7a5e8860-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20805	Hepatocellular carcinoma	 	1318.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594cec-1168-11ea-9bfa-0a42f3c845fe	51		7a5e89be-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	12775	Hepatocellular carcinoma	 	1316.00	475.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multiple organs	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594ed7-1168-11ea-9bfa-0a42f3c845fe	52		7a5e8b61-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14600	Hepatocellular carcinoma	 	1314.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a594fa9-1168-11ea-9bfa-0a42f3c845fe	53		7a5e8c6d-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	14600	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59519f-1168-11ea-9bfa-0a42f3c845fe	54		7a5e8e09-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	25915	Hepatocellular carcinoma	 	1297.00	272.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5952af-1168-11ea-9bfa-0a42f3c845fe	55		7a5e8f18-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	21170	Hepatocellular carcinoma	 	796.00	61.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5954bc-1168-11ea-9bfa-0a42f3c845fe	56		7a5e90c6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21535	Hepatocellular carcinoma	 	1297.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595593-1168-11ea-9bfa-0a42f3c845fe	57		7a5e91f0-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	1299.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5957a7-1168-11ea-9bfa-0a42f3c845fe	58		7a5e9334-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14600	Hepatocellular carcinoma	 	1342.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59588f-1168-11ea-9bfa-0a42f3c845fe	59		7a5e94d8-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18250	Hepatocellular carcinoma	 	1290.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59599a-1168-11ea-9bfa-0a42f3c845fe	60		7a5e95e7-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18250	Hepatocellular carcinoma	 	1290.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595a64-1168-11ea-9bfa-0a42f3c845fe	61		7a5e9781-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	1341.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595bff-1168-11ea-9bfa-0a42f3c845fe	62		7a5e9890-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595cd7-1168-11ea-9bfa-0a42f3c845fe	63		7a5e9a71-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	Hepatocellular carcinoma	 	421.00	421.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595d9d-1168-11ea-9bfa-0a42f3c845fe	64		7a5e9b9c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	25185	Hepatocellular carcinoma	 	715.00	416.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Stomach	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a595f46-1168-11ea-9bfa-0a42f3c845fe	65		7a5e9cf6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	1094.00	610.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer cell proliferation	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59601b-1168-11ea-9bfa-0a42f3c845fe	66		7a5e9e93-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	1286.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5960e0-1168-11ea-9bfa-0a42f3c845fe	67		7a5ea12f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	15330	Hepatocellular carcinoma	 	532.00	502.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596292-1168-11ea-9bfa-0a42f3c845fe	68		7a5ea39c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59636b-1168-11ea-9bfa-0a42f3c845fe	69		7a5ea4f2-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20075	Hepatocellular carcinoma	 	1285.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596431-1168-11ea-9bfa-0a42f3c845fe	70		7a5ea6bb-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	16790	Hepatocellular carcinoma	 	1285.00	343.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5965f2-1168-11ea-9bfa-0a42f3c845fe	71		7a5ea7e8-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20075	Hepatocellular carcinoma	 	1266.00	388.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5966c9-1168-11ea-9bfa-0a42f3c845fe	72		7a5ea9ee-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	25915	Hepatocellular carcinoma	 	889.00	889.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596790-1168-11ea-9bfa-0a42f3c845fe	73		7a5eac47-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17885	Hepatocellular carcinoma	 	1279.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59695f-1168-11ea-9bfa-0a42f3c845fe	74		7a5ead87-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	1281.00	41.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596a2f-1168-11ea-9bfa-0a42f3c845fe	75		7a5eafcc-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	1278.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596af3-1168-11ea-9bfa-0a42f3c845fe	76		7a5eb0fe-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	Hepatocellular carcinoma	 	459.00	459.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596cd2-1168-11ea-9bfa-0a42f3c845fe	77		7a5eb441-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	12.00	12.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a596da6-1168-11ea-9bfa-0a42f3c845fe	78		7a5eb698-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	13505	Hepatocellular carcinoma	 	277.00	277.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59700f-1168-11ea-9bfa-0a42f3c845fe	79		7a5ebe43-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	Hepatocellular carcinoma	 	1258.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5970de-1168-11ea-9bfa-0a42f3c845fe	80		7a5ec44f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	Hepatocellular carcinoma	 	1270.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597372-1168-11ea-9bfa-0a42f3c845fe	81		7a5ec84c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	Hepatocellular carcinoma	 	207.00	207.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597455-1168-11ea-9bfa-0a42f3c845fe	82		7a5ecd4a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	997.00	997.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597664-1168-11ea-9bfa-0a42f3c845fe	83		7a5ece86-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	12045	Hepatocellular carcinoma	 	753.00	753.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597739-1168-11ea-9bfa-0a42f3c845fe	84		7a5ed069-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	498.00	49.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597955-1168-11ea-9bfa-0a42f3c845fe	85		7a5ed19f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	13140	Hepatocellular carcinoma	 	1316.00	232.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597a42-1168-11ea-9bfa-0a42f3c845fe	86		7a5ed2fc-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	24820	Hepatocellular carcinoma	 	1314.00	228.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597b82-1168-11ea-9bfa-0a42f3c845fe	87		7a5ed4a5-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	1309.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597d03-1168-11ea-9bfa-0a42f3c845fe	88		7a5ed5af-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	13140	Hepatocellular carcinoma	 	148.00	148.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597ed1-1168-11ea-9bfa-0a42f3c845fe	89		7a5ed74b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	553.00	553.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a597fab-1168-11ea-9bfa-0a42f3c845fe	90		7a5ed924-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23725	Hepatocellular carcinoma	 	1231.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598074-1168-11ea-9bfa-0a42f3c845fe	91		7a5edaed-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	488.00	183.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59821b-1168-11ea-9bfa-0a42f3c845fe	92		7a5edc19-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14965	Hepatocellular carcinoma	 	1281.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5983e1-1168-11ea-9bfa-0a42f3c845fe	93		7a5edd65-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	Hepatocellular carcinoma	 	343.00	343.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5984b3-1168-11ea-9bfa-0a42f3c845fe	94		7a5edf64-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23360	Hepatocellular carcinoma	 	1121.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598673-1168-11ea-9bfa-0a42f3c845fe	95		7a5ee086-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	2021.00	860.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59874e-1168-11ea-9bfa-0a42f3c845fe	96		7a5ee22e-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	1115.00	791.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598841-1168-11ea-9bfa-0a42f3c845fe	97		7a5ee33b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	547.00	64.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Abdominal cavity	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598a16-1168-11ea-9bfa-0a42f3c845fe	98		7a5ee4e5-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	825.00	825.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598aee-1168-11ea-9bfa-0a42f3c845fe	99		7a5ee609-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	13870	Hepatocellular carcinoma	 	1109.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598bb6-1168-11ea-9bfa-0a42f3c845fe	100		7a5ee758-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21535	Hepatocellular carcinoma	 	1101.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598d92-1168-11ea-9bfa-0a42f3c845fe	101		7a5ee8f8-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	16425	Hepatocellular carcinoma	 	1102.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a598e67-1168-11ea-9bfa-0a42f3c845fe	102		7a5eea1b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	315.00	315.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cerebral Hemorrhage	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59904f-1168-11ea-9bfa-0a42f3c845fe	103		7a5eebbb-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	17520	Hepatocellular carcinoma	 	613.00	96.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Metastasis	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599128-1168-11ea-9bfa-0a42f3c845fe	104		7a5eee07-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	692.00	692.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599315-1168-11ea-9bfa-0a42f3c845fe	105		7a5eefd7-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	365.00	365.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5993ee-1168-11ea-9bfa-0a42f3c845fe	106		7a5ef22a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	475.00	475.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5995e4-1168-11ea-9bfa-0a42f3c845fe	107		7a5ef3ba-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	1083.00	117.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5996bb-1168-11ea-9bfa-0a42f3c845fe	108		7a5ef649-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	1064.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a5998bd-1168-11ea-9bfa-0a42f3c845fe	109		7a5ef7a8-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	29565	Hepatocellular carcinoma	 	1064.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599993-1168-11ea-9bfa-0a42f3c845fe	110		7a5ef95a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23360	Hepatocellular carcinoma	 	1063.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599ba3-1168-11ea-9bfa-0a42f3c845fe	111		7a5eff5f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	1058.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599c7c-1168-11ea-9bfa-0a42f3c845fe	112		7a5f081b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	1031.00	0.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599eac-1168-11ea-9bfa-0a42f3c845fe	113		7a5f0dee-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	14235	Hepatocellular carcinoma	 	515.00	270.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a599fc6-1168-11ea-9bfa-0a42f3c845fe	114		7a5f1016-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	15330	Hepatocellular carcinoma	 	2128.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a0a4-1168-11ea-9bfa-0a42f3c845fe	115		7a5f128c-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22995	Hepatocellular carcinoma	 	1049.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a240-1168-11ea-9bfa-0a42f3c845fe	116		7a5f13c4-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	12410	Hepatocellular carcinoma	 	1034.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a31a-1168-11ea-9bfa-0a42f3c845fe	117		7a5f1575-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	19345	Hepatocellular carcinoma	 	221.00	175.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a3e7-1168-11ea-9bfa-0a42f3c845fe	118		7a5f1680-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	376.00	376.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a58d-1168-11ea-9bfa-0a42f3c845fe	119		7a5f1830-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	Hepatocellular carcinoma	 	221.00	221.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a663-1168-11ea-9bfa-0a42f3c845fe	120		7a5f1951-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17155	Hepatocellular carcinoma	 	1020.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a72a-1168-11ea-9bfa-0a42f3c845fe	121		7a5f1aa1-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	14965	Hepatocellular carcinoma	 	1017.00	230.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59a984-1168-11ea-9bfa-0a42f3c845fe	122		7a5f1c3f-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	Hepatocellular carcinoma	 	509.00	509.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59aa77-1168-11ea-9bfa-0a42f3c845fe	123		7a5f1d6b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23360	Hepatocellular carcinoma	 	1017.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59ab40-1168-11ea-9bfa-0a42f3c845fe	124		7a5f1f0a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	26280	Hepatocellular carcinoma	 	1024.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59ad05-1168-11ea-9bfa-0a42f3c845fe	125		7a5f2015-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	26280	Hepatocellular carcinoma	 	1022.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59add9-1168-11ea-9bfa-0a42f3c845fe	126		7a5f21be-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	15330	Hepatocellular carcinoma	 	1017.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59afa5-1168-11ea-9bfa-0a42f3c845fe	127		7a5f22e4-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	23725	Hepatocellular carcinoma	 	2534.00	1495.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b080-1168-11ea-9bfa-0a42f3c845fe	128		7a5f2435-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	1017.00	704.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b25a-1168-11ea-9bfa-0a42f3c845fe	129		7a5f25d1-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	7300	Hepatocellular carcinoma	 	846.00	846.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b331-1168-11ea-9bfa-0a42f3c845fe	130		7a5f2851-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	1021.00	186.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b510-1168-11ea-9bfa-0a42f3c845fe	131		7a5f2a26-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	16790	Hepatocellular carcinoma	 	1017.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b5e5-1168-11ea-9bfa-0a42f3c845fe	132		7a5f2b39-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	24090	Hepatocellular carcinoma	 	906.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b7dc-1168-11ea-9bfa-0a42f3c845fe	133		7a5f2ce6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	16060	Hepatocellular carcinoma	 	724.00	724.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	HCC recurrence	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59b8b7-1168-11ea-9bfa-0a42f3c845fe	134		7a5f2e11-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20805	Hepatocellular carcinoma	 	938.00	55.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59bab9-1168-11ea-9bfa-0a42f3c845fe	135		7a5f2f68-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	24455	Hepatocellular carcinoma	 	939.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59bb8f-1168-11ea-9bfa-0a42f3c845fe	136		7a5f3101-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	Hepatocellular carcinoma	 	937.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59bd9f-1168-11ea-9bfa-0a42f3c845fe	137		7a5f320a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	125.00	125.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59bea5-1168-11ea-9bfa-0a42f3c845fe	138		7a5f33a1-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	884.00	467.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c0e1-1168-11ea-9bfa-0a42f3c845fe	139		7a5f34a8-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	16425	Hepatocellular carcinoma	 	917.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c1cd-1168-11ea-9bfa-0a42f3c845fe	140		7a5f364d-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	109.00	109.00	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c2dc-1168-11ea-9bfa-0a42f3c845fe	141		7a5f3769-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	16425	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c3a8-1168-11ea-9bfa-0a42f3c845fe	142		7a5f38ba-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21900	Hepatocellular carcinoma	 	902.00	41.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c53f-1168-11ea-9bfa-0a42f3c845fe	143		7a5f3a55-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18980	Hepatocellular carcinoma	 	922.00	132.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c611-1168-11ea-9bfa-0a42f3c845fe	144		7a5f3b62-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21170	Hepatocellular carcinoma	 	922.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c6d6-1168-11ea-9bfa-0a42f3c845fe	145		7a5f42f2-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	17885	Hepatocellular carcinoma	 	925.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c876-1168-11ea-9bfa-0a42f3c845fe	146		7a5f4643-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	476.00	69.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59c947-1168-11ea-9bfa-0a42f3c845fe	147		7a5f4b29-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18250	Hepatocellular carcinoma	 	901.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59ca0a-1168-11ea-9bfa-0a42f3c845fe	148		7a5f4e58-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	12775	Hepatocellular carcinoma	 	897.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59cbb4-1168-11ea-9bfa-0a42f3c845fe	149		7a5f52a7-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	15695	Hepatocellular carcinoma	 	896.00	380.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59cc8d-1168-11ea-9bfa-0a42f3c845fe	150		7a5f57ce-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	Hepatocellular carcinoma	 	897.00	43.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59cd53-1168-11ea-9bfa-0a42f3c845fe	151		7a5f5ac6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	 	 	 	 	 	 	 	 	 	 	 	 	11680	Hepatocellular carcinoma	 	 	 	Not Reported	Not Reported	Not Reported		Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59cf17-1168-11ea-9bfa-0a42f3c845fe	152		7a5f5ed5-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	12045	Hepatocellular carcinoma	 	313.00	36.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59cfee-1168-11ea-9bfa-0a42f3c845fe	153		7a5f601a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	19710	Hepatocellular carcinoma	 	888.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d0ba-1168-11ea-9bfa-0a42f3c845fe	154		7a5f61d6-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	20440	Hepatocellular carcinoma	 	331.00	67.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d289-1168-11ea-9bfa-0a42f3c845fe	155		7a5f630b-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	24455	Hepatocellular carcinoma	 	890.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d35b-1168-11ea-9bfa-0a42f3c845fe	156		7a5f6465-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Dead	 	 	 	 	 	 	 	 	 	 	 	13870	Hepatocellular carcinoma	 	564.00	236.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Lung	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d41b-1168-11ea-9bfa-0a42f3c845fe	157		7a5f65fd-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	18615	Hepatocellular carcinoma	 	983.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d5f9-1168-11ea-9bfa-0a42f3c845fe	158		7a5f670a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	20805	Hepatocellular carcinoma	 	973.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d6ca-1168-11ea-9bfa-0a42f3c845fe	159		7a5f68a5-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Female	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	21170	Hepatocellular carcinoma	 	978.00	0.00	Not Reported	Not Reported	Not Reported	No	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d8b3-1168-11ea-9bfa-0a42f3c845fe	160		7a5f69ae-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Male	Chinese	Alive	 	 	 	 	 	 	 	 	 	 	 	22630	Hepatocellular carcinoma	 	976.00	36.00	Not Reported	Not Reported	Not Reported	Yes	Not Reported	Liver	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59d987-1168-11ea-9bfa-0a42f3c845fe	213		7a5f6b54-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59db85-1168-11ea-9bfa-0a42f3c845fe	214		7a5f6c72-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59dc5c-1168-11ea-9bfa-0a42f3c845fe	351		7a5f6dc0-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59de69-1168-11ea-9bfa-0a42f3c845fe	352		7a5f6f5a-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59df3d-1168-11ea-9bfa-0a42f3c845fe	447		7a5f7064-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e153-1168-11ea-9bfa-0a42f3c845fe	448		7a5f7207-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e23a-1168-11ea-9bfa-0a42f3c845fe	535		7a5f7346-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e341-1168-11ea-9bfa-0a42f3c845fe	536		7a5f7502-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e409-1168-11ea-9bfa-0a42f3c845fe	697		7a5f7629-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e584-1168-11ea-9bfa-0a42f3c845fe	698		7a5f7828-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Hepatocellular Carcinoma 	Liver			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a59e65a-1168-11ea-9bfa-0a42f3c845fe	MIX		7a5f79e9-1168-11ea-9bfa-0a42f3c845fe	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Integrated Proteogenomic Characterization of HBV-related Hepatocellular carcinoma	International Cancer Proteogenome Consortium
7a618496-1fb9-11e9-b7f8-0a80fada099c	C3N-00315		51263608-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-25193	 	1947	 	 	 	 	 	 	 	 	25193	Not Reported	1861.00	1861.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25193\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7a77aded-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A01Z		ff2c9806-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-24990	 	1936	 	 	 	 	 	 	 	 	24990	Not Reported	1126.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Ascending colon	Ascending colon	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7ac17db0-7fd5-4ac1-a8be-f6493c2ebe2c	86		7554b53d-2453-4fbd-9189-0d71983ef5ea	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7ae2b631-118a-11e9-afb9-0a9c39d33490	C3L-01312		063fea40-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-20729	 	1960	 	 	 	 	 	 	 	 	20729	Not Reported	1784.00	1784.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	Unknown	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7af30d07-2bf0-40d2-b07b-58d45cc70b4c	AP-352Q		1529c9cb-80e5-4db1-a478-d69f6eb2517b	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	24106	 	658.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
7b176838-c84f-4d39-a923-75ce677127d5	16-01227		5c1eeff2-3c68-4ce1-b526-25a44eb85b72	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Hispanic or Latino	Female	White	Dead	-14450	433	 	 	39	 	 	false	Medical Record	 	United States	14450	 	433.00	433.00	257.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7b1f0ac3-8130-4fa4-b926-32afcd419746	PDAC085		ed745809-ac7c-4140-96ba-c3c7aa430f25	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	 	289.00	289.00	73.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7b3b844f-47ea-4765-aa3e-9ec2a41fb510	MB095		f96cd89b-1768-4d6b-921f-e5e3815377e5	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
7b889f56-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1557		ff2c3468-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-17943	1213	1951	2003	 	 	 	 	 	 	 	17943	Not Reported	1213.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7b8cb3b0-8e2d-4554-be87-729c28100f7b	PDAC067		1071e473-6308-4cf8-9c3a-27b0f6f89ffe	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18980	 	387.00	387.00	56.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7bae6951-e412-49b7-8a98-4241956c874c	C3L-02346		ab5e12f4-8a9d-455c-bf92-8856754f2ee6	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-25391	999	1947	2020	 	 	 	 	 	 	 	25391	 	999.00	999.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7bb0a4e1-29b3-4b2b-b9ec-62bb6ca48348	PDAC006		63c623b4-21ef-4642-9d4b-316e83fdf272	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24820	 	1111.00	1111.00	1111.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7bb26f73-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A022		ff2c9110-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-32446	 	1917	 	 	 	 	 	 	 	 	32446	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T4	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7bceea7a-6a39-4b5a-a2bd-c97128df85c7	C3L-01976		8132ccc1-18df-43a3-b93e-fcacc9855b52	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Hispanic or Latino	Female	White	Alive	-23587	 	1952	 	 	 	 	 	 	 	 	23587	 	366.00	366.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7bd83ba1-161a-4137-be35-a9d58ee9e7dc	AP-9UHJ		fb271219-9473-445e-846b-c629b327f8ce	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28854	 	484.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
7bdc92f8-8b6c-4635-b8be-ad14726425e3	C3N-01828		688d43ec-a24c-4814-a944-cbfa11313994	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Female	Other	Alive	-24734	 	1949	 	 	 	 	 	 	 	 	24734	 	660.00	660.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7bfae873-1fb9-11e9-b7f8-0a80fada099c	C3N-00317		5135764a-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	17	Not Reported	Female	White	Dead	-27092	1363	1942	2020	 	 	 	 	 	 	 	27092	 	1363.00	1363.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27092\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7c02730b-5240-41ae-88b3-3f4e4514aa21	OSCC_32		3ec66f70-9f61-4209-87fc-fdada35dc4d1	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
7c898ce3-f7c5-4f55-b8cf-9c9a48e247bc	NTN058		38af6c42-5fa8-49f4-98cb-a890f38834f7	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7cc6b787-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1558		ff2eb252-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27004	594	1927	2001	 	 	 	 	 	 	 	27004	Not Reported	594.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7cc8c834-8568-4272-aa30-95107b456187	MDA-06		33e08033-4d05-4996-a59a-f88a77dd925b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	70	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7cf1133a-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A024		ff2c45bf-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Dead	-29708	1188	1924	 	 	 	 	 	 	 	 	29708	Not Reported	61.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Descending colon	Descending colon	Not Reported	Stage II	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7d44718e-77de-4f75-8642-5c22fdf0c0e8	PDAC156		6fb6203c-be04-44de-a5a8-e71717bd3a67	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	 	115.00	115.00	115.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7d468d2e-118a-11e9-afb9-0a9c39d33490	C3L-01744		064ef549-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-22808	 	1954	 	 	 	 	 	 	 	 	22808	Not Reported	953.00	953.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7d5f89fc-e0e0-494f-b250-44dfe5c93355	C3L-01465		5bf92c47-88c9-4b72-a3b0-42625c903eab	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	9	Not Reported	Male	White	Alive	-24603	 	1949	 	 	 	 	 	 	 	 	24603	 	1393.00	1393.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7d5fe672-a977-4463-94b9-2554ae3d600f	NTN023		ce564101-9b3b-4646-a458-b9f4511c41d9	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7d6fbd07-9bfc-437e-9d67-2cf7f008fa21	C3L-02403		41245c05-a483-486d-958c-e14f48129ecf	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-31	Not Reported	Female	White	Alive	-28516	 	1939	 	 	 	 	 	 	 	 	28516	 	375.00	375.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7d95243f-1fb9-11e9-b7f8-0a80fada099c	C3N-00320		5144b84a-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	White	Alive	-24594	 	1949	 	 	 	 	 	 	 	 	24594	 	1849.00	1849.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24594\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7dadea19-53d9-4c5f-a379-916612d948d3	C3N-01085		3859105e-a33b-4b25-9c0f-7051b7392e24	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1974	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7e05678b-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1562		ff2be30e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24747	1384	1932	2002	 	 	 	 	 	 	 	24747	Not Reported	1384.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7e16a4fa-3063-4ead-95e5-922f2cce6fac	OSCC_42		f61c22e7-85a4-48eb-9745-f8834747a807	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Hard Palate	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
7e199623-a32e-40e5-8629-3febb8b42b56	C3N-02763		3e85c22a-b32d-494a-b4d6-a7669168aa89	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	Asian	Alive	-27965	 	1941	 	 	 	 	 	 	 	 	27965	 	1064.00	1064.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7e1df54f-736b-4f3b-968a-954bdc44d34f	17-00613		33d87e65-3c57-4f9b-95b8-e345ac9f00e7	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-13150	370	 	 	36	 	 	false	Medical Record	 	United States	13150	 	370.00	370.00	200.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7e38c19b-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A029		ff2c8a25-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-24686	 	1939	 	 	 	 	 	 	 	 	24686	Not Reported	1581.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7e593a86-39ae-4062-b95b-36ed1c79d031	WHIM2		7b41e082-2a13-4486-ae0f-974aaaa7bd4d	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
7e9a404c-2b80-4ea6-aa7c-7ebc02493cdc	C3N-01714		5e6c7f43-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-23163	435	1953	2018	 	 	 	 	 	 	 	23163	Not Reported	448.00	435.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7eb3e9c7-a440-4e0f-bc6a-d77a0052ffee	WHIM14		07ef52d8-a2ff-4874-b599-6ccef4a16c4e	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7eb59273-13da-4bee-b428-e14dfef3aee6	Core CR		2e6752c4-8dfd-4105-b833-7c28cf4a2388	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7ede448a-2bc6-4685-9db3-b43649777ea7	NTN050		72613744-9bbf-4c27-ad18-a4586b33f88e	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
7ef278e9-118a-11e9-afb9-0a9c39d33490	C3L-01925		06560866-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23870	 	1952	 	 	 	 	 	 	 	 	23870	Not Reported	1806.00	1806.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7f3ad289-d483-4ad6-abaf-0157df4bb0c6	AP-DN2V		9169ea55-5904-4735-9e02-1457a718bf69	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	27758	 	716.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N1	Stage IIIA	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
7f4d826f-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1563		ff2d9016-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-24274	1451	1933	2002	 	 	 	 	 	 	 	24274	Not Reported	1451.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7f53bd9a-71e0-4c91-982a-f7ec8496bf4e	C3L-03143		407851bc-afb4-42d2-8ddf-0d4a9b6cbe0b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	Asian	Alive	-24543	 	1950	 	 	 	 	 	 	 	 	24543	 	767.00	767.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Corpus uteri	Unknown	Not Reported	 	 	 	 	 	 	 	 	 	Stage IVB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7f64ed63-d354-4c71-bec4-3fcad4d1d827	WHIM 06		64229999-fb21-4934-b46b-ec39c72dd1df	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
7f6a0cac-1fb9-11e9-b7f8-0a80fada099c	C3N-00380		51540518-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	Other	Alive	-20938	 	1959	 	 	 	 	 	 	 	 	20938	Not Reported	662.00	662.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20938\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7f6f7909-9446-4ae8-9a9c-cfd1f8823579	PDAC098		9081c019-0877-43a8-a9d9-53043294116d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	17155	 	447.00	447.00	24.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
7f9ddc5a-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02E		ff2cab4d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-30256	90	1925	2007	 	 	 	 	 	 	 	30256	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N1	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
7fcd53f0-1ca9-44bd-9579-a85e614aba33	C3L-02175		5795b550-e3be-4edd-8b64-6e1c0de1dce2	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	20	Not Reported	Female	White	Alive	-17859	 	1968	 	 	 	 	 	 	 	 	17859	 	20.00	20.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
7ff83eb6-a98a-4cf5-b5e6-22479ad984dd	C3L-04072		5c9f1eda-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	Black or African American	Dead	-20413	225	1962	2018	 	 	 	 	 	 	 	20413	Not Reported	213.00	225.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8028ee98-1487-4014-b590-84e6512590c5	PDAC228		46e7abba-7918-40fe-a92d-9e45b522d4a3	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28470	 	427.00	427.00	90.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
808964d8-5b57-4c65-bc80-c13289818e7f	WHIM6		50c0a431-ab4a-4591-a9fc-a56453154200	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
80ad75c2-57a9-4ba1-997f-abdd7817a585	C3L-01102		077ecbd4-781d-4a93-8851-1fbf74d355a4	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Asian	Alive	-17168	 	1970	 	 	 	 	 	 	 	 	17168	 	12.00	12.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
80cea38e-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1565		ff2e659b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27048	312	1923	1997	 	 	 	 	 	 	 	27048	Not Reported	312.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
80dab332-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02H		ff2c1fb4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-27362	61	1933	2007	 	 	 	 	 	 	 	27362	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
80df2d73-b9f8-419c-9feb-c69a82b5fadf	PDAC107		31a5699c-57d6-4968-89df-42b2a1b357d9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	29930	 	370.00	370.00	214.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
810c2c81-1fb9-11e9-b7f8-0a80fada099c	C3N-00390		516348ef-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Male	Other	Alive	-21263	 	1958	 	 	 	 	 	 	 	 	21263	 	687.00	687.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21263\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
811556a8-7ff2-4a9e-be41-7620994b1e9a	AP-6EWG		7df16d7f-d4f8-4128-8274-b927b1633ced	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	20818	 	1782.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
8116b9ae-118a-11e9-afb9-0a9c39d33490	C3N-00151		065e35c1-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-22242	 	1955	 	 	 	 	 	 	 	 	22242	Not Reported	0.00	0.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8144d374-a11a-4a28-9a7b-d867e6333854	2054		b0e6ac18-8901-4b15-947d-1e3309a1ca1a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	50	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
814e1879-8a9a-4b1f-8533-91edbfcaad7a	C3L-00589		5a176f63-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-29322	 	1936	 	 	 	 	 	 	 	 	29322	Not Reported	1752.00	1752.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
81d2f222-b6ea-4593-9ccd-1619546ab73b	C3L-00622		5a450859-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-26616	1041	1944	2020	 	 	 	 	 	 	 	26616	Not Reported	1041.00	1041.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G1	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
81d7909d-4c3a-40ed-8283-0cbc599ac942	C3N-01381		5e4b6226-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-15744	455	1974	2018	 	 	 	 	 	 	 	15744	Not Reported	297.00	455.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8202a1de-9592-456a-a318-6bc1fd56e0a7	C3L-03129		5c15ef10-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Male	Asian	Alive	-24917	 	1949	 	 	 	 	 	 	 	 	24917	Not Reported	1798.00	1798.00	1538.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
82133ac9-a5e7-4b33-b3d4-7774056d17ec	35		92c7f621-7d55-416f-b9e0-fc677a4f542d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	57	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8217472f-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02J		ff2cb37a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-25749	153	1938	2008	 	 	 	 	 	 	 	25749	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N0	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8218cf07-6312-4330-a7e3-bb78dc34700c	C3N-00753		53644b80-0ee4-44ee-a248-ab2badaf7197	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Not Hispanic or Latino	Female	Asian	Not Reported	 	 	1966	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
82219595-3db0-4f7f-b41c-6437462fb11a	NTN007		4b55602e-4c17-441e-99ad-75c70ca27052	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
822fbbdd-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1603		ff2c55ce-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19681	2742	1943	2003	 	 	 	 	 	 	 	19681	Not Reported	2742.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1996	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
826a166b-f659-43a0-8481-e7e7252187b9	NTN033		b4cdc1f3-1d72-4673-b3c6-0cb9ee96ee60	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
829d6e8d-05c3-426e-af02-7b27180d8beb	PDAC124		1efadffc-e5ac-47b1-acf7-04bb2bd2b81b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21170	 	713.00	713.00	633.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
82a380f2-1fb9-11e9-b7f8-0a80fada099c	C3N-00435		51728395-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Other	Alive	-26583	 	1944	 	 	 	 	 	 	 	 	26583	Not Reported	7.00	7.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26583\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
82b7bff1-63d8-47f3-8520-bee0c1b6b14e	OSCC_57		f1e541b5-6256-4861-ab16-3c066f46b834	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
82d09fee-118a-11e9-afb9-0a9c39d33490	C3N-00200		066d7812-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	Black or African American	Dead	-26248	732	1944	2018	 	 	 	 	 	 	 	26248	Not Reported	732.00	732.00	722.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8311ce43-ad06-4c31-97bc-c9aad468d221	7064		be00ba20-564e-4efb-95c3-b5ea135750b9	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Sigmoid colon	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
833606df-5079-4457-9469-416eb4bb5a5c	NTN078		d01c6212-156a-4e9c-90d2-29869e13c3c8	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
833f25bc-c4b4-4550-90fd-42e6dc55a1d0	MDA-18		f989eb07-cda8-47fd-a0bd-478ed9d62840	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	68	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
835b8135-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02O		ff2c26ac-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-30288	 	1923	 	 	 	 	 	 	 	 	30288	Not Reported	28.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Transverse colon	Transverse colon	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
83672c84-e1f2-413a-8e9d-8c13d45f5291	C3N-01383		5e584b49-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-29417	791	1936	2019	 	 	 	 	 	 	 	29417	Not Reported	791.00	791.00	477.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	7	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
83676156-7486-49c6-bc34-20dc924eb0d7	C3L-01033		dcc0fe37-18ac-4a43-ac6d-cc2d816b1837	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	Other	Alive	-25703	 	1947	 	 	 	 	 	 	 	 	25703	 	1086.00	1086.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8369a540-474e-4b9b-8f2b-f96153ac8bfe	OSCC_64		37063e11-9833-4bbb-85e2-39d127122334	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
836ba4d0-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1604		ff2e87c1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24471	2688	1930	2003	 	 	 	 	 	 	 	24471	Not Reported	2688.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1996	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8379de05-5310-4592-8ef4-38374ac89b8e	NTN083		ab2af006-1b1d-4612-bb12-7ec407da20f6	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
83bb8353-bc5f-4d85-b3d3-2a162d4427d4	AP-94ED		c438d250-f623-439e-877f-639078789b98	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	23010	 	23.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
83c86b84-9d2a-49af-8008-8aec71e87f8e	PDAC087		442aa79d-e89f-4536-acb3-31ea222879fb	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28470	 	574.00	574.00	181.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
83d06b87-8b2d-4a02-b816-2644595f4ad8	PDAC267		002c9f32-cef4-43f5-ab88-a94ad9a176a0	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25550	 	906.00	906.00	904.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
84411cf7-1fb9-11e9-b7f8-0a80fada099c	C3N-00437		518223b8-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Female	White	Dead	-25495	1637	1946	2021	 	 	 	 	 	 	 	25495	 	1637.00	1637.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25495\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
844780de-6ff5-4180-8f55-0d8ae5bcaee7	PDAC151		53dbf05a-8820-49be-8190-5aab563717aa	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20075	 	939.00	939.00	554.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8469316e-4ee9-440b-a391-fba8d6ccd2c9	PDAC129		f724848e-906d-41af-a691-a74cc8db3258	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	26280	 	1789.00	1789.00	1789.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8484f653-118a-11e9-afb9-0a9c39d33490	C3N-00321		067ccd3c-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23452	 	1952	 	 	 	 	 	 	 	 	23452	Not Reported	59.00	59.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8498bc72-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02R		ff2c3345-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-30834	670	1922	2007	 	 	 	 	 	 	 	30834	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
84aa3863-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1920		ff2d7dbe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-27042	 	1935	 	 	 	 	 	 	 	 	27042	Not Reported	298.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
84c91871-a0c6-4235-9dc1-e62b3220fa47	4350		74f6271d-422a-4a1d-9140-b3e14fd32918	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
84e5911f-737a-4278-b184-080da277e088	PDAC101		0dbe16bb-ded8-46a4-ad40-c818b5613fe6	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	27010	 	558.00	558.00	0.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8504fb62-b191-4b31-826a-21ec2fd5965e	13-00515		c5f8d35d-04b3-43e6-9b66-5d8d721a21fc	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Dead	-26734	658	 	 	73	 	 	false	Medical Record	 	United States	26734	 	658.00	658.00	 	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8520def8-1bfc-47a4-b65b-3a0aae6f1fa2	NTN031		ab9f593f-84b8-430f-9468-072f4f7c9844	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
854f02aa-4510-42fb-9537-28257187530f	Withdrawn		886446b9-1dfd-4719-bb67-8032806d5876	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
85b024a2-1250-4881-8376-39631d505144	C3L-01864		d394c919-a796-45ce-bb97-9186b0b5cd88	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-29568	 	1936	 	 	 	 	 	 	 	 	29568	 	392.00	392.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
85de9e26-1fb9-11e9-b7f8-0a80fada099c	C3N-00491		5188a681-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Dead	-19779	99	1962	2016	 	 	 	 	 	 	 	19779	Not Reported	77.00	99.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"99\",\"days_to_birth\":\"-19779\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
85e1d2b8-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A02Y		ff2c5724-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Male	Not Reported	Alive	-26724	 	1934	 	 	 	 	 	 	 	 	26724	Not Reported	1216.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Cecum	Cecum	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
85f308a1-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1923		ff2e75d7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18628	690	1950	2002	 	 	 	 	 	 	 	18628	Not Reported	690.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
86340bb8-118a-11e9-afb9-0a9c39d33490	C3N-00322		068c025e-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-25752	 	1946	 	 	 	 	 	 	 	 	25752	Not Reported	694.00	694.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8637d9be-cd81-41a8-960a-eaaf3da55ede	MB248		af28e4de-00a9-4a10-ba9a-91b933c69a98	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	3650	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
86b39157-8b7f-4b7a-a79e-e73d538b7a06	C3N-00303		5d5e84f7-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-24091	599	1950	2018	 	 	 	 	 	 	 	24091	Not Reported	599.00	599.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
87208dbd-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A03F		ff2c86b4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Dead	-32872	549	1914	 	 	 	 	 	 	 	 	32872	Not Reported	0.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Cecum	Cecum	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
872efef8-63d7-11e8-bcf1-0a2705229b82	TCGA-24-1927		ff2bbce0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-21719	500	1940	2000	 	 	 	 	 	 	 	21719	Not Reported	500.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8740338c-97ec-45e2-99e1-4cca2af50d57	JX0088		271146d3-9f40-4714-b8de-3ec5c440f1bf	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8774ddce-24ea-400e-a02e-7168c3eaf00e	PDAC274		f914acaa-2b08-45b0-ab6d-a8eb830e857c	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	28835	 	799.00	799.00	799.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8782e6f7-d072-4107-8688-2289d001557a	OSCC_10		2d2b34c9-20b0-47d0-a5e8-30db59d7d576	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Retromolar area	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
878c2f0d-3bbd-49d3-96ac-11777d884893	C3N-01008		4f3ffa97-ec42-4e3f-b911-a352655c04e5	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	27	Not Reported	Female	White	Alive	-24919	 	1948	 	 	 	 	 	 	 	 	24919	 	318.00	318.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
87b7a6db-1fb9-11e9-b7f8-0a80fada099c	C3N-00492		5191002a-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-17993	 	1967	 	 	 	 	 	 	 	 	17993	Not Reported	1792.00	1792.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17993\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8849af9c-118a-11e9-afb9-0a9c39d33490	C3N-00323		069b46bb-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-28627	 	1938	 	 	 	 	 	 	 	 	28627	Not Reported	1195.00	1195.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
885a1766-22bb-4e34-8283-60d0790d956f	7715		bae80843-8347-435a-a901-ee51ade77f27	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	46	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
885ec435-63d8-11e8-bcf1-0a2705229b82	TCGA-AA-A03J		ff2cba7d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Female	Not Reported	Alive	-23986	 	1939	 	 	 	 	 	 	 	 	23986	Not Reported	1246.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Sigmoid colon	Sigmoid colon	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
886ebf74-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2020		ff2e3ec5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24682	4624	1927	2006	 	 	 	 	 	 	 	24682	Not Reported	4624.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1994	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
890f123e-71fe-4f22-9533-1019138d6aa3	C3L-00102		59cafd03-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-15616	249	1973	2017	 	 	 	 	 	 	 	15616	Not Reported	249.00	249.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8915019a-232e-4338-99a3-24873ec6ccaf	PDAC252		c5cda24f-61a2-4b9e-9d03-a7070a6dc925	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	1030.00	1030.00	685.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
89459e7d-f97a-47ac-b8c4-52fd5e5e5758	JX0128		c50e0d44-9738-4598-8609-69df05951b59	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
89525db0-dfe3-4ba7-a5a8-396454f8888b	58		e8211887-b3e9-4a03-b39a-c52adf4df339	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	American Indian or Alaska Native	 	 	 	 	 	 	 	 	 	 	 	 	54	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8966aab1-1fb9-11e9-b7f8-0a80fada099c	C3N-00494		5197ce2d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	White	Alive	-24122	 	1950	 	 	 	 	 	 	 	 	24122	 	1786.00	1786.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24122\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
89945eae-f410-4ab3-b806-7a2732b66c14	C3L-05571		17cae739-9aa5-4919-bdf7-abb8647e39c1	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	Black or African American	Alive	-21214	 	1961	 	 	 	 	 	 	 	 	21214	 	449.00	449.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC1	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2019	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
89999ae4-63d8-11e8-bcf1-0a2705229b82	TCGA-AF-2691		ff2dfb16-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Hispanic or Latino	Female	White	Alive	-17759	 	1961	 	 	 	 	 	 	 	 	17759	Not Reported	1309.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
89a067a3-0858-49f8-929f-48774c5bb560	C3N-01880		d35b5a85-a9bf-4c08-959e-8a6f00292004	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-24932	 	1949	 	 	 	 	 	 	 	 	24932	 	1872.00	1872.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
89b98008-bc22-4bcb-9869-e67edbc0e272	C3N-00721		56e58698-3d89-4808-b629-1f7d8c1474a8	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Hispanic or Latino	Male	White	Not Reported	 	 	1963	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
89bbca46-eb15-4ad4-8029-3b75fadb9e92	4114		dfd34284-996f-492e-a264-023f289a8cde	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	68	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Uterus, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
89ced9ab-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2023		ff2e0e1a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19901	1364	1940	1997	 	 	 	 	 	 	 	19901	Not Reported	1364.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIA	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1994	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
89d1c327-a12a-42ee-b521-aedbc745dc32	PDAC278		bb8fa274-cdb2-4e99-ae2a-1269da1c40dc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	 	801.00	801.00	801.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
89d63ffe-490c-47b0-8b66-b752f510033b	C3N-03778		602a0806-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-28446	977	1940	2020	 	 	 	 	 	 	 	28446	Not Reported	977.00	977.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
89ea1842-65fd-4195-865d-eef12e8dad4e	PDAC037		387bf2ca-49ef-4bd7-acbd-875d93bd7018	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	1236.00	1236.00	1236.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8a413c6c-118a-11e9-afb9-0a9c39d33490	C3N-00324		06aa89aa-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-24280	 	1949	 	 	 	 	 	 	 	 	24280	Not Reported	710.00	710.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8a4d61f6-776a-4c40-9dd5-fbadbe9b4e90	MB199		35262cf8-92ac-485e-9366-f72a5095b04f	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	3285	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
8aacec66-59fa-4070-9929-b908284c504d	C3N-01806		c9c3fc84-1b2d-4578-bdce-c74a86250003	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20979	 	1960	 	 	 	 	 	 	 	 	20979	 	1292.00	1292.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8ac42bc3-472d-42e8-8455-09528a9977ea	OSCC_28		e6285528-b535-4ed9-bf45-e342da3f95ca	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
8ad3214f-63d8-11e8-bcf1-0a2705229b82	TCGA-AF-2692		ff2d992d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Hispanic or Latino	Female	White	Alive	-19830	 	1955	 	 	 	 	 	 	 	 	19830	Not Reported	412.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8b0bd36f-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2024		ff2f2838-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Dead	-26476	1769	1922	1998	 	 	 	 	 	 	 	26476	Not Reported	1769.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1994	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8b0fd240-1fb9-11e9-b7f8-0a80fada099c	C3N-00495		519ebac7-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-24624	 	1949	 	 	 	 	 	 	 	 	24624	Not Reported	1779.00	1779.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24624\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8b89647a-63d6-11e8-bcf1-0a2705229b82	11CO005		ff30195c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8b92398f-b166-45c1-bf1c-aae152b7bd77	C3L-02857		17d3aea3-deec-4058-b934-63a9ed68a9ad	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Female	White	Alive	-24330	 	1951	 	 	 	 	 	 	 	 	24330	 	13.00	13.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8c09d59a-118a-11e9-afb9-0a9c39d33490	C3N-00326		06b9cc2e-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-16460	 	1971	 	 	 	 	 	 	 	 	16460	Not Reported	682.00	682.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8c19f139-63d8-11e8-bcf1-0a2705229b82	TCGA-AF-3400		ff2dc268-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Hispanic or Latino	Male	White	Alive	-19826	 	1955	 	 	 	 	 	 	 	 	19826	Not Reported	1049.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8c2522ce-85ac-4ea8-b65e-f899c3f8434f	C3L-02214		bc4c2733-4c58-4b4e-a9f1-882a6d98870c	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	White	Alive	-12197	 	1984	 	 	 	 	 	 	 	 	12197	 	44.00	44.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8c308fb6-105e-47b4-baa0-ddb3d8524742	PDAC114		a2f41fe3-e9a8-4ef9-9253-585e68296ea8	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	24090	 	1836.00	1836.00	1836.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8c49b204-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2027		ff2d64c6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18835	3337	1944	2004	 	 	 	 	 	 	 	18835	Not Reported	3337.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1995	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8cbd7a01-1fb9-11e9-b7f8-0a80fada099c	C3N-00573		51a4fd5d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	2	Not Reported	Male	Asian	Alive	-22407	 	1955	 	 	 	 	 	 	 	 	22407	 	6.00	6.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22407\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8cd446ce-a0c7-4d55-ba46-07ffa99752d7	MDA-16		aba64e84-bc85-4a65-b35d-f7c87923b55d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	37	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8ce33989-c9f0-4164-b06b-f50d5012bce5	C3L-01958		0f57bb89-c4ed-4c03-a66a-c9a3f39f3462	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	White	Alive	-22636	 	1955	 	 	 	 	 	 	 	 	22636	 	1268.00	1268.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8cea9947-63d6-11e8-bcf1-0a2705229b82	11CO007		ff3020f5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8d488e7f-5138-4e03-9637-84e5c631b78f	PDAC074		18329a71-03fa-4363-bf87-e6a11291d5fc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	 	610.00	610.00	410.00	Loco-regional recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8d4aad8e-229d-4d7a-9244-b6343cb2fb5a	C3L-03123		5c0f36c9-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Alive	-22137	 	1957	 	 	 	 	 	 	 	 	22137	Not Reported	1777.00	1777.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8d5b1a5f-63d8-11e8-bcf1-0a2705229b82	TCGA-AF-3913		ff2d7ef3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Hispanic or Latino	Male	Black or African American	Dead	-21970	316	1949	2009	 	 	 	 	 	 	 	21970	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage IV	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M1	N1	Stage IV	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8d8d42ae-63d5-11e8-bcf1-0a2705229b82	01CO001		ff2ea5d9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8d929b06-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2030		ff2d3912-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-31900	1701	1908	1999	 	 	 	 	 	 	 	31900	Not Reported	1641.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1995	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8dbf9afd-118a-11e9-afb9-0a9c39d33490	C3N-00328		06c91228-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-22800	 	1954	 	 	 	 	 	 	 	 	22800	Not Reported	697.00	697.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8dc5ed9c-4d11-4cc3-9237-0c2dfa6ba508	PDAC130		fb49039b-65ef-4e7e-bdb4-115316817a2f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26645	 	273.00	273.00	113.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
8dfb4b6d-da44-4873-a312-1f04dc296d94	C3N-02595		30637ddc-0b18-4bce-adae-d692bf9eee79	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	20	Not Reported	Female	White	Alive	-15077	 	1976	 	 	 	 	 	 	 	 	15077	 	980.00	980.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8e1a9c85-c211-421c-a5cb-39af8606231e	CU-41		65cb285c-3aa6-4cb9-841f-f05dac1ceaa9	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	67	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8e2701d6-c0ba-4b8e-b1e1-899e72c35bab	49		e32e1512-0ea4-4d5f-8983-d83dcc3dec69	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8e3984c5-5f03-44b3-85dc-9c033e0310f5	AP-WTXJ		70dc04db-4bb2-4fc9-86f7-f6de6906270e	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	22645	 	1053.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Middle lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
8e4e8ba7-63d6-11e8-bcf1-0a2705229b82	11CO008		ff302d24-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8e59b323-1fb9-11e9-b7f8-0a80fada099c	C3N-00577		51ab6a6f-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Asian	Alive	-26555	 	1944	 	 	 	 	 	 	 	 	26555	 	397.00	397.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26555\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8e72024e-47b0-40c6-85f1-12e241b8ac7a	AP-SS2L		6cffa5b7-d462-4272-8e1a-de5451e703e9	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	23375	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
8e9702c3-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-3574		ff2db9d0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Dead	-32781	1096	1916	 	 	 	 	 	 	 	 	32781	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8e984f66-c1db-4588-bd01-691870ba0225	HumanIR		3dda7dd9-ad98-4ca3-bdde-c9076696767e	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
8ed302f7-63d5-11e8-bcf1-0a2705229b82	01CO005		ff2ea97d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8ed8ea8d-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2033		ff2f08ee-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-31977	562	1908	1996	 	 	 	 	 	 	 	31977	Not Reported	562.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1995	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
8ef381bc-0db3-4fe7-93b9-752bca7ec2d0	C3N-02248		7f216522-0785-4568-9754-22896d26e47d	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Hispanic or Latino	Male	Not Reported	Not Reported	 	 	1953	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8f4ccbd5-8fb7-4f3e-bab8-d5c132a84be7	CU-21		e09a9f06-514c-4c23-9caa-92d000ce018c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	85	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8f594864-d610-414e-8633-4b143afcdd6f	CU-32		ab8d4ef4-d7b4-4875-a97d-f5c8746e2357	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8f7b7b50-118a-11e9-afb9-0a9c39d33490	C3N-00333		06e7930c-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23940	 	1951	 	 	 	 	 	 	 	 	23940	Not Reported	674.00	674.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8fa258e3-9adf-45f8-b4b6-8aca20efbc7e	C3L-02746		3f6365c5-f61c-45c0-80ae-f96dd76a6f61	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-12	Not Hispanic or Latino	Female	White	Alive	-24310	 	1951	 	 	 	 	 	 	 	 	24310	 	313.00	313.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8fb486ea-63d6-11e8-bcf1-0a2705229b82	11CO010		ff3034e5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8fba4d73-5cb9-43fc-b073-ddd05b921cac	AP-ZLDH		f8e7d26a-732b-471e-9129-244de552a75c	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	25932	 	898.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
8fcb9a4a-35cc-4165-a4f7-6e1f7f74275c	H36960-009		ad6b82ca-37da-43ca-8e36-55289f884260	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
8fcfa3a0-13c2-4819-b6f3-a40d99bb1527	C3N-01848		2efb7f2c-4ebe-4c8c-8542-a07448d5053b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-21	Not Reported	Female	Other	Alive	-24957	 	1948	 	 	 	 	 	 	 	 	24957	 	709.00	709.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
8fd2207a-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-3580		ff2e1b9f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-24775	 	1940	 	 	 	 	 	 	 	 	24775	Not Reported	244.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage I	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
900e6eff-63d5-11e8-bcf1-0a2705229b82	01CO006		ff2ead61-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9017ac55-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2260		ff2edf3d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27112	1100	1918	1995	 	 	 	 	 	 	 	27112	Not Reported	1100.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1992	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
901a5db5-1fb9-11e9-b7f8-0a80fada099c	C3N-00646		51b29e90-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Female	White	Alive	-21144	 	1959	 	 	 	 	 	 	 	 	21144	 	-6.00	-6.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21144\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
905a9e60-75b1-4c53-9905-e2d3d171da7b	C3N-03173		5f83d4c9-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-23662	 	1953	 	 	 	 	 	 	 	 	23662	Not Reported	32.00	32.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
90b28d48-fe67-464b-89e2-ee28c7e3573f	AP-EFHT		90d1e6df-3e9b-4793-a8f2-8d2520af0803	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24106	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
90e33601-748b-4df7-bff3-a60ee8a09df3	AP-G79N		ccd4b2c1-6cc2-4316-8c2c-2c4a3bcd1ea4	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	30315	 	821.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
910e8e39-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-3584		ff2d5334-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Dead	-22189	730	1948	 	 	 	 	 	 	 	 	22189	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
91102308-63d6-11e8-bcf1-0a2705229b82	11CO018		ff303896-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9129a6b0-24d9-467c-979e-b1b070c022df	PDAC185		929034e6-ac5b-4e8d-84d8-5031b1e794fc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21170	 	811.00	811.00	671.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
912bec48-118a-11e9-afb9-0a9c39d33490	C3N-00334		06f6cf8a-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-24976	 	1948	 	 	 	 	 	 	 	 	24976	Not Reported	674.00	674.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
914af33a-63d5-11e8-bcf1-0a2705229b82	01CO008		ff2eb126-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
915465f9-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2261		ff2caa24-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27897	24	1916	1992	 	 	 	 	 	 	 	27897	Not Reported	24.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1992	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
91638dc9-fc1a-4721-a1cb-884d3b047f29	C3N-01171		7b731e6c-e642-4a08-b542-b569762303d3	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	White	Dead	-30148	1035	1934	2019	 	 	 	 	 	 	 	30148	 	1009.00	1035.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Cardiovascular Disorder, NOS	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
919c2e2a-a080-4ab9-9338-33defca8d491	PDAC265		2d812658-0a52-4622-8e42-eb298be0f060	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	 	526.00	526.00	126.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
91b4e8bc-1fb9-11e9-b7f8-0a80fada099c	C3N-00733		51bed068-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20507	 	1960	 	 	 	 	 	 	 	 	20507	 	1464.00	1464.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20507\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
91c6ea62-dddf-4812-811a-38d4bbad7c56	C3N-02266		ad22e7d4-dc0b-471e-933d-1495d3e2e2a4	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	14	Not Reported	Male	White	Alive	-20536	 	1961	 	 	 	 	 	 	 	 	20536	 	1834.00	1834.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
91d06323-a8ac-4005-a27d-fef004640099	NTN004		f153cbc0-50ad-4f85-9a83-75e4164ebbe3	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
92543483-685d-4fa4-ac04-870bf7161ec9	C3N-01716		5e792a84-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-18343	335	1966	2018	 	 	 	 	 	 	 	18343	Not Reported	384.00	335.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
92584f35-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-3593		ff2d919e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-26480	 	1935	 	 	 	 	 	 	 	 	26480	Not Reported	1035.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9273e183-63d6-11e8-bcf1-0a2705229b82	11CO019		ff3040cd-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9287d60b-63d5-11e8-bcf1-0a2705229b82	01CO013		ff2ed095-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
92985d1b-bf75-4c22-930a-7ab88e484b90	3480		6a98a756-13cd-42ea-b409-c1bd287cad59	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	59	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
929c0fda-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2267		ff2f20c8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-21293	1446	1935	1996	 	 	 	 	 	 	 	21293	Not Reported	1446.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1993	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
92faa00d-118a-11e9-afb9-0a9c39d33490	C3N-00335		0706fd54-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-21084	 	1958	 	 	 	 	 	 	 	 	21084	Not Reported	686.00	686.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
933a939a-a85b-4d79-8821-765a9b1a8bfd	CU-14		49cf2f28-3058-4f63-a2ae-fa3c5fddf8d7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
934d6b0d-14bf-4c4f-a68f-01c217343789	AP-62LT		15991b3b-48aa-43ee-a655-f46f1266cd27	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	14974	 	1663.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
9361a39d-1fb9-11e9-b7f8-0a80fada099c	C3N-00831		51c5ce36-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Dead	-19085	452	1964	2017	 	 	 	 	 	 	 	19085	Not Reported	374.00	452.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"452\",\"days_to_birth\":\"-19085\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
937c9378-e004-4f89-894e-ad05929b09a5	PDAC096		b3a2521c-07e6-4eda-8c48-5f7800ce71e0	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	25185	 	615.00	615.00	615.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
93988c5e-79b7-4b9b-8c2c-e2de477268be	C3L-02557		253a0e5c-3d02-4031-8f83-b0633c1e8f75	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-22238	 	1956	 	 	 	 	 	 	 	 	22238	 	1765.00	1765.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9398b8ff-6dbe-4ea5-b74b-36a8ec172acf	C3L-07034		5d02f04e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Male	White	Not Reported	 	 	1944	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
939d5b1e-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-3594		ff2d7c7b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Dead	-28277	61	1930	 	 	 	 	 	 	 	 	28277	Not Reported	0.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Rectosigmoid junction	Rectosigmoid junction	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	0	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
93c55f6f-63d5-11e8-bcf1-0a2705229b82	01CO014		ff2ed46e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
93ce8321-821f-4dcb-9e0d-1f1ca91af9e7	WHIM-P94		8916ecef-b887-4f9f-9b51-711c65fa0679	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
93d3df99-63d6-11e8-bcf1-0a2705229b82	11CO020		ff304849-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
93d92ef2-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2288		ff2bb819-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-25831	25	1929	1999	 	 	 	 	 	 	 	25831	Not Reported	25.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
93f75337-fc67-4033-a03d-3d405759082c	C3L-01107		3c0d5d1a-9fe8-4579-880c-91ef9a1a6e43	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Reported	Male	Asian	Alive	-16020	 	1973	 	 	 	 	 	 	 	 	16020	 	446.00	446.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
93f8de86-55ac-4e9f-b6dd-7afa39ed9d81	AP-8PRJ		a169376c-0e3e-488c-ac33-39b3d0c88849	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	27393	 	898.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Unknown	 	 	 	 	 	 	 	M0	NX	Unknown	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
941865bf-bef9-4e9a-b430-4e6e6956570d	C3L-02119		0b32e2bd-3f04-40b3-843f-5cb65b6d2990	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-19	Not Hispanic or Latino	Female	White	Alive	-26423	 	1944	 	 	 	 	 	 	 	 	26423	 	567.00	567.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
94383f6d-aa4d-4a34-966c-a33cdcc0e984	IR		26fb648a-8707-4d52-b3bc-d59913dcdf5d	 	Qualified	Other	Not Applicable			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
9494db09-6942-43e6-99f8-7fff17b895cc	C3N-01086		46e556dd-9c55-4105-b570-55593366c9fb	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	White	Not Reported	 	 	1955	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
94bad53c-118a-11e9-afb9-0a9c39d33490	C3N-00337		0716181c-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-24501	 	1949	 	 	 	 	 	 	 	 	24501	Not Reported	701.00	701.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
94c16198-7dbb-4956-bd96-9c1b7957a253	CAKI-1		8bb15d2d-d2ff-41ad-a406-a9eaede12dd2	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
94d189be-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-4007		ff2e08b2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-31776	 	1920	 	 	 	 	 	 	 	 	31776		31.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Colon, NOS	Colon, NOS	Not Reported	Stage IV	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 		--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
94fe058e-1fb9-11e9-b7f8-0a80fada099c	C3N-00832		51ce2f4d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-28920	 	1937	 	 	 	 	 	 	 	 	28920	Not Reported	1770.00	1770.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-28920\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9505127b-63d5-11e8-bcf1-0a2705229b82	01CO015		ff2ed8cc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9517810d-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2289		ff2c2462-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-25191	2049	1929	2002	 	 	 	 	 	 	 	25191	Not Reported	2049.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
95307d66-63d6-11e8-bcf1-0a2705229b82	11CO021		ff30565c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9530b47e-9017-4dec-bd62-60ae4386aed9	C3L-03356		5c23183e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Alive	-26098	 	1946	 	 	 	 	 	 	 	 	26098	Not Reported	550.00	550.00	497.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9548db2a-702d-46a0-8d02-bfdc497bdca8	OSCC_44		6405e77c-8d59-4cfd-8611-f9b07dfb3214	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
957077dd-f8b9-43c4-8ce7-dfe673e78607	NTN075		51ec7882-b4e0-4637-89ac-de2216d603ca	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
957b07d7-77f3-4753-a873-2bb00948b4f0	C3N-03018		18e0c2e8-78f0-41ab-8b1b-5abad502d1b0	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	12	Not Reported	Male	White	Alive	-23958	 	1952	 	 	 	 	 	 	 	 	23958	 	1416.00	1416.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
95fc8706-06da-4652-bcbb-0c02c4faeedd	C3N-00516		5dba0897-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-25164	1152	1948	2020	 	 	 	 	 	 	 	25164	Not Reported	1152.00	1152.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIA	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
960bf328-4e1d-4334-9a85-44faba6f5bd0	NTN029		727a8ad1-0da0-4e96-82f4-15d7b133fdf3	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9615897c-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A002		ff2e2420-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-13090	 	1974	 	 	 	 	 	 	 	 	13090	Not Reported	638.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
961fcdab-129c-4ae9-8abc-2ec9ae61c866	NTN089		78986b23-7e74-447e-a422-48f5c1aef06f	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
964ccbbb-63d5-11e8-bcf1-0a2705229b82	01CO019		ff2ee0e3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIC	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
96501b19-4b91-49c1-beff-06b3c46dbc3f	C3N-03665		5ffe3ad9-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Alive	-23168	 	1954	 	 	 	 	 	 	 	 	23168	Not Reported	728.00	728.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	N2	Stage III	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
96710b08-ebcc-45ed-9a71-19811c4f5fe0	91		84db30b1-17c5-4a5b-aa64-cd00eb4d9564	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	63	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
967262c9-118a-11e9-afb9-0a9c39d33490	C3N-00339		07249589-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-16577	 	1971	 	 	 	 	 	 	 	 	16577	Not Reported	701.00	701.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9688e191-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2290		ff2f2a94-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20530	1102	1941	2000	 	 	 	 	 	 	 	20530	Not Reported	1102.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1997	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9691960e-63d6-11e8-bcf1-0a2705229b82	11CO022		ff305dae-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
96d4ed52-1fb9-11e9-b7f8-0a80fada099c	C3N-00834		51dd5f9e-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-23908	 	1951	 	 	 	 	 	 	 	 	23908	Not Reported	1755.00	1755.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-23908\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
96eacdef-56fd-463c-9e56-304464a5cded	JX0211		1a6d9c5f-b915-4e3a-8577-014942803049	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
96fdbd9a-c9a5-4db9-8e0d-6ea200f975db	OSCC_19		c7513c15-9434-44d0-b44c-d1232fb7c3ec	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
971bd7fb-c34f-4ff7-94cb-700d3853bbb3	PDAC195		237ca449-06fb-4457-9e86-7df61f29a5ca	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25185	 	521.00	521.00	377.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
974f5654-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A008		ff2d687b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-18416	 	1959	 	 	 	 	 	 	 	 	18416	Not Reported	424.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
976bd9ec-7d84-4b17-adec-2ea094d79111	C3L-02741		0f5c271b-0374-428e-b524-6d2c651136f8	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-19	Not Hispanic or Latino	Female	White	Alive	-21785	 	1958	 	 	 	 	 	 	 	 	21785	 	750.00	750.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9791bd4c-63d5-11e8-bcf1-0a2705229b82	01CO022		ff2ee48b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage1	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
97b079c8-c207-41ea-8e2f-4b6117dd8dd5	C3L-01631		4876e537-668b-4ae5-9969-79d4b67ebc7d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-20745	798	1960	2019	 	 	 	 	 	 	 	20745	 	798.00	798.00	762.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
97b695fa-ba2e-4529-af38-f969bc759baf	PDAC251		898ed44e-fad0-47b6-8e11-0971583bd038	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	21535	 	1070.00	1070.00	1070.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
97c10567-b2f7-4175-b1ec-871dca5d1e41	CU-27		8ac8038e-e505-41df-948a-38c06eff4411	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	74	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
97ccecc5-b1ca-4b96-bec9-c8b79e5a39cd	MB270		cd365f3e-4c02-442e-bb08-a726bb65ef5f	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1825	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
97d4f695-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2295		ff2c992f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-25416	1007	1926	1997	 	 	 	 	 	 	 	25416	Not Reported	1007.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1995	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
97f45829-63d6-11e8-bcf1-0a2705229b82	11CO027		ff306781-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9858289a-118a-11e9-afb9-0a9c39d33490	C3N-00340		0733de1f-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-22158	 	1955	 	 	 	 	 	 	 	 	22158	Not Reported	722.00	722.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
98738137-a994-4f40-9c30-28f5ed8b3dd7	MDA-07		db2c3206-7827-4f7d-aafa-deae24fc5300	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	59	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9875f1f5-77ed-4620-a3ed-5687dac3b33b	AP-5MX6		9e83902d-2a06-447a-b7d3-dbaf651a4671	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	17896	 	1570.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
98766248-72e8-4c82-a6ba-63880d9afdf5	AP-7GDN		fd651ed4-a76d-450a-bb44-52582e0a3647	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28854	 	1810.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
987b103d-1fb9-11e9-b7f8-0a80fada099c	C3N-00852		51ecd3e8-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	Other	Alive	-22718	 	1954	 	 	 	 	 	 	 	 	22718	 	620.00	620.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22718\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
988d66de-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A00C		ff2d569f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-18201	 	1958	 	 	 	 	 	 	 	 	18201		183.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIIB	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 		--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
989bf594-7d76-4bf8-a5d8-76cdb9cd4326	AP-W455		b2e66510-6f2b-4b59-99b0-7f34c572458b	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	23375	 	1760.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
991a95d6-63d7-11e8-bcf1-0a2705229b82	TCGA-24-2298		ff2b7e1f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20453	1620	1938	1997	 	 	 	 	 	 	 	20453	Not Reported	1620.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1993	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
99250cb9-2a52-47ad-893c-b29eb9d9d698	C3N-01654		3da5e532-7edd-41d1-bc45-9e73cb057047	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	18	Not Reported	Female	White	Alive	-23413	 	1953	 	 	 	 	 	 	 	 	23413	 	1903.00	1903.00	1205.00	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
99295144-497e-4739-a12b-37f2dd7b41c0	14-00537		c0cd898e-5f96-41e8-88ff-44bbf83e7c57	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Alive	-6407	 	 	 	17	 	 	false	 	 	United States	6407	 	74.00	74.00	 	Tumor free	Not Reported	Acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
99502308-63d6-11e8-bcf1-0a2705229b82	11CO030		ff3070b3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9955c013-c8fd-4315-8946-f0c41edb024d	C3L-03350		5c1ca035-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Male	White	Dead	-23078	613	1954	2019	 	 	 	 	 	 	 	23078	Not Reported	588.00	613.00	301.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
99cb2cec-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A00H		ff2da4e1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-27485	 	1933	 	 	 	 	 	 	 	 	27485	Not Reported	790.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIA	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
99f28016-6f48-46d2-b9eb-5ec1727a1fee	C3L-01729		9578d3ac-2169-4fa2-b19a-5b60e2766d91	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-29	Not Reported	Female	White	Alive	-21974	 	1957	 	 	 	 	 	 	 	 	21974	 	981.00	981.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
99fb2339-e843-4d1c-a322-5c0de83396ae	MDA-19		6148ada3-b511-41f5-b07a-8030411d4db7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	38	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9a0345e6-ba08-4f07-b768-79a039ba14f2	C3L-00819		5a639879-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-27104	603	1942	2018	 	 	 	 	 	 	 	27104	Not Reported	601.00	603.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9a2f657d-5c27-40db-9d87-ffabb7f6b9b6	C3N-01380		5e44c591-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-24117	400	1951	2018	 	 	 	 	 	 	 	24117	Not Reported	426.00	400.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M1	N1	Stage IV	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9a36e995-118a-11e9-afb9-0a9c39d33490	C3N-00377		0743bb97-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23630	 	1951	 	 	 	 	 	 	 	 	23630	Not Reported	707.00	707.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9a4966c2-1fb9-11e9-b7f8-0a80fada099c	C3N-00953		51fbda73-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	Asian	Alive	-15137	 	1975	 	 	 	 	 	 	 	 	15137	 	1785.00	1785.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-15137\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9a58eb4b-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1312		ff2e42a4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-25537	31	1932	2001	 	 	 	 	 	 	 	25537	Not Reported	31.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9a6ff46f-8382-49a0-aecf-2cb1aee9f7e1	JX0236		f5e116b8-10ef-4797-acbf-b34943200ba9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9a9977f0-63d6-11e8-bcf1-0a2705229b82	11CO031		ff30811e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9aa58058-d5c7-4f5a-8b68-30d1e0a02d59	NTN039		818260b2-2655-4971-b1ea-fad1ff463ae5	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9ac73d0c-5990-4f08-a0ef-cdc100d02b40	NX024		2720cac1-87c5-4ea2-b6f2-54195baebc83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9add0362-ce18-4488-b9b2-5fe670d21001	38		36982b1d-57fb-46ad-ae24-28458e6ba118	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9ae40b89-f98a-4a17-899e-b6655a549fc5	C3L-02555		55b1b133-e9b6-4bc8-8af4-b29e72ad7245	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-26112	1421	1946	2021	 	 	 	 	 	 	 	26112	 	1421.00	1421.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9af63f66-dad7-4ab0-9204-84b3b672c564	PDAC021		c573c77a-5523-4863-9b0d-873ef0010318	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	747.00	747.00	451.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9b082d45-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A00Y		ff2df1fc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-24837	 	1940	 	 	 	 	 	 	 	 	24837	Not Reported	700.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9b2c1ef9-147b-4d75-ae09-f160293efd10	MB106		582fb30c-9b8f-4d18-a643-f8e10991ad1e	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
9b4f319e-9d9d-4069-9fd8-2b5fd2c13aad	C3N-01344		5f0cfa86-1ef8-425f-9b46-c853aaa29e81	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	21	Not Reported	Female	White	Dead	-29270	1359	1937	2020	 	 	 	 	 	 	 	29270	 	1011.00	1359.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9b6173e3-9d50-40d2-aa8a-d45440a6c168	2553		d89f4de0-a46d-4f10-bfa0-857db16ba2b6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9bad78c0-6cb9-45bf-85e8-86cffe0b96fc	OSCC_04		f4e75435-a0c2-4d97-86d5-054b5354b72b	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
9bb79b5f-fa75-4d05-8a23-eda606a6cfdc	C3N-00249		5d3ffcd2-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-26108	1590	1945	2020	 	 	 	 	 	 	 	26108	Not Reported	1590.00	1590.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9bb8865d-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1313		ff2dfc53-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22982	820	1938	2002	 	 	 	 	 	 	 	22982	Not Reported	820.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9bbde4ad-dc88-487f-aa15-652be70975aa	786-O		f1377983-7a2d-435f-8a6e-8738e8d14e8b	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9bdc5a63-63d6-11e8-bcf1-0a2705229b82	11CO032		ff308c6e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9beb3211-118a-11e9-afb9-0a9c39d33490	C3N-00379		0752636d-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-15271	 	1974	 	 	 	 	 	 	 	 	15271	Not Reported	658.00	658.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9bebecf3-1fb9-11e9-b7f8-0a80fada099c	C3N-01175		520b1d93-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-22205	 	1956	 	 	 	 	 	 	 	 	22205	Not Reported	1714.00	1714.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22205\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9c1806eb-a8b0-42d8-a2ce-2271142900b2	PDAC041		c926655d-8006-4a0b-9eb4-0b864abd1880	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	12775	 	29.00	29.00	29.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	Unknown	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9c46406b-3ebe-44c9-82cc-6baf3467878a	C3N-02296		7a45db03-0316-4812-8d71-729ee69e3c32	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-30417	1268	1934	2020	 	 	 	 	 	 	 	30417	 	974.00	1268.00	750.00	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9c4dfa82-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A011		ff2daa54-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-29463	 	1929	 	 	 	 	 	 	 	 	29463	Not Reported	1126.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9c960cec-278f-4287-b11a-b3599560be25	WHIM17		461c8965-b3db-4eee-a112-98120348db77	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
9ccab32d-c30d-49eb-b861-333139365cfa	MB206		70c4f78e-af3e-4d3b-9c54-441ae5118d80	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1825	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
9cf6e69d-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1316		ff2c3b5f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-20331	1279	1945	2003	 	 	 	 	 	 	 	20331	Not Reported	1126.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9d148516-e96f-4731-ac97-34a3beab00e7	PDAC139		75fbfe53-d868-4e0b-829d-ea9ee7f36518	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	855.00	855.00	197.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9d1df687-63d6-11e8-bcf1-0a2705229b82	11CO033		ff3094ae-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9d7c0e43-f9f6-4504-8d4d-f6a9a71bf0f5	PDAC011		a4d520dc-9ad2-42f3-b64d-ad0e732a2f07	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	140.00	140.00	82.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9d8d548f-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A014		ff2d5ed7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-31718	 	1923	 	 	 	 	 	 	 	 	31718	Not Reported	485.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage I	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9d8e171a-1fb9-11e9-b7f8-0a80fada099c	C3N-01176		521a6206-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-25950	 	1945	 	 	 	 	 	 	 	 	25950	Not Reported	1710.00	1710.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25950\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9dbb38e7-6af8-4247-8628-e53fd73dde3f	PDAC258		ce22737b-10af-4de3-aa3e-aac7ae5dbc3d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28105	 	888.00	888.00	232.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9e2da4f9-118a-11e9-afb9-0a9c39d33490	C3N-00383		0761e257-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-22259	 	1955	 	 	 	 	 	 	 	 	22259	Not Reported	790.00	790.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9e32b552-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1318		ff2c5152-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-19755	1064	1946	2002	 	 	 	 	 	 	 	19755	Not Reported	1064.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9e5a2210-63d6-11e8-bcf1-0a2705229b82	11CO036		ff309f53-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9e623d92-7acf-48bd-bd72-5c1802b7df86	PDAC266		9560a7ac-f4d9-4e6a-91e0-0a0c7e3994ce	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	20440	 	959.00	959.00	959.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9e7efd1e-83a8-4700-8c8c-26f91061687b	WHIM 12		54285f01-a3ae-4e38-a2d2-4cea68c9a1fa	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
9e815dee-cfa4-46a0-a284-741ca0547c92	C3L-03639		5c88ddfb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-27761	246	1942	2019	 	 	 	 	 	 	 	27761	Not Reported	246.00	246.00	169.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9e8e80e5-d732-11ea-b1fd-0aad30af8a83	ICBI-000001		9e8ecfed-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Bronchiolo-alveolar carcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8659-d732-11ea-b1fd-0aad30af8a83	ICBI-000002		9e8ed259-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e87a3-d732-11ea-b1fd-0aad30af8a83	ICBI-000003		9e8ed3f6-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Clear cell adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e89de-d732-11ea-b1fd-0aad30af8a83	ICBI-000004		9e8ed5bb-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8ad9-d732-11ea-b1fd-0aad30af8a83	ICBI-000005		9e8ed6de-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8bb4-d732-11ea-b1fd-0aad30af8a83	ICBI-000006		9e8ed891-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenosquamous carcinoma	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8d94-d732-11ea-b1fd-0aad30af8a83	ICBI-000007		9e8ed9c2-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8e7b-d732-11ea-b1fd-0aad30af8a83	ICBI-000008		9e8edb7a-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e8f51-d732-11ea-b1fd-0aad30af8a83	ICBI-000009		9e8edcbe-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e9134-d732-11ea-b1fd-0aad30af8a83	ICBI-000010		9e8ede30-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Lung Adenocarcinoma	Lung			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	With tumor	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Lung, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9e8e9259-d732-11ea-b1fd-0aad30af8a83	ReferenceMix		9e8edf4b-d732-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Georgetown Lung Cancer Proteomics Study	Georgetown Proteomics Research Program
9ec81956-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A015		ff2e208c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-23496	 	1945	 	 	 	 	 	 	 	 	23496	Not Reported	1096.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage I	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9f588023-1fb9-11e9-b7f8-0a80fada099c	C3N-01178		5229a7b1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-21476	 	1958	 	 	 	 	 	 	 	 	21476	Not Reported	1703.00	1703.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21476\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9f59690e-edc2-4abb-8c8c-fb5fda41498b	16-01259		92ea8907-5896-41ab-9916-92aa8227c961	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-22463	316	 	 	61	 	 	false	Medical Record	 	United States	22463	 	316.00	316.00	 	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
9f5c28b5-7ff0-42d5-a112-c12bc43fa797	AP-9LNA		8b0d4043-2ac2-410b-b2da-276fdf2f3ae9	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	27027	 	1810.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
9f71a995-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1319		ff2e783e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26786	1977	1927	2005	 	 	 	 	 	 	 	26786	Not Reported	1977.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
9fa2feac-63d6-11e8-bcf1-0a2705229b82	11CO037		ff30a570-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
9fa742ba-a536-4674-98f6-994758bd69ca	PDAC137		2c71e7fc-eab0-4a7c-82c3-0a8a04b412e1	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26645	 	342.00	342.00	62.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
9fbb232c-c471-4953-8ffd-fd4bddcf480e	C3N-02082		578c7444-91d1-4196-9e46-36261df70656	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Female	Asian	Alive	-24439	 	1950	 	 	 	 	 	 	 	 	24439	 	352.00	352.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a005feb4-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A016		ff2d627c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-20178	 	1954	 	 	 	 	 	 	 	 	20178	Not Reported	276.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M1	N2	Stage IV	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a008f512-5b53-4dc7-876f-b421e931ad50	7301		177f1a00-5255-488c-9967-2b9e37d4f2dc	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	68	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a023e964-118a-11e9-afb9-0a9c39d33490	C3N-00386		0770e321-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-16190	 	1972	 	 	 	 	 	 	 	 	16190	Not Reported	673.00	673.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a048c5a5-69a5-49b5-b179-1e6cacbfe92e	14		7b065ad2-0709-4e0a-8888-c35a86230914	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	79	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a06eaca6-d26c-40c4-90e4-4748e277c876	AP-SC6Y		d41ec93a-0fec-4b04-b54e-5d60a97a4e6a	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
a0ad4f83-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1320		ff3175fa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-24018	1155	1936	2004	 	 	 	 	 	 	 	24018	Not Reported	1124.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a0e04ed9-63d6-11e8-bcf1-0a2705229b82	11CO039		ff30ad9d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a0f46ace-1fb9-11e9-b7f8-0a80fada099c	C3N-01179		5238e591-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-26483	 	1944	 	 	 	 	 	 	 	 	26483	Not Reported	1816.00	1816.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a10fd102-5146-4fb9-b0e0-86f0f76806f7	MDA-15		11ba09d3-760d-4315-a637-80fc4310610a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	66	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a136beb8-8193-4b45-81e2-43b39b1cc8e5	WHIM26		5fd4f70e-3fa4-446a-b20a-b5351026c9db	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
a1414a42-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A01J		ff2d4f59-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-21581	 	1950	 	 	 	 	 	 	 	 	21581	Not Reported	31.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a168b146-c127-43ac-aa86-3c16c18fdd26	MDA-03		042ee7af-89a5-4917-95fe-0f6d0adb1e4a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	62	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a16d828e-b6a6-4884-92a4-884ef03de57c	WHIM30		85d3610f-6af8-4452-abd2-37f3f2d37629	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a1d6b22d-118a-11e9-afb9-0a9c39d33490	C3N-00388		07804922-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-21570	 	1957	 	 	 	 	 	 	 	 	21570	Not Reported	645.00	645.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a1f1f212-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1321		ff2bf188-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-23987	1033	1936	2003	 	 	 	 	 	 	 	23987	Not Reported	1033.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a20a1e37-4031-408f-a09f-98bd3bfecfc2	PDAC180		53a8eae3-cc5d-4f5c-bb5a-d9ee26efe801	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24820	 	496.00	496.00	258.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
a21c4839-63d6-11e8-bcf1-0a2705229b82	11CO042		ff30b3e7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a2391397-3980-463e-8d1b-2290a993893b	C3N-03426		5fb19890-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-24994	123	1949	2018	 	 	 	 	 	 	 	24994	Not Reported	31.00	123.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a251b23a-ae5b-4319-ab5b-ad425071eac3	C3N-01011		5e0cac80-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Alive	-28289	 	1939	 	 	 	 	 	 	 	 	28289	Not Reported	1068.00	1068.00	623.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N1	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a25d73bd-a0e9-45de-bd29-6ab859d46306	MDA-08		277f5ba4-68bc-44db-8bac-4de3a7b97582	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	66	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a27abe5c-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A01L		ff2d870c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-21369	 	1951	 	 	 	 	 	 	 	 	21369	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a296befc-1fb9-11e9-b7f8-0a80fada099c	C3N-01180		52481eb1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-18748	 	1965	 	 	 	 	 	 	 	 	18748	Not Reported	1815.00	1815.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18748\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a32f28e0-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1322		ff2c9f0c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22646	91	1939	2001	 	 	 	 	 	 	 	22646	Not Reported	91.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a3328f69-121c-481c-8c49-5d01685aaa3b	Pros BRCA CR		0466c964-ae24-46ef-9a48-7974b88df361	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a359097e-63d6-11e8-bcf1-0a2705229b82	11CO043		ff30bf97-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a3842772-b155-4d18-bc2a-966c960c1b67	82		d94f8f7c-eabc-4cf8-856a-29ff2d817e66	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	70	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a3b1451a-118a-11e9-afb9-0a9c39d33490	C3N-00389		0790360a-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-22951	 	1953	 	 	 	 	 	 	 	 	22951	Not Reported	671.00	671.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a3b8a741-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A01N		ff2d837d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-25049	 	1941	 	 	 	 	 	 	 	 	25049	Not Reported	943.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IV	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	M1	N0	Stage IV	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a3cbf3f4-b398-43c8-b323-c4e07c04d8d7	C3N-03884		604ee87c-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-23590	680	1953	2020	 	 	 	 	 	 	 	23590	Not Reported	598.00	680.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a3e3b167-2d2b-462d-9d3b-849a5f7ddea6	C3N-01166		5e232671-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-22892	1170	1954	2020	 	 	 	 	 	 	 	22892	Not Reported	1170.00	1170.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	7	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a406851b-a980-4a6b-85fe-074a626a7035	78		488cfcf8-ee57-4bc7-a05c-01ce3dfa5164	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	85	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a406851b-a980-4a6b-85fe-074a626a7035	78		88e6505c-4619-4bcb-a9e8-963081b83412	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	85	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a415f239-a6ca-451d-81eb-196a7e7183d2	C3L-00598		5a268785-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-22466	422	1955	2017	 	 	 	 	 	 	 	22466	Not Reported	422.00	422.00	348.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	13	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a4300f90-1fb9-11e9-b7f8-0a80fada099c	C3N-01200		524f06c0-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	9	Not Reported	Female	Other	Dead	-20550	47	1960	2017	 	 	 	 	 	 	 	20550	 	47.00	47.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"47\",\"days_to_birth\":\"-20550\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a451fbab-fdef-4ce8-adbe-547e02e11f89	79		3eb5e6df-9c88-4163-8653-817e56a88964	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	64	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a46d3e08-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1323		ff319462-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26602	395	1929	2002	 	 	 	 	 	 	 	26602	Not Reported	365.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a494498b-63d6-11e8-bcf1-0a2705229b82	11CO044		ff30c282-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a4b96c1c-6508-4439-84fe-39e3c5c37a79	KoreanReference3		608ddb77-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a4f480ac-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A01W		ff2ddc70-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-24745	 	1937	 	 	 	 	 	 	 	 	24745	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a50105c7-df56-4233-a96c-fdb0e2baeefe	P94		04b63e6d-5528-41bb-975f-0058cd90c031	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a5418e71-773e-4d52-9191-acebd509970f	PDAC241		0718ea24-ffa0-4303-9f4f-1beb43264cc0	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27740	 	260.00	260.00	260.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
a55164b4-5970-4737-8947-968a9fb766e0	C3L-01681		18a04511-f654-4d17-a20a-d3e0ce685356	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Hispanic or Latino	Male	White	Dead	-27785	1534	1941	2021	 	 	 	 	 	 	 	27785	 	1534.00	1534.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a57fa8f2-118a-11e9-afb9-0a9c39d33490	C3N-00729		079eace0-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-31527	 	1930	 	 	 	 	 	 	 	 	31527	Not Reported	873.00	873.00	820.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IB	Not Reported	8th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a5a73d5c-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1329		ff2d85d9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-28093	457	1926	2003	 	 	 	 	 	 	 	28093	Not Reported	90.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a5c16e2b-139d-4779-95b8-8b7c2cc39290	PDAC112		fac9ee75-09e2-43e3-801d-a1a4655e0aad	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20440	 	473.00	473.00	293.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
a5cc95b2-1fb9-11e9-b7f8-0a80fada099c	C3N-01213		5266aca3-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Other	Alive	-24944	 	1948	 	 	 	 	 	 	 	 	24944	Not Reported	654.00	654.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24944\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a5d790a6-63d6-11e8-bcf1-0a2705229b82	11CO045		ff30cb43-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a638bb20-4185-45d5-8953-f28d96a766c2	NX032		2bde6916-31bc-4d6a-9060-ab3a803e2fab	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a639563c-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A01Y		ff2de891-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-18112	 	1955	 	 	 	 	 	 	 	 	18112	Not Reported	0.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a6dbcdb1-55f0-4afb-af56-b2fc0839ce53	PDAC196		5025336f-966d-467d-a16b-d10d36abecca	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	 	941.00	941.00	738.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
a6e43985-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1623		ff2e7185-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26060	565	1935	2007	 	 	 	 	 	 	 	26060	Not Reported	565.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a70dd091-32f2-4964-a23c-0504be46371e	AP-4HYT		153fdf7a-63da-4413-b383-270e0cd873de	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
a725c269-63d6-11e8-bcf1-0a2705229b82	11CO047		ff30cef1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a73281f0-258d-44d2-ab2c-e58d9794a6a2	C3N-01079		e7007e26-ccc0-40d8-a680-511192f9ef2c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1939	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a7378d52-118a-11e9-afb9-0a9c39d33490	C3N-00734		07a5281e-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-19402	 	1963	 	 	 	 	 	 	 	 	19402	Not Reported	1094.00	1094.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a744a4c1-0ada-44d3-8dbd-b074d0b5ca41	72		e25fb15a-a7e9-4a32-876f-f40d01561961	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	74	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a767e303-1fb9-11e9-b7f8-0a80fada099c	C3N-01214		5275eba1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Male	Other	Alive	-22241	 	1956	 	 	 	 	 	 	 	 	22241	 	653.00	653.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22241\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a774825f-9658-4e89-936b-9cb69b36cbfd	C3N-02066		3cf0109b-eacf-4c83-a218-0088e00ea2a1	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Female	Asian	Alive	-22385	 	1956	 	 	 	 	 	 	 	 	22385	 	358.00	358.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a77625be-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A020		ff2e10aa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Female	Not Reported	Alive	-20851	 	1948	 	 	 	 	 	 	 	 	20851	Not Reported	31.00	 	 	Not Reported	8480/3	Mucinous adenocarcinoma	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a7c49126-6bd2-4f9b-a700-d24c1e8813ae	C3L-02747		77e47582-6872-4780-8c16-c15fb354b9f1	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-7	Not Hispanic or Latino	Female	White	Alive	-24345	 	1951	 	 	 	 	 	 	 	 	24345	 	355.00	355.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a7db3849-04ef-49c3-8313-82bb4b02bc9b	AP-FX68		f50331a0-a5dc-4a79-b46f-554afc144c15	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	24106	 	992.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
a7f7f405-c063-4bc7-8653-338f04dce30c	7078		e861a997-141e-4bf5-a989-6a16122da9b6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
a8629627-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1628		ff2c074b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-24488	627	1935	2003	 	 	 	 	 	 	 	24488	Not Reported	627.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a8735982-63d6-11e8-bcf1-0a2705229b82	11CO048		ff30d342-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a908ac2c-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A026		ff2d5a53-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Dead	-24413	59	1940	2006	 	 	 	 	 	 	 	24413	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T4	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a90d356a-1fb9-11e9-b7f8-0a80fada099c	C3N-01220		52852d28-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	9	Not Reported	Male	Other	Dead	-18748	633	1965	2018	 	 	 	 	 	 	 	18748	 	633.00	633.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18748\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a91770bc-118a-11e9-afb9-0a9c39d33490	C3N-00743		07adeb62-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	Black or African American	Alive	-19452	 	1963	 	 	 	 	 	 	 	 	19452	Not Reported	584.00	584.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a92fe986-efba-4604-9fdc-9186b2b32f34	C3N-00954		5df717a8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-30720	 	1932	 	 	 	 	 	 	 	 	30720	Not Reported	218.00	218.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Pancreas, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a940e7fe-84e0-41f7-87fa-d188db8435f1	C3L-02463		5bc2d043-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-23313	 	1953	 	 	 	 	 	 	 	 	23313	Not Reported	740.00	740.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a99f5b43-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1630		ff2e850e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-27006	1162	1929	2005	 	 	 	 	 	 	 	27006	Not Reported	239.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
a9c38858-adc7-4d21-b930-1328205b5994	C3L-02354		4455dde4-ba78-48b1-82ed-ec0ac17d2a28	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20260	 	1962	 	 	 	 	 	 	 	 	20260	 	1749.00	1749.00	1294.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a9cb3450-63d6-11e8-bcf1-0a2705229b82	11CO051		ff30d729-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
a9fe12f6-af72-4d0e-954e-00309fce3120	AP-MGNN		ead70efa-6046-490b-92e2-63a6805cf3ca	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	17531	 	1825.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
aa29ba3e-538e-4cef-8fa9-0d8a9c7c56b7	CU-09		be781830-c88f-4860-8a36-e4c756b3f649	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Appendix	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
aa4629a7-d6b5-4ab7-92d5-d4c07b92a415	C3N-01875		96442473-ab91-4cfa-ab57-847d11292d9f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	19	Not Reported	Female	White	Alive	-24349	 	1950	 	 	 	 	 	 	 	 	24349	 	48.00	48.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
aa60046f-d90d-4ee7-b787-eae328dab7b4	AP-QUHC		dd64cc09-5e06-4698-9f9e-804f19e7331c	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	20453	 	1825.00	 	 	Not Reported	8253/3	Invasive mucinous adenocarcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
aa68d315-3c85-4ca4-acc8-a83631bb35d4	WHIM8		25890dfe-6f83-43de-b44d-77686696742a	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
aa6d638b-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A02N		ff2d65ee-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-24687	 	1938	 	 	 	 	 	 	 	 	24687	Not Reported	1885.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage II	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
aaa5ac4e-74c3-4d42-ae0d-f672aa3ed6da	C3L-01160		e2170d77-e54f-46d8-a72e-847f3d089ddf	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	28	Not Reported	Female	Other	Dead	-22041	140	1957	2017	 	 	 	 	 	 	 	22041	Not Reported	140.00	140.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
aaa7336a-1fb9-11e9-b7f8-0a80fada099c	C3N-01261		52946e80-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	3	Not Reported	Male	Other	Alive	-24825	 	1949	 	 	 	 	 	 	 	 	24825	 	680.00	680.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24825\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
aad9f35e-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1631		ff2ee352-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26687	9	1929	2002	 	 	 	 	 	 	 	26687	Not Reported	9.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ab0c12f7-63d6-11e8-bcf1-0a2705229b82	11CO052		ff30dab6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ab577840-9ea6-4118-93ff-edfac0420cf3	PDAC198		3ca1a227-7bb8-47f0-bd87-8ad685d4edcd	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	398.00	398.00	205.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
ab61bb80-118a-11e9-afb9-0a9c39d33490	C3N-00836		07b4c3dd-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-27509	 	1941	 	 	 	 	 	 	 	 	27509	Not Reported	665.00	665.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ab9faea6-5f31-4fb3-9aa6-7438f616827d	MDA-14		767ddfdc-8a0c-429e-8477-e7308ca3a894	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
abb6edd1-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A02X		ff2dd3b8-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-28399	 	1930	 	 	 	 	 	 	 	 	28399	Not Reported	1247.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ac10781e-c6a4-43b0-a763-9cf54ca8493c	31		52c2887f-af5c-4719-8071-670541c24816	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	38	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ac397d48-5a9a-43e5-9f4a-fc174ce3671f	CU-22		aeaca62f-5db9-4766-b90f-c87035cbc801	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ac462fbe-4974-446a-b66e-bd5be817c526	CU-04		b988cdfa-fa1a-41b0-abc5-fbc9dd147922	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ac4960f0-1fb8-11e9-b7f8-0a80fada099c	C3L-00004		4dd613ea-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-26409	 	1943	 	 	 	 	 	 	 	 	26409	Not Reported	384.00	384.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R1	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26409\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ac5af110-1fb9-11e9-b7f8-0a80fada099c	C3N-01361		52a3b16f-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-17562	 	1968	 	 	 	 	 	 	 	 	17562	Not Reported	1811.00	1811.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17562\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ac5bbaf4-63d7-11e8-bcf1-0a2705229b82	TCGA-25-1635		ff2c4dcc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26200	1583	1931	2006	 	 	 	 	 	 	 	26200	Not Reported	1558.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ac628f19-20c7-420e-8a7c-10db8ab77656	C3N-00436		5d6dbe08-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-25422	718	1947	2018	 	 	 	 	 	 	 	25422	Not Reported	718.00	718.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
aca14699-63d6-11e8-bcf1-0a2705229b82	11CO053		ff30df40-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
acf3687c-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A032		ff2d9576-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-24865	 	1939	 	 	 	 	 	 	 	 	24865	Not Reported	1157.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ad580ba0-118a-11e9-afb9-0a9c39d33490	C3N-00847		07bb8c33-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23757	 	1951	 	 	 	 	 	 	 	 	23757	Not Reported	682.00	682.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ada3f24a-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2396		ff2d97df-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26145	92	1933	2004	 	 	 	 	 	 	 	26145	Not Reported	92.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
add7dfac-63d6-11e8-bcf1-0a2705229b82	11CO054		ff30e905-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ade302cd-1fb8-11e9-b7f8-0a80fada099c	C3L-00010		4ddef7bb-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-11025	 	1986	 	 	 	 	 	 	 	 	11025	Not Reported	896.00	896.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-11025\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
adfe3073-938e-4789-bb6e-3e18c0c226ee	WHIM46		52d7eeaa-3dab-45b7-9ebc-c31fee11bad7	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
ae0489d0-1fb9-11e9-b7f8-0a80fada099c	C3N-01522		52b33b3f-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Male	Other	Alive	-29350	 	1936	 	 	 	 	 	 	 	 	29350	 	692.00	692.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-29350\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ae1e8dc5-856f-4133-8853-3656c9708a17	BCN 1359		f6ed88bb-ee90-4e81-8aea-03f0e0013dba	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
ae381fa3-63d8-11e8-bcf1-0a2705229b82	TCGA-AG-A036		ff2d8c3d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Rectum Adenocarcinoma	Rectum			Not Reported	Male	Not Reported	Alive	-26206	 	1931	 	 	 	 	 	 	 	 	26206	Not Reported	3562.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Rectum, NOS	Rectum, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage III	T3	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ae9df8dd-d642-402b-a24c-b6d36f5767c6	59		ec355a57-948d-4959-a9dc-92604aa567da	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	56	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
aee1b135-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2397		ff2e6d50-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-21581	365	1945	2005	 	 	 	 	 	 	 	21581	Not Reported	365.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
aee46ef0-7fd7-4ff8-b2d6-5911beac7108	WHIM 21		0b00a6ab-3885-459c-8208-fb3893ee1842	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
aef60166-8440-40a9-875c-4fe7e125bdde	C3L-01833		207f2179-afcd-4022-bd89-7b541c0860ce	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-44	Not Reported	Female	White	Alive	-22921	 	1954	 	 	 	 	 	 	 	 	22921	 	1030.00	1030.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af051b71-95cf-495b-93cb-da7d5457a586	BCN 1300		5eb7db77-9294-484a-8f5b-053569d77906	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
af12abd4-d315-4bc6-b8be-cc4308cd0105	C3N-02005		df97d371-00d9-4474-8cb0-7be3671eda40	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	5	Not Reported	Male	Asian	Alive	-23084	 	1954	 	 	 	 	 	 	 	 	23084	 	345.00	345.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af16947d-3bda-4bd2-99db-57b1bf7426d2	JX0135		2fdf08da-3304-41d9-8973-fcd9db789ea0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
af1784da-7316-4196-ac4a-dcb601506093	CU-30		62972100-78e2-4d02-af1e-b3a8644add4b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
af1d550b-63d6-11e8-bcf1-0a2705229b82	11CO057		ff30f168-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af254622-f443-4020-84e1-095a9f3319f2	PDAC199		daf474a4-ff09-4344-b0e4-b818356025e4	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	289.00	289.00	108.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
af3bac3b-118a-11e9-afb9-0a9c39d33490	C3N-00848		07c48428-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-24214	 	1950	 	 	 	 	 	 	 	 	24214	Not Reported	658.00	658.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af5e6b3c-eece-4a71-b205-929b3d368620	MDA-10		bb892b46-9a35-4446-b13d-6f6231c64930	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	48	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
af727cc6-3100-46b0-be52-8c8eded0215d	C3L-02353		5c67484f-910d-4074-a3ad-37cd8b5e6137	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-29240	 	1937	 	 	 	 	 	 	 	 	29240	 	1705.00	1705.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af738f95-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A04A		ff314e6b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-13445	 	1972	 	 	 	 	 	 	 	 	13445	Not Reported	90.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T2	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
af749561-63d5-11e8-bcf1-0a2705229b82	01OV047		ff2ea492-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
af7c2225-1fb8-11e9-b7f8-0a80fada099c	C3L-00011		4de5a2f0-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Dead	-23307	241	1952	2016	 	 	 	 	 	 	 	23307	Not Reported	229.00	241.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R1	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"241\",\"days_to_birth\":\"-23307\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
afb7f148-60b8-415d-be35-a60ed7be197e	C3N-02068		1facaf1c-fb33-41a9-b3c9-f175f9bd98ed	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Female	Asian	Alive	-17306	 	1969	 	 	 	 	 	 	 	 	17306	 	345.00	345.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
aff10fc2-1fb9-11e9-b7f8-0a80fada099c	C3N-01524		52c25a87-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Male	Other	Alive	-22558	 	1955	 	 	 	 	 	 	 	 	22558	 	694.00	694.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22558\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b0216d38-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2399		ff2dabb4-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-29373	608	1924	2005	 	 	 	 	 	 	 	29373	Not Reported	608.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b02967d7-2b61-4785-a583-4a7797229545	PDAC247		accaf746-cb3e-46cb-8d4f-bae6a94d9c45	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	27740	 	1065.00	1065.00	1065.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b0323adb-21db-403f-8568-f2894e58f5a7	X5M15		24e39fd7-d4d3-4bc5-8565-0e274310f3c7	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	9855	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
b046b38f-3da2-4e95-a32e-7fce831be20a	C3L-01954		d99c4da8-7eb7-4e4e-b9d8-a38acd2216c1	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	43	Not Reported	Female	White	Alive	-24719	 	1949	 	 	 	 	 	 	 	 	24719	 	55.00	55.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b05c2057-63d6-11e8-bcf1-0a2705229b82	11CO058		ff30ffd1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b0cedd28-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0AJ		ff2bd8a1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-29131	 	1931	 	 	 	 	 	 	 	 	29131	Not Reported	303.00	 	 	Not Reported	8522/3	Infiltrating duct and lobular carcinoma	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIB	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b0effb8f-118a-11e9-afb9-0a9c39d33490	C3N-00850		07cb0b2a-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23707	 	1951	 	 	 	 	 	 	 	 	23707	Not Reported	682.00	682.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b118086f-1fb8-11e9-b7f8-0a80fada099c	C3L-00026		4dee3ea9-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-23881	 	1950	 	 	 	 	 	 	 	 	23881	Not Reported	1769.00	1769.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-23881\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b11be1d7-8f96-4d28-b965-7ee2891291c6	C3L-04080		5cad1c3f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-25862	20	1947	2018	 	 	 	 	 	 	 	25862	Not Reported	20.00	20.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b135787d-c6ac-4704-8f78-d11b2ab863e8	NX037		87ba2912-4971-402d-8385-ba9654426d7b	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b1456e51-a18a-431c-8899-ead3cdcf23b8	C3L-02208		7c0f6853-0869-43e6-9840-c7e6ec0d9930	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	20	Not Reported	Male	White	Alive	-25198	 	1948	 	 	 	 	 	 	 	 	25198	 	1080.00	1080.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b15da313-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2400		ff318274-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-27789	1278	1928	2007	 	 	 	 	 	 	 	27789	Not Reported	1278.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b1ec90cb-652b-421d-a81d-6f5c208a4e4b	PDAC269		a4dd0e57-d0bb-47de-9e32-9a8244ab5946	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	25550	 	939.00	939.00	48.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b224e773-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0AL		ff2f3318-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-15286	 	1969	 	 	 	 	 	 	 	 	15286	Not Reported	227.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIIB	T4	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b2412ff4-1532-4ace-b1ef-78ef45f492f2	C3N-04119		6055670b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-19826	305	1964	2019	 	 	 	 	 	 	 	19826	Not Reported	270.00	305.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b26b8168-7348-47be-b119-a9c3398ff545	C3N-03019		8bc32603-8d30-42d7-8aee-cdd302521d00	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	12	Not Reported	Male	White	Alive	-16917	 	1971	 	 	 	 	 	 	 	 	16917	 	1416.00	1416.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b28a9345-4e6f-46e9-8e21-10afd81fb12c	C3N-02264		89917149-91e8-4cdc-8451-e8ff5c03dc45	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	15	Not Reported	Male	White	Alive	-25037	 	1948	 	 	 	 	 	 	 	 	25037	 	1498.00	1498.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b28c1aba-1655-404b-8363-9774c22eff7f	MDA-11		91a469d2-2ffd-4a51-93ec-d7f109a2ce05	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	67	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b29c76cc-34e3-4af5-bcc1-2894f1127384	PDAC174		078b1287-220a-4578-a8d7-451788848f61	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	1332.00	1332.00	1032.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b2a27cfc-118a-11e9-afb9-0a9c39d33490	C3N-00858		07d150ea-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-24019	 	1951	 	 	 	 	 	 	 	 	24019	Not Reported	736.00	736.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b2a4a0c4-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2404		ff2c4a43-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	American Indian or Alaska Native	Dead	-14184	883	1967	2007	 	 	 	 	 	 	 	14184	Not Reported	883.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b2a945e3-e5cb-47d3-b74c-8bbf03fd33f2	OSCC_63		2ba21956-7dcb-4119-ad36-a815500f0a1b	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
b2aeaffe-1fb8-11e9-b7f8-0a80fada099c	C3L-00079		4dfd8002-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Dead	-18021	274	1967	2017	 	 	 	 	 	 	 	18021	Not Reported	245.00	274.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"274\",\"days_to_birth\":\"-18021\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b2b2422f-dab0-466a-8e6f-2f2981aac1fa	AP-EZEX		441b5e42-e0f7-4420-9da2-f247965a86d1	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	24836	 	913.00	 	 	Not Reported	8253/3	Invasive mucinous adenocarcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
b2dc3f43-63d6-11e8-bcf1-0a2705229b82	11CO060		ff311a1c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b31b57b6-50ba-4048-8bc7-3c6586bc23dd	PDAC015		ef6aa812-a84c-401c-90d4-771df28c729e	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	914.00	914.00	617.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b325c35f-1fb9-11e9-b7f8-0a80fada099c	C3N-01646		52d17ebc-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-25523	 	1947	 	 	 	 	 	 	 	 	25523	Not Reported	1952.00	1952.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25523\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b3282736-70aa-444c-a3a4-d1c9b36d1ceb	PDAC093		53f08728-e8dc-4cd5-acc1-456ec362de63	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	19710	 	638.00	638.00	406.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b32ade51-63d5-11e8-bcf1-0a2705229b82	02OV006		ff2eafe9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b3683350-3f71-4826-b8a4-2e5d56dd01da	JX0223		5df9c8fc-844e-4510-b192-f5bca3e6afa3	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b36a5af5-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0AM		ff2bd64e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-20713	 	1954	 	 	 	 	 	 	 	 	20713	Not Reported	5.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b389c04b-e42a-4143-970b-f39cc6882ba0	C3N-01997		5e943feb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-23169	1035	1953	2020	 	 	 	 	 	 	 	23169	Not Reported	1002.00	1035.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b39822b8-075d-48f2-9495-f59a3ed3cfbd	C3L-01462		ce22ee7d-32fb-429e-8177-4150d23b5a78	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	6	Not Reported	Male	White	Alive	-24927	 	1948	 	 	 	 	 	 	 	 	24927	 	1519.00	1519.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b3c36b01-fa4a-43d6-b387-b99a3eabf2af	C3L-01158		36a243eb-77ea-4ca2-b554-9d4b1f9242b4	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	70	Not Reported	Female	Other	Dead	-25247	980	1948	2020	 	 	 	 	 	 	 	25247	Not Reported	980.00	980.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b3ebc033-63d7-11e8-bcf1-0a2705229b82	TCGA-25-2409		ff2bb25a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-26267	821	1934	2007	 	 	 	 	 	 	 	26267	Not Reported	821.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b3f6b689-48fb-4713-a052-b9e26ef7001e	PDAC160		90343812-8c33-4d00-8fb7-be713e92fc2b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	 	244.00	244.00	35.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b406d900-ac1d-4f98-bdc5-94e791bc96f0	MB275		52e03802-426c-46c9-a0bf-df636f0c0edb	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
b4188575-63d6-11e8-bcf1-0a2705229b82	11CO061		ff311cbc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b43c7c9d-ec92-47f1-9c61-7e68554cf66b	C3N-03020		0615bfae-e2e8-4a75-8522-ad7dadba7e16	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	White	Dead	-23772	1210	1952	2021	 	 	 	 	 	 	 	23772	 	1210.00	1210.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b4430371-3c29-47e0-844f-4dba28914afa	WU-PDA1		60f8ab06-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b445c2be-1fb8-11e9-b7f8-0a80fada099c	C3L-00088		4e06486f-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Dead	-26509	694	1943	2018	 	 	 	 	 	 	 	26509	Not Reported	687.00	694.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Infection	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R1	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"694\",\"days_to_birth\":\"-26509\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b44f3ebf-e0aa-4e5e-ab5b-8b19933b8ce1	WHIM18		5d3ea01d-f982-4488-8699-edc1a025a032	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
b455abd8-118a-11e9-afb9-0a9c39d33490	C3N-00866		07d794e2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-28243	 	1939	 	 	 	 	 	 	 	 	28243	Not Reported	511.00	511.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b49991d9-7696-4476-8e59-5d8c6a82496b	JX0156		15956c16-9ad5-4cbc-a079-89e7c60d2c01	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b4a640a3-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0AS		ff2bc3fa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-25658	 	1940	 	 	 	 	 	 	 	 	25658	Not Reported	10.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b4cf9982-5ded-42d0-be02-cad563d11ac0	PDAC249		4505062e-738a-4b76-9896-8f90a8db3aaf	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	423.00	423.00	104.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b506fab4-6ae4-49d1-b504-e9eea92143a1	CU-02		276eb343-ecde-48fd-b0d8-c4ae4371bfd0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	66	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b5158703-1fb9-11e9-b7f8-0a80fada099c	C3N-01648		52e0b88a-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-25227	 	1948	 	 	 	 	 	 	 	 	25227	Not Reported	1939.00	1939.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25227\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b52c7e99-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1688		ff2c4136-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-14574	2400	1953	1998	 	 	 	 	 	 	 	14574	Not Reported	2400.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1992	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b554027e-63d6-11e8-bcf1-0a2705229b82	11CO062		ff31283b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b55d40a5-36e0-4c30-922e-eee7bbfc269b	C3L-02468		7a1630b1-cb42-4b74-b3c4-dc34b705016f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Hispanic or Latino	Female	White	Alive	-23177	 	1954	 	 	 	 	 	 	 	 	23177	 	1.00	1.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b56f311f-4d04-468c-a549-05b7b87c4492	C3N-01873		7508c8bd-7413-4260-92ec-24c0616139df	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	White	Alive	-26044	 	1945	 	 	 	 	 	 	 	 	26044	 	1325.00	1325.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b5988f8a-f71d-43f8-9474-51a8974e0bf7	OSCC_22		9cbcacf8-7995-4187-824b-2e70616d3cc5	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
b5a7edc1-93ae-4f26-b129-cf897c58179f	H36960-01		4d89904c-c67e-417d-866e-ed02bf80011f	 	Disqualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b5caec24-aa6e-4ef2-b74a-0bba909ce63f	26		82dcb828-cf2e-4dc6-96c4-d2c231477383	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	50	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b5caec24-aa6e-4ef2-b74a-0bba909ce63f	26		c3c11b2c-cc73-4e3f-a739-48058cf24a8a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	50	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b5d88141-1fb8-11e9-b7f8-0a80fada099c	C3L-00096		4e137306-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Dead	-19180	71	1963	2016	 	 	 	 	 	 	 	19180	Not Reported	68.00	71.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IV	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Unknown	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"71\",\"days_to_birth\":\"-19180\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b5e2fb26-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0FK		ff301df3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-32462	 	1922	 	 	 	 	 	 	 	 	32462	Not Reported	213.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIIB	T4		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b5f71e03-9c44-48ee-99b8-cf0fe4cb4dfe	C3L-02809		5bf3c806-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-30685	68	1933	2017	 	 	 	 	 	 	 	30685	Not Reported	68.00	68.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b6063e07-2258-4d24-8923-9d05cef350c9	AP-SJVE		7bcb50f2-edb6-42ec-af1c-863c540e0dae	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	21549	 	240.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
b609ffcc-118a-11e9-afb9-0a9c39d33490	C3N-00880		07de0f47-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-22438	 	1955	 	 	 	 	 	 	 	 	22438	Not Reported	1757.00	1757.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b61e6d54-fe64-45c6-a226-09a7aaf805ec	C3L-02177		e6cfe426-491b-44aa-b02d-0c80ffcac709	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Reported	Male	White	Alive	-18822	 	1965	 	 	 	 	 	 	 	 	18822	 	13.00	13.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b66911c2-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1690		ff2bd38f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-24319	1448	1927	1996	 	 	 	 	 	 	 	24319	Not Reported	1360.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1993	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b692a393-63d6-11e8-bcf1-0a2705229b82	11CO070		ff3130f3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b6aab1d8-57e5-4061-ac48-8513b7c98bfe	PDAC040		dc070c9f-10f5-4b82-966e-0a8984013b4e	 	Disqualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	 	991.00	991.00	38.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
b6b4f9ee-1fb9-11e9-b7f8-0a80fada099c	C3N-01649		52f021b9-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-18993	 	1965	 	 	 	 	 	 	 	 	18993	Not Reported	1943.00	1943.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18993\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b6e87c18-64e7-40d4-acc9-32f5016249b1	NTN017		f759c73d-be25-43ba-9170-30db9e75065d	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b72047f9-63d8-11e8-bcf1-0a2705229b82	TCGA-AN-A0FL		ff2bad7d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-22805	 	1948	 	 	 	 	 	 	 	 	22805	Not Reported	231.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b76d3749-1fb8-11e9-b7f8-0a80fada099c	C3L-00097		4e1a8aa6-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-21624	 	1957	 	 	 	 	 	 	 	 	21624	Not Reported	1735.00	1735.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21624\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b77fc649-9ec6-4f67-82d6-f34923b4e1f0	2		bc6df300-fe0a-4cdf-bfa2-8b2c00e89267	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b7a788a4-f3a7-11e8-a44b-0a9c39d33490	CA25730263-1		b5c9ce9e-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	23725	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	G2	pT3a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT3a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
b7ac2e48-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1693		ff2da7cd-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-26300	 	1929	 	 	 	 	 	 	 	 	26300	Not Reported	3096.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b7d3d05e-118a-11e9-afb9-0a9c39d33490	C3N-01001		07e612dd-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Not Reported	Alive	-26444	 	1944	 	 	 	 	 	 	 	 	26444	 	588.00	588.00	0.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Stage II	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b7dd9263-594e-4fc7-b808-d09fef308f04	JX0169		6b5f5746-6c08-4f9a-b6a1-c4f67483e4c0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b7dda873-63d6-11e8-bcf1-0a2705229b82	11CO072		ff31349f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b7e61ab2-6828-4d4b-b12c-b82d6c77386d	NX027		9d9dac67-48fe-4205-a084-fac8b537a7dc	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b80397c3-a8f4-485f-9ef1-f954272d1493	H36960-019		24f837e5-731f-426d-a7bd-fcfec5af9b50	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b8514a40-1fb9-11e9-b7f8-0a80fada099c	C3N-01651		52ff3c11-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-21464	 	1958	 	 	 	 	 	 	 	 	21464	Not Reported	1942.00	1942.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-21464\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b85900d3-7ec2-4f21-9b0e-f58d42ccccbb	C3N-01879		aa0c92d2-3860-4f14-b418-4f237ab13e53	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	White	Alive	-24542	 	1950	 	 	 	 	 	 	 	 	24542	 	489.00	489.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b85cf2e2-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A03O		ff2b7a60-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Dead	-25362	2483	1933	2008	 	 	 	 	 	 	 	25362	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b89cddd6-7cfb-44c7-8e16-a2e55810dc83	C3L-02894		fc58bd22-97a6-4592-bec0-08a94803c9cd	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-24775	431	1950	2019	 	 	 	 	 	 	 	24775	 	428.00	431.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IVB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b8c57863-cf07-4f82-a425-4fdfb1883776	NTN006		5380780f-8044-44f5-8caa-72bb24e978a9	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b8d7abe1-55e9-4395-8ad0-fd6275a9a94a	C3N-02249		e0b81e3a-a18b-4188-8c2d-d1f42e0dcab3	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Hispanic or Latino	Female	White	Not Reported	 	 	1953	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b8ebbb4c-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1696		ff2e6a76-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-15818	1032	1960	2005	 	 	 	 	 	 	 	15818	Not Reported	1025.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b9017fed-1fb8-11e9-b7f8-0a80fada099c	C3L-00103		4e2137d1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-20598	1659	1960	2021	 	 	 	 	 	 	 	20598	 	1659.00	1659.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20598\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b913cd6a-96b9-4a57-af8a-462443313235	AP-KX5B		bdb16a24-f782-45ac-8fa2-f5d478925cd4	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	31045	 	1114.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Middle lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
b9178503-63d6-11e8-bcf1-0a2705229b82	11CO077		ff313965-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b9458a58-f3a7-11e8-a44b-0a9c39d33490	CA25730263-2		bd360ffe-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	17155	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	G3	pT4	60	 	Not Reported	Not Reported	Not Reported	Not Reported	pT4	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
b9620eff-fa18-49d2-92ca-77c8aa54662d	CU-10		fdd3c086-f37a-453f-a821-c83d95d8c42e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Other	 	 	 	 	 	 	 	 	 	 	 	 	56	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b98022cb-cdc7-4e76-9894-37309c1c656b	39		6daabcfd-b680-488e-836b-0e842e29bc6a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	83	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
b988a348-eb1d-4725-a5ab-0f94eea576d6	C3N-00732		f8338c3b-da54-4844-8357-7b9401783fe0	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-46	Not Hispanic or Latino	Female	White	Alive	-20659	 	1960	 	 	 	 	 	 	 	 	20659	 	1558.00	1558.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b9986c9b-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0J6		ff309667-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-22462	 	1947	 	 	 	 	 	 	 	 	22462	Not Reported	1140.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
b9a07a90-78e8-439e-96fb-8c1201042e6f	C3N-02723		d9c50641-b294-4e01-878c-d4e52e08e157	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Female	Other	Dead	-31587	-6	1931	2017	 	 	 	 	 	 	 	31587	 	-6.00	-6.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b9bcc643-118a-11e9-afb9-0a9c39d33490	C3N-01003		07ecf104-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Dead	-26984	759	1943	2018	 	 	 	 	 	 	 	26984	Not Reported	606.00	759.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVB	Not Reported	8th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
b9c7c8c2-271c-4eae-87f2-19a89b1ac58f	OSCC_45		dc28129c-7368-46e7-b54f-3aa345c23b26	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
ba01d738-63d5-11e8-bcf1-0a2705229b82	02OV029		ff2ee21e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ba206c6a-65fb-4eb8-952e-5bb9b95e63c1	CU-46		241b7293-825f-4793-aebf-814c62a1f404	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	54	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ba2f7e13-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1697		ff2f1d40-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-22933	949	1941	2005	 	 	 	 	 	 	 	22933	Not Reported	949.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ba309c4e-94b2-49e7-9bff-2af5030c3270	CU-24		b391a5b1-7f35-4d89-a33f-ee89ccc943df	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	83	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ba6da9c2-63d6-11e8-bcf1-0a2705229b82	11CO079		ff3141c3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
baa3b600-ddfd-4051-a31a-cae0ba143592	JX0163		de3ac265-e498-4865-920c-6084aa32b4b6	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
baa53a6c-e81c-45a6-92c9-8b9c6f0632db	C3L-02347		6e52327f-31c2-4a3b-a4f0-b26d5c6f8922	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-22868	 	1954	 	 	 	 	 	 	 	 	22868	 	1807.00	1807.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
baa9907d-f3a7-11e8-a44b-0a9c39d33490	CA25730263-3		c5265dc3-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	24455	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	G2	pT1	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT1	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
bab03920-691e-459e-b3b4-b6ce61a924a6	AP-EPNF		b521f022-33c8-4dbf-b5e3-38e964c56eeb	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	27027	 	1825.00	 	 	Not Reported	8250/3	Lepidic adenocarcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
bad4ad66-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0J9		ff2bf03e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-22642	 	1946	 	 	 	 	 	 	 	 	22642	Not Reported	1613.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3	Stage IIIC	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bad5524f-7eee-4486-bafb-97b745f66613	C3L-03513		5c442ac2-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Female	Unknown	Not Reported	 	 	1950	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bb203813-c038-4f9b-9436-a8c5e0f8f0cf	PDAC279		97d40987-7553-4815-992d-763c2c576db7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	22265	 	779.00	779.00	227.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
bb359ce4-a2d0-41eb-8b5c-b514a3686b6c	AP-MJ52		227a1ef0-24f7-4124-813c-b6a47a5e7184	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	25932	 	1806.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIB	 	 	 	 	 	 	 	M0	N0	Stage IIB	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
bb65da7b-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1698		ff2ba98e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Alive	-19611	 	1951	 	 	 	 	 	 	 	 	19611	Not Reported	2078.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bb7a9ee6-ba4c-4052-b826-d966016d90d2	C3N-03428		5fc0ddf7-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-23159	286	1954	2018	 	 	 	 	 	 	 	23159	Not Reported	184.00	286.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bb818b02-118a-11e9-afb9-0a9c39d33490	C3N-01211		07f33599-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-21688	 	1957	 	 	 	 	 	 	 	 	21688	Not Reported	740.00	740.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bbd98dcb-2e48-48d5-9a23-a90e36ef9bb4	pooled sample		609679db-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bc01b9f6-2355-47c8-bc06-6ad5865804ad	C3L-03394		5c370227-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-24110	635	1952	2019	 	 	 	 	 	 	 	24110	Not Reported	635.00	635.00	558.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bc0d56fb-ce83-4b9e-afd1-366077467d1b	H36960-023		4953a9c4-1f29-4de7-a275-319cd38a2ea9	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
bc10255d-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0JC		ff306eca-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-23404	 	1942	 	 	 	 	 	 	 	 	23404	Not Reported	1547.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bc2a1a07-f3a7-11e8-a44b-0a9c39d33490	CA25730263-4		cd2be25d-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Papillary Renal Cell Carcinoma	Kidney			Not Reported	Male	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	23360	Papillary RCC	0.00	0.00	0.00	Not Reported	Not Reported	Papillary RCC	Not Reported	kidney	kidney	G3	pT1a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT1a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
bc2e2a27-9d23-4749-a2b4-ce6bbcad85b7	C3L-02408		e212fc69-9506-44e0-96e2-148d31fc3f55	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-10	Not Hispanic or Latino	Female	White	Alive	-22191	 	1956	 	 	 	 	 	 	 	 	22191	 	442.00	442.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bc3637d1-a28b-4143-b77e-745b985a59f7	JX0176		2cfd2b50-8839-4e77-8251-29fa14b6183b	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bc4ae19c-1fb8-11e9-b7f8-0a80fada099c	C3L-00183		4e2b8393-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Hispanic or Latino	Female	White	Alive	-12359	 	1982	 	 	 	 	 	 	 	 	12359	Not Reported	227.00	227.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-12359\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bca26d15-e38c-4220-a193-143c5496d20a	C3L-01971		5b66f6ec-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Dead	-24359	276	1950	2018	 	 	 	 	 	 	 	24359	Not Reported	38.00	276.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IIA	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bca9389e-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1702		ff2e52d9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-30910	728	1921	2006	 	 	 	 	 	 	 	30910	Not Reported	568.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bcaa0cc4-074f-4e5f-ae52-bc757045b062	Basal (WHIM2)		756f523b-3754-4793-951e-3a11ed28ce5f	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
bcc85534-ab8a-4522-b3e9-502ca3cd1e27	BCN 1331		1091ab68-cc10-43f7-a5b8-39cf1a06e717	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
bcd05dfe-d499-4f4b-bef9-12205ac394b6	C3L-02384		308afe4d-f34d-42b0-890f-1b6bd25ee562	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-46	Not Reported	Female	White	Alive	-29731	 	1935	 	 	 	 	 	 	 	 	29731	 	907.00	907.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bcd1c547-3d14-48f4-9398-a775697cbcfc	C3L-03388		5c30ad2c-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-24887	11	1950	2018	 	 	 	 	 	 	 	24887	Not Reported	11.00	11.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bd34a905-c5a0-4866-8e0a-20b56730b40a	NTN081		4d7995a9-b3dc-4529-8be2-2306d114974b	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
bd4adbe5-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0JE		ff2bb122-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Alive	-19516	 	1952	 	 	 	 	 	 	 	 	19516	Not Reported	2335.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bd69cf78-118a-11e9-afb9-0a9c39d33490	C3N-01212		07f9c1be-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-23206	 	1953	 	 	 	 	 	 	 	 	23206	Not Reported	680.00	680.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bd83e74c-a1c3-4ff0-aa9d-8dc879d44c88	MB278		d6e9b497-48e7-4433-8cda-a51b2b3cf2bb	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2920	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
bd90e5fe-c02d-4e0d-8a58-23a7f0f8bae9	AP-JKPX		afa7143d-e43d-4950-b2a8-23b0a8b18d66	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	22279	 	1484.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
bd982628-14a2-461d-af9b-7050661e9bca	PDAC178		a721c39b-5773-4c40-82f2-bf5bb0b504e7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22995	 	1227.00	1227.00	231.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
bdc07b2c-f3a7-11e8-a44b-0a9c39d33490	CA25730263-5		d4c8eed9-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Chromophobe Renal Cell Carcinoma	Kidney			Not Reported	Female	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	25915	Chromophobe RCC	0.00	0.00	0.00	Not Reported	Not Reported	Chromophobe RCC	Not Reported	kidney	kidney	G2	pT3a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT3a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
bddeedd9-1fb8-11e9-b7f8-0a80fada099c	C3L-00359		4e3a8e64-2c37-11ec-b712-0a4e2186f121	 	Qualified	Non-Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Dead	-26864	1779	1943	2021	 	 	 	 	 	 	 	26864	Not Reported	1779.00	1779.00	1402.00	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26864\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bde12fa7-63d5-11e8-bcf1-0a2705229b82	02OV036		ff2ef2ea-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bde8765e-c891-42e5-acae-ff865d307dd4	MDA-02		e8f305f0-b19e-471e-b118-57ae10b4b1ba	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	76	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
bde9c627-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1705		ff2c20d1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-17530	555	1958	2006	 	 	 	 	 	 	 	17530	Not Reported	555.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
be3b9ad4-2351-4809-87b4-15ad70153300	65		74c74e7b-a29a-4ab5-b741-ae1df32c79ab	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
be3b9ad4-2351-4809-87b4-15ad70153300	65		75fe4f02-5264-4948-bbe1-c888fc0744ef	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
be3b9ad4-2351-4809-87b4-15ad70153300	65		99247f61-d337-4c89-9061-2d1bdc2e0426	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
be491e8c-3ffe-4b60-91a9-416db5e65ffd	WHIM16		64ea9543-8cd8-40aa-a9b9-1d32d01a4426	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
be63d5b8-5304-4669-8b03-b7970913f63f	14-00034		78eb1284-5985-498c-bf50-3ac931000a87	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Alive	-20246	 	 	 	55	 	 	false	 	 	United States	20246	 	2733.00	2733.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated CEBPA	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
be6e2dbe-dbc4-4a6b-9736-7481a973ad2b	AP-WEHE		0a39e8fa-7bff-40fd-a2b9-2ea57d8bab6a	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
be87bdee-8b47-42de-be58-c866e86e9997	AP-AAFC		2692314d-2367-4f65-b0d4-9f6bb142a8eb	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	27393	 	1722.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
be89e3d3-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0JJ		ff30ecbe-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-19758	 	1952	 	 	 	 	 	 	 	 	19758	Not Reported	1887.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
becc9d95-b799-4238-ab2e-0da05d48179a	C3N-03780		60307800-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-25275	20	1949	2018	 	 	 	 	 	 	 	25275	Not Reported	20.00	20.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bed55930-5999-4000-ab9e-b2a50149c47e	C3L-01664		bda9d4ae-f4d1-4abb-998b-60e0c7b75edc	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-27611	 	1941	 	 	 	 	 	 	 	 	27611	 	1537.00	1537.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bef66096-682b-4cb6-8e55-3fc4876904e3	P93		28e5d352-ac17-4681-9704-aaf4c5152359	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bf0af6d2-0d83-410f-b2cc-df04521f05e3	KoreanReference1		607c87cd-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bf1d2010-01e1-4070-9de9-413bd3838384	PDAC110		e3a3b183-16d8-4823-a52e-f1c84c7798a3	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	16060	 	776.00	776.00	374.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
bf1f593d-118a-11e9-afb9-0a9c39d33490	C3N-01217		080078af-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-21296	 	1958	 	 	 	 	 	 	 	 	21296	Not Reported	715.00	715.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bf27811f-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1710		ff2c7e90-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19969	951	1952	2008	 	 	 	 	 	 	 	19969	Not Reported	889.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
bf5e9985-f3a7-11e8-a44b-0a9c39d33490	CA25730263-6		dc425dc0-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	28105	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	High Grade	pT3a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT3a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
bf7ade95-1fb8-11e9-b7f8-0a80fada099c	C3L-00360		4e49ce7c-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-26395	 	1944	 	 	 	 	 	 	 	 	26395	Not Reported	1780.00	1780.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-26395\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bf8aa73f-1189-11e9-afb9-0a9c39d33490	C3L-00006		03a05092-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23700	 	1951	 	 	 	 	 	 	 	 	23700	Not Reported	737.00	737.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
bfc9877a-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0JL		ff317940-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-21895	 	1947	 	 	 	 	 	 	 	 	21895	Not Reported	1683.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c03d373a-86f1-4837-90e0-27ff5833b14c	NX034		b86bf0e7-3b56-459d-a073-b00cace97ba9	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c0597d45-63d5-11e8-bcf1-0a2705229b82	02OV041		ff2f0676-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IV	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c0618182-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1711		ff2d4957-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Alive	-16485	 	1961	 	 	 	 	 	 	 	 	16485	Not Reported	1053.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c088d9bd-8c58-4faa-91f8-0cf015ef304c	AP-RQNH		b4ce3da8-9d76-4a67-bc09-4d3bfd81f513	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24106	 	1799.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
c09dce21-2ac7-4fb7-b4e1-60fd978e246e	16-00611		d3b06f4c-b9d4-49c7-a539-34db2fd41bf4	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	Black or African American	Dead	-18056	972	 	 	49	 	 	false	Medical Record	 	United States	18056	 	972.00	972.00	372.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c0b461af-63d6-11e8-bcf1-0a2705229b82	13CO001		ff31486c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		0.00	 	 	Not Reported	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c0d54c8c-118a-11e9-afb9-0a9c39d33490	C3N-01219		0808071e-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-21421	 	1958	 	 	 	 	 	 	 	 	21421	Not Reported	738.00	738.00	591.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c0ec6f7a-f3a7-11e8-a44b-0a9c39d33490	CA25730263-7		e3d97776-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	27010	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	G3	pT3a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT3a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
c10409cb-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A0JM		ff30de0f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	Not Reported	Alive	-14653	 	1965	 	 	 	 	 	 	 	 	14653	Not Reported	2184.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c106307c-4293-4411-bd4d-32ce535fa9fb	PDAC075		f1d15c8b-7975-4fa0-9871-a28e0b2b221b	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	17155	 	2191.00	2191.00	2191.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
c1195940-1fb8-11e9-b7f8-0a80fada099c	C3L-00369		4e590ce1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-32848	91	1926	2016	 	 	 	 	 	 	 	32848	 	91.00	91.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Dead\",\"days_to_death\":\"91\",\"days_to_birth\":\"-32848\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c18d71bc-38a8-416b-8f0c-7daf32ff1e00	88		74d4590b-447a-4785-9f69-c758fac36547	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	65	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c1a229cb-ff73-4461-87a0-ca58baa83078	C3N-02265		96655e36-8a3c-4074-943a-d6349ba9e188	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Reported	Female	White	Alive	-20336	 	1961	 	 	 	 	 	 	 	 	20336	 	1840.00	1840.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c1a57e52-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1762		ff2e485c-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-21879	2634	1939	2005	 	 	 	 	 	 	 	21879	Not Reported	2606.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c1aad942-4fd5-47cb-bda0-f1c89b428e37	17-00638		674e3f39-6d66-4937-9850-f9545d626eb8	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	White	Dead	-21958	1	 	 	60	 	 	false	Medical Record	 	United States	21958	 	1.00	1.00	 	With tumor	Not Reported	Therapy-related acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c1ef8404-63d6-11e8-bcf1-0a2705229b82	13OV003		ff303760-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c1fe6bed-f3a7-11e8-a44b-0a9c39d33490	CA25730263-8		ec3be85b-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	24455	Clear cell RCC	0.00	0.00	0.00	Not Reported	Not Reported	Clear cell RCC	Not Reported	kidney	kidney	G3	pT3a	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT3a	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
c2633b5b-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A126		ff300e01-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-14264	 	1963	 	 	 	 	 	 	 	 	14264	Not Reported	3307.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c289029e-118a-11e9-afb9-0a9c39d33490	C3N-01267		080e5db4-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-20897	 	1959	 	 	 	 	 	 	 	 	20897	Not Reported	663.00	663.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c295a6e0-06dd-4ff0-9b1f-f3f8ecc8a56e	AP-KXUT		1a1b0c74-5b60-4f99-b38c-a94d37d65ba5	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	28854	 	724.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
c2b91945-1fb8-11e9-b7f8-0a80fada099c	C3L-00416		4e693f60-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-22653	 	1954	 	 	 	 	 	 	 	 	22653	Not Reported	608.00	608.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22653\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c2cd08c2-f3a7-11e8-a44b-0a9c39d33490	CA25730263-9		f45b8c0e-fa64-11e8-a44b-0a9c39d33490	 	Qualified	Papillary Renal Cell Carcinoma	Kidney			Not Reported	Male	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	25185	Papillary RCC	0.00	0.00	0.00	Not Reported	Not Reported	Papillary RCC	Not Reported	kidney	kidney	Low Grade	pT1b	>90	 	Not Reported	Not Reported	Not Reported	Not Reported	pT1b	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported							Not Reported				Not Reported	Not Reported			 	Not Reported	Not Reported				Not Reported	Not Reported			Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Quantitative digital maps of tissue biopsies	Quantitative digital maps of tissue biopsies
c2cf7e96-63d5-11e8-bcf1-0a2705229b82	02OV044		ff2f0dd0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c2d6a31d-87b5-4a84-9d9c-44ee8642c8f3	NTN011		9e3ca7cd-7e16-42c7-bc1e-13ecc7027c09	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c2e2d572-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1763		ff2dbecb-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Alive	-16021	 	1961	 	 	 	 	 	 	 	 	16021	Not Reported	2032.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c3112d27-f661-4e23-8344-fb446cccd32b	C3L-01840		8fc0fb78-c91e-4179-b41b-c24b0ea5ff29	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20522	 	1961	 	 	 	 	 	 	 	 	20522	 	1763.00	1763.00	1243.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c318158c-4c5a-41e0-840d-287badd34b26	AP-4HAU		ca63ae95-9d87-4ff5-941c-027e3177fb4f	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28123	 	1712.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
c31ccaca-1fb9-11e9-b7f8-0a80fada099c	C3N-01808		530e81ee-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-17422	 	1969	 	 	 	 	 	 	 	 	17422	Not Reported	778.00	778.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-17422\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c32220ca-6d32-4f31-a90b-77494e68e28d	14-00495		82f0a218-75dc-4261-b0ca-f36ef17a5fa5	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Dead	-22986	568	 	 	62	 	 	false	Medical Record	 	United States	22986	 	568.00	568.00	187.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c3a38e6a-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A12B		ff2febc6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Female	White	Alive	-23150	 	1941	 	 	 	 	 	 	 	 	23150	Not Reported	2989.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c3c8dc70-898b-469c-919d-2ea39c0d71db	WHIM 16		45cc3ded-4808-47f7-9c6f-f6345d640b99	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c3ca10d9-1189-11e9-afb9-0a9c39d33490	C3L-00008		03afffa2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-21504	 	1957	 	 	 	 	 	 	 	 	21504	Not Reported	898.00	898.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c3d87659-d18b-4f58-8ff1-e4780d5e5a74	AP-27JZ		71ad488f-b314-4932-acf7-9561761c6ec2	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	24836	 	1283.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
c4228beb-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1766		ff2ea715-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27359	1199	1932	2009	 	 	 	 	 	 	 	27359	Not Reported	1190.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c4417cc1-118a-11e9-afb9-0a9c39d33490	C3N-01346		08149ed9-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Alive	-23139	 	1953	 	 	 	 	 	 	 	 	23139	Not Reported	1715.00	1715.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c4452d81-fb01-488e-998e-032af8453e4b	C3L-02118		5bb33f1b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-24832	632	1949	2019	 	 	 	 	 	 	 	24832	Not Reported	631.00	632.00	517.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c455fb22-1fb8-11e9-b7f8-0a80fada099c	C3L-00418		4e77d7de-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20747	 	1959	 	 	 	 	 	 	 	 	20747	 	1714.00	1714.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20747\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c45a1331-dab4-4ba1-8237-5dc4a6991f6a	C3L-01037		5a87d67e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-15630	300	1974	2018	 	 	 	 	 	 	 	15630	Not Reported	300.00	300.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c4deba9f-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A12D		ff31932e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-15774	 	1962	 	 	 	 	 	 	 	 	15774	Not Reported	2515.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIA	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c524794e-ccd7-49ae-a005-eba41cfdb6b3	C3L-03515		5c51417e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Male	Not Reported	Not Reported	 	 	1954	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c531b8d3-736b-4f87-b4f5-0234f5475cf5	C3N-03839		603ae8a2-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	-19956	 	1963	 	 	 	 	 	 	 	 	19956	Not Reported	696.00	696.00	430.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c566f20e-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1768		ff2cbb99-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-18396	952	1956	2008	 	 	 	 	 	 	 	18396	Not Reported	950.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c58bad65-63d5-11e8-bcf1-0a2705229b82	02OV046		ff2f13b3-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c5b44d89-ce0f-44cc-ac74-676022932372	PDAC024		0b2a19c8-02f2-40b2-942d-ad894b730277	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	22630	 	2791.00	2791.00	484.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
c5e27ec2-15ed-4952-a050-d1426382ac50	NTN060		a072c0c6-d2a6-497d-95fc-9df3f3f6bec3	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
c5f06f4e-1189-11e9-afb9-0a9c39d33490	C3L-00032		03beda39-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-18578	 	1965	 	 	 	 	 	 	 	 	18578	Not Reported	1710.00	1710.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c5f5e38e-118a-11e9-afb9-0a9c39d33490	C3N-01349		081b57d3-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	White	Dead	-28217	555	1939	2018	 	 	 	 	 	 	 	28217	Not Reported	850.00	555.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c5f8631d-1fb8-11e9-b7f8-0a80fada099c	C3L-00447		4e86da1d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-12822	 	1981	 	 	 	 	 	 	 	 	12822	 	671.00	671.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-12822\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c61a65b2-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A12E		ff30a349-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-18721	 	1954	 	 	 	 	 	 	 	 	18721	Not Reported	2142.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i+)	Stage IIB	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c61eaf35-9aa3-4f69-ab5d-2fea5eb1bb34	AP-NCLP		91c708b5-c5af-4f23-a061-a0625fcb44b4	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
c6931b91-32cb-442c-9b0b-41f418f84509	C3N-01874		3c519f4f-8a97-42c2-b259-08d95fb929cb	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Dead	-30958	1267	1932	2020	 	 	 	 	 	 	 	30958	 	1027.00	1267.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c6b6a66e-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1769		ff2d5574-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-14754	 	1967	 	 	 	 	 	 	 	 	14754	Not Reported	699.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c6b87349-293d-40c9-9f30-3d267681c0d1	C3N-01905		a067ed9b-056e-4952-a51d-38e4f11490de	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	19	Not Reported	Male	White	Alive	-21631	 	1958	 	 	 	 	 	 	 	 	21631	 	1854.00	1854.00	1449.00	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c737b5c2-3ea1-4a84-b297-4e74cb3fba23	C3L-01599		7ecaca2c-b1c0-45e0-bcf7-6bf32ba8db16	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-24089	 	1951	 	 	 	 	 	 	 	 	24089	 	1791.00	1791.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c757547c-63d8-11e8-bcf1-0a2705229b82	TCGA-AO-A12F		ff2fc5cb-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-13409	 	1970	 	 	 	 	 	 	 	 	13409	Not Reported	1842.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c7722558-6d06-4049-bf4c-aadaf32b2dff	C3N-01172		2865d43a-65d6-4da0-b3d1-86c0c5f9a982	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Alive	-20873	 	1959	 	 	 	 	 	 	 	 	20873	 	1945.00	1945.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c78d3ad0-1fb8-11e9-b7f8-0a80fada099c	C3L-00448		4e9617e6-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-24253	 	1950	 	 	 	 	 	 	 	 	24253	Not Reported	1758.00	1758.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24253\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c7a2171c-64dd-443f-8a69-1e4577c8e310	BCN 1325		03480012-4109-4fed-b6de-161a85752b77	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
c7a90e98-6f13-4480-8f69-74eea9e6efa6	OSCC_50		8af84477-21a1-4b87-b5cf-e14538df503c	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
c7ab207d-118a-11e9-afb9-0a9c39d33490	C3N-01510		082235d2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-19465	 	1963	 	 	 	 	 	 	 	 	19465	Not Reported	1100.00	1100.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c7fc73e0-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1770		ff2bd776-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-20015	 	1953	 	 	 	 	 	 	 	 	20015	Not Reported	741.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c81ae16c-1189-11e9-afb9-0a9c39d33490	C3L-00084		03cfdf7e-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-27032	 	1942	 	 	 	 	 	 	 	 	27032	 	335.00	335.00	0.00	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Stage I	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c863a18c-a537-436e-90ef-880ae59b20b4	PDAC043		99b876aa-f0b2-46ee-8823-b39912f697b4	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	16790	 	843.00	843.00	194.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
c86c67c3-63d6-11e8-bcf1-0a2705229b82	14CO001		ff314c16-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Reported	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 		0.00	 	 	Not Reported	Not Reported	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage III	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c89444ff-1751-41b1-af47-b96e36037a65	C3L-02109		5b763642-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Alive	-28885	 	1938	 	 	 	 	 	 	 	 	28885	Not Reported	261.00	261.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c894884f-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0TR		ff30125b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-25190	160	1938	2006	 	 	 	 	 	 	 	25190	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c8f56efe-fb3d-4f96-88d2-1c0e3b7bdd38	C3L-01031		5a797e79-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Alive	-23784	 	1952	 	 	 	 	 	 	 	 	23784	Not Reported	369.00	369.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c90b0d73-297a-405b-973c-40df3ac96525	C3L-02411		a31ba72b-4dc4-43f7-af4f-4b3f0cc54480	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-9	Not Hispanic or Latino	Female	White	Alive	-29915	 	1935	 	 	 	 	 	 	 	 	29915	 	784.00	784.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c922e604-c549-4629-a2e9-be8e4564e4b4	MB177		c507c2d9-d76a-467c-8260-0a01d45b4467	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2190	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
c92573e1-305e-4b91-9eb0-f1ae3a9db84c	PDAC209		51027de6-74b1-4d7e-9ced-2efa4efe087d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20805	 	299.00	299.00	49.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
c9374747-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1771		ff2cb4ac-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-28093	 	1931	 	 	 	 	 	 	 	 	28093	Not Reported	686.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c9556afa-1fb8-11e9-b7f8-0a80fada099c	C3L-00561		4ea5615b-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-18481	 	1966	 	 	 	 	 	 	 	 	18481	Not Reported	1796.00	1796.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-18481\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c955e0ee-8b00-48ab-9a48-1094f1f11c06	C3N-04126		605bed15-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-15708	348	1975	2019	 	 	 	 	 	 	 	15708	Not Reported	257.00	348.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c962a026-05d7-456e-83d2-376c20ca42f5	C3N-01877		5b66b6f6-8de0-4390-8617-69397acc359b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	16	Not Reported	Female	White	Dead	-27005	912	1943	2019	 	 	 	 	 	 	 	27005	 	678.00	912.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c9ab199d-63d6-11e8-bcf1-0a2705229b82	14CO002		ff31527d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage II	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c9bdcd45-118a-11e9-afb9-0a9c39d33490	C3N-01520		0829cc39-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Dead	-25521	287	1947	2017	 	 	 	 	 	 	 	25521	Not Reported	287.00	287.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
c9d1d603-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0TT		ff2b8461-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	Alive	-19679	 	1953	 	 	 	 	 	 	 	 	19679	Not Reported	3316.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
c9df2c84-48ba-4cc3-b692-b4947f53d927	AP-4WDE		d9e4f8d7-4ca2-4f88-9baf-f60b2a5ba80d	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ca087e3a-9e96-48e3-a28d-10bfaa39bcf1	OSCC_48		0172f45e-6608-4627-a774-06837c68fa82	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
ca27c5c6-2aad-4acb-bb1a-557d4738227c	C3N-00860		0c6c7a6d-e1f8-41be-ac48-f275f6c69a5d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	White	Alive	-24752	 	1949	 	 	 	 	 	 	 	 	24752	 	451.00	451.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ca63469f-6f24-47be-8333-ebd44c3f831d	C3N-00513		5d9b8154-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-23121	394	1953	2017	 	 	 	 	 	 	 	23121	Not Reported	394.00	394.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ca7f4369-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1774		ff2ca6ab-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-29991	 	1926	 	 	 	 	 	 	 	 	29991	Not Reported	527.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ca8c623c-2c48-4dfa-b9a5-c3522d9c249f	KoreanReference2		608733eb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ca9dc6e8-2862-427d-bc6a-987ba71c8e83	C3L-00981		3fb16280-d485-4870-8d0e-88f85af57d09	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	Other	Alive	-19908	 	1962	 	 	 	 	 	 	 	 	19908	 	271.00	271.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cadfbcb2-8840-46ba-95b6-1cc0ab1569fa	64		31b0f570-ad48-42ed-8f84-6bdc4dbc00ac	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cae72878-63d6-11e8-bcf1-0a2705229b82	14CO003		ff3157a1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
caf0e98e-1fb8-11e9-b7f8-0a80fada099c	C3L-00581		4eb49c02-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-19213	1230	1964	2020	 	 	 	 	 	 	 	19213	 	1230.00	1230.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-19213\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cb07dc57-1189-11e9-afb9-0a9c39d33490	C3L-00090		03dd6349-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-27587	1281	1940	2019	 	 	 	 	 	 	 	27587	Not Reported	1279.00	1281.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cb0d61b4-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0TV		ff3065c6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-24279	 	1939	 	 	 	 	 	 	 	 	24279	Not Reported	2288.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cb4522d8-9b62-47af-9e5b-52bc868edec4	MB037		f20d168c-f5e4-4089-a141-ac8ada35ad44	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	365	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
cb689d01-77cf-4552-ace6-f3a4a5512768	Refmix-P29		0555dde7-0be3-478a-8ec2-52b0efdb0dac	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
cb74e02b-315f-4638-8820-56fb0345e9b9	C3N-02976		15ab8b80-8f21-4252-b985-9523ed5c9d1d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	20	Not Reported	Female	White	Alive	-25797	 	1947	 	 	 	 	 	 	 	 	25797	 	1310.00	1310.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Fundus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cb83f272-118a-11e9-afb9-0a9c39d33490	C3N-01521		08304f27-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-27702	 	1941	 	 	 	 	 	 	 	 	27702	Not Reported	728.00	728.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cbbb778c-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1775		ff318d2d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-18943	 	1957	 	 	 	 	 	 	 	 	18943	Not Reported	376.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cbe590cc-9aa6-4531-b824-28b2c7d47363	PDAC058		316a11c5-475e-41b7-9764-4e6e1d93c685	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27740	 	616.00	616.00	376.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
cc25d271-63d6-11e8-bcf1-0a2705229b82	14CO005		ff315b26-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cc4a5557-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0TX		ff2bc79e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Alive	-23653	 	1941	 	 	 	 	 	 	 	 	23653	Not Reported	1972.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIA	T1		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cc53495d-f1bb-4f1e-af95-939b785288f6	4237		2ab6b9cc-e728-4630-908f-01408dab11f6	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cc8a63fd-1fb8-11e9-b7f8-0a80fada099c	C3L-00583		4ec3dd66-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Hispanic or Latino	Male	White	Alive	-20237	 	1961	 	 	 	 	 	 	 	 	20237	 	301.00	301.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20237\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ccc50dce-95dc-4c4a-92b5-c4863e996c0d	AP-A5NG		e170a853-efc0-4432-bbce-ff30fcd16f2c	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	27393	 	725.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ccd36fc0-a116-4083-bdac-49b0a54e2ea0	CU-07		ef687929-711e-4931-a167-66df4e275303	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	83	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ccfe401b-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1776		ff2bf604-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	Alive	-23016	 	1945	 	 	 	 	 	 	 	 	23016	Not Reported	360.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cd1375b8-77f3-4c0c-ae1e-009720f46551	AP-U8MP		165eb8a2-cdb4-4cbf-b572-241cf9ed7d83	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	25201	 	1314.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
cd1b1b0f-8641-4e2f-bc83-26c377c14e30	C3N-01077		52c58c4a-f8c1-499d-beaa-1bcb05feee52	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	White	Not Reported	 	 	1956	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cd22c2f3-2474-4543-86c7-b67b8cc2a7a5	PDAC256		aed92525-c5e9-4fb7-8564-980558f25157	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28470	 	327.00	327.00	327.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
cd32ac83-7414-465a-b679-788e5c451d20	PDAC136		622aa944-0fa5-44d0-8454-12c90acf257a	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	 	1359.00	1359.00	1275.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
cd581d86-118a-11e9-afb9-0a9c39d33490	C3N-01537		08373da2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-27304	 	1942	 	 	 	 	 	 	 	 	27304	Not Reported	698.00	698.00	58.00	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cd7679be-a992-47a9-8216-6c8cc6cd82e6	CU-25		b1bc49f2-e5b9-424c-a636-5f9443933cda	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	69	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cd853e7e-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0TY		ff2bb4aa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-19836	1699	1950	2008	 	 	 	 	 	 	 	19836	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cd8fe248-0dfc-47c7-a91a-007c45c8bf00	48		ce02615a-ef9b-459f-b999-43d023c537c2	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cdbb0274-1189-11e9-afb9-0a9c39d33490	C3L-00098		03eca322-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23197	 	1952	 	 	 	 	 	 	 	 	23197	Not Reported	1748.00	1748.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ce22af84-1fb8-11e9-b7f8-0a80fada099c	C3L-00606		4ed31e85-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-27636	1045	1941	2019	 	 	 	 	 	 	 	27636	 	1045.00	1045.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27636\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ce397416-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1777		ff2e8f46-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-17356	 	1961	 	 	 	 	 	 	 	 	17356	Not Reported	374.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ceb780d1-4198-4910-a41e-f65660b17f38	36		970b4043-f831-4319-acc6-ec96510a7276	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ceb780d1-4198-4910-a41e-f65660b17f38	36		99900bd7-5076-47ab-a883-2e6f83a2bb8a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	58	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cec09f8e-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A0U4		ff2fb629-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-19729	 	1952	 	 	 	 	 	 	 	 	19729	Not Reported	3261.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ced7d55d-fcb5-4b4a-8ba2-aaca18b958d7	OSCC_51		8da3d8bd-3efc-4651-a454-1c782ffbf9c3	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
cf30c228-aa32-45e8-8b46-fed54dac650e	C3N-02940		5f0193f4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	-23550	 	1953	 	 	 	 	 	 	 	 	23550	Not Reported	1015.00	1015.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cf31f3d1-118a-11e9-afb9-0a9c39d33490	C3N-01802		083dfb56-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	Black or African American	Alive	-31052	 	1932	 	 	 	 	 	 	 	 	31052	Not Reported	775.00	775.00	598.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cf60430a-2699-4645-a093-3ab0fbad7939	Cell_line-bridge		c76794de-1b1f-45be-872e-e07c3883d3ef	 	Qualified	Other	Not Reported			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
cf669d6c-266e-47b6-b223-103f74a963d8	C3N-01764		081546f8-c59d-48df-95ee-39322f34d51b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	21	Not Reported	Female	White	Alive	-26880	 	1943	 	 	 	 	 	 	 	 	26880	 	1800.00	1800.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cf738c51-63d7-11e8-bcf1-0a2705229b82	TCGA-29-1785		ff3190b5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-20417	1104	1951	2009	 	 	 	 	 	 	 	20417	Not Reported	1053.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
cfa371c9-3ade-4102-ac44-57c9095ce581	WHIM-P93		347d040d-6529-4262-ba1e-e3fe9b6f6b32	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
cfc5cdbe-604a-4546-9f51-d277a8da8237	C3L-02556		f8e78061-3791-475e-a07e-27d0f74d60f5	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-31315	 	1931	 	 	 	 	 	 	 	 	31315	 	562.00	562.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cfcf52bd-f674-4475-82bc-433183b6fd52	AP-2XNK		0054ae28-a7dd-499b-af97-296cb2e4a72f	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	18262	 	1825.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
cfd3d3fd-1fb8-11e9-b7f8-0a80fada099c	C3L-00607		4ee25fe5-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Dead	-24311	781	1950	2018	 	 	 	 	 	 	 	24311	Not Reported	781.00	781.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24311\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cfd7ba3c-afab-465b-a121-c951b3fca259	C3N-01719		5e7feb15-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-23073	547	1954	2018	 	 	 	 	 	 	 	23073	Not Reported	547.00	547.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
cff55ae5-9f39-4197-b4a0-d8bd4c06d910	PDAC173		376f543d-7caf-4bd4-ae47-47564ecef9e9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24090	 	451.00	451.00	110.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
cffaa5e5-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A1AP		ff2fc97e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-29406	 	1927	 	 	 	 	 	 	 	 	29406	Not Reported	2856.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d027bc04-d1b4-4af1-b578-e6dd62fa8a1d	CU-03		270f5139-fd9e-4cb0-b178-0cee3e3f97db	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Other	 	 	 	 	 	 	 	 	 	 	 	 	82	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d05e193d-6d8d-437b-8f72-ed0b915a58af	12-00211		c4d18a81-8c42-4552-bf0a-c01aca79a45b	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Alive	-18419	 	 	 	50	 	 	false	 	 	United States	18419	 	3476.00	3476.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d0612cb8-1860-47a1-9ecd-7480023c7f18	PDAC232		31d2161f-367a-4141-a9cb-ae7c4b8fd8b7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28105	 	385.00	385.00	385.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
d08d263d-ff5e-11e9-9a07-0a80fada099c	C102459		d091207a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1986	Initial CNS Tumor	3812.00	3812.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d2acb-ff5e-11e9-9a07-0a80fada099c	C112176		d09123ea-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2687	Progressive	3568.00	3568.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Thalamus	Thalamus	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d2c22-ff5e-11e9-9a07-0a80fada099c	C112422		d0912739-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4574	Progressive	6256.00	6256.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d2e3b-ff5e-11e9-9a07-0a80fada099c	C114759		d0912a94-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	560	Initial CNS Tumor	858.00	858.00	 	With tumor	9400/3	Glioma, NOS	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d2f50-ff5e-11e9-9a07-0a80fada099c	C115251		d0912e1f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	5804	Initial CNS Tumor	7502.00	7502.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Brain Stem- Midbrain/Tectum	Brain Stem- Midbrain/Tectum	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3049-ff5e-11e9-9a07-0a80fada099c	C116850		d0913093-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	623	Initial CNS Tumor	992.00	992.00	 	Unknown tumor status	9400/3	Glioma, NOS	Yes	Optic Pathway,Suprasellar/Hypothalamic/Pituitary	Optic Pathway,Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d313c-ff5e-11e9-9a07-0a80fada099c	C121524		d091335c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1391	Initial CNS Tumor	1902.00	1902.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3236-ff5e-11e9-9a07-0a80fada099c	C121647		d0913546-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2967	Recurrence	 	 	1089.00	Unknown tumor status	9391/3	Ependymoma, NOS	No	Spinal Cord- Lumbar/Thecal Sac	Spinal Cord- Lumbar/Thecal Sac	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3236-ff5e-11e9-9a07-0a80fada099c	C121647		d0913803-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1878	Initial CNS Tumor	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3322-ff5e-11e9-9a07-0a80fada099c	C121893		d09139d6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Dead	 	 	 	 	 	 	 	 	 	 	 	398	Initial CNS Tumor	 	 	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d340f-ff5e-11e9-9a07-0a80fada099c	C127182		d0913cc3-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	4438	Initial CNS Tumor	5660.00	5660.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d34f8-ff5e-11e9-9a07-0a80fada099c	C136161		d0913eb2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4676	Progressive	685.00	685.00	 	Unknown tumor status	9400/3	Glioma, NOS	Yes	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Temporal Lobe	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d34f8-ff5e-11e9-9a07-0a80fada099c	C136161		d09140ef-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3977	Progressive	685.00	685.00	 	Unknown tumor status	9400/3	Glioma, NOS	Yes	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Temporal Lobe	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d365c-ff5e-11e9-9a07-0a80fada099c	C136284		d09143a4-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5738	Initial CNS Tumor	6024.00	6024.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d37cd-ff5e-11e9-9a07-0a80fada099c	C138990		d0914586-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2365	Initial CNS Tumor	3715.00	3715.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Frontal Lobe,Parietal Lobe	Frontal Lobe,Parietal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d38f4-ff5e-11e9-9a07-0a80fada099c	C140097		d091487d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4261	Initial CNS Tumor	5803.00	5803.00	 	With tumor	9400/3	Glioma, NOS	Yes	Frontal Lobe,Parietal Lobe	Frontal Lobe,Parietal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3a0b-ff5e-11e9-9a07-0a80fada099c	C140343		d0914a4b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	481	Initial CNS Tumor	923.00	923.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Cerebellum/Posterior Fossa,Suprasellar/Hypothalamic/Pituitary	Cerebellum/Posterior Fossa,Suprasellar/Hypothalamic/Pituitary	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3a0b-ff5e-11e9-9a07-0a80fada099c	C140343		d0914d10-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	576	Progressive	923.00	923.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Occipital Lobe,Suprasellar/Hypothalamic/Pituitary	Occipital Lobe,Suprasellar/Hypothalamic/Pituitary	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3ad2-ff5e-11e9-9a07-0a80fada099c	C140466		d0914efa-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6552	Progressive	8092.00	8092.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Optic Pathway	Optic Pathway	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3c6d-ff5e-11e9-9a07-0a80fada099c	C140712		d0915125-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1904	Progressive	1902.00	1902.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3c6d-ff5e-11e9-9a07-0a80fada099c	C140712		d09153ea-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1506	Initial CNS Tumor	1902.00	1902.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	No	Temporal Lobe	Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3ebf-ff5e-11e9-9a07-0a80fada099c	C146124		d09155b8-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5203	Initial CNS Tumor	 	 	 	With tumor	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3fc4-ff5e-11e9-9a07-0a80fada099c	C146247		d091586b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1545	Progressive	1374.00	1374.00	 	With tumor	9470/3	Medulloblastoma, NOS	Yes	Brain Stem- Midbrain/Tectum,Cerebellum/Posterior Fossa,Occipital Lobe,Optic Pathway,Parietal Lobe,Temporal Lobe	Brain Stem- Midbrain/Tectum,Cerebellum/Posterior Fossa,Occipital Lobe,Optic Pathway,Parietal Lobe,Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d3fc4-ff5e-11e9-9a07-0a80fada099c	C146247		d0915a4b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1221	Initial CNS Tumor	1374.00	1374.00	 	With tumor	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4169-ff5e-11e9-9a07-0a80fada099c	C15252		d0915d08-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	604	Initial CNS Tumor	939.00	939.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4235-ff5e-11e9-9a07-0a80fada099c	C15498		d0915f03-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	3633	Progressive	3553.00	3553.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d42ee-ff5e-11e9-9a07-0a80fada099c	C155103		d0916154-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	735	Initial CNS Tumor	911.00	911.00	 	With tumor	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4587-ff5e-11e9-9a07-0a80fada099c	C15744		d09163ff-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1571	Initial CNS Tumor	8425.00	8425.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4667-ff5e-11e9-9a07-0a80fada099c	C15990		d09165b6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	636	Initial CNS Tumor	996.00	996.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Frontal Lobe	Frontal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4738-ff5e-11e9-9a07-0a80fada099c	C16605		d0916854-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1645	Recurrence	11859.00	11859.00	718.00	With tumor	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4986-ff5e-11e9-9a07-0a80fada099c	C16974		d0916a1f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1302	Initial CNS Tumor	4273.00	4273.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4a5d-ff5e-11e9-9a07-0a80fada099c	C17466		d0916ce7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5666	Initial CNS Tumor	7441.00	7441.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	Yes	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4b17-ff5e-11e9-9a07-0a80fada099c	C177366		d0916eec-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	American Indian or Alaska Native	Dead	 	 	 	 	 	 	 	 	 	 	 	2399	Progressive	880.00	880.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4cd8-ff5e-11e9-9a07-0a80fada099c	C18081		d091712c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	715	Initial CNS Tumor	927.00	927.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4d99-ff5e-11e9-9a07-0a80fada099c	C182655		d0917401-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1818	Initial CNS Tumor	2505.00	2505.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d4e51-ff5e-11e9-9a07-0a80fada099c	C186714		d09175d6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2964	Initial CNS Tumor	3653.00	3653.00	 	With tumor	9505/1	Ganglioglioma, NOS	Yes	Occipital Lobe,Temporal Lobe	Occipital Lobe,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d501a-ff5e-11e9-9a07-0a80fada099c	C186837		d091788f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	395	Initial CNS Tumor	895.00	895.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d50db-ff5e-11e9-9a07-0a80fada099c	C187083		d0917a6f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2810	Initial CNS Tumor	3090.00	3090.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5194-ff5e-11e9-9a07-0a80fada099c	C19065		d0917d2c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6259	Initial CNS Tumor	7682.00	7682.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d53a7-ff5e-11e9-9a07-0a80fada099c	C196554		d0917f27-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	544	Initial CNS Tumor	477.00	477.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	No	Skull	Skull	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5476-ff5e-11e9-9a07-0a80fada099c	C19680		d091817f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4740	Initial CNS Tumor	6465.00	6465.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5531-ff5e-11e9-9a07-0a80fada099c	C20172		d09184f5-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	8339	Recurrence	8640.00	8640.00	1644.00	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Frontal Lobe,Parietal Lobe,Temporal Lobe	Frontal Lobe,Parietal Lobe,Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d571e-ff5e-11e9-9a07-0a80fada099c	C20418		d09186cb-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	4337	Initial CNS Tumor	4662.00	4662.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d57dc-ff5e-11e9-9a07-0a80fada099c	C20541		d0918980-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	6938	Initial CNS Tumor	9945.00	9945.00	 	Unknown tumor status	9400/3	Glioma, NOS	Yes	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d57dc-ff5e-11e9-9a07-0a80fada099c	C20541		d0918b33-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	11150	Progressive	9945.00	9945.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	Brain Stem- Midbrain/Tectum,Brain Stem- Pons,Cerebellum/Posterior Fossa	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d59eb-ff5e-11e9-9a07-0a80fada099c	C21402		d0918e08-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1384	Initial CNS Tumor	4898.00	4898.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5afe-ff5e-11e9-9a07-0a80fada099c	C216111		d0918fd7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	3676	Initial CNS Tumor	4814.00	4814.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	Yes	Occipital Lobe,Temporal Lobe	Occipital Lobe,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5bf5-ff5e-11e9-9a07-0a80fada099c	C216603		d09191f1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	7884	Second Malignancy	8008.00	8008.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Temporal Lobe	Temporal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5d7d-ff5e-11e9-9a07-0a80fada099c	C21771		d0919485-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4199	Initial CNS Tumor	6019.00	6019.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5e3c-ff5e-11e9-9a07-0a80fada099c	C22140		d0919648-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4344	Initial CNS Tumor	6835.00	6835.00	 	Unknown tumor status	9400/3	Glioma, NOS	Yes	Spinal Cord- Cervical,Spinal Cord- Thoracic	Spinal Cord- Cervical,Spinal Cord- Thoracic	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d5ef9-ff5e-11e9-9a07-0a80fada099c	C22263		d0919903-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4068	Initial CNS Tumor	5850.00	5850.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d607d-ff5e-11e9-9a07-0a80fada099c	C22509		d0919ae4-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1469	Initial CNS Tumor	1686.00	1686.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6139-ff5e-11e9-9a07-0a80fada099c	C22878		d0919db2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Dead	 	 	 	 	 	 	 	 	 	 	 	5694	Second Malignancy	6218.00	6218.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6212-ff5e-11e9-9a07-0a80fada099c	C230871		d0919f9a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5213	Initial CNS Tumor	5983.00	5983.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6480-ff5e-11e9-9a07-0a80fada099c	C230994		d091a21e-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3026	Initial CNS Tumor	4139.00	4139.00	 	Tumor free	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6561-ff5e-11e9-9a07-0a80fada099c	C23862		d091a4f1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	3472	Initial CNS Tumor	4008.00	4008.00	 	Tumor free	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d661a-ff5e-11e9-9a07-0a80fada099c	C253872		d091a6c8-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3143	Initial CNS Tumor	7428.00	7428.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Frontal Lobe	Frontal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d67c3-ff5e-11e9-9a07-0a80fada099c	C25461		d091a985-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6381	Progressive	8159.00	8159.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Occipital Lobe	Occipital Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6885-ff5e-11e9-9a07-0a80fada099c	C25584		d091ab62-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2507	Initial CNS Tumor	3591.00	3591.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6941-ff5e-11e9-9a07-0a80fada099c	C25830		d091ae32-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	5534	Initial CNS Tumor	6905.00	6905.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6941-ff5e-11e9-9a07-0a80fada099c	C25830		d091b01d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	6992	Progressive	6905.00	6905.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6af6-ff5e-11e9-9a07-0a80fada099c	C262605		d091b274-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	779	Initial CNS Tumor	1541.00	1541.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6bb3-ff5e-11e9-9a07-0a80fada099c	C270477		d091b561-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4774	Initial CNS Tumor	 	 	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6cd6-ff5e-11e9-9a07-0a80fada099c	C270723		d091b73b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4021	Progressive	 	 	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6cd6-ff5e-11e9-9a07-0a80fada099c	C270723		d091ba0a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3332	Initial CNS Tumor	 	 	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6ea0-ff5e-11e9-9a07-0a80fada099c	C271092		d091bc00-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1840	Progressive	1972.00	1972.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Cerebellum/Posterior Fossa,Frontal Lobe	Cerebellum/Posterior Fossa,Frontal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6ea0-ff5e-11e9-9a07-0a80fada099c	C271092		d091bed3-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	2203	Progressive	1972.00	1972.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Cerebellum/Posterior Fossa,Hippocampus,Other locations NOS,Spinal Cord- Thoracic,Temporal Lobe,Thalamus	Cerebellum/Posterior Fossa,Hippocampus,Other locations NOS,Spinal Cord- Thoracic,Temporal Lobe,Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d6f5e-ff5e-11e9-9a07-0a80fada099c	C27798		d091c0f2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4457	Initial CNS Tumor	5961.00	5961.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7016-ff5e-11e9-9a07-0a80fada099c	C28659		d091c34a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4334	Initial CNS Tumor	5302.00	5302.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d71f0-ff5e-11e9-9a07-0a80fada099c	C28905		d091c61d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	4234	Initial CNS Tumor	6003.00	6003.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d72af-ff5e-11e9-9a07-0a80fada099c	C29151		d091c7f2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	675	Initial CNS Tumor	1805.00	1805.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d73c3-ff5e-11e9-9a07-0a80fada099c	C29397		d091cab3-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	3354	Initial CNS Tumor	4499.00	4499.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d76eb-ff5e-11e9-9a07-0a80fada099c	C30012		d091ccaf-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	3941	Progressive	976.00	976.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Cerebellum/Posterior Fossa,Ventricles	Cerebellum/Posterior Fossa,Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d77c4-ff5e-11e9-9a07-0a80fada099c	C30258		d091cf93-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	11184	Second Malignancy	11795.00	11795.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Brain Stem- Pons,Brain Stem-Medulla,Spinal Cord- Cervical,Spinal Cord- Thoracic,Suprasellar/Hypothalamic/Pituitary	Brain Stem- Pons,Brain Stem-Medulla,Spinal Cord- Cervical,Spinal Cord- Thoracic,Suprasellar/Hypothalamic/Pituitary	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d78a0-ff5e-11e9-9a07-0a80fada099c	C30381		d091d1ae-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4519	Initial CNS Tumor	6220.00	6220.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Occipital Lobe	Occipital Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d79ac-ff5e-11e9-9a07-0a80fada099c	C308730		d091d3e6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4601	Initial CNS Tumor	5777.00	5777.00	 	Tumor free	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7a66-ff5e-11e9-9a07-0a80fada099c	C308853		d091d6ac-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3902	Initial CNS Tumor	 	 	 	Tumor free	9400/3	Glioma, NOS	No	Ventricles	Ventricles	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7bf0-ff5e-11e9-9a07-0a80fada099c	C310083		d091d87d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2927	Recurrence	3336.00	3336.00	2362.00	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7cb4-ff5e-11e9-9a07-0a80fada099c	C311067		d091db35-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4186	Initial CNS Tumor	4662.00	4662.00	 	Tumor free	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7dba-ff5e-11e9-9a07-0a80fada099c	C311436		d091dd09-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4513	Initial CNS Tumor	5301.00	5301.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d7f46-ff5e-11e9-9a07-0a80fada099c	C311559		d091dfdb-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	7149	Initial CNS Tumor	7932.00	7932.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d800f-ff5e-11e9-9a07-0a80fada099c	C337143		d091e1ea-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	2307	Initial CNS Tumor	 	 	 	With tumor	9380/3	Glioma, malignant	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d80c8-ff5e-11e9-9a07-0a80fada099c	C33825		d091e452-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	7945	Initial CNS Tumor	9341.00	9341.00	 	With tumor	9400/3	Glioma, NOS	Yes	Cerebellum/Posterior Fossa,Frontal Lobe	Cerebellum/Posterior Fossa,Frontal Lobe	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8262-ff5e-11e9-9a07-0a80fada099c	C340710		d091e72f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1897	Initial CNS Tumor	 	 	 	With tumor	9380/3	Glioma, malignant	No	Thalamus	Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8323-ff5e-11e9-9a07-0a80fada099c	C34440		d091e91b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	4188	Recurrence	5980.00	5980.00	2992.00	Unknown tumor status	9391/3	Ependymoma, NOS	No	Frontal Lobe	Frontal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d83da-ff5e-11e9-9a07-0a80fada099c	C35670		d091ebe4-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	6286	Initial CNS Tumor	 	 	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8582-ff5e-11e9-9a07-0a80fada099c	C35793		d091edf6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1223	Initial CNS Tumor	3743.00	3743.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8582-ff5e-11e9-9a07-0a80fada099c	C35793		d091f0b1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2338	Recurrence	3743.00	3743.00	1115.00	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8678-ff5e-11e9-9a07-0a80fada099c	C35916		d091f2c4-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2396	Initial CNS Tumor	 	 	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8733-ff5e-11e9-9a07-0a80fada099c	C36408		d091f527-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	American Indian or Alaska Native	Alive	 	 	 	 	 	 	 	 	 	 	 	4776	Progressive	3335.00	3335.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	Yes	Parietal Lobe,Temporal Lobe	Parietal Lobe,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8733-ff5e-11e9-9a07-0a80fada099c	C36408		d091f7e9-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	American Indian or Alaska Native	Alive	 	 	 	 	 	 	 	 	 	 	 	155	Progressive	3335.00	3335.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	Yes	Parietal Lobe,Temporal Lobe	Parietal Lobe,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d88e7-ff5e-11e9-9a07-0a80fada099c	C36900		d091f9c5-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5984	Recurrence	7113.00	7113.00	4131.00	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d89aa-ff5e-11e9-9a07-0a80fada099c	C372321		d091fc80-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3402	Initial CNS Tumor	4038.00	4038.00	 	Tumor free	9400/3	Glioma, NOS	No	Frontal Lobe	Frontal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8a61-ff5e-11e9-9a07-0a80fada099c	C37392		d091fe61-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5401	Initial CNS Tumor	9182.00	9182.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8c30-ff5e-11e9-9a07-0a80fada099c	C374289		d0920144-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4295	Initial CNS Tumor	4613.00	4613.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8cee-ff5e-11e9-9a07-0a80fada099c	C374412		d0920348-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	190	Initial CNS Tumor	527.00	527.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Other locations NOS,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic,Temporal Lobe	Other locations NOS,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic,Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8cee-ff5e-11e9-9a07-0a80fada099c	C374412		d092054d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	713	Progressive	527.00	527.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Other locations NOS,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic,Ventricles	Other locations NOS,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic,Ventricles	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8dc2-ff5e-11e9-9a07-0a80fada099c	C37638		d09206f0-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1933	Initial CNS Tumor	3033.00	3033.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d8f9c-ff5e-11e9-9a07-0a80fada099c	C377856		d0920803-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	3810	Initial CNS Tumor	3982.00	3982.00	 	With tumor	9380/3	Glioma, malignant	Yes	Temporal Lobe,Thalamus,Ventricles	Temporal Lobe,Thalamus,Ventricles	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d9058-ff5e-11e9-9a07-0a80fada099c	C387450		d0920aff-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4994	Initial CNS Tumor	6097.00	6097.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d910d-ff5e-11e9-9a07-0a80fada099c	C387573		d0920c43-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	2963	Progressive	3096.00	3096.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d92f9-ff5e-11e9-9a07-0a80fada099c	C38868		d0920ddb-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4937	Initial CNS Tumor	7134.00	7134.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d92f9-ff5e-11e9-9a07-0a80fada099c	C38868		d0920f0e-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6061	Recurrence	7134.00	7134.00	4962.00	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d93b7-ff5e-11e9-9a07-0a80fada099c	C38991		d09210a8-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3917	Initial CNS Tumor	5399.00	5399.00	 	With tumor	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d95ca-ff5e-11e9-9a07-0a80fada099c	C393477		d0921355-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5083	Initial CNS Tumor	6163.00	6163.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d96d5-ff5e-11e9-9a07-0a80fada099c	C39483		d0921513-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	8422	Initial CNS Tumor	8737.00	8737.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Frontal Lobe	Frontal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d978d-ff5e-11e9-9a07-0a80fada099c	C39606		d09217a1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1389	Initial CNS Tumor	3075.00	3075.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Frontal Lobe	Frontal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d990a-ff5e-11e9-9a07-0a80fada099c	C39729		d0921992-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1235	Initial CNS Tumor	2669.00	2669.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d99ca-ff5e-11e9-9a07-0a80fada099c	C406761		d0921bb7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	1038	Initial CNS Tumor	 	 	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	No	Frontal Lobe	Frontal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d9a87-ff5e-11e9-9a07-0a80fada099c	C41451		d0921cef-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1232	Initial CNS Tumor	2744.00	2744.00	 	Tumor free	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d9c10-ff5e-11e9-9a07-0a80fada099c	C431607		d0921eb1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5012	Initial CNS Tumor	5519.00	5519.00	 	Tumor free	9505/1	Ganglioglioma, NOS	No	Frontal Lobe	Frontal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d9d5c-ff5e-11e9-9a07-0a80fada099c	C43542		d0922234-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Reported	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	8226	Recurrence	8371.00	8371.00	2011.00	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Frontal Lobe	Frontal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08d9e76-ff5e-11e9-9a07-0a80fada099c	C440832		d09223c7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6236	Initial CNS Tumor	 	 	 	With tumor	9400/3	Glioma, NOS	Yes	Occipital Lobe,Temporal Lobe	Occipital Lobe,Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da02d-ff5e-11e9-9a07-0a80fada099c	C46371		d092256a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2419	Initial CNS Tumor	4047.00	4047.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da0eb-ff5e-11e9-9a07-0a80fada099c	C46494		d0922676-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	1808	Initial CNS Tumor	3456.00	3456.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Parietal Lobe	Parietal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da1a2-ff5e-11e9-9a07-0a80fada099c	C46617		d0922823-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2857	Initial CNS Tumor	4333.00	4333.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da346-ff5e-11e9-9a07-0a80fada099c	C466170		d0922a46-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	7354	Progressive	7706.00	7706.00	 	With tumor	9380/3	Glioma, malignant	No	Frontal Lobe	Frontal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da406-ff5e-11e9-9a07-0a80fada099c	C466293		d0922c9a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	383	Initial CNS Tumor	921.00	921.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Parietal Lobe,Temporal Lobe	Parietal Lobe,Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da4c1-ff5e-11e9-9a07-0a80fada099c	C47478		d0922f5b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	2530	Initial CNS Tumor	2531.00	2531.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Thalamus	Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da670-ff5e-11e9-9a07-0a80fada099c	C476010		d0923144-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5028	Initial CNS Tumor	6471.00	6471.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da768-ff5e-11e9-9a07-0a80fada099c	C47724		d0923429-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	4710	Initial CNS Tumor	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da768-ff5e-11e9-9a07-0a80fada099c	C47724		d0923603-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	5233	Progressive	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Occipital Lobe,Parietal Lobe	Occipital Lobe,Parietal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da81f-ff5e-11e9-9a07-0a80fada099c	C48216		d09238b5-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2265	Initial CNS Tumor	5616.00	5616.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08da9e1-ff5e-11e9-9a07-0a80fada099c	C50553		d0923a1c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1441	Initial CNS Tumor	3198.00	3198.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08daaa1-ff5e-11e9-9a07-0a80fada099c	C50799		d0923ba1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3408	Initial CNS Tumor	6836.00	6836.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dab5d-ff5e-11e9-9a07-0a80fada099c	C524349		d0923d45-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	4402	Initial CNS Tumor	4804.00	4804.00	 	With tumor	9380/3	Glioma, malignant	Yes	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Thalamus	Optic Pathway,Suprasellar/Hypothalamic/Pituitary,Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dad31-ff5e-11e9-9a07-0a80fada099c	C53013		d0923e41-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	9602	Progressive	9456.00	9456.00	 	Unknown tumor status	9380/3	Glioma, malignant	No	Basal Ganglia	Basal Ganglia	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dad31-ff5e-11e9-9a07-0a80fada099c	C53013		d092403f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	9714	Progressive	9456.00	9456.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Basal Ganglia,Thalamus	Basal Ganglia,Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dade9-ff5e-11e9-9a07-0a80fada099c	C53382		d0924234-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	660	Initial CNS Tumor	988.00	988.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08daeba-ff5e-11e9-9a07-0a80fada099c	C56826		d09244e6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	3324	Initial CNS Tumor	 	 	 	Unknown tumor status	9380/3	Glioma, malignant	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db0a4-ff5e-11e9-9a07-0a80fada099c	C579945		d0924644-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	3355	Initial CNS Tumor	4118.00	4118.00	 	Tumor free	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db15f-ff5e-11e9-9a07-0a80fada099c	C580068		d09247b0-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5766	Initial CNS Tumor	6415.00	6415.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db366-ff5e-11e9-9a07-0a80fada099c	C58056		d0924949-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1857	Initial CNS Tumor	3275.00	3275.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db475-ff5e-11e9-9a07-0a80fada099c	C58179		d0924ab0-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4216	Initial CNS Tumor	4955.00	4955.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db531-ff5e-11e9-9a07-0a80fada099c	C584373		d0924d5b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	230	Initial CNS Tumor	532.00	532.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Brain Stem- Midbrain/Tectum	Brain Stem- Midbrain/Tectum	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db6b8-ff5e-11e9-9a07-0a80fada099c	C584496		d0924f37-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Reported	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	6152	Initial CNS Tumor	6768.00	6768.00	 	Tumor free	9391/3	Ependymoma, NOS	Yes	Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db79e-ff5e-11e9-9a07-0a80fada099c	C584742		d0925214-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	5937	Initial CNS Tumor	 	 	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db858-ff5e-11e9-9a07-0a80fada099c	C584865		d0925413-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3979	Initial CNS Tumor	5111.00	5111.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08db9db-ff5e-11e9-9a07-0a80fada099c	C58917		d092565d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	1575	Initial CNS Tumor	 	 	 	With tumor	9470/3	Medulloblastoma, NOS	Yes	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dba97-ff5e-11e9-9a07-0a80fada099c	C59409		d0925938-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6287	Initial CNS Tumor	7025.00	7025.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbb4d-ff5e-11e9-9a07-0a80fada099c	C59532		d0925b1d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2480	Initial CNS Tumor	4156.00	4156.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbcde-ff5e-11e9-9a07-0a80fada099c	C60024		d0925d83-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	3109	Initial CNS Tumor	4178.00	4178.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbd9e-ff5e-11e9-9a07-0a80fada099c	C607743		d0925f48-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	738	Initial CNS Tumor	920.00	920.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	Cerebellum/Posterior Fossa,Spinal Cord- Cervical,Spinal Cord- Lumbar/Thecal Sac,Spinal Cord- Thoracic	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbe53-ff5e-11e9-9a07-0a80fada099c	C623856		d0926239-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3602	Initial CNS Tumor	4313.00	4313.00	 	With tumor	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbff3-ff5e-11e9-9a07-0a80fada099c	C62484		d0926410-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	271	Initial CNS Tumor	744.00	744.00	 	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Frontal Lobe	Frontal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dbff3-ff5e-11e9-9a07-0a80fada099c	C62484		d0926605-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2816	Recurrence	744.00	744.00	2545.00	Unknown tumor status	9505/1	Ganglioglioma, NOS	No	Frontal Lobe	Frontal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc0ae-ff5e-11e9-9a07-0a80fada099c	C625947		d0926883-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	3529	Initial CNS Tumor	4492.00	4492.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc161-ff5e-11e9-9a07-0a80fada099c	C626070		d0926a13-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	535	Progressive	444.00	444.00	 	With tumor	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Basal Ganglia,Temporal Lobe	Basal Ganglia,Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc311-ff5e-11e9-9a07-0a80fada099c	C626193		d0926c7a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Dead	 	 	 	 	 	 	 	 	 	 	 	170	Initial CNS Tumor	 	 	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Frontal Lobe,Parietal Lobe,Temporal Lobe	Frontal Lobe,Parietal Lobe,Temporal Lobe	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc3d0-ff5e-11e9-9a07-0a80fada099c	C62730		d0926e22-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	7562	Progressive	8256.00	8256.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc484-ff5e-11e9-9a07-0a80fada099c	C650178		d09270bf-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	809	Initial CNS Tumor	1557.00	1557.00	 	With tumor	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc646-ff5e-11e9-9a07-0a80fada099c	C65559		d09272c7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	2800	Initial CNS Tumor	3527.00	3527.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc708-ff5e-11e9-9a07-0a80fada099c	C663585		d092749a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3747	Initial CNS Tumor	4315.00	4315.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Parietal Lobe	Parietal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dc7bd-ff5e-11e9-9a07-0a80fada099c	C66420		d0927738-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1855	Progressive	2343.00	2343.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dca30-ff5e-11e9-9a07-0a80fada099c	C68388		d092791a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2750	Initial CNS Tumor	3837.00	3837.00	 	With tumor	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dcb0f-ff5e-11e9-9a07-0a80fada099c	C68634		d0927b4c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1178	Initial CNS Tumor	2701.00	2701.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dcbc5-ff5e-11e9-9a07-0a80fada099c	C686955		d0927c6a-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4590	Initial CNS Tumor	5303.00	5303.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dcdb6-ff5e-11e9-9a07-0a80fada099c	C692613		d0927e05-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3606	Initial CNS Tumor	4326.00	4326.00	 	With tumor	9470/3	Medulloblastoma, NOS	Yes	Cerebellum/Posterior Fossa,Suprasellar/Hypothalamic/Pituitary	Cerebellum/Posterior Fossa,Suprasellar/Hypothalamic/Pituitary	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dce79-ff5e-11e9-9a07-0a80fada099c	C699624		d0927f32-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1436	Initial CNS Tumor	1566.00	1566.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd09a-ff5e-11e9-9a07-0a80fada099c	C70602		d09281b9-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4417	Initial CNS Tumor	6227.00	6227.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd1a3-ff5e-11e9-9a07-0a80fada099c	C70848		d092841e-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Dead	 	 	 	 	 	 	 	 	 	 	 	4808	Progressive	4682.00	4682.00	 	Unknown tumor status	9380/3	Glioma, malignant	Yes	Occipital Lobe,Parietal Lobe,Temporal Lobe	Occipital Lobe,Parietal Lobe,Temporal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd257-ff5e-11e9-9a07-0a80fada099c	C70971		d092853d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3725	Initial CNS Tumor	5558.00	5558.00	 	Tumor free	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd3dd-ff5e-11e9-9a07-0a80fada099c	C71094		d09286c7-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	1985	Initial CNS Tumor	 	 	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd498-ff5e-11e9-9a07-0a80fada099c	C714384		d09287d9-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	2869	Initial CNS Tumor	 	 	 	Unknown tumor status	9380/3	Glioma, malignant	No	Thalamus	Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd54b-ff5e-11e9-9a07-0a80fada099c	C71586		d0928968-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1344	Initial CNS Tumor	1344.00	1344.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd6d3-ff5e-11e9-9a07-0a80fada099c	C717336		d0928a87-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1357	Initial CNS Tumor	 	 	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd7ca-ff5e-11e9-9a07-0a80fada099c	C720165		d0928d17-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	4326	Initial CNS Tumor	4747.00	4747.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dd884-ff5e-11e9-9a07-0a80fada099c	C722502		d0928eb1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2834	Initial CNS Tumor	3557.00	3557.00	 	Tumor free	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddb5b-ff5e-11e9-9a07-0a80fada099c	C72324		d0928fb3-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2478	Initial CNS Tumor	3616.00	3616.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddc45-ff5e-11e9-9a07-0a80fada099c	C72570		d0929138-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	3557	Initial CNS Tumor	3873.00	3873.00	 	With tumor	9470/3	Medulloblastoma, NOS	Yes	Cerebellum/Posterior Fossa,Meninges/Dura,Spinal Cord- Cervical,Spinal Cord- Thoracic,Ventricles	Cerebellum/Posterior Fossa,Meninges/Dura,Spinal Cord- Cervical,Spinal Cord- Thoracic,Ventricles	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddd03-ff5e-11e9-9a07-0a80fada099c	C73062		d0929248-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	421	Initial CNS Tumor	712.00	712.00	 	With tumor	9400/3	Glioma, NOS	Yes	Optic Pathway,Suprasellar/Hypothalamic/Pituitary	Optic Pathway,Suprasellar/Hypothalamic/Pituitary	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddd03-ff5e-11e9-9a07-0a80fada099c	C73062		d09293e0-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1083	Recurrence	712.00	712.00	744.00	With tumor	9400/3	Glioma, NOS	Yes	Cerebellum/Posterior Fossa,Optic Pathway,Other locations NOS,Suprasellar/Hypothalamic/Pituitary,Thalamus	Cerebellum/Posterior Fossa,Optic Pathway,Other locations NOS,Suprasellar/Hypothalamic/Pituitary,Thalamus	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddead-ff5e-11e9-9a07-0a80fada099c	C73308		d0929503-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	362	Initial CNS Tumor	 	 	 	With tumor	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08ddf6f-ff5e-11e9-9a07-0a80fada099c	C736401		d0929653-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	996	Initial CNS Tumor	1671.00	1671.00	 	With tumor	9400/3	Glioma, NOS	Yes	Brain Stem-Medulla,Ventricles	Brain Stem-Medulla,Ventricles	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de025-ff5e-11e9-9a07-0a80fada099c	C74292		d09297e2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3991	Progressive	6049.00	6049.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de025-ff5e-11e9-9a07-0a80fada099c	C74292		d09298ed-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4222	Recurrence	6049.00	6049.00	1563.00	Unknown tumor status	9400/3	Glioma, NOS	Yes	Brain Stem- Midbrain/Tectum,Ventricles	Brain Stem- Midbrain/Tectum,Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de1d8-ff5e-11e9-9a07-0a80fada099c	C744888		d0929a79-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3998	Initial CNS Tumor	4697.00	4697.00	 	With tumor	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de294-ff5e-11e9-9a07-0a80fada099c	C745011		d0929b81-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6256	Initial CNS Tumor	6391.00	6391.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de34b-ff5e-11e9-9a07-0a80fada099c	C75276		d0929d20-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	796	Initial CNS Tumor	2843.00	2843.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de511-ff5e-11e9-9a07-0a80fada099c	C75522		d0929e45-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4938	Initial CNS Tumor	5683.00	5683.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de5cf-ff5e-11e9-9a07-0a80fada099c	C77367		d0929f9c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3870	Initial CNS Tumor	4646.00	4646.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de690-ff5e-11e9-9a07-0a80fada099c	C78597		d092a127-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2589	Initial CNS Tumor	4285.00	4285.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de86c-ff5e-11e9-9a07-0a80fada099c	C78966		d092a22d-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	637	Initial CNS Tumor	 	 	 	With tumor	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de939-ff5e-11e9-9a07-0a80fada099c	C794457		d092a3b6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2696	Initial CNS Tumor	3210.00	3210.00	 	Tumor free	9470/3	Medulloblastoma, NOS	No	Ventricles	Ventricles	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08de9f0-ff5e-11e9-9a07-0a80fada099c	C801468		d092a4b2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2199	Progressive	2681.00	2681.00	 	With tumor	9380/3	Glioma, malignant	No	Thalamus	Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08debdf-ff5e-11e9-9a07-0a80fada099c	C808110		d092a644-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	3765	Initial CNS Tumor	4052.00	4052.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dec9c-ff5e-11e9-9a07-0a80fada099c	C818688		d092a764-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1612	Initial CNS Tumor	2003.00	2003.00	 	With tumor	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08deea7-ff5e-11e9-9a07-0a80fada099c	C82041		d092a8be-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	2541	Initial CNS Tumor	2946.00	2946.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08defaf-ff5e-11e9-9a07-0a80fada099c	C82164		d092aa4f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	1936	Progressive	3652.00	3652.00	 	Unknown tumor status	9508/3	Atypical teratoid/rhabdoid tumor	Yes	Cerebellum/Posterior Fossa,Other locations NOS	Cerebellum/Posterior Fossa,Other locations NOS	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df067-ff5e-11e9-9a07-0a80fada099c	C829512		d092ab4f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4932	Initial CNS Tumor	5038.00	5038.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df1f2-ff5e-11e9-9a07-0a80fada099c	C831849		d092acdf-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1352	Initial CNS Tumor	1815.00	1815.00	 	With tumor	9400/3	Glioma, NOS	No	Frontal Lobe	Frontal Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df2b0-ff5e-11e9-9a07-0a80fada099c	C837507		d092adf4-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	55	Progressive	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Brain Stem- Pons,Brain Stem-Medulla,Cerebellum/Posterior Fossa,Spinal Cord- Cervical	Brain Stem- Pons,Brain Stem-Medulla,Cerebellum/Posterior Fossa,Spinal Cord- Cervical	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df2b0-ff5e-11e9-9a07-0a80fada099c	C837507		d092b054-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Dead	 	 	 	 	 	 	 	 	 	 	 	54	Initial CNS Tumor	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df366-ff5e-11e9-9a07-0a80fada099c	C841320		d092b18b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	797	Progressive	949.00	949.00	 	With tumor	9391/3	Ependymoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df551-ff5e-11e9-9a07-0a80fada099c	C84747		d092b2e2-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	7398	Progressive	8144.00	8144.00	 	Unknown tumor status	9470/3	Medulloblastoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G4	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df679-ff5e-11e9-9a07-0a80fada099c	C85731		d092b469-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4379	Initial CNS Tumor	6213.00	6213.00	 	Tumor free	9391/3	Ependymoma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df738-ff5e-11e9-9a07-0a80fada099c	C857433		d092b56f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4738	Initial CNS Tumor	5292.00	5292.00	 	With tumor	9391/3	Ependymoma, NOS	No	Occipital Lobe	Occipital Lobe	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df8cf-ff5e-11e9-9a07-0a80fada099c	C86100		d092b6ff-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	4087	Initial CNS Tumor	5808.00	5808.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Spinal Cord- Cervical	Spinal Cord- Cervical	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08df986-ff5e-11e9-9a07-0a80fada099c	C881049		d092b801-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2143	Initial CNS Tumor	2469.00	2469.00	 	With tumor	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dfa48-ff5e-11e9-9a07-0a80fada099c	C88314		d092b992-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	2241	Initial CNS Tumor	4114.00	4114.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dfbeb-ff5e-11e9-9a07-0a80fada099c	C883509		d092bab9-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6149	Progressive	6480.00	6480.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dfca4-ff5e-11e9-9a07-0a80fada099c	C883632		d092bd9b-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1982	Initial CNS Tumor	 	 	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dfd56-ff5e-11e9-9a07-0a80fada099c	C883755		d092bf8c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4361	Initial CNS Tumor	4539.00	4539.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dff03-ff5e-11e9-9a07-0a80fada099c	C88683		d092c0a6-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	American Indian or Alaska Native	Alive	 	 	 	 	 	 	 	 	 	 	 	1359	Initial CNS Tumor	3126.00	3126.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Ventricles	Ventricles	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08dffb9-ff5e-11e9-9a07-0a80fada099c	C88806		d092c22e-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Dead	 	 	 	 	 	 	 	 	 	 	 	6234	Progressive	6192.00	6192.00	 	With tumor	9380/3	Glioma, malignant	Yes	Frontal Lobe,Suprasellar/Hypothalamic/Pituitary,Thalamus,Ventricles	Frontal Lobe,Suprasellar/Hypothalamic/Pituitary,Thalamus,Ventricles	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e006b-ff5e-11e9-9a07-0a80fada099c	C907125		d092c339-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Black or African American	Alive	 	 	 	 	 	 	 	 	 	 	 	3511	Progressive	4045.00	4045.00	 	Unknown tumor status	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0273-ff5e-11e9-9a07-0a80fada099c	C907371		d092c4ce-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4482	Initial CNS Tumor	5032.00	5032.00	 	Tumor free	9505/1	Ganglioglioma, NOS	Yes	Frontal Lobe,Parietal Lobe	Frontal Lobe,Parietal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0330-ff5e-11e9-9a07-0a80fada099c	C907617		d092c5f1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	4786	Progressive	5375.00	5375.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Parietal Lobe	Parietal Lobe	Low Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e03e9-ff5e-11e9-9a07-0a80fada099c	C916473		d092c74e-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1956	Progressive	2257.00	2257.00	 	Tumor free	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e05bc-ff5e-11e9-9a07-0a80fada099c	C91881		d092c8db-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	371	Initial CNS Tumor	915.00	915.00	 	Unknown tumor status	9391/3	Ependymoma, NOS	No	Ventricles	Ventricles	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0676-ff5e-11e9-9a07-0a80fada099c	C94956		d092c9da-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	7387	Recurrence	 	 	5100.00	Unknown tumor status	9380/3	Glioma, malignant	No	Temporal Lobe	Temporal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0676-ff5e-11e9-9a07-0a80fada099c	C94956		d092cb6f-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	6779	Initial CNS Tumor	 	 	 	Unknown tumor status	9380/3	Glioma, malignant	No	Temporal Lobe	Temporal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e072c-ff5e-11e9-9a07-0a80fada099c	C949929		d092cc74-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	1828	Initial CNS Tumor	2114.00	2114.00	 	Tumor free	9350/1	Craniopharyngioma	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e090f-ff5e-11e9-9a07-0a80fada099c	C95079		d092ce0c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	Not Reported	Alive	 	 	 	 	 	 	 	 	 	 	 	1464	Progressive	1668.00	1668.00	 	With tumor	9505/1	Ganglioglioma, NOS	No	Temporal Lobe	Temporal Lobe	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0ac0-ff5e-11e9-9a07-0a80fada099c	C952635		d092cf33-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2446	Initial CNS Tumor	 	 	 	Unknown tumor status	9380/3	Glioma, malignant	No	Temporal Lobe	Temporal Lobe	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0d18-ff5e-11e9-9a07-0a80fada099c	C96063		d092d095-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	2280	Progressive	 	 	 	Unknown tumor status	9391/3	Ependymoma, NOS	Yes	Brain Stem- Pons,Cerebellum/Posterior Fossa	Brain Stem- Pons,Cerebellum/Posterior Fossa	G2	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0e26-ff5e-11e9-9a07-0a80fada099c	C96186		d092d22c-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Female	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5399	Initial CNS Tumor	6399.00	6399.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Suprasellar/Hypothalamic/Pituitary	Suprasellar/Hypothalamic/Pituitary	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e0ede-ff5e-11e9-9a07-0a80fada099c	C98031		d092d422-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Not Hispanic or Latino	Male	White	Alive	 	 	 	 	 	 	 	 	 	 	 	5262	Initial CNS Tumor	6316.00	6316.00	 	Unknown tumor status	9400/3	Glioma, NOS	No	Cerebellum/Posterior Fossa	Cerebellum/Posterior Fossa	G1	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e1056-ff5e-11e9-9a07-0a80fada099c	C99753		d092d5bc-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Hispanic or Latino	Male	Native Hawaiian or Other Pacific Islander	Dead	 	 	 	 	 	 	 	 	 	 	 	2606	Initial CNS Tumor	3998.00	3998.00	 	With tumor	9380/3	Glioma, malignant	No	Thalamus	Thalamus	High Grade	Unknown	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e111c-ff5e-11e9-9a07-0a80fada099c	7316-157		d092d6c0-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e11e6-ff5e-11e9-9a07-0a80fada099c	7316-3057		d092d85a-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e136a-ff5e-11e9-9a07-0a80fada099c	7316-334		d092d977-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e1428-ff5e-11e9-9a07-0a80fada099c	7316-4341		d092dc0f-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e14e3-ff5e-11e9-9a07-0a80fada099c	7316-51		d092ddd3-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e166e-ff5e-11e9-9a07-0a80fada099c	7316-70		d092df9e-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e172a-ff5e-11e9-9a07-0a80fada099c	7316-952		d092e13a-ff5e-11e9-9a07-0a80fada099c	 	Disqualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d08e17df-ff5e-11e9-9a07-0a80fada099c	Bridge		d092e2e1-ff5e-11e9-9a07-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Analysis of Pediatric Brain Cancer Tumors Pilot Study	Pediatric Brain Tumor Atlas - CBTN
d0b0f8b4-63d7-11e8-bcf1-0a2705229b82	TCGA-29-2414		ff2e27b9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-27417	2621	1923	2005	 	 	 	 	 	 	 	27417	Not Reported	2621.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1998	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d0be692b-a112-4263-9538-aa719b588f33	63		ecd23d18-6571-4e49-a688-784708922b71	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d0f63b69-1189-11e9-afb9-0a9c39d33490	C3L-00136		03fbdd13-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-18533	 	1965	 	 	 	 	 	 	 	 	18533	Not Reported	1794.00	1794.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d10cafea-118a-11e9-afb9-0a9c39d33490	C3N-01825		084461c4-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Reported	Female	Other	Alive	-25659	 	1946	 	 	 	 	 	 	 	 	25659	Not Reported	687.00	687.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d10e77a2-fc25-463f-b3f4-ecb738069aed	C3N-02010		5ea23632-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	Black or African American	Alive	-22742	 	1956	 	 	 	 	 	 	 	 	22742	Not Reported	449.00	449.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	N2	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d11317a3-bac7-47ee-9547-c7790aaf0467	AP-WPAM		05aa1ffe-4f2a-4444-a28c-8e656b4d37c3	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	23010	 	456.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
d136d079-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A1AQ		ff2fef66-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-18109	 	1958	 	 	 	 	 	 	 	 	18109	Not Reported	3021.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d13f25c9-9b53-4cc3-a3c0-eefae74d695a	AP-CT3G		3404b974-ae7e-4be7-a29e-90baf1c68a62	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	25932	 	1617.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
d13f4bd1-0510-46a7-bd51-90546b8bfe4c	C3L-03630		5c5f2d39-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Alive	-28674	 	1939	 	 	 	 	 	 	 	 	28674	Not Reported	78.00	78.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d156dfa2-d56a-4c56-b6a6-b6007f84db27	61		e8ae6632-37f0-41b0-81e0-55754d6f57ae	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	38	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d1643329-ccde-48ae-a4c3-93f269eaffd7	21		aa1617f4-e3e5-43ca-bde6-40ca5d5f948c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	56	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d173b7b0-63d6-11e8-bcf1-0a2705229b82	15CO001		ff315d83-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Hispanic or Latino	Female	Asian	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d1ed97b4-63d7-11e8-bcf1-0a2705229b82	TCGA-29-2427		ff2b81f5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-21940	 	1944	 	 	 	 	 	 	 	 	21940	Not Reported	1900.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d1f00743-1fb8-11e9-b7f8-0a80fada099c	C3L-00610		4ef19f02-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-20900	 	1959	 	 	 	 	 	 	 	 	20900	Not Reported	1472.00	1472.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20900\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d21fa2fa-9a2d-4baa-b7d8-601b906a16c7	C3N-03069		5f6b8c4b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-18530	20	1967	2018	 	 	 	 	 	 	 	18530	Not Reported	10.00	20.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d22024c6-0674-4a57-a38a-185046a0fb8c	17		e59fcaa2-4f2e-412e-8a50-06a81cb656c4	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	73	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d26a6b06-5d02-4220-9ec3-5788c0b643ec	C3L-02701		5bec3697-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-26345	243	1946	2019	 	 	 	 	 	 	 	26345	Not Reported	304.00	243.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	7th	 	 	 	 	 	 	Cardiovascular Disorder, NOS	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d270e7a5-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A1AS		ff314ae0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Asian	Alive	-20028	 	1953	 	 	 	 	 	 	 	 	20028	Not Reported	1150.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d2b0df58-63d6-11e8-bcf1-0a2705229b82	15CO002		ff315fd6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	Black or African American	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d2ca9397-5a6f-40db-ace6-5742f753eb5a	C3N-01081		4cf823a5-f485-483c-81d0-4ac7387b746b	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1948	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d2ede591-f704-46e5-8ebc-d19c72ea4c26	C3L-01470		a594e969-606b-44e3-bc19-ab87223e201f	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Not Reported	Alive	-18613	 	1966	 	 	 	 	 	 	 	 	18613	 	202.00	202.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d2ff9543-d032-4025-8e56-8efdf062da59	MB247		f7fe06b1-9750-49f9-82dd-b586894eee00	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1460	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
d32af673-556f-4195-8391-39cd5189c282	C3N-00755		77e4cc8c-ba88-4028-ac8b-8e05e078484b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Hispanic or Latino	Female	Not Reported	Not Reported	 	 	1975	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d3302e81-63d7-11e8-bcf1-0a2705229b82	TCGA-29-2431		ff2bfd06-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-21833	 	1947	 	 	 	 	 	 	 	 	21833	Not Reported	1285.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d38f3993-b08a-400e-893a-ce75821d2c9b	CR5		d5c2240d-7f12-4c4c-8030-339f612f9e96	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
d3aef0d7-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A1AV		ff3025ac-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Hispanic or Latino	Male	White	Alive	-24875	 	1939	 	 	 	 	 	 	 	 	24875	Not Reported	1864.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d3c09427-73eb-4159-806d-2bc7fcdb9423	1711		761bc787-ed8a-4682-bc0a-069b1b051f5e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	49	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d3cad9e3-843a-41cf-b335-40dbc287b4e9	CR1		f1f7d5bf-e8c1-40e4-b406-a79706eaa133	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
d4129001-7324-4a1b-a876-2cf981fa9191	769-P		621e4cec-8014-496a-8541-fbcc8d6b1e7d	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d430a3f8-5314-4efa-b904-2aa17ecc88af	C3L-05849		f5fdbbff-2fb7-470b-8523-4d734957947b	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-7	Not Hispanic or Latino	Female	Black or African American	Alive	-23490	 	1955	 	 	 	 	 	 	 	 	23490	 	385.00	385.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC2	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2019	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d43bcf73-1fb8-11e9-b7f8-0a80fada099c	C3L-00765		4f00e0cc-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-22351	 	1955	 	 	 	 	 	 	 	 	22351	Not Reported	1414.00	1414.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22351\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d46de821-63d7-11e8-bcf1-0a2705229b82	TCGA-29-2432		ff2bf96d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-22605	653	1947	2009	 	 	 	 	 	 	 	22605	Not Reported	360.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d4873729-1189-11e9-afb9-0a9c39d33490	C3L-00137		040b206b-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-22142	 	1955	 	 	 	 	 	 	 	 	22142	Not Reported	823.00	823.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d4ab7ec5-327f-4e42-9096-7d8e012cf215	C3L-00991		655201f5-cd45-4415-98cc-d3d93800f769	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	7	Not Reported	Male	Other	Alive	-16703	 	1971	 	 	 	 	 	 	 	 	16703	 	336.00	336.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d4cd4b91-118a-11e9-afb9-0a9c39d33490	NX1		084b46c6-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d4d98800-dd46-4d74-8a94-d39627ae8c3f	16-00886		584010f1-9edf-4426-affc-7f2adaaf8d2b	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-10683	129	 	 	29	 	 	false	Medical Record	 	United States	10683	 	129.00	129.00	85.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d4e8179c-63d8-11e8-bcf1-0a2705229b82	TCGA-AR-A1AW		ff30bae9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-23855	 	1942	 	 	 	 	 	 	 	 	23855	Not Reported	2632.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d58a7e0b-c515-4402-aa5d-c11eec85085c	85		72b96139-36b3-4111-9454-ae9d9a413b69	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	46	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d5ac1143-63d7-11e8-bcf1-0a2705229b82	TCGA-30-1866		ff2d5912-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22562	1114	1942	2006	 	 	 	 	 	 	 	22562	Not Reported	1114.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d5b43f05-8489-44b4-8b3c-81a428f17fbd	OSCC_46		caa8cf53-e54f-4810-87bb-b109ea7eed30	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
d609a99b-d412-42e0-9d43-ef303948316e	WHIM18		c97b1a7d-a643-487a-a332-41b736b56fbf	 	Qualified	Breast Invasive Carcinoma	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
d610d697-1fb8-11e9-b7f8-0a80fada099c	C3L-00766		4f102a0f-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-20879	 	1959	 	 	 	 	 	 	 	 	20879	Not Reported	266.00	266.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20879\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d625ee3c-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0AV		ff315672-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	Alive	-19314	 	1956	 	 	 	 	 	 	 	 	19314	Not Reported	1820.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage I	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage I	T1c	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d66d8cc1-63d6-11e8-bcf1-0a2705229b82	16CO002		ff316122-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d67d5dca-d8a6-4105-8899-022724a8ce03	PDAC169		dfbd3452-3dec-47d3-8e44-54ecba85c592	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25915	 	630.00	630.00	630.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
d6a94773-118a-11e9-afb9-0a9c39d33490	NX2		08a0cc15-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d6e830e8-4fc3-42bb-b271-5957b2a5e525	C3L-01739		983adada-584b-4584-b03e-be7bbc229236	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Reported	Female	White	Alive	-26003	 	1946	 	 	 	 	 	 	 	 	26003	 	1147.00	1147.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d6eaaeea-63d7-11e8-bcf1-0a2705229b82	TCGA-30-1887		ff2ed32b-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-24495	738	1938	2007	 	 	 	 	 	 	 	24495	Not Reported	738.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d705133b-96f1-41dc-b613-3672f1d93488	Universal Ref		dc1db9b5-829c-4420-a7e4-c195c16433ac	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d7480a6b-7963-4f93-b213-8e5f46a0bf69	PDAC253		48e8d334-9aa0-4ed4-9491-307a425c1a9d	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	24090	 	1074.00	1074.00	1074.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
d758a19f-0401-4af4-b1ac-976f82017cf7	AP-HML4		42f4ca56-007d-418a-9e8f-0abcd43e8cb8	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	24836	 	1711.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
d7597e55-49af-4dc7-b471-3d08a801c331	C3N-01907		5e8d95b7-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Male	White	Dead	-22813	440	1954	2018	 	 	 	 	 	 	 	22813	Not Reported	407.00	440.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d75d7689-4481-42ec-ac0a-61da6ed2b991	PDAC211		a30ca82a-139f-422d-a9c8-a23c138e39d7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23360	 	562.00	562.00	472.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
d770baff-a23c-4de2-a152-6e78200df061	C3L-02176		d5ee17e7-56d4-474b-b8e5-ceebdc52ef84	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Female	White	Alive	-28912	 	1938	 	 	 	 	 	 	 	 	28912	 	306.00	306.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d77d0758-e697-4cd4-8e31-4aeb6f8e749c	MB284		294a7d1f-8545-4b98-afe1-689d74ae1aa6	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	10585	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
d7988a9c-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0BV		ff2fb9c5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-28699	 	1928	 	 	 	 	 	 	 	 	28699	Not Reported	1519.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d7b50f28-63d6-11e8-bcf1-0a2705229b82	16CO003		ff316385-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d7e4e6ae-165e-44c5-943d-7a58f9d37931	C3N-04284		60760508-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-29323	8	1938	2018	 	 	 	 	 	 	 	29323	Not Reported	8.00	8.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d82e4023-63d7-11e8-bcf1-0a2705229b82	TCGA-30-1891		ff2c6764-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22344	914	1943	2006	 	 	 	 	 	 	 	22344	Not Reported	914.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d859d6df-0a57-47bd-9a36-e7ceed71c946	2710		c50ee04d-7fff-435e-9830-4f7a39c6615b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	74	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d887c51c-75ff-4e36-975c-60604c54c6f5	PDAC276		774e8337-c677-4706-b0bc-65d3da66c718	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22265	 	237.00	237.00	160.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
d8936359-79bf-43ad-a0a4-4641d4503a14	BCN 1368		528b543b-637e-4f75-a9cb-ced245594c03	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
d898b2a0-1189-11e9-afb9-0a9c39d33490	C3L-00139		041a786e-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-30538	422	1932	2017	 	 	 	 	 	 	 	30538	Not Reported	422.00	422.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	Unknown	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"dead\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d8abeae0-f8ea-4a7f-9d80-064dcd7a5173	NTN087		a4cfc731-7be1-4d3b-a473-7ab5750517ee	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d8ac4953-118a-11e9-afb9-0a9c39d33490	NX3		08a89ddd-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d8dc8ed7-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0BZ		ff2beca2-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-21856	 	1948	 	 	 	 	 	 	 	 	21856	Not Reported	2255.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d903920d-63d6-11e8-bcf1-0a2705229b82	16CO006		ff3177e0-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IVA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IVA	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d9465f75-1a21-4c4f-8b6f-14e0600dffda	C3N-03840		6041d868-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	-21749	 	1958	 	 	 	 	 	 	 	 	21749	Not Reported	696.00	696.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d95673ac-1fb8-11e9-b7f8-0a80fada099c	C3L-00790		4f1f6c24-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-16335	 	1972	 	 	 	 	 	 	 	 	16335	Not Reported	441.00	441.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-16335\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d96dc4bd-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1569		ff2d8236-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-19151	 	1955	 	 	 	 	 	 	 	 	19151	Not Reported	885.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
d977d424-bfc6-4cb7-b9db-67e6e3fad6e8	51		4862e036-01c3-479a-811e-bd14999b9e67	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	50	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d99c4c13-8b14-4340-bb4f-eff79d433c55	C3L-07033		5cf3ae7f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Unknown	Male	White	Not Reported	 	 	1947	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d9bb3679-4610-4ab7-9ebc-9059f5db23c7	NX019		a7b802e9-f385-4ff9-a390-960341411c03	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
d9cf41d0-1646-4b43-ad34-f35cf1d96b05	4787		84c578fa-403c-426d-b91c-cf4fd2b0a083	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
d9eff2f2-2098-497d-91f2-f89165e25033	C3L-03632		5c6a5fe8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Alive	-27050	 	1944	 	 	 	 	 	 	 	 	27050	Not Reported	1439.00	1439.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Pancreas, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
da202cfd-bff0-4cfd-9d08-92e917ad5a6f	PDAC048		23429231-76dd-45dd-b84e-09dab5da0f04	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	27375	 	2576.00	2576.00	249.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
da282277-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0C0		ff2fbeb5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-23006	 	1945	 	 	 	 	 	 	 	 	23006	Not Reported	1270.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIA	T1c		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
da3a693f-01f0-4d7b-ae52-95c5438733d8	C3N-03670		601c63c5-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Alive	-22035	 	1957	 	 	 	 	 	 	 	 	22035	Not Reported	1113.00	1113.00	785.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
da4722f0-63d6-11e8-bcf1-0a2705229b82	16CO011		ff317fe7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Colon Adenocarcinoma	Colon			Not Hispanic or Latino	Male	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Not Reported	Colon, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage IIIB	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 		 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
da69274f-118a-11e9-afb9-0a9c39d33490	NX4		08b1544e-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
daabb823-5e5e-4446-b14b-6962cd3d1111	C3L-04495		5ccad408-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-13477	288	1981	2019	 	 	 	 	 	 	 	13477	Not Reported	288.00	288.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Pancreas, NOS	Pancreas, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dab3a19a-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1570		ff2bc066-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-17956	 	1958	 	 	 	 	 	 	 	 	17956	Not Reported	655.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
dae8930e-1fb8-11e9-b7f8-0a80fada099c	C3L-00791		4f2eefdf-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-27902	 	1940	 	 	 	 	 	 	 	 	27902	Not Reported	708.00	708.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27902\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
db0bca1e-182f-42de-9320-3a7dfe7f7c63	PDAC271		8510a081-0b4d-420e-b486-21183009d6d3	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	23725	 	132.00	132.00	124.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
db5c3f2f-3bda-472f-8806-c3345cf1050e	95		abff3bf8-4024-4124-a91c-583806047f78	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	37	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
db60fa6c-6138-442b-9760-90386debca6b	C3N-02069		5eae3115-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-26675	788	1944	2019	 	 	 	 	 	 	 	26675	Not Reported	629.00	788.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
db63cb90-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0C1		ff2fcd22-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-22377	1411	1946	 	 	 	 	 	 	 	 	22377	Not Reported	1339.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
db881926-36a3-4c78-808a-cc50b867af9d	MB288		e8c9b696-9be4-421e-a00e-4c2da01bca86	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	2190	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
dbc5d128-9919-4828-82a8-0edf911934c8	Cell based ref		30b8bd55-d3bb-43b2-96d5-6e5ccd9c5479	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dbf2e1fa-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1571		ff2df7e5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Dead	-19608	695	1954	2008	 	 	 	 	 	 	 	19608	Not Reported	695.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
dc436ad3-e534-41d5-9b2a-afb13e45240d	PDAC255		829a8bce-9cc3-465c-80da-a9234afd1edc	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	22630	 	854.00	854.00	553.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
dc4c0919-e02b-4c2f-8a43-2102cf535bca	C3N-02636		3179fb7e-b617-4207-8128-0b107fe21679	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	22	Not Reported	Female	White	Dead	-26559	1165	1944	2020	 	 	 	 	 	 	 	26559	 	1096.00	1165.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dc5c98c3-f062-4a93-917f-1854af37c3f4	C3N-00511		5d7d05d3-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-16455	991	1971	2019	 	 	 	 	 	 	 	16455	Not Reported	991.00	991.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dc69117a-ea67-4beb-91d5-301c8ef2c7db	Reference		55279727-6887-430b-8e98-04ab300e0dec	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dc6e3ede-118a-11e9-afb9-0a9c39d33490	NX5		08c09b16-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dc7b5f90-ea1e-4e4d-8445-ec2950cf5d55	C3L-03743		5c8f2105-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-26051	732	1947	2020	 	 	 	 	 	 	 	26051	Not Reported	48.00	732.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dc7bd788-1fb8-11e9-b7f8-0a80fada099c	C3L-00792		4f3df0dd-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Female	White	Alive	-32872	 	1926	 	 	 	 	 	 	 	 	32872	Not Reported	1419.00	1419.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage II	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-33046\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dc9f2a6d-1189-11e9-afb9-0a9c39d33490	C3L-00143		042b06ed-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-25407	 	1946	 	 	 	 	 	 	 	 	25407	Not Reported	1708.00	1708.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dca21779-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0C7		ff30c3bc-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-17871	 	1958	 	 	 	 	 	 	 	 	17871	Not Reported	2767.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1mi	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
dca5e9bc-74e5-4e1d-b549-d8c3f472ac48	MB277		21a04fc1-bc27-4edb-9b4b-a4ed33caf2f8	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1460	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
dce1ec8e-8e5c-4f65-a171-bdfd0acc339f	C3N-01878		3ff4d7f7-cbdf-4af1-9028-cceca914c1a2	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	26	Not Reported	Female	White	Alive	-21655	 	1958	 	 	 	 	 	 	 	 	21655	 	162.00	162.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dce382d2-eaa9-42a3-8fdd-cf0e39555c75	MB164		6ca94dfd-2991-416b-b5e6-2784231994f1	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1241	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
dd2d82ac-a0a8-4f6c-9f07-8534c7f9663b	8228		d149c0a7-a3bc-4b37-9ac8-4c2a7e3da3ef	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	51	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dd374872-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1576		ff31899d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-27778	 	1930	 	 	 	 	 	 	 	 	27778	Not Reported	915.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
dd7e1d91-d297-4933-b37c-4d69bec00cc7	WU-pooled sample		61108edb-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ddc466c8-7e8f-453c-920d-25ebb56be20f	C3L-00599		5a35cc6b-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-22828	1305	1954	2020	 	 	 	 	 	 	 	22828	Not Reported	1305.00	1305.00	1034.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Pancreas, NOS	G1	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dde21323-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0DD		ff30e752-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Male	White	Alive	-21386	 	1948	 	 	 	 	 	 	 	 	21386	Not Reported	2486.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
de1260e6-4932-4d48-bdac-0e02abaf11ec	C3L-00943		f298dd22-77cd-44d9-93eb-8d90b5773cfb	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-27	Not Reported	Female	White	Alive	-23047	 	1953	 	 	 	 	 	 	 	 	23047	 	1457.00	1457.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
de178b14-1fb8-11e9-b7f8-0a80fada099c	C3L-00796		4f44ef45-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-24549	 	1949	 	 	 	 	 	 	 	 	24549	Not Reported	333.00	333.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-24549\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
de1f0e2a-972d-44dd-b988-b218b42fd20a	C3L-01978		f9541375-7ac2-4762-bab4-c51e3627420e	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20952	 	1960	 	 	 	 	 	 	 	 	20952	 	5.00	5.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
de3650a9-118a-11e9-afb9-0a9c39d33490	NX6		08cfd571-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
de421f1c-fbdc-4f9a-a474-77bd828cb428	MB244		d75581be-f811-46ce-b213-748f6fbca4a2	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M1	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
de6ce6a6-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1577		ff2c0176-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Asian	Alive	-15804	 	1964	 	 	 	 	 	 	 	 	15804	Not Reported	783.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
de73a14b-36e1-4c67-b674-21d38f9d4a3a	PDAC030		9a99b73f-4270-4d82-80c1-5b0f31c9a677	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	763.00	763.00	417.00	Distant met recurrence/progression	8480/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
dea8bbca-b6b1-4247-98c3-ec4ea86a61c1	16-01219		41de3652-005c-4470-a6f9-65c2e3026bbc	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Unknown	-17225	 	 	 	47	 	 	false	 	 	United States	17225	 	214.00	214.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated CEBPA	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dec06ee9-6531-4bf0-b9e3-495f84f6de41	C3L-00970		b7ed3aa7-3deb-443d-bc39-d232b1dbbb03	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	1	Not Reported	Male	Other	Alive	-20187	 	1961	 	 	 	 	 	 	 	 	20187	 	415.00	415.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df044e27-1d57-4877-8cf0-86ae0f5908b5	CR4		67daa1e2-ca7f-4724-9d35-0615916e84fd	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
df0ee52d-df43-401b-909e-ca25f708ae64	C3L-03395		5c3d56cd-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-28498	88	1941	2019	 	 	 	 	 	 	 	28498	Not Reported	88.00	88.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2019	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df0fa249-a467-46ba-8fc9-0befa6d8d97e	PDAC170		5523f416-014f-40b0-bd17-963a25f8823a	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21535	 	173.00	173.00	97.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
df249a75-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0DG		ff315c52-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Black or African American	Alive	-11204	 	1977	 	 	 	 	 	 	 	 	11204	Not Reported	2041.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
df39bf96-1f43-48bd-85a5-fde1d3bf3396	74		118ae6f4-190b-4768-8fbb-c7a614b49955	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
df4e907e-8f98-11ea-b1fd-0aad30af8a83	C3L-00977		64d2c3a1-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Dead	-20653	1537	1960	2021	 	 	 	 	 	 	 	20653	Not Reported	1537.00	1537.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Overlapping lesion of lip, oral cavity and pharynx	G1	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T1	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20653\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e95d2-8f98-11ea-b1fd-0aad30af8a83	C3L-00987		64d940cf-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-22430	 	1955	 	 	 	 	 	 	 	 	22430	Not Reported	429.00	429.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22430\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e970b-8f98-11ea-b1fd-0aad30af8a83	C3L-00994		64e00f97-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Dead	-18263	202	1967	2017	 	 	 	 	 	 	 	18263	Not Reported	133.00	202.00	133.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N0	Stage II	T2	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"201\",\"days_to_birth\":\"-18263\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9966-8f98-11ea-b1fd-0aad30af8a83	C3L-00995		64e64bf1-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Dead	-20780	-9	1960	2017	 	 	 	 	 	 	 	20780	Not Reported	-10.00	-9.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Cheek mucosa	Cheek mucosa	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T2	7th	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"-9\",\"days_to_birth\":\"-20780\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9a58-8f98-11ea-b1fd-0aad30af8a83	C3L-00997		64ecdbfe-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-17253	 	1970	 	 	 	 	 	 	 	 	17253	Not Reported	442.00	442.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Oropharynx, NOS	Oropharynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17253\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9b42-8f98-11ea-b1fd-0aad30af8a83	C3L-00999		64f3126c-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-20513	 	1961	 	 	 	 	 	 	 	 	20513	Not Reported	1137.00	1137.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20513\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9d3d-8f98-11ea-b1fd-0aad30af8a83	C3L-01138		64f98f28-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-22715	 	1955	 	 	 	 	 	 	 	 	22715	Not Reported	367.00	367.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22715\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9e22-8f98-11ea-b1fd-0aad30af8a83	C3L-01237		6500272c-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-20956	 	1960	 	 	 	 	 	 	 	 	20956	Not Reported	20.00	20.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N2	Stage IVA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20956\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4e9ef8-8f98-11ea-b1fd-0aad30af8a83	C3L-02617		65063ce7-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23710	 	1953	 	 	 	 	 	 	 	 	23710	Not Reported	1394.00	1394.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	Unknown	 	 	 	Unknown	NX	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23710\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea101-8f98-11ea-b1fd-0aad30af8a83	C3L-02621		650cf942-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-25156	 	1949	 	 	 	 	 	 	 	 	25156	Not Reported	314.00	314.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	Unknown	 	 	 	Unknown	NX	Stage I	T1	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25156\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea1e7-8f98-11ea-b1fd-0aad30af8a83	C3L-02651		65133ab5-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-29752	 	1937	 	 	 	 	 	 	 	 	29752	Not Reported	291.00	291.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	MX	 	 	 	MX	NX	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29752\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea3f5-8f98-11ea-b1fd-0aad30af8a83	C3L-03378		6519d22c-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-20019	 	1963	 	 	 	 	 	 	 	 	20019	Not Reported	1175.00	1175.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Overlapping lesion of lip, oral cavity and pharynx	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N2c	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20019\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea4dc-8f98-11ea-b1fd-0aad30af8a83	C3L-04025		6520afcb-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-25290	 	1949	 	 	 	 	 	 	 	 	25290	Not Reported	470.00	470.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Cheek mucosa	Cheek mucosa	G2	Not Reported	 	 	No	Unknown	 	 	 	Unknown	NX	Stage I	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25290\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea6f3-8f98-11ea-b1fd-0aad30af8a83	C3L-04350		6526d18e-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Male	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	G2	Not Reported	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea7d8-8f98-11ea-b1fd-0aad30af8a83	C3L-04354		652d39e7-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-22041	 	1958	 	 	 	 	 	 	 	 	22041	Not Reported	1393.00	1393.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	MX	 	 	 	MX	NX	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22041\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ea9fe-8f98-11ea-b1fd-0aad30af8a83	C3L-04791		65338be6-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-29749	 	1937	 	 	 	 	 	 	 	 	29749	Not Reported	273.00	273.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	MX	 	 	 	MX	NX	Stage I	T1	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29749\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eaafe-8f98-11ea-b1fd-0aad30af8a83	C3L-04844		65399c19-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Alive	-22268	 	1957	 	 	 	 	 	 	 	 	22268	Not Reported	1376.00	1376.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Oropharynx, NOS	Tonsil, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N3	Stage IVB	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22269\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eac21-8f98-11ea-b1fd-0aad30af8a83	C3L-04849		6543a48f-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-23099	 	1955	 	 	 	 	 	 	 	 	23099	Not Reported	356.00	356.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Head, face or neck, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N3	Stage IVB	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23099\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ead02-8f98-11ea-b1fd-0aad30af8a83	C3L-05257		6549d29e-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	G1	Not Reported	 	 	No	Unknown	 	 	 	Unknown	N0	 	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eaeb4-8f98-11ea-b1fd-0aad30af8a83	C3N-00204		65529b27-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Dead	-23017	175	1953	2017	 	 	 	 	 	 	 	23017	Not Reported	145.00	175.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"175\",\"days_to_birth\":\"-23017\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eaf8f-8f98-11ea-b1fd-0aad30af8a83	C3N-00295		655c0c9b-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Dead	-19751	1687	1962	2021	 	 	 	 	 	 	 	19751	Not Reported	1687.00	1687.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	NX	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19751\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb063-8f98-11ea-b1fd-0aad30af8a83	C3N-00297		6562bb39-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-25254	 	1947	 	 	 	 	 	 	 	 	25254	Not Reported	1734.00	1734.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25254\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb20d-8f98-11ea-b1fd-0aad30af8a83	C3N-00299		656b4d3a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-19881	231	1962	2017	 	 	 	 	 	 	 	19881	Not Reported	-20.00	231.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Lip, NOS	Lip, NOS	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"294\",\"days_to_birth\":\"-19881\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb2e7-8f98-11ea-b1fd-0aad30af8a83	C3N-00306		657a9211-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-18561	645	1965	2018	 	 	 	 	 	 	 	18561	Not Reported	645.00	645.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage III	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18561\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb3f1-8f98-11ea-b1fd-0aad30af8a83	C3N-00307		6589e4fa-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-25727	270	1946	2017	 	 	 	 	 	 	 	25727	Not Reported	270.00	270.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	Yes	M0	 	 	 	M0	NX	Stage IVA	T4a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"199\",\"days_to_birth\":\"-25727\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb5b7-8f98-11ea-b1fd-0aad30af8a83	C3N-00498		65909327-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23112	 	1953	 	 	 	 	 	 	 	 	23112	Not Reported	1704.00	1704.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Overlapping lesion of lip, oral cavity and pharynx	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N1	Stage III	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23112\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb697-8f98-11ea-b1fd-0aad30af8a83	C3N-00519		659eeda2-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24556	258	1949	2017	 	 	 	 	 	 	 	24556	Not Reported	258.00	258.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24556\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb76a-8f98-11ea-b1fd-0aad30af8a83	C3N-00822		65a86c34-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Dead	-19536	978	1963	2019	 	 	 	 	 	 	 	19536	Not Reported	978.00	978.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N0	Stage III	T3	7th	 	 	 	 	 	 	Cardiovascular Disorder, NOS	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cardiovascular Disorder, NOS\",\"vital_status\":\"Dead\",\"days_to_death\":\"978\",\"days_to_birth\":\"-19536\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eb92f-8f98-11ea-b1fd-0aad30af8a83	C3N-00825		65ae9a54-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-19686	 	1962	 	 	 	 	 	 	 	 	19686	Not Reported	1730.00	1730.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19686\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eba07-8f98-11ea-b1fd-0aad30af8a83	C3N-00828		65b79f60-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24489	948	1949	2019	 	 	 	 	 	 	 	24489	Not Reported	948.00	948.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	NX	Stage II	T2	7th	 	 	 	 	 	 	Cardiovascular Disorder, NOS	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cardiovascular Disorder, NOS\",\"vital_status\":\"Dead\",\"days_to_death\":\"951\",\"days_to_birth\":\"-24489\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ebbd7-8f98-11ea-b1fd-0aad30af8a83	C3N-00829		65bde6de-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-19384	958	1963	2019	 	 	 	 	 	 	 	19384	Not Reported	952.00	958.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Floor of mouth, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IVA	T2	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"958\",\"days_to_birth\":\"-19384\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ebcaf-8f98-11ea-b1fd-0aad30af8a83	C3N-00846		65c6dc7a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-24608	 	1949	 	 	 	 	 	 	 	 	24608	Not Reported	644.00	644.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Tongue, NOS	Tongue, NOS	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage I	T1	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24608\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ebebb-8f98-11ea-b1fd-0aad30af8a83	C3N-00857		65d6226c-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-23545	636	1952	2018	 	 	 	 	 	 	 	23545	Not Reported	636.00	636.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage IVA	T4a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23545\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ebfa3-8f98-11ea-b1fd-0aad30af8a83	C3N-00871		65e56e4d-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-21468	400	1958	2018	 	 	 	 	 	 	 	21468	Not Reported	344.00	400.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Overlapping lesion of lip, oral cavity and pharynx	G2	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IVA	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"415\",\"days_to_birth\":\"-21468\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec190-8f98-11ea-b1fd-0aad30af8a83	C3N-01337		65f4b236-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-19312	 	1964	 	 	 	 	 	 	 	 	19312	Not Reported	616.00	616.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IVA	T4	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19312\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec26a-8f98-11ea-b1fd-0aad30af8a83	C3N-01338		6603eb7e-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-18322	585	1967	2018	 	 	 	 	 	 	 	18322	Not Reported	574.00	585.00	492.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N1	Stage III	T2	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18322\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec459-8f98-11ea-b1fd-0aad30af8a83	C3N-01339		66132ab2-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Dead	-25041	211	1948	2017	 	 	 	 	 	 	 	25041	Not Reported	203.00	211.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage IVA	T4	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"214\",\"days_to_birth\":\"-25041\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec539-8f98-11ea-b1fd-0aad30af8a83	C3N-01340		66226f83-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26376	1388	1944	2020	 	 	 	 	 	 	 	26376	Not Reported	1264.00	1388.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	M0	N0	Stage IVA	T4a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26376\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec739-8f98-11ea-b1fd-0aad30af8a83	C3N-01620		6631abe5-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-20774	 	1960	 	 	 	 	 	 	 	 	20774	Not Reported	1202.00	1202.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20774\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ec812-8f98-11ea-b1fd-0aad30af8a83	C3N-01643		664131af-2850-11ec-b712-0a4e2186f121	 	Disqualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-24920	 	1948	 	 	 	 	 	 	 	 	24920	Not Reported	1460.00	1460.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24920\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eca22-8f98-11ea-b1fd-0aad30af8a83	C3N-01645		665033ce-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26258	563	1945	2018	 	 	 	 	 	 	 	26258	Not Reported	563.00	563.00	374.00	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N0	Stage III	T3	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26258\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ecafb-8f98-11ea-b1fd-0aad30af8a83	C3N-01752		665f7940-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26753	998	1944	2020	 	 	 	 	 	 	 	26753	Not Reported	998.00	998.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage IVA	T4a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26753\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ecd30-8f98-11ea-b1fd-0aad30af8a83	C3N-01754		666eba2b-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23404	 	1953	 	 	 	 	 	 	 	 	23404	Not Reported	1535.00	1535.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Head, face or neck, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23404\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ece54-8f98-11ea-b1fd-0aad30af8a83	C3N-01755		667e002e-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-24868	 	1949	 	 	 	 	 	 	 	 	24868	Not Reported	1701.00	1701.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24868\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ecf32-8f98-11ea-b1fd-0aad30af8a83	C3N-01756		668d4474-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-22915	 	1954	 	 	 	 	 	 	 	 	22915	Not Reported	1894.00	1894.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N2c	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22915\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed0d5-8f98-11ea-b1fd-0aad30af8a83	C3N-01757		669c8650-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23506	 	1952	 	 	 	 	 	 	 	 	23506	Not Reported	1927.00	1927.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	NX	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23506\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed1b2-8f98-11ea-b1fd-0aad30af8a83	C3N-01758		66abd3e3-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-21708	712	1957	2019	 	 	 	 	 	 	 	21708	Not Reported	702.00	712.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage IVA	T4a	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21708\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed282-8f98-11ea-b1fd-0aad30af8a83	C3N-01858		66bb07df-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-22982	 	1954	 	 	 	 	 	 	 	 	22982	Not Reported	598.00	598.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N3b	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22982\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed42c-8f98-11ea-b1fd-0aad30af8a83	C3N-01859		66ca4712-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24594	1039	1950	2020	 	 	 	 	 	 	 	24594	Not Reported	1039.00	1039.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	MX	N2c	Stage IVA	T4a	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24594\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed504-8f98-11ea-b1fd-0aad30af8a83	C3N-01943		66d9d54a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-23038	852	1954	2019	 	 	 	 	 	 	 	23038	Not Reported	840.00	852.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N3a	Stage IVA	T4a	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23038\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed5d3-8f98-11ea-b1fd-0aad30af8a83	C3N-01944		66e8ceda-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24082	438	1951	2018	 	 	 	 	 	 	 	24082	Not Reported	438.00	438.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Floor of mouth, NOS	Tongue, NOS	G3	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage IVA	T4a	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24082\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed786-8f98-11ea-b1fd-0aad30af8a83	C3N-01945		66f814bb-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-22403	1115	1956	2020	 	 	 	 	 	 	 	22403	Not Reported	1115.00	1115.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T2	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22403\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ed85e-8f98-11ea-b1fd-0aad30af8a83	C3N-01946		66fe9c01-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23694	 	1952	 	 	 	 	 	 	 	 	23694	Not Reported	1335.00	1335.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23694\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eda1a-8f98-11ea-b1fd-0aad30af8a83	C3N-01947		67074dfa-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-18216	 	1967	 	 	 	 	 	 	 	 	18216	Not Reported	1191.00	1191.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Not Reported	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Stage IVA	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18216\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4edaf6-8f98-11ea-b1fd-0aad30af8a83	C3N-01948		670ddfae-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Alive	-20359	 	1961	 	 	 	 	 	 	 	 	20359	Not Reported	422.00	422.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Head, face or neck, NOS	Tongue, NOS	G2	Not Reported	 	 	Unknown	M0	 	 	 	M0	N2b	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20359\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4edcd7-8f98-11ea-b1fd-0aad30af8a83	C3N-02275		671c4588-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-25376	 	1947	 	 	 	 	 	 	 	 	25376	Not Reported	1358.00	1358.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25376\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eddbb-8f98-11ea-b1fd-0aad30af8a83	C3N-02279		672263ee-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-21586	 	1958	 	 	 	 	 	 	 	 	21586	Not Reported	414.00	414.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21586\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4edf88-8f98-11ea-b1fd-0aad30af8a83	C3N-02333		672886c6-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-22285	 	1956	 	 	 	 	 	 	 	 	22285	Not Reported	735.00	735.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22285\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee063-8f98-11ea-b1fd-0aad30af8a83	C3N-02693		673b1dd9-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-15703	 	1974	 	 	 	 	 	 	 	 	15703	Not Reported	1349.00	1349.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-15703\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee240-8f98-11ea-b1fd-0aad30af8a83	C3N-02694		6741b7c6-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-20892	617	1960	2019	 	 	 	 	 	 	 	20892	Not Reported	617.00	617.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Stage IVA	T2	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21257\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee338-8f98-11ea-b1fd-0aad30af8a83	C3N-02695		6748b230-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-16652	 	1971	 	 	 	 	 	 	 	 	16652	Not Reported	1577.00	1577.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16652\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee534-8f98-11ea-b1fd-0aad30af8a83	C3N-02700		674eca7e-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Alive	-29529	 	1936	 	 	 	 	 	 	 	 	29529	Not Reported	5.00	5.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lip, NOS	Lip, NOS	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29529\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee623-8f98-11ea-b1fd-0aad30af8a83	C3N-02713		675545e6-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-23707	 	1952	 	 	 	 	 	 	 	 	23707	Not Reported	744.00	744.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	No	M0	 	 	 	Unknown	N2	Stage IVA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23707\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee821-8f98-11ea-b1fd-0aad30af8a83	C3N-02714		675b7d2a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-8551	 	1993	 	 	 	 	 	 	 	 	8551	Not Reported	907.00	907.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-8551\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ee8fe-8f98-11ea-b1fd-0aad30af8a83	C3N-02716		67620d51-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-28077	 	1941	 	 	 	 	 	 	 	 	28077	Not Reported	258.00	258.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lip, NOS	Lip, NOS	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage I	T1	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28077\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eeb29-8f98-11ea-b1fd-0aad30af8a83	C3N-02727		676909d8-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-18210	 	1967	 	 	 	 	 	 	 	 	18210	Not Reported	693.00	693.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18210\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eec12-8f98-11ea-b1fd-0aad30af8a83	C3N-02730		67700dbe-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Alive	-14629	 	1977	 	 	 	 	 	 	 	 	14629	Not Reported	365.00	365.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T1	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-14629\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eee28-8f98-11ea-b1fd-0aad30af8a83	C3N-02925		67766bff-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Asian	Alive	-25138	 	1948	 	 	 	 	 	 	 	 	25138	Not Reported	1022.00	1022.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IV	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25138\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4eef1c-8f98-11ea-b1fd-0aad30af8a83	C3N-03008		677cf42f-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Dead	-23789	158	1952	2018	 	 	 	 	 	 	 	23789	Not Reported	146.00	158.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N2c	Stage IVB	T4a	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"158\",\"days_to_birth\":\"-23789\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef039-8f98-11ea-b1fd-0aad30af8a83	C3N-03009		67832304-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-21529	655	1958	2019	 	 	 	 	 	 	 	21529	Not Reported	636.00	655.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage I	T1	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"655\",\"days_to_birth\":\"-21529\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef10e-8f98-11ea-b1fd-0aad30af8a83	C3N-03011		67894dfa-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-22872	598	1955	2019	 	 	 	 	 	 	 	22872	Not Reported	598.00	598.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G3	Not Reported	 	 	Yes	M0	 	 	 	MX	N2b	Stage IVA	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"598\",\"days_to_birth\":\"-22872\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef2ab-8f98-11ea-b1fd-0aad30af8a83	C3N-03012		678fbb7e-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26252	1333	1945	2021	 	 	 	 	 	 	 	26252	Not Reported	1333.00	1333.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	MX	N0	Stage IVA	T4a	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26252\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef386-8f98-11ea-b1fd-0aad30af8a83	C3N-03013		67991914-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-21782	 	1958	 	 	 	 	 	 	 	 	21782	Not Reported	1389.00	1389.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	No	Head, face or neck, NOS	Tongue, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	MX	NX	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21782\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef458-8f98-11ea-b1fd-0aad30af8a83	C3N-03015		67a0ccdb-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-22292	 	1956	 	 	 	 	 	 	 	 	22292	Not Reported	1493.00	1493.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G3	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Stage IVB	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22292\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef6b1-8f98-11ea-b1fd-0aad30af8a83	C3N-03027		67af2d7a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-23896	211	1952	2018	 	 	 	 	 	 	 	23896	Not Reported	211.00	211.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Overlapping lesion of lip, oral cavity and pharynx	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	NX	Stage II	T2	8th	 	 	 	 	 	 	Not Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":\"-23896\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef7ac-8f98-11ea-b1fd-0aad30af8a83	C3N-03028		67b5b830-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-21881	 	1957	 	 	 	 	 	 	 	 	21881	Not Reported	1337.00	1337.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Stage IVA	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21881\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4ef87b-8f98-11ea-b1fd-0aad30af8a83	C3N-03042		67be68c4-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Hispanic or Latino	Female	Not Reported	Not Reported	-24572	 	1951	 	 	 	 	 	 	 	 	24572	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Overlapping lesion of lip, oral cavity and pharynx	Overlapping lesion of lip, oral cavity and pharynx	G2	Not Reported	 	 	Not Reported	M0	 	 	 	Unknown	N3b	Stage IVB	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-24572\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4efa74-8f98-11ea-b1fd-0aad30af8a83	C3N-03045		67c53eee-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Hispanic or Latino	Male	Not Reported	Not Reported	-28410	 	1940	 	 	 	 	 	 	 	 	28410	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Tongue, NOS	Tongue, NOS	G1	Not Reported	 	 	Not Reported	M0	 	 	 	Unknown	N1	Stage III	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-28410\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4efb5a-8f98-11ea-b1fd-0aad30af8a83	C3N-03226		67d53b48-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-19938	 	1963	 	 	 	 	 	 	 	 	19938	Not Reported	730.00	730.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N2b	Stage IVA	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19938\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4efd1a-8f98-11ea-b1fd-0aad30af8a83	C3N-03433		67db6809-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-28032	960	1941	2020	 	 	 	 	 	 	 	28032	Not Reported	960.00	960.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28032\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4efdf1-8f98-11ea-b1fd-0aad30af8a83	C3N-03456		67e2e06f-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-23616	 	1953	 	 	 	 	 	 	 	 	23616	Not Reported	1426.00	1426.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Overlapping lesion of lip, oral cavity and pharynx	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage IVA	T4	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23616\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4effbc-8f98-11ea-b1fd-0aad30af8a83	C3N-03457		67e95c42-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-26052	 	1946	 	 	 	 	 	 	 	 	26052	Not Reported	1395.00	1395.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26052\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0094-8f98-11ea-b1fd-0aad30af8a83	C3N-03458		67f27c1a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-25648	 	1947	 	 	 	 	 	 	 	 	25648	Not Reported	1393.00	1393.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25648\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0263-8f98-11ea-b1fd-0aad30af8a83	C3N-03487		67fb6cdf-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Alive	-19702	 	1964	 	 	 	 	 	 	 	 	19702	Not Reported	728.00	728.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Gum, NOS	Gum, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N0	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19702\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0338-8f98-11ea-b1fd-0aad30af8a83	C3N-03488		68020a7a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-23634	 	1953	 	 	 	 	 	 	 	 	23634	Not Reported	706.00	706.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Head, face or neck, NOS	Head, face or neck, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23634\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0514-8f98-11ea-b1fd-0aad30af8a83	C3N-03490		680ab9e5-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-23729	 	1953	 	 	 	 	 	 	 	 	23729	Not Reported	634.00	634.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Base of tongue, NOS	Base of tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N0	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23729\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f05ee-8f98-11ea-b1fd-0aad30af8a83	C3N-03612		68115a90-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-18832	 	1966	 	 	 	 	 	 	 	 	18832	Not Reported	697.00	697.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Oropharynx, NOS	Oropharynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18832\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f07d3-8f98-11ea-b1fd-0aad30af8a83	C3N-03619		681a7065-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-21757	 	1958	 	 	 	 	 	 	 	 	21757	Not Reported	97.00	97.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N0	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21757\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f08ad-8f98-11ea-b1fd-0aad30af8a83	C3N-03620		682946c7-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-22641	 	1956	 	 	 	 	 	 	 	 	22641	Not Reported	728.00	728.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage II	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22641\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0a9f-8f98-11ea-b1fd-0aad30af8a83	C3N-03664		6838c631-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-21361	 	1959	 	 	 	 	 	 	 	 	21361	Not Reported	733.00	733.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N2c	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21361\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0b7a-8f98-11ea-b1fd-0aad30af8a83	C3N-03781		6847c025-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24899	1235	1949	2021	 	 	 	 	 	 	 	24899	Not Reported	1235.00	1235.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage IVA	T4a	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24899\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0d7f-8f98-11ea-b1fd-0aad30af8a83	C3N-03782		685706fc-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	White	Alive	-18540	 	1967	 	 	 	 	 	 	 	 	18540	Not Reported	1088.00	1088.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage IVA	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18540\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f0e55-8f98-11ea-b1fd-0aad30af8a83	C3N-03783		685d5a1d-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24500	952	1951	2020	 	 	 	 	 	 	 	24500	Not Reported	952.00	952.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Gum, NOS	Gum, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Stage IVA	T2	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24500\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1067-8f98-11ea-b1fd-0aad30af8a83	C3N-03785		686c32ff-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-24203	1152	1951	2021	 	 	 	 	 	 	 	24203	Not Reported	658.00	1152.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	NX	Stage I	T1	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24203\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1155-8f98-11ea-b1fd-0aad30af8a83	C3N-03837		687b3d16-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Alive	-19778	 	1964	 	 	 	 	 	 	 	 	19778	Not Reported	706.00	706.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Lip, NOS	Lip, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N0	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19778\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1268-8f98-11ea-b1fd-0aad30af8a83	C3N-03841		68940ad2-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Dead	-21732	753	1958	2020	 	 	 	 	 	 	 	21732	Not Reported	331.00	753.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	Yes	Head, face or neck, NOS	Head, face or neck, NOS	G3	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T3	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Unknown\",\"vital_status\":\"Dead\",\"days_to_death\":\"753\",\"days_to_birth\":\"-21732\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1344-8f98-11ea-b1fd-0aad30af8a83	C3N-03849		68a35f4e-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Alive	-20363	 	1962	 	 	 	 	 	 	 	 	20363	Not Reported	335.00	335.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IVA	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20363\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f14e8-8f98-11ea-b1fd-0aad30af8a83	C3N-03876		68b28d75-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Dead	-23849	465	1952	2019	 	 	 	 	 	 	 	23849	Not Reported	422.00	465.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N2b	Stage IVA	T3	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23849\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f15be-8f98-11ea-b1fd-0aad30af8a83	C3N-03878		68c1cddb-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Asian	Alive	-19338	 	1965	 	 	 	 	 	 	 	 	19338	Not Reported	650.00	650.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	M0	N1	Stage III	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19338\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1689-8f98-11ea-b1fd-0aad30af8a83	C3N-03888		68d10f44-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-21474	 	1959	 	 	 	 	 	 	 	 	21474	Not Reported	675.00	675.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21474\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1830-8f98-11ea-b1fd-0aad30af8a83	C3N-03889		68e054bf-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-19505	 	1964	 	 	 	 	 	 	 	 	19505	Not Reported	694.00	694.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Gum, NOS	Gum, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N0	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19505\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1907-8f98-11ea-b1fd-0aad30af8a83	C3N-03928		68ef9643-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Alive	-22113	 	1957	 	 	 	 	 	 	 	 	22113	Not Reported	702.00	702.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Tongue, NOS	Tongue, NOS	G1	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22113\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f19d3-8f98-11ea-b1fd-0aad30af8a83	C3N-03933		68fed57f-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Female	Other	Alive	-25635	 	1947	 	 	 	 	 	 	 	 	25635	Not Reported	749.00	749.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N1	Stage III	T2	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25635\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1b8c-8f98-11ea-b1fd-0aad30af8a83	C3N-04152		690e1883-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Alive	-19705	 	1964	 	 	 	 	 	 	 	 	19705	Not Reported	671.00	671.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Oropharynx, NOS	Oropharynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	N2b	Stage IVA	T4a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19705\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1c60-8f98-11ea-b1fd-0aad30af8a83	C3N-04273		6914edd5-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26874	425	1944	2019	 	 	 	 	 	 	 	26874	Not Reported	377.00	425.00	 	With tumor	8070/3	Squamous cell carcinoma, NOS	No	Oropharynx, NOS	Oropharynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N2b	Unknown	T2	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Cancer Related\",\"vital_status\":\"Dead\",\"days_to_death\":\"425\",\"days_to_birth\":\"-26874\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1d2d-8f98-11ea-b1fd-0aad30af8a83	C3N-04275		691d5a0a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-22645	 	1956	 	 	 	 	 	 	 	 	22645	Not Reported	1516.00	1516.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22645\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1ef8-8f98-11ea-b1fd-0aad30af8a83	C3N-04276		6923f558-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-24876	 	1950	 	 	 	 	 	 	 	 	24876	Not Reported	1165.00	1165.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	MX	N0	Stage IVA	T4a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24876\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f1fff-8f98-11ea-b1fd-0aad30af8a83	C3N-04277		692c9c67-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-26445	 	1945	 	 	 	 	 	 	 	 	26445	Not Reported	1162.00	1162.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	NX	Unknown	T3	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26445\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f20dd-8f98-11ea-b1fd-0aad30af8a83	C3N-04278		6932e81f-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Dead	-26252	576	1946	2019	 	 	 	 	 	 	 	26252	Not Reported	576.00	576.00	 	Unknown tumor status	8070/3	Squamous cell carcinoma, NOS	Yes	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	Yes	M0	 	 	 	MX	NX	Unknown	T3	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26252\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f22b3-8f98-11ea-b1fd-0aad30af8a83	C3N-04279		69398191-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-24049	 	1952	 	 	 	 	 	 	 	 	24049	Not Reported	1139.00	1139.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	Not Reported	Floor of mouth, NOS	Floor of mouth, NOS	G2	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24049\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f238b-8f98-11ea-b1fd-0aad30af8a83	C3N-04280		69407715-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	White	Alive	-24126	 	1952	 	 	 	 	 	 	 	 	24126	Not Reported	1447.00	1447.00	 	Tumor free	8070/3	Squamous cell carcinoma, NOS	No	Larynx, NOS	Larynx, NOS	G1	Not Reported	 	 	No	M0	 	 	 	MX	N0	Stage II	T2	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24126\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2567-8f98-11ea-b1fd-0aad30af8a83	C3N-04611		69472e1a-2850-11ec-b712-0a4e2186f121	 	Qualified	Head and Neck Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Other	Not Reported	-20250	 	1963	 	 	 	 	 	 	 	 	20250	Not Reported	 	 	 	Not Reported	8070/3	Squamous cell carcinoma, NOS	Not Reported	Larynx, NOS	Larynx, NOS	G2	Not Reported	 	 	No	M0	 	 	 	Unknown	NX	Stage III	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Yes	 	 	 	 	 	 	 	 	RX	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":\"-20250\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f263e-8f98-11ea-b1fd-0aad30af8a83	pooled sample		69612ec1-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2713-8f98-11ea-b1fd-0aad30af8a83	LungTumor1		694d7710-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f290c-8f98-11ea-b1fd-0aad30af8a83	LungTumor2		6953fe14-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f29e2-8f98-11ea-b1fd-0aad30af8a83	LungTumor3		695a648e-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2aaf-8f98-11ea-b1fd-0aad30af8a83	QC1		6967c785-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2cbd-8f98-11ea-b1fd-0aad30af8a83	QC2		696fad67-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2d98-8f98-11ea-b1fd-0aad30af8a83	QC3		6975e616-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f2e68-8f98-11ea-b1fd-0aad30af8a83	QC4		6981023a-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f3083-8f98-11ea-b1fd-0aad30af8a83	QC5		69882c09-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f3172-8f98-11ea-b1fd-0aad30af8a83	QC6		698e8091-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f3281-8f98-11ea-b1fd-0aad30af8a83	QC7		6997b48b-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df4f334e-8f98-11ea-b1fd-0aad30af8a83	QC9		69a6b387-2850-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df6bef95-c233-4b10-b321-36ef4e79b5d4	OSCC_40		aa24d55d-9793-4d25-ba17-1629ba8d605a	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Hard Palate	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
df77dbcd-94d7-4a66-b15c-9564f86ee42e	C3N-02998		5f1901a5-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-23734	650	1952	2019	 	 	 	 	 	 	 	23734	Not Reported	650.00	650.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
df877063-1fa1-4c40-9539-38bd91484810	MDA-12		0264b88d-8c55-4234-a2b6-12c49e63f636	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dfb55980-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1578		ff2e2b57-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Alive	-23329	 	1944	 	 	 	 	 	 	 	 	23329	Not Reported	847.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
dfbdbf47-7379-4d98-b6e4-175cd09ff0a4	C3L-04479		5cc428f5-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Alive	-24207	 	1952	 	 	 	 	 	 	 	 	24207	Not Reported	1454.00	1454.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dfc9d964-1fb8-11e9-b7f8-0a80fada099c	C3L-00799		4f4d2ed3-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Male	White	Alive	-15150	 	1975	 	 	 	 	 	 	 	 	15150	Not Reported	495.00	495.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-15150\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
dfca24ba-e158-46e1-99d6-dc0431fc85a8	MDA-17		553fac61-cb28-4269-b14d-acb55dcd2746	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	51	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
dff78dee-118a-11e9-afb9-0a9c39d33490	NX7		08df17d1-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e02faabb-6243-43ec-8dda-37931212a7fe	8986		47029998-a19a-4927-bd98-48b66e067e0e	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	46	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e035bd2a-9a53-47f2-9a34-0c93380ac6c7	C3N-02028		c27192f7-1795-45ab-bade-d529d493f3c3	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-35	Not Reported	Female	Other	Not Reported	-24954	 	1949	 	 	 	 	 	 	 	 	24954	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e0617dfe-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0E0		ff3003b1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-14175	 	1971	 	 	 	 	 	 	 	 	14175	Not Reported	134.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N3a	Stage IIIC	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e061c1ea-1189-11e9-afb9-0a9c39d33490	C3L-00145		0438ef67-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-21900	 	1956	 	 	 	 	 	 	 	 	21900	Not Reported	1799.00	1799.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e0865cab-fcae-41a2-b51c-b49614be7f11	Burdenko_1360		2a552d40-fe2f-4321-a3f2-c4ac21d99d08	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Unknown	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	N/A	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
e0f3cdc7-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1580		ff2e8a28-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Dead	-29992	737	1925	2009	 	 	 	 	 	 	 	29992	Not Reported	737.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e11e9155-4ac6-43dc-b8e5-1be822cd2dab	OSCC_47		ecee1b49-6b8f-4914-8a39-8a505a4ac204	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
e146ea33-991d-40e0-81c1-d33f9c719f62	C3L-00017		59bbb7c8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-25349	 	1946	 	 	 	 	 	 	 	 	25349	Not Reported	426.00	426.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e1559e51-1c77-4528-b69c-5fd3a9d23a14	C3L-02545		03297e0d-a914-497a-88ab-4d9e2a750149	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Alive	-20431	 	1961	 	 	 	 	 	 	 	 	20431	 	1782.00	1782.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e156560e-76b6-4eeb-ad0c-ead6b310b76f	10		83eaefe3-011e-4e05-8ee7-28399bb61ea0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	58	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e156560e-76b6-4eeb-ad0c-ead6b310b76f	10		ac6c2b29-29c9-4b2d-9bfe-f8d7e66e7478	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	58	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e169f383-1fb8-11e9-b7f8-0a80fada099c	C3L-00800		4f53b06d-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-15279	 	1975	 	 	 	 	 	 	 	 	15279	Not Reported	344.00	344.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-15279\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e183cc13-0800-4d5c-b63d-8b135026cb3e	MB268		b2613eea-a787-4b53-98dd-bbec2ef94d76	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	1095	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
e1a03084-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0E1		ff304212-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-19192	 	1957	 	 	 	 	 	 	 	 	19192	Not Reported	477.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e1b97674-6507-4955-bb07-cf8c617b9c69	WHIM35		bb46835b-08c5-4f16-9230-04aa747489fb	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
e1e441b1-118a-11e9-afb9-0a9c39d33490	NX8		08ee5850-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e1f526c3-081b-42fd-923f-e270066b1ed3	32		4c5c1dfa-04c8-4aab-81de-1fc873802fb2	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e2024061-4f11-4af3-9b92-224cc5e45310	NTN084		070fb2f7-4abb-4297-8186-1c98f777a6d7	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e207114a-9e45-443b-91c9-cabf93168f19	NTN059		3b6b6b58-639c-48bb-820d-17f4ed0858d1	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e2392707-63d7-11e8-bcf1-0a2705229b82	TCGA-36-1581		ff2c730d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-23272	 	1944	 	 	 	 	 	 	 	 	23272	Not Reported	751.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e2a46f60-056b-428c-898d-d10c2f80baf6	C3N-02302		e5766c29-d5a5-40a3-acc6-52ffda8e774d	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-25399	 	1947	 	 	 	 	 	 	 	 	25399	 	1720.00	1720.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e2aa4eca-a6fd-43bd-b606-9f80bd481c0e	AP-DM87		9b964a48-0e5a-4680-8630-2a2691d51da8	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	20088	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IB	 	 	 	 	 	 	 	M0	N0	Stage IB	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e2d732d4-a3cf-471a-927d-0be3e77404e4	CU-26		080b40f4-9084-47a4-896f-092a757dd6f9	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e2e48fc0-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0E9		ff318f87-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-19415	 	1953	 	 	 	 	 	 	 	 	19415	Not Reported	2489.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1a	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e2fc7190-63d6-11e8-bcf1-0a2705229b82	17OV010		ff3097a5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Not Reported/Unknown	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e30c24ef-1fb8-11e9-b7f8-0a80fada099c	C3L-00812		4f5aa24c-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-27323	 	1942	 	 	 	 	 	 	 	 	27323	Not Reported	8.00	8.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27323\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e36bdcd3-9b01-4229-8011-bbe47072aa6d	NTN042		c0b8aeae-aaad-4b1c-9b46-2ad38afe1a35	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e37e827e-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2529		ff2be0be-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-26092	 	1936	 	 	 	 	 	 	 	 	26092	Not Reported	1066.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e3831ddc-cf80-45fa-b1e0-3f548bc5abf9	PDAC049		6666ce90-47e2-4c58-b597-538440e1d708	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	19345	 	2247.00	2247.00	2247.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
e3a54828-b184-470c-ad3f-955f16a9d6e8	PDAC144		0a3f34ec-4201-42f1-8a26-2e1afa8701d9	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	13505	 	1756.00	1756.00	1756.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
e3ac310a-32e2-4392-a89a-34c47bd0f8f4	NCI-7		4d09eaf0-767a-4908-bda9-71e36f5cb2ca	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
e3c38f0f-db71-445b-95e6-f189c2504bc0	AP-E98M		1b8296ef-3951-493b-9127-5e6ba8a6b63f	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	25201	 	1825.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e3cf305c-f83f-474a-a095-542970bbf3c8	C3N-02592		5ef18faa-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-23318	294	1953	2018	 	 	 	 	 	 	 	23318	Not Reported	294.00	294.00	129.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e3e93bc1-118a-11e9-afb9-0a9c39d33490	NX9		08f55621-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e3f3601e-5f96-4430-b601-1f95e6b9c330	AP-JBET		6322317d-f35a-4de6-81ee-131d8cd39242	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	29949	 	1798.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e421b52e-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0EE		ff2bdf92-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-24850	 	1939	 	 	 	 	 	 	 	 	24850	Not Reported	943.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIB	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e4796a23-6e79-4159-8547-d7fbe13098c9	15-00756		8cc7700e-26d3-4321-8fb5-022ec8d45da8	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Unknown	-13225	 	 	 	36	 	 	false	 	 	United States	13225	 	552.00	552.00	 	Tumor free	Not Reported	Acute myeloid leukemia, t(8;21)(q22;q22)	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e47da4ba-1189-11e9-afb9-0a9c39d33490	C3L-00156		0448ee3b-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-20525	 	1960	 	 	 	 	 	 	 	 	20525	Not Reported	1776.00	1776.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e4a0071d-1fb8-11e9-b7f8-0a80fada099c	C3L-00813		4f626041-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-22521	 	1955	 	 	 	 	 	 	 	 	22521	Not Reported	13.00	13.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22521\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e4a4fa78-b429-4274-a2a9-9bd08f2114f8	AP-3336		c8778256-102a-48db-b90f-47c63e90d9b1	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	28854	 	1713.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e4bc1db1-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2530		ff2d4cf7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Alive	-13885	 	1969	 	 	 	 	 	 	 	 	13885	Not Reported	1004.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e4d5011a-6006-4ba7-8955-d4594c91576a	PDAC031		4c85c894-a87a-4e9a-871b-f005429c2e53	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	20440	 	750.00	750.00	539.00	Loco-regional recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
e544fb5a-5b53-4e1d-a3ab-e80239baca87	BCN 1326		d064a4a3-5017-49aa-9c62-6f654feb19c7	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
e54b0487-4eac-4d6f-8491-3bbdbf23614a	NX038		c36d976e-de5c-4b66-a111-a6e313131289	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e58a8242-3535-49f4-b083-9914c933088d	C3L-01034		c654d6a3-fee6-4c43-894b-6c352fcf979b	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Other	Alive	-24745	 	1949	 	 	 	 	 	 	 	 	24745	 	1105.00	1105.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e59670cd-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0HK		ff31886d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-29751	 	1929	 	 	 	 	 	 	 	 	29751	Not Reported	178.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e59ead0d-ee08-4c0e-bf73-8953587b49fb	C3L-04027		5c981e80-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Alive	-25375	 	1949	 	 	 	 	 	 	 	 	25375	Not Reported	240.00	240.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e5d39201-72d3-4911-9077-bb15eee72e33	C3N-01091		e3445e3c-0219-4e09-8e27-8b240b9e24cb	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Male	White	Not Reported	 	 	1963	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e5fb589e-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2532		ff2dd945-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-22333	 	1946	 	 	 	 	 	 	 	 	22333	Not Reported	897.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e63a8d1a-1fb8-11e9-b7f8-0a80fada099c	C3L-00814		4f692a76-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	Not Reported	Alive	-30635	 	1933	 	 	 	 	 	 	 	 	30635	Not Reported	15.00	15.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-30635\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e64a4ea3-1723-4efa-910e-74adea72179e	28		4b788f1b-d113-4b15-b8cb-6c15017a27d0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	49	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e64e9303-894e-464d-83a0-a66e08d2c385	C3N-00750		c57dc9a3-a1ed-46d9-87c3-0e4e3ba74a94	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent		Hispanic or Latino	Female	White	Not Reported	 	 	1972	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e67bed99-1189-11e9-afb9-0a9c39d33490	C3L-00157		0458d031-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Hispanic or Latino	Female	White	Dead	-22118	1396	1956	2020	 	 	 	 	 	 	 	22118	Not Reported	1396.00	1396.00	1337.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage III	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e696328d-d090-4405-99f9-57b0e2de7012	NX022		817ed553-6e8f-4e88-bdbc-8818fb709caa	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e6cf0d7b-c1cc-4155-9139-ffc921c2b772	C3N-02062		da471a8f-8d6b-401d-a113-30b5eda26663	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-61	Not Reported	Female	Other	Not Reported	-24730	 	1949	 	 	 	 	 	 	 	 	24730	 	 	 	 	Not Reported	8380/3	Endometrioid adenocarcinoma, NOS	Not Reported	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e6e186c1-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A0HP		ff30aab6-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	Alive	-23883	 	1944	 	 	 	 	 	 	 	 	23883	Not Reported	414.00	 	 	Not Reported	8520/3	Lobular carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T3		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e6fa63df-b57c-4ed2-8456-38b831e5a800	16-00494		4e94aba9-9f06-42b2-89fa-30ab8ed7b021	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-26353	148	 	 	72	 	 	false	Medical Record	 	United States	26353	 	148.00	148.00	 	With tumor	Not Reported	Therapy-related acute myeloid leukemia, NOS	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e7044d5a-0e07-49cc-af0b-1322a782da3c	PDAC083		9bdf9f3d-32b8-45a0-afa2-836b963926c4	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26645	 	209.00	209.00	209.00	Unknown Tumor Status	8500/3	Pancreatic endocrine tumor, malignant	Unknown	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
e741fc42-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2534		ff2c37c7-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Alive	-26621	 	1935	 	 	 	 	 	 	 	 	26621	Not Reported	907.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e75de5e1-5746-404a-adfe-52d1402f0e08	C3N-01379		5e3e4798-2b80-11ec-b712-0a4e2186f121	 	Disqualified	Other	Not Reported			Not Reported	Female	White	Dead	-23775	971	1951	2019	 	 	 	 	 	 	 	23775	Not Reported	971.00	971.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e799c252-9519-42d5-9ce8-dda625bfa323	NX023		85fdbb36-79f7-47bc-a6eb-6352573a11f1	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e7bc21c5-8d21-445c-b150-7927d213ea32	AP-4M7L		9016bb7b-1d3b-43c3-b017-904368cc1cbb	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	28488	 	1638.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N0	Stage IIA	T2b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e7c0a24c-0ec8-4e07-9517-b0449b5cb08c	C3N-01083		6e00d6a6-5bec-4705-962e-ed5b5323732c	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent		Not Reported	Female	White	Not Reported	 	 	1962	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e7ee4f4f-418f-4f96-aed6-0856d94f02f2	C3L-00189		59da3ce4-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-24958	1036	1948	2019	 	 	 	 	 	 	 	24958	Not Reported	1036.00	1036.00	424.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T3	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R1	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e81fdd02-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A18N		ff318c05-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-32404	1148	1913	2004	 	 	 	 	 	 	 	32404	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1b	Stage IIA	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e879fba9-0a5b-44fd-a26e-4ceb51f97ceb	JX0108		a408ff6c-8426-422a-92ff-36540153ccc4	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e88917ea-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2537		ff2b7248-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-14595	 	1969	 	 	 	 	 	 	 	 	14595	Not Reported	788.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e8d51d01-693a-11ea-b1fd-0aad30af8a83	1		e8dc0dca-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d51ec9-693a-11ea-b1fd-0aad30af8a83	2		e8dc0ff5-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d51fb3-693a-11ea-b1fd-0aad30af8a83	3		e8dc1114-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d52234-693a-11ea-b1fd-0aad30af8a83	4		e8dc48a3-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d55d7f-693a-11ea-b1fd-0aad30af8a83	5		e8dc4a96-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d55f58-693a-11ea-b1fd-0aad30af8a83	6		e8dc4c66-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5605f-693a-11ea-b1fd-0aad30af8a83	7		e8dc4d7d-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56253-693a-11ea-b1fd-0aad30af8a83	8		e8dc4f48-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56345-693a-11ea-b1fd-0aad30af8a83	9		e8dc5086-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56429-693a-11ea-b1fd-0aad30af8a83	10		e8dc52b0-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d565f6-693a-11ea-b1fd-0aad30af8a83	11		e8dc8aec-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d566e0-693a-11ea-b1fd-0aad30af8a83	12		e8dc8cd2-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d567bd-693a-11ea-b1fd-0aad30af8a83	13		e8dc8ec1-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5698f-693a-11ea-b1fd-0aad30af8a83	14		e8dc905d-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56a7d-693a-11ea-b1fd-0aad30af8a83	15		e8dc9213-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56b56-693a-11ea-b1fd-0aad30af8a83	16		e8dc9438-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56d36-693a-11ea-b1fd-0aad30af8a83	17		e8dc95fb-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56e95-693a-11ea-b1fd-0aad30af8a83	18		e8dcc901-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d56feb-693a-11ea-b1fd-0aad30af8a83	19		e8dccb3c-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d571e2-693a-11ea-b1fd-0aad30af8a83	20		e8dccd93-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d572cc-693a-11ea-b1fd-0aad30af8a83	21		e8dccef9-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d573ad-693a-11ea-b1fd-0aad30af8a83	22		e8dcd0c8-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d575af-693a-11ea-b1fd-0aad30af8a83	23		e8dcd1fb-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d57696-693a-11ea-b1fd-0aad30af8a83	24		e8dcd3c6-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d578a1-693a-11ea-b1fd-0aad30af8a83	25		e8dd0587-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5798b-693a-11ea-b1fd-0aad30af8a83	26		e8dd0777-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d57c15-693a-11ea-b1fd-0aad30af8a83	27		e8dd095e-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d57cfb-693a-11ea-b1fd-0aad30af8a83	28		e8dd0ac7-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d57f0d-693a-11ea-b1fd-0aad30af8a83	29		e8dd0c94-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d58072-693a-11ea-b1fd-0aad30af8a83	30		e8dd0dc3-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d582aa-693a-11ea-b1fd-0aad30af8a83	31		e8dd0f87-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d58460-693a-11ea-b1fd-0aad30af8a83	32		e8dd4554-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5d358-693a-11ea-b1fd-0aad30af8a83	33		e8dd475b-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, intestinal type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5d5bc-693a-11ea-b1fd-0aad30af8a83	34		e8dd4953-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5d6ea-693a-11ea-b1fd-0aad30af8a83	35		e8dd4a8c-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5d8e5-693a-11ea-b1fd-0aad30af8a83	36		e8dd4c4f-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5d9dc-693a-11ea-b1fd-0aad30af8a83	37		e8dd4d7e-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5db73-693a-11ea-b1fd-0aad30af8a83	38		e8dd4f4f-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5dd83-693a-11ea-b1fd-0aad30af8a83	39		e8dd86de-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5de83-693a-11ea-b1fd-0aad30af8a83	40		e8dd88d0-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5df6b-693a-11ea-b1fd-0aad30af8a83	41		e8dd8abe-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e145-693a-11ea-b1fd-0aad30af8a83	42		e8dd8bf4-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e233-693a-11ea-b1fd-0aad30af8a83	43		e8dd8dc2-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e352-693a-11ea-b1fd-0aad30af8a83	44		e8dd8ef4-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e53f-693a-11ea-b1fd-0aad30af8a83	45		e8dd90c3-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e62c-693a-11ea-b1fd-0aad30af8a83	46		e8ddbc93-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e707-693a-11ea-b1fd-0aad30af8a83	47		e8ddbe7c-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e8f8-693a-11ea-b1fd-0aad30af8a83	48		e8ddc071-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5e9de-693a-11ea-b1fd-0aad30af8a83	49		e8ddc1a1-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5eab5-693a-11ea-b1fd-0aad30af8a83	50		e8ddc367-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5ecd7-693a-11ea-b1fd-0aad30af8a83	51		e8ddc497-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5edcb-693a-11ea-b1fd-0aad30af8a83	52		e8ddc66d-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5efda-693a-11ea-b1fd-0aad30af8a83	53		e8de0579-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5f0cc-693a-11ea-b1fd-0aad30af8a83	54		e8de0774-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, intestinal type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5f2f1-693a-11ea-b1fd-0aad30af8a83	55		e8de0964-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5f3d8-693a-11ea-b1fd-0aad30af8a83	56		e8de0a9e-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Carcinoma, undifferentiated, NOS	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5f604-693a-11ea-b1fd-0aad30af8a83	57		e8de0c61-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5f6f3-693a-11ea-b1fd-0aad30af8a83	58		e8de0d8e-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5fa33-693a-11ea-b1fd-0aad30af8a83	59		e8de0f87-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Carcinoma, undifferentiated, NOS	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d5fba5-693a-11ea-b1fd-0aad30af8a83	60		e8de5149-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d62e91-693a-11ea-b1fd-0aad30af8a83	61		e8de5361-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, intestinal type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d631ab-693a-11ea-b1fd-0aad30af8a83	62		e8de556d-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d632ed-693a-11ea-b1fd-0aad30af8a83	63		e8de57e6-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d6351c-693a-11ea-b1fd-0aad30af8a83	64		e8de5a0a-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d6361d-693a-11ea-b1fd-0aad30af8a83	65		e8de5b46-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d63703-693a-11ea-b1fd-0aad30af8a83	66		e8de5d15-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d638c3-693a-11ea-b1fd-0aad30af8a83	67		e8df7e2a-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d639ac-693a-11ea-b1fd-0aad30af8a83	68		e8df8066-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d63a87-693a-11ea-b1fd-0aad30af8a83	69		e8df858f-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d63c4d-693a-11ea-b1fd-0aad30af8a83	70		e8df876e-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d63d36-693a-11ea-b1fd-0aad30af8a83	71		e8df894d-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d63e0e-693a-11ea-b1fd-0aad30af8a83	72		e8df8a84-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d64095-693a-11ea-b1fd-0aad30af8a83	73		e8df8c59-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d641ae-693a-11ea-b1fd-0aad30af8a83	74		e8e1dedb-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d6429c-693a-11ea-b1fd-0aad30af8a83	75		e8e1e2a7-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d64485-693a-11ea-b1fd-0aad30af8a83	76		e8e1e4d2-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d64572-693a-11ea-b1fd-0aad30af8a83	77		e8e1e6c0-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d64650-693a-11ea-b1fd-0aad30af8a83	78		e8e1e9a7-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d6484a-693a-11ea-b1fd-0aad30af8a83	79		e8e1ec10-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8d64935-693a-11ea-b1fd-0aad30af8a83	80		e8e1ee80-693a-11ea-b1fd-0aad30af8a83	 	Qualified	Early Onset Gastric Cancer	Stomach			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Adenocarcinoma, diffuse type	Not Reported	Stomach, NOS	Stomach, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Pathologic Review	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Human Early-Onset Gastric Cancer - Korea University	International Cancer Proteogenome Consortium
e8e42739-58ce-4e65-afe2-1d6e948ae103	C3N-02063		22889c3f-d153-4735-b204-b32dd36e5fb3	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Male	Other	Alive	-18159	 	1967	 	 	 	 	 	 	 	 	18159	 	13.00	13.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e90c7ab7-4382-434f-b13e-44bf0966d21a	97		50962e63-af7b-4460-88c5-7ed4a48afa76	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	53	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e93b3594-bcce-4234-b748-2ee7e555ddff	AP-LWHD		80b96f71-97d3-448e-aa08-92f88b3deba1	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	26297	 	4.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Middle lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
e959b0d7-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A18Q		ff2fe44f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-20675	1692	1945	2005	 	 	 	 	 	 	 	20675	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Overlapping lesion of breast	Overlapping lesion of breast	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1b	Stage IIB	T2		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e99a4313-ae34-4cc9-925e-6f5250833e93	2510		69208fff-b348-4fe6-a3e6-0181e986d5a1	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	59	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
e9ac28c9-1fb8-11e9-b7f8-0a80fada099c	C3L-00817		4f704df1-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Reported	Male	White	Alive	-29511	 	1936	 	 	 	 	 	 	 	 	29511	Not Reported	1365.00	1365.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-29511\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e9c69663-652f-428e-8f4c-d0e4545a0fdd	C3N-02274		ad4ac203-f013-4530-b88b-13ffac684fae	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-29493	1102	1936	2020	 	 	 	 	 	 	 	29493	 	971.00	1102.00	 	Unknown tumor status	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e9cb13b8-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2542		ff2dcc08-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Asian	Alive	-21902	 	1949	 	 	 	 	 	 	 	 	21902	Not Reported	657.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
e9e9baad-0996-4fee-91f3-3d10de0ac5ab	C3N-02436		220b2d29-5081-44de-ae54-bec221694eee	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-33	Not Hispanic or Latino	Female	White	Alive	-18937	 	1965	 	 	 	 	 	 	 	 	18937	 	1732.00	1732.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e9f88e5c-8015-4c3d-ada9-6001e0fba4a0	QC3		60c43ade-2b80-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
e9f9f658-9dc7-46a2-afc3-b90f10721909	PDAC116		db6401d4-2caf-411d-ad5c-c641121c9d4e	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	25915	 	359.00	359.00	122.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
ea711b96-7083-4514-93ce-701a345052a3	C3N-03415		edfd106f-bde9-4f39-9bdd-98e9ad79b101	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Dead	-31332	1047	1932	2020	 	 	 	 	 	 	 	31332	 	870.00	1047.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ea7c9fbd-8353-4f3c-9fea-2fba79140536	OSCC_56		e8adcdcd-36d4-444e-9c83-d9fe640dd5b4	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Cheek mucosa	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
ea9581b7-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A18R		ff2b53af-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-18524	1142	1951	2004	 	 	 	 	 	 	 	18524	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIA	T2b		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
eb1039c3-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2543		ff2b8595-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Dead	-31211	68	1923	2008	 	 	 	 	 	 	 	31211	Not Reported	68.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
eb3dc37a-1fb8-11e9-b7f8-0a80fada099c	C3L-00902		4f76c1ea-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-25512	 	1947	 	 	 	 	 	 	 	 	25512	Not Reported	1791.00	1791.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-25512\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ebab18a1-9760-4e31-8255-23082ad5c097	C3N-01388		5e5eb3de-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-19447	811	1963	2019	 	 	 	 	 	 	 	19447	Not Reported	1056.00	811.00	676.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage III	T2	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	23	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ebc4f8fa-4364-4057-9671-8f146f02ac67	AP-AGZG		5f029278-247d-48a2-ad00-61afbeb100bf	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	25932	 	1753.00	 	 	Not Reported	8250/3	Lepidic adenocarcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ebd22406-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A18U		ff2bcb21-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-26426	1563	1931	2007	 	 	 	 	 	 	 	26426	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Upper-outer quadrant of breast	Upper-outer quadrant of breast	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2a	Stage IIIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2003	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ebe993cd-c210-459b-85c6-30c03fcca5f0	C3N-03439		5fdf8b35-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-20776	458	1961	2019	 	 	 	 	 	 	 	20776	Not Reported	458.00	458.00	204.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ec338fe9-3c52-4b17-b5b6-259c4d63ff46	MB266		408543db-7afb-412e-88c9-35aa5884eb96	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	438	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
ec5cacb8-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2544		ff2bc9fa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-21384	 	1950	 	 	 	 	 	 	 	 	21384	Not Reported	638.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Specified parts of peritoneum	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ec955c22-1189-11e9-afb9-0a9c39d33490	C3L-00161		0466b063-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Hispanic or Latino	Female	White	Alive	-16864	 	1970	 	 	 	 	 	 	 	 	16864	Not Reported	1775.00	1775.00	1369.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Endometrium	G2	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	RX	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
eca2961a-e130-48aa-9707-7ef3d7cc3230	AP-XCJX		b01b3029-9ed9-44f4-846c-45113916e40e	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	29219	 	634.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IIA	 	 	 	 	 	 	 	M0	N1	Stage IIA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ecbde1d1-d1d9-4de5-913d-090a0571edd9	15-00276		4a790e6b-2111-4bd3-b079-5b06b06ca609	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Dead	-22149	870	 	 	60	 	 	false	Medical Record	 	United States	22149	 	870.00	870.00	769.00	With tumor	Not Reported	Acute myeloid leukemia with mutated NPM1	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ecd1a90e-1fb8-11e9-b7f8-0a80fada099c	C3L-00907		4f7d8034-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	4	Not Hispanic or Latino	Male	White	Alive	-20369	 	1961	 	 	 	 	 	 	 	 	20369	 	1791.00	1791.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-20369\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ecec76a4-c717-4db8-b55d-599bac282d9f	CU-43		d8e7aded-1d1d-42e6-8780-bbeb5a897d9b	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	78	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ed0e994d-63d8-11e8-bcf1-0a2705229b82	TCGA-BH-A18V		ff303627-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Dead	-17682	1556	1953	2005	 	 	 	 	 	 	 	17682	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Upper-outer quadrant of breast	Upper-outer quadrant of breast	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1b	Stage IIB	T2	5th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ed8b6ab4-a0b4-4341-88f5-375d0e221a59	HCI009		0784868d-bbd5-44c2-b112-dd86a61f895c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ed932161-7b37-4bc4-aa09-b8adeb044f17	C3L-01053		5ab00df6-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-27798	191	1941	2017	 	 	 	 	 	 	 	27798	Not Reported	20.00	191.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
eda3394b-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2545		ff2e21c1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-15444	 	1966	 	 	 	 	 	 	 	 	15444	Not Reported	557.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIA	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
edb6bf02-d2e5-4f38-9da6-d93bbcec9c92	CU-37		7ad417bd-cfb4-4e75-807b-10bc554f1052	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
eddbeb2f-7472-4a03-8c72-a8ea47349071	AP-N8FG		1a7e7175-3239-493f-b65f-135f122655a3	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	25566	 	60.00	 	 	Not Reported	8260/3	Papillary adenocarcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G2	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1b	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
edde06b2-4a6b-4e5b-9be1-33d6efe922bc	C3N-03061		5f5c5f6e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	-22974	139	1955	2018	 	 	 	 	 	 	 	22974	Not Reported	120.00	139.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ee23abd7-b967-4831-bca5-0e6b53396a78	AP-HKYN		a005b4c0-6f86-4aa6-91ee-8268b0959685	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Male	White	 	 	 	 	 	 	 	 	 	 	 	 	26297	 	1759.00	 	 	Not Reported	8550/3	Acinar cell carcinoma	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ee36f076-932f-42c7-9481-aafdbb3e61da	JX0030		7c4824dc-5e3d-4983-8fdb-1ca765273e94	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ee487139-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12L		ff2fcf87-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-24710	 	1943	 	 	 	 	 	 	 	 	24710	Not Reported	363.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0 (i-)	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ee6b0cb5-1fb8-11e9-b7f8-0a80fada099c	C3L-00908		4f84b909-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	10	Not Hispanic or Latino	Female	White	Alive	-22179	 	1956	 	 	 	 	 	 	 	 	22179	 	1785.00	1785.00	 	With tumor	8312/3	Renal cell carcinoma, NOS	Yes	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-22179\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
eea05bd3-0759-4685-b6db-2354c1475184	PDAC154		6926b41f-dcc6-4319-b7d5-341b86654b80	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	18615	 	975.00	975.00	442.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
eedf8a3d-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2547		ff2e9639-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-23706	 	1944	 	 	 	 	 	 	 	 	23706	Not Reported	624.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ef64289b-f333-49f6-a05b-043ed6455e10	C3N-02971		5f0f3348-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Female	White	Dead	-28635	70	1939	2018	 	 	 	 	 	 	 	28635	Not Reported	70.00	70.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	No	Tail of pancreas	Tail of pancreas	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ef6488d1-fbef-4022-ac95-d65b8d4090ea	AP-RBLG		f9794de3-daf1-43ef-ba7a-6d731e2109e6	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	21549	 	984.00	 	 	Not Reported	8230/3	Solid carcinoma, NOS	Yes	Upper lobe, lung	Lung, NOS	G3	Stage IA	 	 	 	 	 	 	 	M0	N0	Stage IA	T1a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
ef6c1f02-9077-45aa-a09c-90ede66e6fb3	PDAC044		664fc379-31ea-4dd8-9af4-8ddffb2dfa1f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	278.00	278.00	184.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
ef7219fa-63d6-11e8-bcf1-0a2705229b82	17OV027		ff30e06e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	Not Reported/Unknown	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ef85a16e-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12P		ff30d5fa-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-20332	 	1955	 	 	 	 	 	 	 	 	20332	Not Reported	358.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
efd77164-77f5-4871-b0fa-025e390d5a58	PDAC097		14e6e22e-5342-4b95-aa9f-0ea7174452d0	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	24455	 	622.00	622.00	622.00	Tumor Free	8035/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
effb1654-1fb8-11e9-b7f8-0a80fada099c	C3L-00910		4f901ee0-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Not Hispanic or Latino	Female	White	Alive	-27654	 	1941	 	 	 	 	 	 	 	 	27654	Not Reported	1797.00	1797.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-27654\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f01b8281-63d7-11e8-bcf1-0a2705229b82	TCGA-36-2549		ff2c1d52-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	Alive	-20076	 	1954	 	 	 	 	 	 	 	 	20076	Not Reported	184.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f01cf81b-5a50-479e-91d9-efe329f5f0a7	NTN067		725ce3b7-694d-4d94-87ff-85d55302fab8	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f024723c-8b33-4505-841a-a6ff9ea4cada	MB088		b82a5fbd-b336-4196-895a-bd2fcec6ea79	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	730	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M0	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
f0cb13ee-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12Q		ff2fe833-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Dead	-28733	385	1932	 	 	 	 	 	 	 	 	28733	Not Reported	2.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T1		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f0da0133-d922-487c-a7f5-f962aa6d6123	2313		2f31e474-9b1c-41e3-a8b4-8d5eb7cf1144	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	60	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f158835b-63d7-11e8-bcf1-0a2705229b82	TCGA-42-2588		ff2c8592-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-22377	880	1948	 	 	 	 	 	 	 	 	22377	Not Reported	287.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f1909c4f-1fb8-11e9-b7f8-0a80fada099c	C3L-00917		4f997936-2c37-11ec-b712-0a4e2186f121	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney			Hispanic or Latino	Male	White	Alive	-13840	 	1978	 	 	 	 	 	 	 	 	13840	Not Reported	1783.00	1783.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	not reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":\"Not Reported\",\"vital_status\":\"Alive\",\"days_to_death\":\"0\",\"days_to_birth\":\"-13840\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1b49b2f-6b64-47e0-b993-8cde8a7c5c14	NTN054		cc76fd38-4215-4bb5-8055-70fc7d18c80c	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f1ed884e-cf1e-11e9-9a07-0a80fada099c	11LU013		2888fe8a-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Not Reported	-21627	 	1956	 	 	 	 	 	 	 	 	21627	 	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Lung, NOS	GX	Not Reported	 	 	 	M0	 	 	 	Unknown	N1	Stage IIIA	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2015	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21627\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9457-cf1e-11e9-9a07-0a80fada099c	11LU016		28907377-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-22733	445	1953	2016	 	 	 	 	 	 	 	22733	 	445.00	445.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	GX	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T1b	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2015	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"445\",\"days_to_birth\":\"-22733\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed961a-cf1e-11e9-9a07-0a80fada099c	11LU022		2897e2b8-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-19370	 	1962	 	 	 	 	 	 	 	 	19370	 	7.00	7.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	GX	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2015	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19370\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9765-cf1e-11e9-9a07-0a80fada099c	11LU035		289ecce9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21677	 	1956	 	 	 	 	 	 	 	 	21677	 	7.00	7.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	GX	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2015	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21677\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed989e-cf1e-11e9-9a07-0a80fada099c	C3L-00001		28a532df-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-22455	 	1954	 	 	 	 	 	 	 	 	22455	Primary	1837.00	1837.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22455\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed99fb-cf1e-11e9-9a07-0a80fada099c	C3L-00009		28abfb62-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-27968	577	1939	2017	 	 	 	 	 	 	 	27968	 	545.00	577.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	M0	N0	Stage IA	T1a	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"577\",\"days_to_birth\":\"-27968\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9b2e-cf1e-11e9-9a07-0a80fada099c	C3L-00080		28b272ff-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-21194	 	1958	 	 	 	 	 	 	 	 	21194	 	1805.00	1805.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21194\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9c5a-cf1e-11e9-9a07-0a80fada099c	C3L-00083		28b954be-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-26127	 	1944	 	 	 	 	 	 	 	 	26127	 	1790.00	1790.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26127\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9d81-cf1e-11e9-9a07-0a80fada099c	C3L-00093		28bfabe1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Dead	-24301	1703	1949	2021	 	 	 	 	 	 	 	24301	 	1698.00	1703.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24301\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9eb2-cf1e-11e9-9a07-0a80fada099c	C3L-00094		28c67971-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-25560	889	1946	2018	 	 	 	 	 	 	 	25560	 	889.00	889.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Middle lobe, lung	Middle lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25560\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ed9fdb-cf1e-11e9-9a07-0a80fada099c	C3L-00095		28cd1954-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-22863	 	1953	 	 	 	 	 	 	 	 	22863	 	1794.00	1794.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22863\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda113-cf1e-11e9-9a07-0a80fada099c	C3L-00140		28d42980-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25869	 	1945	 	 	 	 	 	 	 	 	25869	 	1802.00	1802.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G1	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25869\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda242-cf1e-11e9-9a07-0a80fada099c	C3L-00144		28db9d73-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-21487	 	1957	 	 	 	 	 	 	 	 	21487	 	578.00	578.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21487\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda37f-cf1e-11e9-9a07-0a80fada099c	C3L-00263		28e25b8b-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-29164	 	1936	 	 	 	 	 	 	 	 	29164	 	1157.00	1157.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29164\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda4a7-cf1e-11e9-9a07-0a80fada099c	C3L-00279		28e8f221-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	White	Alive	-26600	 	1943	 	 	 	 	 	 	 	 	26600	 	606.00	606.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage I	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26600\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda5d6-cf1e-11e9-9a07-0a80fada099c	C3L-00368		28efa017-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-24636	 	1949	 	 	 	 	 	 	 	 	24636	 	141.00	141.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G1	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24636\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda701-cf1e-11e9-9a07-0a80fada099c	C3L-00412		28f6a056-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	American Indian or Alaska Native	Dead	-23597	162	1952	2017	 	 	 	 	 	 	 	23597	 	162.00	162.00	72.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N2	Stage III	T3	7th	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	11	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"162\",\"days_to_birth\":\"-23597\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda832-cf1e-11e9-9a07-0a80fada099c	C3L-00422		28fdbd06-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Hispanic or Latino	Female	Unknown	Alive	-12844	 	1981	 	 	 	 	 	 	 	 	12844	 	1916.00	1916.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-12844\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eda95d-cf1e-11e9-9a07-0a80fada099c	C3L-00510		29046488-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Unknown	Alive	-29337	 	1936	 	 	 	 	 	 	 	 	29337	 	38.00	38.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G1	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R2	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29337\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edaa88-cf1e-11e9-9a07-0a80fada099c	C3L-00604		290f27a4-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-22335	 	1955	 	 	 	 	 	 	 	 	22335	 	1801.00	1801.00	332.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	7	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22335\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edac24-cf1e-11e9-9a07-0a80fada099c	C3L-00893		291e685f-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Hispanic or Latino	Male	Unknown	Alive	-26209	 	1945	 	 	 	 	 	 	 	 	26209	 	23.00	23.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G1	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26209\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edadb4-cf1e-11e9-9a07-0a80fada099c	C3L-00913		292db00a-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-24378	73	1950	2017	 	 	 	 	 	 	 	24378	 	73.00	73.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"73\",\"days_to_birth\":\"-24378\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edaee5-cf1e-11e9-9a07-0a80fada099c	C3L-00973		293cef57-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-27798	 	1941	 	 	 	 	 	 	 	 	27798	 	1435.00	1435.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27798\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb013-cf1e-11e9-9a07-0a80fada099c	C3L-01330		294385b9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-25076	 	1948	 	 	 	 	 	 	 	 	25076	 	1595.00	1595.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25076\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb141-cf1e-11e9-9a07-0a80fada099c	C3L-01632		294a4159-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Dead	-22145	717	1956	2019	 	 	 	 	 	 	 	22145	 	717.00	717.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22145\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb38f-cf1e-11e9-9a07-0a80fada099c	C3L-01682		295226f6-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-28669	 	1938	 	 	 	 	 	 	 	 	28669	 	1799.00	1799.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28669\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb50d-cf1e-11e9-9a07-0a80fada099c	C3L-01683		295b6fe1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-28432	1046	1939	2020	 	 	 	 	 	 	 	28432	 	1046.00	1046.00	876.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	Infection	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28432\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb635-cf1e-11e9-9a07-0a80fada099c	C3L-01862		296207f6-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-29843	594	1935	2018	 	 	 	 	 	 	 	29843	 	581.00	594.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"594\",\"days_to_birth\":\"-29843\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb75d-cf1e-11e9-9a07-0a80fada099c	C3L-01889		29709a50-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-26205	 	1945	 	 	 	 	 	 	 	 	26205	 	1799.00	1799.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26205\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb882-cf1e-11e9-9a07-0a80fada099c	C3L-01890		297a77c6-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-21246	 	1959	 	 	 	 	 	 	 	 	21246	 	671.00	671.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G1	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21246\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edb9a5-cf1e-11e9-9a07-0a80fada099c	C3L-01924		2989388b-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-25001	 	1949	 	 	 	 	 	 	 	 	25001	 	1133.00	1133.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	M0	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25001\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edbacb-cf1e-11e9-9a07-0a80fada099c	C3L-02219		29990919-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-28347	931	1939	2019	 	 	 	 	 	 	 	28347	 	931.00	931.00	217.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28347\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edbbf2-cf1e-11e9-9a07-0a80fada099c	C3L-02345		29a7bec6-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-22572	 	1955	 	 	 	 	 	 	 	 	22572	 	1796.00	1796.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M1	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22572\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edbde6-cf1e-11e9-9a07-0a80fada099c	C3L-02348		29b6fbe9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Alive	-21302	 	1959	 	 	 	 	 	 	 	 	21302	 	1791.00	1791.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	M0	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21302\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edbfe5-cf1e-11e9-9a07-0a80fada099c	C3L-02350		29c63dbe-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-25374	 	1947	 	 	 	 	 	 	 	 	25374	 	1950.00	1950.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25374\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edc1bc-cf1e-11e9-9a07-0a80fada099c	C3L-02365		29d57ff7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Dead	-22934	627	1954	2019	 	 	 	 	 	 	 	22934	 	625.00	627.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T2b	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22934\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edcba2-cf1e-11e9-9a07-0a80fada099c	C3L-02508		29e4c0f1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Hispanic or Latino	Male	White	Alive	-23855	 	1952	 	 	 	 	 	 	 	 	23855	 	1013.00	1013.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23855\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edcd99-cf1e-11e9-9a07-0a80fada099c	C3L-02549		29f40e85-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Dead	-25447	447	1947	2018	 	 	 	 	 	 	 	25447	 	447.00	447.00	216.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G1	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"447\",\"days_to_birth\":\"-25447\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edcf73-cf1e-11e9-9a07-0a80fada099c	C3N-00167		2a0355d9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23543	 	1952	 	 	 	 	 	 	 	 	23543	 	842.00	842.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23543\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edd1df-cf1e-11e9-9a07-0a80fada099c	C3N-00169		2a129dba-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21005	 	1959	 	 	 	 	 	 	 	 	21005	 	376.00	376.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21005\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edd3ac-cf1e-11e9-9a07-0a80fada099c	C3N-00175		2a21d4ca-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-26470	308	1944	2017	 	 	 	 	 	 	 	26470	 	308.00	308.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"308\",\"days_to_birth\":\"-26470\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edd776-cf1e-11e9-9a07-0a80fada099c	C3N-00180		2a31179a-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-20625	355	1960	2017	 	 	 	 	 	 	 	20625	 	355.00	355.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N1	Stage IIIA	T3	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"355\",\"days_to_birth\":\"-20625\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edd951-cf1e-11e9-9a07-0a80fada099c	C3N-00199		2a40696b-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-24010	 	1950	 	 	 	 	 	 	 	 	24010	 	1721.00	1721.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24010\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eddb3c-cf1e-11e9-9a07-0a80fada099c	C3N-00203		2a4733f7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Other	Not Reported	-26353	 	1944	 	 	 	 	 	 	 	 	26353	 	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26353\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1eddd2a-cf1e-11e9-9a07-0a80fada099c	C3N-00217		2a5edbeb-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Other	Alive	-21854	 	1957	 	 	 	 	 	 	 	 	21854	 	668.00	668.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21854\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ededdc-cf1e-11e9-9a07-0a80fada099c	C3N-00223		2a6e51a7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	Asian	Alive	-25368	 	1947	 	 	 	 	 	 	 	 	25368	 	49.00	49.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	N0	Stage I	T2a	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25368\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edf269-cf1e-11e9-9a07-0a80fada099c	C3N-00293		2a7d6180-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-26774	 	1943	 	 	 	 	 	 	 	 	26774	 	1832.00	1832.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	GX	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26774\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edf49c-cf1e-11e9-9a07-0a80fada099c	C3N-00294		2a8ca147-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	White	Alive	-21155	 	1958	 	 	 	 	 	 	 	 	21155	 	1848.00	1848.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	GX	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage IIB	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21155\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edf6fb-cf1e-11e9-9a07-0a80fada099c	C3N-00433		2a932cb7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-21129	 	1958	 	 	 	 	 	 	 	 	21129	 	60.00	60.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21129\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edf936-cf1e-11e9-9a07-0a80fada099c	C3N-00545		2a9be13f-27a4-11ec-b712-0a4e2186f121	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21607	 	1957	 	 	 	 	 	 	 	 	21607	 	650.00	650.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21607\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edfb6c-cf1e-11e9-9a07-0a80fada099c	C3N-00546		2aa32b8c-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21464	 	1958	 	 	 	 	 	 	 	 	21464	 	382.00	382.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21464\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edfd98-cf1e-11e9-9a07-0a80fada099c	C3N-00547		2aab2316-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22202	 	1956	 	 	 	 	 	 	 	 	22202	 	474.00	474.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIA	T2b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22202\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1edffb2-cf1e-11e9-9a07-0a80fada099c	C3N-00549		2ab168fc-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21402	 	1958	 	 	 	 	 	 	 	 	21402	 	791.00	791.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21402\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee01d7-cf1e-11e9-9a07-0a80fada099c	C3N-00550		2aba5d09-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-19107	 	1964	 	 	 	 	 	 	 	 	19107	 	401.00	401.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N1	Stage IIB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19107\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0373-cf1e-11e9-9a07-0a80fada099c	C3N-00551		2ac101ed-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-19986	 	1962	 	 	 	 	 	 	 	 	19986	 	391.00	391.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19986\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee049b-cf1e-11e9-9a07-0a80fada099c	C3N-00552		2ac780e9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-18163	 	1967	 	 	 	 	 	 	 	 	18163	 	396.00	396.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18163\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee05e4-cf1e-11e9-9a07-0a80fada099c	C3N-00556		2acf6ea2-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-25462	 	1947	 	 	 	 	 	 	 	 	25462	 	394.00	394.00	341.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25462\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee070d-cf1e-11e9-9a07-0a80fada099c	C3N-00559		2ad63981-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-20344	 	1961	 	 	 	 	 	 	 	 	20344	 	398.00	398.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20344\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0832-cf1e-11e9-9a07-0a80fada099c	C3N-00560		2add073d-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20372	 	1961	 	 	 	 	 	 	 	 	20372	 	378.00	378.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	2	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20372\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0957-cf1e-11e9-9a07-0a80fada099c	C3N-00572		2ae49092-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-17745	 	1968	 	 	 	 	 	 	 	 	17745	 	431.00	431.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17745\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0a7e-cf1e-11e9-9a07-0a80fada099c	C3N-00574		2aeaf994-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-14867	 	1976	 	 	 	 	 	 	 	 	14867	 	397.00	397.00	199.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-14867\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0bb0-cf1e-11e9-9a07-0a80fada099c	C3N-00578		2af1765d-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-17824	24	1968	2016	 	 	 	 	 	 	 	17824	 	24.00	24.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	5	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"24\",\"days_to_birth\":\"-17824\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0cd9-cf1e-11e9-9a07-0a80fada099c	C3N-00579		2af83fd3-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-24755	 	1949	 	 	 	 	 	 	 	 	24755	 	477.00	477.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24755\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee0f62-cf1e-11e9-9a07-0a80fada099c	C3N-00580		2aff1deb-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20730	 	1960	 	 	 	 	 	 	 	 	20730	 	386.00	386.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20730\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1093-cf1e-11e9-9a07-0a80fada099c	C3N-00704		2b06c6c9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	White	Not Reported	-24887	 	1948	 	 	 	 	 	 	 	 	24887	 	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	M0	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24887\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee11c0-cf1e-11e9-9a07-0a80fada099c	C3N-00737		2b15f8b5-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-26067	 	1945	 	 	 	 	 	 	 	 	26067	 	384.00	384.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26067\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee12e4-cf1e-11e9-9a07-0a80fada099c	C3N-00738		2b25404d-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Female	Black or African American	Not Reported	-25891	 	1945	 	 	 	 	 	 	 	 	25891	 	 	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G1	Not Reported	 	 	 	Unknown	 	 	 	M0	N0	Stage IA	T1b	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25891\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee140a-cf1e-11e9-9a07-0a80fada099c	C3N-00959		2b347eb5-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-24361	 	1950	 	 	 	 	 	 	 	 	24361	 	1758.00	1758.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	RX	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24361\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee154d-cf1e-11e9-9a07-0a80fada099c	C3N-01016		2b43b8e1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20787	 	1960	 	 	 	 	 	 	 	 	20787	 	428.00	428.00	306.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20787\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee167b-cf1e-11e9-9a07-0a80fada099c	C3N-01021		2b52fb30-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-16139	 	1973	 	 	 	 	 	 	 	 	16139	 	434.00	434.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	10	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16139\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee179a-cf1e-11e9-9a07-0a80fada099c	C3N-01023		2b625ddd-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21265	 	1959	 	 	 	 	 	 	 	 	21265	 	422.00	422.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21265\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee18d4-cf1e-11e9-9a07-0a80fada099c	C3N-01024		2b7183ff-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-24110	 	1950	 	 	 	 	 	 	 	 	24110	 	419.00	419.00	413.00	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	M0	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24110\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1a01-cf1e-11e9-9a07-0a80fada099c	C3N-01030		2b77f6bf-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20772	 	1960	 	 	 	 	 	 	 	 	20772	 	443.00	443.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20772\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1bf7-cf1e-11e9-9a07-0a80fada099c	C3N-01071		2b80d72e-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-17831	 	1968	 	 	 	 	 	 	 	 	17831	 	44.00	44.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-17831\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1da6-cf1e-11e9-9a07-0a80fada099c	C3N-01072		2b90110a-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-22957	 	1954	 	 	 	 	 	 	 	 	22957	 	449.00	449.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22957\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1ecb-cf1e-11e9-9a07-0a80fada099c	C3N-01074		2b9f5043-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-20803	229	1960	2017	 	 	 	 	 	 	 	20803	 	229.00	229.00	 	Unknown tumor status	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"229\",\"days_to_birth\":\"-20803\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee1feb-cf1e-11e9-9a07-0a80fada099c	C3N-01405		2bae90e1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21609	 	1958	 	 	 	 	 	 	 	 	21609	 	418.00	418.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	Not Reported	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21609\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2117-cf1e-11e9-9a07-0a80fada099c	C3N-01410		2bcd2acd-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23442	 	1953	 	 	 	 	 	 	 	 	23442	 	436.00	436.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23442\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee223b-cf1e-11e9-9a07-0a80fada099c	C3N-01413		2bdc6bc8-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-22704	 	1955	 	 	 	 	 	 	 	 	22704	 	444.00	444.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-22704\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2374-cf1e-11e9-9a07-0a80fada099c	C3N-01414		2beb97c1-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21232	 	1958	 	 	 	 	 	 	 	 	21232	 	820.00	820.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21232\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee249b-cf1e-11e9-9a07-0a80fada099c	C3N-01415		2bfad6f7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-26008	 	1945	 	 	 	 	 	 	 	 	26008	 	792.00	792.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-26008\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee25c3-cf1e-11e9-9a07-0a80fada099c	C3N-01416		2c0a16fb-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-24540	 	1950	 	 	 	 	 	 	 	 	24540	 	434.00	434.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24540\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee26e0-cf1e-11e9-9a07-0a80fada099c	C3N-01488		2c195ece-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-19817	 	1963	 	 	 	 	 	 	 	 	19817	 	409.00	409.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19817\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee27ff-cf1e-11e9-9a07-0a80fada099c	C3N-01489		2c28a042-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23810	 	1952	 	 	 	 	 	 	 	 	23810	 	434.00	434.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23810\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2921-cf1e-11e9-9a07-0a80fada099c	C3N-01799		2c2f1342-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Hispanic or Latino	Male	White	Alive	-29707	 	1935	 	 	 	 	 	 	 	 	29707	 	1545.00	1545.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	Unknown	 	 	 	M0	N1	Stage IIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29707\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2bd6-cf1e-11e9-9a07-0a80fada099c	C3N-01823		2c37d78f-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Other	Dead	-23322	351	1953	2018	 	 	 	 	 	 	 	23322	 	351.00	351.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	17	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"351\",\"days_to_birth\":\"-23322\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2d3e-cf1e-11e9-9a07-0a80fada099c	C3N-01842		2c3ef06f-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Other	Alive	-25527	 	1947	 	 	 	 	 	 	 	 	25527	 	681.00	681.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IA	T1a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25527\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2e74-cf1e-11e9-9a07-0a80fada099c	C3N-02000		2c471bac-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-16924	 	1971	 	 	 	 	 	 	 	 	16924	 	1086.00	1086.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16924\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee2f9f-cf1e-11e9-9a07-0a80fada099c	C3N-02002		2c4daa82-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-27900	 	1940	 	 	 	 	 	 	 	 	27900	 	355.00	355.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27900\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee30c8-cf1e-11e9-9a07-0a80fada099c	C3N-02003		2c565ff7-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20728	 	1960	 	 	 	 	 	 	 	 	20728	 	353.00	353.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20728\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee31ed-cf1e-11e9-9a07-0a80fada099c	C3N-02067		2c5d1f6b-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-13731	 	1979	 	 	 	 	 	 	 	 	13731	 	1081.00	1081.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-13731\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee331b-cf1e-11e9-9a07-0a80fada099c	C3N-02087		2c6383d9-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Dead	-22433	303	1956	2018	 	 	 	 	 	 	 	22433	 	303.00	303.00	 	With tumor	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T2a	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":\"303\",\"days_to_birth\":\"-22433\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee343a-cf1e-11e9-9a07-0a80fada099c	C3N-02089		2c6a4673-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-27910	 	1941	 	 	 	 	 	 	 	 	27910	 	403.00	403.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-27910\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee355d-cf1e-11e9-9a07-0a80fada099c	C3N-02145		2c70cbe0-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-24986	 	1949	 	 	 	 	 	 	 	 	24986	 	405.00	405.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IB	T2a	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-24986\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3682-cf1e-11e9-9a07-0a80fada099c	C3N-02149		2c771657-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23517	 	1953	 	 	 	 	 	 	 	 	23517	 	413.00	413.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23517\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee37a4-cf1e-11e9-9a07-0a80fada099c	C3N-02155		2c7db8f2-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-16568	 	1972	 	 	 	 	 	 	 	 	16568	 	423.00	423.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Lung, NOS	Lung, NOS	G3	Not Reported	 	 	 	M0	 	 	 	Unknown	N0	Stage IIB	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16568\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee38cb-cf1e-11e9-9a07-0a80fada099c	C3N-02158		2c8a2176-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-19855	 	1963	 	 	 	 	 	 	 	 	19855	 	423.00	423.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lung, NOS	Lung, NOS	G2	Not Reported	 	 	 	M0	 	 	 	Unknown	N2	Stage IIIA	T3	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-19855\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee39ee-cf1e-11e9-9a07-0a80fada099c	C3N-02379		2c90a691-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Dead	-20827	443	1960	2018	 	 	 	 	 	 	 	20827	 	429.00	443.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20827\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3b12-cf1e-11e9-9a07-0a80fada099c	C3N-02380		2c978d01-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-20483	 	1961	 	 	 	 	 	 	 	 	20483	 	1059.00	1059.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20483\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3c31-cf1e-11e9-9a07-0a80fada099c	C3N-02421		2c9deb9a-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-21515	 	1958	 	 	 	 	 	 	 	 	21515	 	1171.00	1171.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21515\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3d65-cf1e-11e9-9a07-0a80fada099c	C3N-02422		2ca588ab-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Dead	-20562	650	1961	2019	 	 	 	 	 	 	 	20562	 	552.00	650.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-20562\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3e8b-cf1e-11e9-9a07-0a80fada099c	C3N-02423		2cb1eef3-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-25686	 	1947	 	 	 	 	 	 	 	 	25686	 	695.00	695.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25686\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee3fad-cf1e-11e9-9a07-0a80fada099c	C3N-02424		2cc13a4f-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-23634	 	1952	 	 	 	 	 	 	 	 	23634	 	355.00	355.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-23634\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee40d4-cf1e-11e9-9a07-0a80fada099c	C3N-02433		2cd0766e-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-25140	 	1948	 	 	 	 	 	 	 	 	25140	 	1137.00	1137.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25140\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee41f0-cf1e-11e9-9a07-0a80fada099c	C3N-02529		2cdfff0c-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Dead	-29049	849	1938	2019	 	 	 	 	 	 	 	29049	 	664.00	849.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Middle lobe, lung	Middle lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-29049\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4315-cf1e-11e9-9a07-0a80fada099c	C3N-02572		2cef0210-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-18003	 	1968	 	 	 	 	 	 	 	 	18003	 	1135.00	1135.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-18003\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4435-cf1e-11e9-9a07-0a80fada099c	C3N-02582		2cfe3edc-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-28227	888	1940	2020	 	 	 	 	 	 	 	28227	 	802.00	888.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-28227\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee455a-cf1e-11e9-9a07-0a80fada099c	C3N-02586		2d0d8821-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-27040	30	1943	2017	 	 	 	 	 	 	 	27040	 	30.00	30.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Upper lobe, lung	Upper lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	Surgical Complications	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":\"-27040\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4684-cf1e-11e9-9a07-0a80fada099c	C3N-02587		2d1d4e06-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Female	Asian	Alive	-21789	 	1957	 	 	 	 	 	 	 	 	21789	 	1111.00	1111.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-21789\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee47a8-cf1e-11e9-9a07-0a80fada099c	C3N-02588		2d2c0fab-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Alive	-25225	 	1948	 	 	 	 	 	 	 	 	25225	 	1106.00	1106.00	 	Tumor free	8140/3	Adenocarcinoma, NOS	No	Lower lobe, lung	Lower lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-25225\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee48c6-cf1e-11e9-9a07-0a80fada099c	C3N-02729		2d3b6eb6-27a4-11ec-b712-0a4e2186f121	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Male	Asian	Dead	-16705	820	1971	2019	 	 	 	 	 	 	 	16705	 	694.00	820.00	 	With tumor	8140/3	Adenocarcinoma, NOS	Yes	Upper lobe, lung	Upper lobe, lung	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIA	 	7th	 	 	 	 	 	 	Unknown	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":\"-16705\"}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee49ee-cf1e-11e9-9a07-0a80fada099c	Internal Reference - Pooled Sample		2d4a8871-27a4-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	N/A	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4b27-cf1e-11e9-9a07-0a80fada099c	Normal Only IR		2d59cb9b-27a4-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4c54-cf1e-11e9-9a07-0a80fada099c	Taiwanese IR		2d690868-27a4-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4d80-cf1e-11e9-9a07-0a80fada099c	Tumor Only IR		2d7871bf-27a4-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee4ead-cf1e-11e9-9a07-0a80fada099c	WHIM-P93		aed6da5e-ba22-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1ee500a-cf1e-11e9-9a07-0a80fada099c	WHIM-P94		aed6dc1a-ba22-11ea-b1fd-0aad30af8a83	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f1f7923f-f867-4950-ae41-c65a1bd9eb04	CU-16		6a8fa224-a92d-4332-869e-1ab0d7763b1c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	69	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Colon, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f209fb00-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12T		ff2f38f9-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	 	 	1967	 	 	 	 	 	 	 	 	 	Not Reported	0.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f293c3e0-5589-49d3-afd2-3bfc9b0c9a5c	13280		54b6a984-e91f-4d20-bc90-06d02351fd76	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	55	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f294b8c4-63d7-11e8-bcf1-0a2705229b82	TCGA-42-2590		ff2e6e85-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-20965	317	1952	 	 	 	 	 	 	 	 	20965	Not Reported	227.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IV	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2009	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f2cbeec4-baa8-4e6c-b61b-11166d5438c7	C3L-02399		cf7d9fc7-38a3-405e-9435-59887b1681a8	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-14	Not Reported	Female	White	Alive	-26413	 	1945	 	 	 	 	 	 	 	 	26413	 	1121.00	1121.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f343a3fa-f425-4b0b-b784-d14881ac869d	PDAC007		83ad302f-be31-4388-b02e-175139dbbef4	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	839.00	839.00	334.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f35034a7-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12U		ff3196bf-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-17045	 	1964	 	 	 	 	 	 	 	 	17045	Not Reported	385.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f35f1a07-ac40-4e9b-9260-bc555c01b4d5	C3L-02553		ad318d50-e2af-4360-a7f5-841ac7a2f0f4	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Alive	-20920	 	1960	 	 	 	 	 	 	 	 	20920	 	1793.00	1793.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f3c29dab-039e-4ead-b074-a75d30dd4a36	C3L-02201		b04ebc68-d065-4c4f-96ea-2c3f4be9cb62	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	White	Alive	-24924	 	1949	 	 	 	 	 	 	 	 	24924	 	1067.00	1067.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f3d461cc-63d7-11e8-bcf1-0a2705229b82	TCGA-59-2348		ff2d943d-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	 	 	1935	 	 	 	 	 	 	 	 	 	Not Reported	5481.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1994	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f3f4d99e-152f-4e65-8eef-6521081b1ba7	C3L-05848		cedce418-9e0c-4d2a-8b08-7d8eaf29a4f5	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-12	Not Hispanic or Latino	Female	White	Dead	-25797	153	1948	2019	 	 	 	 	 	 	 	25797	 	153.00	153.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IVB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2019	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f40fb1ed-230f-497a-bf2a-0cc032d47aa9	C3L-02392		1f00f01f-9c52-4968-9df4-0044a355f5eb	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-51	Not Reported	Female	White	Alive	-21470	 	1958	 	 	 	 	 	 	 	 	21470	 	966.00	966.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f41ad01e-3bc0-4520-ae7f-e69dd205901b	PDAC138		f033de05-305e-4e47-86eb-6e46b6a7a47f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27010	 	456.00	456.00	42.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f46d8b34-63d6-11e8-bcf1-0a2705229b82	17OV033		ff30f325-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	American Indian or Alaska Native	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Not Reported/Unknown	 	 	Yes	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f48ec6e9-5efc-41a8-8fa4-4508b31ef9c2	C3L-02897		5c015dd2-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Alive	-29507	 	1937	 	 	 	 	 	 	 	 	29507	Not Reported	256.00	256.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f49043f6-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12V		ff2f2f7e-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-20346	 	1955	 	 	 	 	 	 	 	 	20346	Not Reported	385.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f4c7d3bb-f214-4fb6-b2d7-bc173b715220	C3L-02115		5b94bd04-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-29237	723	1937	2019	 	 	 	 	 	 	 	29237	Not Reported	723.00	723.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f4da9ff8-fd5d-4793-9214-8cda7b221ebb	JX0244		4857bd91-b2b3-4d5b-8691-852698562ba0	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f4dff951-f359-40af-aa22-71b4b4c24e5a	AP-VLXG		edff2cd9-28f0-4429-8923-1b4e455d01a1	 	Qualified	Lung Adenocarcinoma	Bronchus and lung			Unknown	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	19723	 	1825.00	 	 	Not Reported	8140/3	Adenocarcinoma, NOS	Yes	Lower lobe, lung	Lung, NOS	G3	Stage IIIA	 	 	 	 	 	 	 	M0	N2	Stage IIIA	T2a	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
f5242085-63d7-11e8-bcf1-0a2705229b82	TCGA-59-2351		ff2d6153-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	 	 	1948	 	 	 	 	 	 	 	 	 	Not Reported	3532.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	1999	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f554b94d-dc6a-4d43-82c6-365a3a69570c	C3L-02856		f0b68fd0-b162-415f-8d15-3863c0a3f557	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	13	Not Reported	Female	White	Alive	-32731	 	1928	 	 	 	 	 	 	 	 	32731	 	15.00	15.00	 	Unknown tumor status	8312/3	Renal cell carcinoma, NOS	Not Reported	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f569d994-6edf-4471-9227-d0fed6a0df18	15-00701		9dc86999-342a-436e-b24e-b3d89df3f6ff	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Dead	-18316	302	 	 	50	 	 	false	Medical Record	 	United States	18316	 	302.00	302.00	115.00	With tumor	Not Reported	Acute myeloid leukemia, minimal differentiation	Yes	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f5719333-bb76-4355-b59b-a35510350492	MB091		7b1f5f1f-0d43-441f-ae1d-c3ba02ba304e	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	5475	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M3	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
f581075d-1b69-4812-9fe4-2bde4aad8bf2	OSCC_38		be6c0a43-9ca3-4b25-bc58-d2bc278642e7	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Tongue, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
f5cb2682-d250-4727-834c-222c47662412	WHIM12		7d53bf5c-b859-4c6f-946c-e992d017766d	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
f5ccbe11-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12W		ff30ef49-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-18140	 	1961	 	 	 	 	 	 	 	 	18140	Not Reported	385.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIIB	T4	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f60c0cf2-0b8a-4c81-a125-662367790ce9	MDA-01		529af03a-0b44-41b3-9cd9-803279b613fb	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	69	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f610bc43-1189-11e9-afb9-0a9c39d33490	C3L-00356		046d25e5-27be-11ec-b712-0a4e2186f121	 	Disqualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Dead	-26668	1351	1943	2020	 	 	 	 	 	 	 	26668	Not Reported	1351.00	1351.00	934.00	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Cancer Related	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f61365bc-8ba9-4de8-9c11-368e75d272ba	C3N-02431		8c79e3db-6ffc-4b70-a84c-b1502eee34c6	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	Asian	Alive	-17309	 	1970	 	 	 	 	 	 	 	 	17309	 	1070.00	1070.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f61386d0-dcb2-4d44-adf7-7b2cdae98b7c	C3N-03754		60230a35-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-16266	815	1973	2020	 	 	 	 	 	 	 	16266	Not Reported	767.00	815.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f62ac819-d30a-41c3-adf7-40243db4b068	4050		43f71f52-48c3-4309-8729-8b8461c7dca9	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	78	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f636bb3a-687b-457b-bad9-10a2b759eabb	7924		eb1d0e41-e79c-49a0-ad67-43427393fcc8	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	80	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f665049e-63d7-11e8-bcf1-0a2705229b82	TCGA-59-2352		ff2da3a1-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	 	286	1924	2002	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2002	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f6a031f1-4c5a-48bd-89ba-fd410c52c663	PDAC263		ea1e2a7b-18df-4130-b934-1bf46b3bb197	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	21170	 	282.00	282.00	254.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f6d401bb-8001-4157-a2ff-82fc946ba933	C3N-00709		5de7d82f-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Hispanic or Latino	Male	White	Not Reported	 	 	1935	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Pancreas, NOS	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Not Reported	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f6ec2b0d-cb36-4c41-8b7e-3c5d5a5fba83	C3N-01830		5292cb48-3977-4955-8914-812299a6a121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-35	Not Reported	Female	Other	Alive	-26812	 	1943	 	 	 	 	 	 	 	 	26812	 	716.00	716.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f70a83c6-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A12Z		ff2bcd70-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-16508	 	1965	 	 	 	 	 	 	 	 	16508	Not Reported	382.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f7558b71-faed-47a9-87e7-b71813be4cab	14-00127		21f00e48-1643-4d89-9491-577dfc5362ca	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Male	White	Dead	-13781	207	 	 	37	 	 	false	Medical Record	 	United States	13781	 	207.00	207.00	 	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f777c0f1-e13a-4b07-9a07-97a44e6f43a3	C3N-01871		4375737a-6709-45b6-b2b6-918908c8be5f	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	14	Not Reported	Female	White	Alive	-28366	 	1939	 	 	 	 	 	 	 	 	28366	 	1412.00	1412.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f77f177d-411b-4038-9a09-2301a4032044	NTN046		2cfbe277-b8b2-4d2a-bee1-342a024aa5b6	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f78c3797-dd47-4d93-aacd-1d406cfcf36e	C3L-02116		5ba3feb0-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	-24692	1063	1949	2020	 	 	 	 	 	 	 	24692	Not Reported	1024.00	1063.00	673.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Body of pancreas	Body of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f7a2ad1e-63d7-11e8-bcf1-0a2705229b82	TCGA-59-2372		ff2d7980-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	 	1363	1932	2008	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2005	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f81f0851-dc81-4c8f-b7d7-94f40c542b26	MB269		0b8019a8-19b5-4b76-bdf6-f29932f9ac56	 	Qualified	Pediatric/AYA Brain Tumors	Brain			Unknown	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	3285	 	 	 	 	Not Reported	Unknown	Medulloblastoma, NOS	unknown	Unknown	Unknown	Unknown	M2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Broad	Broad Institute
f83c359b-a08e-4403-a88a-ce41eb58bda9	17-00093		260555cd-4ffa-4ecf-9204-ebf958604b46	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Black or African American	Unknown	-15745	 	 	 	43	 	 	false	 	 	United States	15745	 	35.00	 	 	Unknown tumor status	Not Reported	Acute myeloid leukemia, NOS	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f84e09f9-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A130		ff2b7ce5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-19117	 	1958	 	 	 	 	 	 	 	 	19117	Not Reported	370.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T3	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f86d2084-8fc6-4835-ae08-3bcfde9b8e9f	C3L-02842		4ebe6e16-5759-4079-9f11-36df8e57b34a	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Reported	Female	White	Alive	-24927	 	1949	 	 	 	 	 	 	 	 	24927	 	1112.00	1112.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f8e64f02-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1724		ff2c0995-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-17168	637	1960	2008	 	 	 	 	 	 	 	17168	Not Reported	637.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f9149c15-2d78-4d42-815b-53fdbef4ed6b	C3L-01036		5a8080b9-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-23457	881	1953	2019	 	 	 	 	 	 	 	23457	Not Reported	1247.00	881.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f91c655f-1189-11e9-afb9-0a9c39d33490	C3L-00358		0475f448-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-32872	 	1926	 	 	 	 	 	 	 	 	32872	Not Reported	164.00	164.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"lost to follow-up\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f91df0ed-73ba-402f-8ca6-18aaaf557625	71		5fe044c5-f14d-4a72-b58d-00c4258d95ea	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f91df0ed-73ba-402f-8ca6-18aaaf557625	71		8fbd619e-e8b6-4178-bba0-d5b54ca7cbd7	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	72	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G2	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f923570b-d47a-4574-9b2a-0a1f0986e847	PDAC223		cad71c21-a4f6-4339-aff1-ff018c7b96df	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Alive	 	 	 	 	 	 	 	 	 	 	 	24090	 	1239.00	1239.00	1239.00	Tumor Free	8500/3	Pancreatic endocrine tumor, malignant	No	Not Reported	Pancreas, NOS	Not Reported	Stage I	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Alive\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f946f751-b5ac-4940-b869-accbc3765257	C3N-02637		70310c5d-483b-487b-9634-637a075aab50	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	1	Not Reported	Female	White	Alive	-19558	 	1964	 	 	 	 	 	 	 	 	19558	 	1401.00	1401.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f9687f24-63d6-11e8-bcf1-0a2705229b82	17OV040		ff312360-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Not Reported	 	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	8441/3	Serous adenocarcinoma, NOS	Not Reported	Not Reported	Ovary	Not Reported	Stage IIIC	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Confirmatory	Clinical Proteomic Tumor Analysis Consortium
f98c2cb5-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A131		ff31813f-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-29966	 	1928	 	 	 	 	 	 	 	 	29966	Not Reported	411.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
f998e351-96b1-4f92-9b0d-ccc02fdaa29d	PDAC063		192b4e01-330a-4e40-99c9-8b62a88bff77	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	27375	 	226.00	226.00	125.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f99dcf8b-7dff-4150-9871-e484d9cdc646	PDAC260		a14e7a63-840f-4b50-a7a9-030937f49776	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	28835	 	1011.00	1011.00	563.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
f9ee7fef-2289-4046-9a9e-73a12f522e53	11		0b28cd63-fdaf-4495-a7d2-210d665f0e32	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	77	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
f9f676ce-fe0c-4c60-9216-a61f4066b99d	PDAC057		bef31e9b-25d8-4f26-a2f4-6c07612b9f0f	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Asian	Dead	 	 	 	 	 	 	 	 	 	 	 	26280	 	354.00	354.00	191.00	Distant met recurrence/progression	8500/3	Pancreatic endocrine tumor, malignant	Yes	Not Reported	Pancreas, NOS	Not Reported	Stage II	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Dead\",\"days_to_death\":null,\"days_to_birth\":null}	Proteogenomics Analysis to Develop Precision Medicine for Treatment-Resistant Pancreatic Cancer	International Cancer Proteogenome Consortium
fa05727b-01b1-48c3-9b1d-93d2a1cc0cef	C3L-01665		426904a2-d876-4864-a08e-1d001db3d243	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	0	Not Hispanic or Latino	Male	White	Dead	-24663	1175	1949	2020	 	 	 	 	 	 	 	24663	 	1170.00	1175.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fa22022f-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1727		ff2e93d5-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-27203	 	1933	 	 	 	 	 	 	 	 	27203	Not Reported	564.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2007	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
faca7c9c-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A134		ff313239-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-19010	 	1958	 	 	 	 	 	 	 	 	19010	Not Reported	383.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fae3dcf4-0303-4d82-8be4-c388ab49e7e6	C3N-03006		5f3787ea-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Alive	-23492	 	1953	 	 	 	 	 	 	 	 	23492	Not Reported	708.00	708.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fb05051c-d318-464c-a4b6-06c3558ab79e	H36960-018		4f2fbe31-a017-4c33-84b6-11e306ee056a	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Asian	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fb0acaa6-876d-4fb1-8cc1-d301a72bff28	C3N-02631		a772dfce-03ed-4343-bfc5-82787d3d94b1	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	3	Not Reported	Female	White	Alive	-28135	 	1940	 	 	 	 	 	 	 	 	28135	 	1425.00	1425.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Endometrium	Endometrium	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage II	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Multifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fb24b127-337a-407c-b22c-9ae110971499	7339		abd6b830-dd2a-4cd5-87a3-241e3a8896b1	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	61	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	IV	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fb305e6f-1189-11e9-afb9-0a9c39d33490	C3L-00361		047cf0f5-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-23458	 	1952	 	 	 	 	 	 	 	 	23458	Not Reported	1707.00	1707.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Endometrium	Endometrium	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fb3935ed-d07e-41b9-9347-14e72af3210a	8		b4261575-4828-4c14-bb7d-0d8c5869b85d	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	69	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fb3ea6ea-190c-4acd-8302-d3121e8ffc2b	50		761287b9-cdd3-4329-b8b8-532b48f6e576	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	86	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fb5f829f-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1741		ff2ef080-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Dead	-27762	1024	1928	2006	 	 	 	 	 	 	 	27762	Not Reported	1024.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2004	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fb670370-be43-4608-83d2-f2ae18484b28	C3N-01843		400523c6-5de0-40a7-8042-d0548e88ec0c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-36	Not Reported	Female	Other	Alive	-25136	 	1948	 	 	 	 	 	 	 	 	25136	 	738.00	738.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fbabfdb8-3113-4086-af3a-35cfec53009d	C3L-03467		f0d8e57f-8977-4346-b25b-f4d3ce87501c	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-18	Not Hispanic or Latino	Female	White	Alive	-26781	 	1944	 	 	 	 	 	 	 	 	26781	 	410.00	410.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIC1	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fbc79ab1-bbfe-40bb-8854-3b3072cf53fc	C3L-02841		6bb66d38-48dd-47a0-91fe-df41f9cffde1	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	10	Not Reported	Male	White	Alive	-22011	 	1957	 	 	 	 	 	 	 	 	22011	 	1062.00	1062.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G4	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fbe0c8fa-12b4-4c24-86c6-b57085bdd95b	WHIMIR		1e810132-b291-4dc3-9ae8-5d1c3f28eed5	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
fbe4f529-26b6-4203-9f83-4a0405c9cf74	6		36d1d2f5-ab12-497d-a3e8-021068153b2a	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	68	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Ovary	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fbf58ac5-2c80-45d7-9eca-ac9aa92a979f	4968		d1294788-846b-423d-9b47-b16a94561fba	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	63	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fbf8485f-63d5-4027-ba04-648297745a75	WHIM 04		72322f48-3eb9-48dc-bde3-728cc050fa15	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2-Other	Clinical Proteomic Tumor Analysis Consortium
fc0205dc-9920-44e2-939e-e8bd7c2737ae	NX030		0ef3b35c-5b66-4d83-81ab-c1524446319d	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fc08d3b9-1ea0-4926-922e-d4f4d4a77767	C3L-03635		5c79a1a8-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	Other	Dead	-23274	854	1954	2020	 	 	 	 	 	 	 	23274	Not Reported	854.00	854.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Tail of pancreas	Tail of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fc0ec4a7-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A135		ff2bba76-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-23667	 	1946	 	 	 	 	 	 	 	 	23667	Not Reported	393.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N1	Stage IIB	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fc14681f-89d3-4f29-a644-cd78fb3aff02	C3N-02372		f64e882f-da61-44a8-a118-757afe551dce	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	-31	Not Reported	Female	Other	Alive	-19828	 	1963	 	 	 	 	 	 	 	 	19828	 	818.00	818.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fc1d46fb-2394-4f4d-a94c-5d06256a810d	NTN038		df784441-6649-466d-901b-5ead59f8e1d9	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	White	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fc5b03d9-405b-4514-9a4b-4b64761c48fd	C3L-02606		5bd807ea-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	Other	Dead	-25148	403	1948	2018	 	 	 	 	 	 	 	25148	Not Reported	403.00	403.00	251.00	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Yes	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fc9d336a-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1900		ff2c7693-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Black or African American	Alive	-18963	 	1957	 	 	 	 	 	 	 	 	18963	Not Reported	176.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIB	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2008	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fcfe466a-ca53-4a30-94b1-f071130286db	C3N-03440		5feeea8d-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Alive	-19891	 	1963	 	 	 	 	 	 	 	 	19891	Not Reported	315.00	315.00	 	Unknown tumor status	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R1	 	2018	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fd439626-0a37-4700-ae6b-c564c8e016c6	16-01253		f7a25fbb-d163-49e8-90b2-ada04ac78231	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Not Hispanic or Latino	Female	White	Alive	-14111	 	 	 	38	 	 	false	 	 	United States	14111	 	1586.00	1586.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fd4c139d-63d8-11e8-bcf1-0a2705229b82	TCGA-C8-A138		ff310861-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	Asian	Alive	-20053	 	1956	 	 	 	 	 	 	 	 	20053	Not Reported	380.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIIA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N2	Stage IIIA	T2	6th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fd688ca2-82e1-4a6e-95b6-e7c78f273b97	C3L-01951		8d70ddb5-ca77-46fa-89b5-5ccaa0de24f9	 	Qualified	Clear Cell Renal Cell Carcinoma	Kidney	Informed Consent	8	Not Reported	Male	White	Alive	-18722	 	1966	 	 	 	 	 	 	 	 	18722	 	398.00	398.00	 	Tumor free	8312/3	Renal cell carcinoma, NOS	No	Kidney, NOS	Kidney, NOS	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fd785cee-89b5-404a-9d5a-f6608db928e7	C3L-01672		6b35e317-8887-4a2e-a022-980842d46a9e	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Hispanic or Latino	Female	White	Alive	-19576	 	1963	 	 	 	 	 	 	 	 	19576	 	1001.00	1001.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIIA	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	RX	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fd9b930b-debe-4c99-8a0e-23b2c424b836	NTN080		efbb12d5-bbc6-42f3-8a5e-b71b28503aac	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Other	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fda378ef-6b26-4983-b9ad-5f7fdc178d4d	14-00359		6dec8421-5b0b-4f25-9b1b-72971ca5a0f1	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	Unknown	Alive	-21314	 	 	 	58	 	 	false	 	 	United States	21314	 	1250.00	1250.00	 	Tumor free	Not Reported	Acute myeloid leukemia, inv(16)(p13;q22)	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fdc414bb-04a1-4990-8921-baa6c205f1a9	C3N-03430		5fd02d3d-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-19939	39	1963	2018	 	 	 	 	 	 	 	19939	Not Reported	30.00	39.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IV	 	8th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R2	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fdcf8b88-8aa6-42f8-a422-6874afebae9d	AP-Q7SA		225d4792-07ff-4b7a-b84b-d46613f2f6e6	 	Disqualified	Lung Adenocarcinoma	Bronchus and lung			Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	APOLLO1	Applied Proteogenomics OrganizationaL Learning and Outcomes - APOLLO
fde688bb-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1907		ff2c27ce-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-23204	 	1943	 	 	 	 	 	 	 	 	23204	Not Reported	952.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fdf5a66b-89af-467f-b6d1-26a5821bf22c	C3N-00520		3e689ccd-8fb4-406a-a489-8d5aaa282264	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	13	Not Reported	Female	White	Dead	-21463	1239	1957	2020	 	 	 	 	 	 	 	21463	 	1169.00	1239.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Fundus uteri	Endometrium	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage III	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fdfb2d41-b56d-43b2-8817-b1a30058d47d	CU-23		8044115d-e42f-48c1-a530-356c1278bb4c	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Reported	Female	Black or African American	 	 	 	 	 	 	 	 	 	 	 	 	57	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Peritoneum, NOS	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fdfb73d7-a1c1-4c3a-8a7b-bb9157af50d2	C3N-01165		5e1c4dad-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Female	White	Dead	-23060	241	1953	2017	 	 	 	 	 	 	 	23060	Not Reported	241.00	241.00	 	With tumor	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	M0	 	 	 	M0	N1	Stage III	T3	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fe090773-9de2-4fbb-b832-7cc057bc1862	C3L-00086		89146637-44ef-419d-baef-e8621b5d0913	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS	Informed Consent	0	Not Hispanic or Latino	Female	White	Dead	-20790	1578	1959	2020	 	 	 	 	 	 	 	20790	 	1578.00	1578.00	 	With tumor	8380/3	Endometrioid adenocarcinoma, NOS	Yes	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	 	 	 	 	 	 	Stage I	 	7th	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fe0c8f04-c46e-4252-812d-d70e34bfe984	62		6a79736d-785c-4f6d-a7d7-68b542c7a778	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	58	Metastasis	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Connective, subcutaneous and other soft tissues of abdomen	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	FALSE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
fe3b4978-c450-4943-bf87-e5974562f62f	C3L-02112		5b85800e-2b80-11ec-b712-0a4e2186f121	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas			Not Reported	Male	White	Dead	-24455	1747	1950	2022	 	 	 	 	 	 	 	24455	Not Reported	1747.00	1747.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G2	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	8th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	0	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":null,\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fe3bc4e6-ecc4-11e9-81b4-2a2ae2dbcce4	Ref		090ce1bf-27be-11ec-b712-0a4e2186f121	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"Not Reported\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fe883733-63d8-11e8-bcf1-0a2705229b82	TCGA-D8-A13Y		ff2fd443-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-19028	 	1958	 	 	 	 	 	 	 	 	19028	Not Reported	1728.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IA	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IA	T1c		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
fe9f9137-1189-11e9-afb9-0a9c39d33490	C3L-00362		048b3ba2-27be-11ec-b712-0a4e2186f121	 	Qualified	Uterine Corpus Endometrial Carcinoma	Uterus, NOS			Not Hispanic or Latino	Female	White	Alive	-14058	 	1978	 	 	 	 	 	 	 	 	14058	Not Reported	1745.00	1745.00	 	Tumor free	8380/3	Endometrioid adenocarcinoma, NOS	No	Corpus uteri	Corpus uteri	G1	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Stage I	Not Reported	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	R0	Not Reported	2016	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	{\"cause_of_death\":null,\"vital_status\":\"alive\",\"days_to_death\":null,\"days_to_birth\":null}	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
fea28bab-ee73-49f6-908f-001fba904960	3812		7065063e-219e-4335-bc3b-80c30009f2a0	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	52	Primary	 	 	 	Not Reported	8441/3	Not Reported	Not Reported	Fallopian tube	Not Reported	G3	III	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	{\"micropapillary_features\":null,\"mitotic_count\":null}	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ff01e476-7788-4169-b0c3-c1326df53754	14-00240		57b822fc-51a3-4e65-a42b-3bd8e28e39ef	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Female	Unknown	Dead	-28566	37	 	 	78	 	 	false	Medical Record	 	United States	28566	 	37.00	37.00	 	With tumor	Not Reported	Acute myeloid leukemia with multilineage dysplasia	No	Blood	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Cancer Related	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
ff073c3d-e1b2-4baf-a817-7101fd29ab41	BCN 1358		10b8e974-f290-4912-9646-a38dd1d17297	 	Qualified	Breast Invasive Carcinoma	Breast			Not Reported	Female	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3-Other	Clinical Proteomic Tumor Analysis Consortium
ff24e095-63d7-11e8-bcf1-0a2705229b82	TCGA-61-1910		ff2c113a-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Ovarian Serous Cystadenocarcinoma	Ovary			Not Hispanic or Latino	Female	White	Alive	-20779	 	1950	 	 	 	 	 	 	 	 	20779	Not Reported	1127.00	 	 	Not Reported	8441/3	Serous cystadenocarcinoma, NOS	Not Reported	Ovary	Ovary	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported		Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Stage IIC	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2006	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ff40730d-1fb9-11e9-b7f8-0a80fada099c	NCI7-1		910d4390-3040-11e9-8379-0a80fada099c	 	Qualified	Other	Not Reported			Not Reported	Not Reported	Not Reported	Not Reported	0	 	 	 	 	 	 	 	 	 	 	0	Not Reported	0.00	0.00	0.00	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	Not Reported	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	 	Not Reported	Not Reported	 	 	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ff5a631f-93b9-486e-beb9-d16737db8c9e	OSCC_58		107c25fa-4685-48e5-9f27-5d0316c67a4d	 	Qualified	Oral Squamous Cell Carcinoma	Head and Neck			Not Reported	Male	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	Not Reported	 	 	 	Not Reported	Not Reported	Not Reported	Not Reported	Not Reported	Gum, NOS	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Oral Squamous Cell Carcinoma - Chang Gung University	International Cancer Proteogenome Consortium
ffc0f05f-8915-4db9-ae61-f0cee8d80b2c	C3L-01032		f70c05d6-05ad-4e26-af22-c090bfbdeaf7	 	Qualified	Pancreatic Ductal Adenocarcinoma	Pancreas	Informed Consent	20	Not Reported	Female	Other	Dead	-19276	108	1964	2017	 	 	 	 	 	 	 	19276	Not Reported	108.00	108.00	 	Tumor free	8500/3	Infiltrating duct carcinoma, NOS	No	Head of pancreas	Head of pancreas	G3	Not Reported	 	 	 	 	 	 	 	 	 	Stage IIB	 	7th	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	R0	 	2017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	Unifocal	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	True	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC3 Discovery and Confirmatory	Clinical Proteomic Tumor Analysis Consortium
ffc8b74d-63d8-11e8-bcf1-0a2705229b82	TCGA-D8-A142		ff315ead-70ca-11e8-bcf1-0a2705229b82	 	Qualified	Breast Invasive Carcinoma	Breast			Not Hispanic or Latino	Female	White	Alive	-27313	 	1936	 	 	 	 	 	 	 	 	27313	Not Reported	425.00	 	 	Not Reported	8500/3	Infiltrating duct carcinoma, NOS	Not Reported	Breast, NOS	Breast, NOS	Not Reported	Stage IIB	 	 	No	Not Reported	Not Reported	Not Reported	Not Reported	M0	N0	Stage IIB	T3	7th	Not Reported	Not Reported	Not Reported	Not Reported	 	Not Reported	 	--	--	 	0	--	--	Not Reported	--	--	--	Not Reported	Not Reported	--	--	--	Not Reported	Not Reported	--	--	 	Not Reported	No	 	 	Not Reported	Not Reported	2010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	CPTAC2 Retrospective	Clinical Proteomic Tumor Analysis Consortium
ffcc7499-e355-4b45-8359-55e00a9a8fa8	16-00278		18f049e9-9fd7-4283-8c84-83af67d4b9c8	 	Qualified	Acute Myeloid Leukemia	Hematopoietic and reticuloendothelial systems	Informed Consent		Unknown	Male	White	Alive	-23431	 	 	 	64	 	 	false	 	 	United States	23431	 	636.00	636.00	 	Tumor free	Not Reported	Acute myeloid leukemia with mutated NPM1	No	Bone marrow	Bone marrow	Not Reported	Not Reported	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	TRUE	 	 	 	 	 	 	 	 	 	 	 	 	 	Proteogenomic Translational Research Centers (PTRC)	Clinical Proteomic Tumor Analysis Consortium
